data_5j18_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5j18 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.531 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 23.2 Cg_endo . . . . . 0 N--CA 1.462 -0.372 0 N-CA-C 111.504 -0.229 . . . . 0.48999999999999999 111.504 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.28 153.05 19.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.423 0.63 . . . . 1.3700000000000001 112.321 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -130.34 126.98 62.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.079 -0.964 . . . . 1.5900000000000001 109.248 173.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.626 ' HG2' HG13 ' A' ' 168' ' ' VAL . 52.8 mtm-85 -94.68 126.29 39.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.516 -0.766 . . . . 3.4199999999999999 110.739 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 222' ' ' LEU . 3.5 t -108.86 124.27 65.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.842 -0.617 . . . . 1.1000000000000001 111.15 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 25.3 m-85 -76.62 102.9 6.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 110.147 -0.316 . . . . 0.76000000000000001 110.147 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.542 HD22 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -63.02 161.36 31.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 121.071 0.463 . . . . 1.95 111.515 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 77.0 Cg_exo -47.71 153.19 2.43 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.291 2.661 . . . . 0.56000000000000005 111.783 168.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 4.6 m-20 70.76 18.15 6.31 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.78 0.432 . . . . 2.4199999999999999 110.804 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 67.48 36.46 3.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.941 -0.572 . . . . 3.1299999999999999 111.996 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -95.18 174.47 7.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.458 -0.942 . . . . 2.02 108.458 174.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.7 ttp180 -147.39 129.47 15.49 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.811 -0.755 . . . . 2.8300000000000001 111.953 175.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.542 ' HB ' HD22 ' A' ' 161' ' ' LEU . 12.5 t -107.99 175.9 5.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.48 -1.237 . . . . 0.92000000000000004 109.41 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.626 HG13 ' HG2' ' A' ' 158' ' ' ARG . 5.7 t -141.27 128.97 22.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.022 -0.733 . . . . 1.1899999999999999 109.022 172.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.416 HG21 ' CD1' ' A' ' 214' ' ' ILE . 6.4 m -124.94 137.45 29.64 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.892 -0.594 . . . . 1.77 109.619 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 50.0 Cg_exo -53.99 142.96 63.38 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.902 1.734 . . . . 0.82999999999999996 110.175 171.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.531 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -67.26 83.09 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.615 0.721 . . . . 0.34999999999999998 109.771 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.561 ' HB3' HG22 ' A' ' 175' ' ' VAL . 18.5 mmm180 -66.73 111.03 3.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.358 -1.292 . . . . 3.2799999999999998 111.134 -174.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 14.3 p -77.67 132.86 38.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 2.1899999999999999 110.43 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.42 17.75 79.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.608 -0.806 . . . . 0.42999999999999999 111.129 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 172' ' ' ARG . 34.2 t -121.89 133.19 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.247 0.546 . . . . 1.46 110.708 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.7 p -83.73 155.93 22.84 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.543 -0.753 . . . . 0.78000000000000003 110.593 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.672 ' O ' HD12 ' A' ' 181' ' ' LEU . 67.2 t -45.09 -47.37 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 123.33 0.394 . . . . 2.04 110.709 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 0.7 OUTLIER -49.6 -43.55 46.54 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 113.165 0.802 . . . . 4.25 113.165 -174.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.6 t70 -72.34 -50.76 24.4 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.803 0.811 . . . . 1.1899999999999999 109.824 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.4 p -61.56 -50.53 72.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.301 -1.318 . . . . 1.76 110.474 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.15 -5.75 54.55 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.28 -0.968 . . . . 1.5 113.174 -175.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.558 ' N ' HD11 ' A' ' 181' ' ' LEU . 18.0 ptpt -69.18 -31.31 69.84 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 117.845 -1.542 . . . . 1.6399999999999999 107.864 169.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.437 ' HD2' ' HE1' ' A' ' 187' ' ' MET . 0.0 OUTLIER -62.79 -44.49 96.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.466 -0.788 . . . . 2.2599999999999998 109.008 168.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -50.05 -50.32 48.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.639 -0.709 . . . . 0.79000000000000004 111.892 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.88 -52.06 67.37 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 2.2400000000000002 110.524 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.7 mmt -60.69 -25.8 66.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.935 -0.575 . . . . 2.1299999999999999 112.371 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.437 ' HE1' ' HD2' ' A' ' 183' ' ' LYS . 20.0 mmt -75.15 -18.01 60.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.126 0.489 . . . . 1.3 110.862 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.434 ' HD3' ' CB ' ' A' ' 165' ' ' GLN . 10.9 mmm180 -95.25 -21.11 18.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.579 0.704 . . . . 2.5600000000000001 109.679 171.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.95 10.86 36.04 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.897 -1.047 . . . . 0.53000000000000003 111.143 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.98 177.21 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 2.0499999999999998 110.685 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 16.5 pt -129.08 145.26 55.92 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.028 -0.533 . . . . 0.58999999999999997 111.079 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.777 ' HA ' ' SG ' ' A' ' 195' ' ' CYS . 61.4 Cg_endo -72.54 -4.19 14.83 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.381 2.721 . . . . 0.63 113.759 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.31 -49.76 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.939 0.4 . . . . 1.74 111.725 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 77.2 m -96.34 16.42 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.734 0.642 . . . . 2.3999999999999999 112.734 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.777 ' SG ' ' HA ' ' A' ' 192' ' ' PRO . 1.3 p -115.88 160.52 20.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 1.03 111.981 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.45 ' HA ' ' HE1' ' A' ' 210' ' ' TRP . . . -125.38 155.16 40.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.398 -0.819 . . . . 0.67000000000000004 109.292 169.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.494 HG23 ' CE2' ' A' ' 210' ' ' TRP . 17.6 t -117.39 122.07 69.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.372 0.606 . . . . 1.6200000000000001 111.097 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.526 ' HH ' ' HG3' ' A' ' 225' ' ' GLU . 50.6 p90 . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.222 -0.899 . . . . 2.8399999999999999 109.405 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.43 HD13 HG11 ' A' ' 197' ' ' VAL . 5.4 mt . . . . . 0 N--CA 1.447 -0.582 0 N-CA-C 110.291 -0.262 . . . . 1.6100000000000001 110.291 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.42 145.81 17.91 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.694 -0.765 . . . . 0.46000000000000002 111.229 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.656 ' CZ3' HD13 ' A' ' 181' ' ' LEU . 48.7 m95 -66.76 -16.05 63.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.166 0.508 . . . . 0.37 110.29 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 2.2999999999999998 110.769 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.59 ' O ' HG22 ' A' ' 177' ' ' VAL . 24.1 m -70.18 137.29 50.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.398 -0.364 . . . . 0.68999999999999995 110.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.03 116.16 10.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.432 -0.581 . . . . 1.73 109.432 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.416 ' CD1' HG21 ' A' ' 169' ' ' VAL . 7.7 tt -69.68 -20.86 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.292 0.479 . . . . 0.51000000000000001 112.292 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 81.6 p -71.0 -6.57 39.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 1.5800000000000001 111.261 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -91.73 -16.42 26.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.262 0.553 . . . . 4.6299999999999999 110.975 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.5 mp -99.41 11.93 37.75 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.077 0.941 . . . . 1.75 111.035 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.51 ' CG2' ' HB2' ' A' ' 155' ' ' PRO . 4.3 m -50.0 138.67 15.15 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.516 -1.674 . . . . 0.55000000000000004 113.293 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.41 -2.63 28.48 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.53000000000000003 112.798 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.561 ' O ' HG21 ' A' ' 157' ' ' VAL . 48.2 mt-10 -115.1 131.77 56.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.885 -0.413 . . . . 2.1600000000000001 109.885 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.7 mt-10 -83.4 136.08 34.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.717 0.77 . . . . 2.0299999999999998 111.032 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.489 ' HB2' HG11 ' A' ' 159' ' ' VAL . 54.1 mt -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.552 -1.204 . . . . 1.97 110.58 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -127.33 134.52 49.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.241 0.544 . . . . 3.3599999999999999 110.815 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.511 ' CG2' HD23 ' A' ' 181' ' ' LEU . 86.5 t -114.76 116.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.555 -0.748 . . . . 1.55 109.145 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.526 ' HG3' ' HH ' ' A' ' 198' ' ' TYR . 66.0 mm-40 -120.16 133.66 55.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.542 -0.754 . . . . 1.9399999999999999 109.925 -172.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 116.135 -0.484 . . . . 1.8600000000000001 111.092 -176.145 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.52 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 42.3 Cg_endo . . . . . 0 N--CA 1.458 -0.565 0 N-CA-C 111.736 -0.14 . . . . 0.48999999999999999 111.736 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.417 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 16.6 pt -143.13 143.94 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.175 0.512 . . . . 1.3700000000000001 111.545 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 220' ' ' GLU . 89.3 t -117.59 117.73 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.627 -0.879 . . . . 1.5900000000000001 108.627 170.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.544 ' HG2' HG13 ' A' ' 168' ' ' VAL . 87.4 mtm180 -97.28 113.62 25.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.039 -0.528 . . . . 3.4199999999999999 110.867 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 222' ' ' LEU . 24.3 t -99.04 126.54 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.214 -0.448 . . . . 1.1000000000000001 111.456 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 25.1 m-85 -78.25 101.05 6.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.647 -0.501 . . . . 0.76000000000000001 109.647 171.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 165' ' ' GLN . 0.4 OUTLIER -58.72 168.36 1.45 Allowed Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 122.553 0.341 . . . . 1.95 111.789 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 81.7 Cg_exo -47.12 149.44 3.63 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.915 2.41 . . . . 0.56000000000000005 111.449 167.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.83 8.22 6.65 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.709 0.766 . . . . 2.4199999999999999 109.22 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.671 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.83 48.44 16.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.153 -1.385 . . . . 3.1299999999999999 112.022 178.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.581 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 11.9 mm-40 -80.39 -176.91 5.91 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.628 -1.619 . . . . 2.02 106.628 166.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -147.56 131.09 16.75 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.56 -1.256 . . . . 2.8300000000000001 112.052 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.529 HG22 ' CB ' ' A' ' 184' ' ' ALA . 5.5 t -112.18 173.0 6.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.125 -1.398 . . . . 0.92000000000000004 108.988 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.544 HG13 ' HG2' ' A' ' 158' ' ' ARG . 3.3 t -139.37 129.08 30.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.818 -0.438 . . . . 1.1899999999999999 109.818 172.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.27 120.95 22.42 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.461 -0.79 . . . . 1.77 109.615 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 52.1 Cg_exo -50.22 135.28 38.35 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.008 2.472 . . . . 0.82999999999999996 111.454 174.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.88 105.96 0.52 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.34999999999999998 110.243 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.67 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 3.6 mmp_? -100.7 111.04 23.21 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 3.2799999999999998 111.31 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.83 123.82 26.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.76 -0.654 . . . . 2.1899999999999999 109.886 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 -7.69 59.29 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.683 -0.967 . . . . 0.42999999999999999 110.683 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 172' ' ' ARG . 53.7 t -103.7 128.54 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.215 0.531 . . . . 1.46 110.047 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 178' ' ' ARG . 25.5 p -78.08 156.63 29.89 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.528 -0.76 . . . . 0.78000000000000003 110.062 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.659 ' O ' HD12 ' A' ' 181' ' ' LEU . 23.3 t -48.39 -43.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.851 -0.425 . . . . 2.04 109.851 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 1.3 ptm180 -53.56 -47.01 70.45 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 112.726 0.639 . . . . 4.25 112.726 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.479 ' HB3' HG11 ' A' ' 175' ' ' VAL . 21.0 t70 -68.12 -50.25 55.91 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.698 0.761 . . . . 1.1899999999999999 109.875 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.1 p -59.62 -55.53 33.3 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.091 -1.413 . . . . 1.76 110.732 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.691 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -91.93 -2.5 56.75 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 118.78 -1.168 . . . . 1.5 113.334 -174.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.514 ' N ' HD11 ' A' ' 181' ' ' LEU . 18.5 ptpt -70.95 -32.76 69.74 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 117.989 -1.485 . . . . 1.6399999999999999 107.909 169.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -37.55 87.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.169 -0.678 . . . . 2.2599999999999998 109.169 169.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -52.04 -52.52 50.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.694 -0.23 . . . . 0.79000000000000004 111.283 173.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.74 -52.23 65.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.798 0.333 . . . . 2.2400000000000002 110.59 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 17.6 mmt -62.79 -22.37 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.667 0.617 . . . . 2.1299999999999999 112.667 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 18.1 mmt -71.65 -38.22 70.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.823 0.345 . . . . 1.3 110.207 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.504 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 11.8 mmm180 -73.85 -23.6 59.64 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.519 0.676 . . . . 2.5600000000000001 109.685 172.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.77 9.52 37.43 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.022 -0.99 . . . . 0.53000000000000003 111.468 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.99 177.0 5.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.937 0.398 . . . . 2.0499999999999998 110.666 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 193' ' ' GLU . 41.1 pt -124.8 141.77 39.05 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.58999999999999997 110.776 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.415 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 60.9 Cg_endo -72.26 -10.01 25.13 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 123.242 2.628 . . . . 0.63 112.472 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.518 ' HB3' HD11 ' A' ' 191' ' ' ILE . 15.4 tt0 -54.57 -48.01 72.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.825 -0.625 . . . . 1.74 111.301 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 83.7 m -102.3 25.78 8.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.49 -0.777 . . . . 2.3999999999999999 111.173 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.547 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 78.0 m -131.79 151.41 51.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.555 -0.293 . . . . 1.03 110.764 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.35 158.67 30.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.402 -0.592 . . . . 0.67000000000000004 109.402 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.404 HG11 HD13 ' A' ' 208' ' ' ILE . 41.4 t -112.22 134.67 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.895 0.855 . . . . 1.6200000000000001 112.474 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--N 1.316 -0.855 0 CA-C-N 114.17 -1.377 . . . . 2.8399999999999999 109.913 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 209' ' ' GLY . 16.3 mt . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.125 0.488 . . . . 1.6100000000000001 111.304 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -97.51 145.53 17.86 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.884 -0.887 . . . . 0.46000000000000002 110.884 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.573 ' CZ3' HD13 ' A' ' 181' ' ' LEU . 62.0 m95 -70.73 -18.39 62.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.951 0.405 . . . . 0.37 110.791 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -89.58 -5.78 56.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 2.2999999999999998 110.387 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.436 ' O ' HG21 ' A' ' 177' ' ' VAL . 98.0 m -69.34 146.6 52.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.68999999999999995 110.071 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.455 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 12.1 t70 -79.1 129.8 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.851 -0.426 . . . . 1.73 109.851 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.87 -21.68 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.832 0.348 . . . . 0.51000000000000001 111.759 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 44.6 t -75.85 -7.75 55.24 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.098 -0.376 . . . . 1.5800000000000001 110.399 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 13.0 m0 -82.36 -11.12 58.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.385 0.612 . . . . 4.6299999999999999 109.586 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 220' ' ' GLU . 18.8 mt -114.54 6.87 15.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.468 -0.787 . . . . 1.75 110.385 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.457 HG23 ' HB2' ' A' ' 155' ' ' PRO . 21.1 m -42.94 134.71 3.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.091 0.774 . . . . 0.55000000000000004 113.091 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 71.36 12.68 73.14 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.87 -0.605 . . . . 0.53000000000000003 112.266 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.46 ' O ' HG11 ' A' ' 157' ' ' VAL . 7.5 tp10 -115.33 141.21 48.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.956 -0.387 . . . . 2.1600000000000001 109.956 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.9 123.07 33.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 2.0299999999999998 110.123 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.402 ' HB2' HG21 ' A' ' 159' ' ' VAL . 8.7 mp -99.29 170.5 8.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.625 -0.716 . . . . 1.97 110.121 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -149.0 130.25 14.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.509 -0.552 . . . . 3.3599999999999999 109.509 174.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 47.3 t -98.57 135.37 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.105 -0.498 . . . . 1.55 110.794 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -118.95 126.22 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.091 -0.958 . . . . 1.9399999999999999 110.231 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.421 . . . . 1.8600000000000001 111.384 -179.234 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.491 ' HB2' HG23 ' A' ' 218' ' ' THR . 95.9 Cg_endo . . . . . 0 C--O 1.236 0.384 0 N-CA-C 112.977 0.337 . . . . 0.48999999999999999 112.977 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.8 pt -140.13 154.75 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.696 -0.684 . . . . 1.3700000000000001 110.701 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.4 t -121.2 126.86 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 108.814 -0.81 . . . . 1.5900000000000001 108.814 172.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.499 ' CG ' HG13 ' A' ' 168' ' ' VAL . 11.1 mtp180 -102.9 107.03 17.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.401 -0.818 . . . . 3.4199999999999999 110.879 -174.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' A' ' 222' ' ' LEU . 3.5 t -97.44 125.56 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.471 -0.331 . . . . 1.1000000000000001 111.441 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -72.63 103.23 3.51 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.189 0.518 . . . . 0.76000000000000001 110.232 173.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.681 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 28.3 mt -56.86 155.02 16.24 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 1.95 110.963 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 62.8 Cg_exo -53.17 153.8 15.5 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.8 2.333 . . . . 0.56000000000000005 111.421 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 5.2 m-20 71.79 18.48 5.14 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.428 0.632 . . . . 2.4199999999999999 110.474 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.26 35.4 5.96 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.985 -1.007 . . . . 3.1299999999999999 112.558 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.681 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.5 mm100 -94.49 -179.62 4.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.602 -1.258 . . . . 2.02 107.602 171.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -147.24 138.33 23.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.871 -0.732 . . . . 2.8300000000000001 110.704 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.458 HG22 ' CB ' ' A' ' 184' ' ' ALA . 13.5 t -119.17 171.96 7.92 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.854 -1.066 . . . . 0.92000000000000004 109.042 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.499 HG13 ' CG ' ' A' ' 158' ' ' ARG . 3.1 t -141.17 129.82 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.748 -0.464 . . . . 1.1899999999999999 109.748 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.49 HG11 ' CD1' ' A' ' 214' ' ' ILE . 3.3 p -131.75 130.39 22.29 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.274 -0.875 . . . . 1.77 109.251 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -49.24 144.01 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.359 2.706 . . . . 0.82999999999999996 112.014 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.73 82.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.29 0.567 . . . . 0.34999999999999998 109.76 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.505 ' HB3' HG22 ' A' ' 175' ' ' VAL . 36.9 mmt180 -70.76 110.65 5.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.282 -0.872 . . . . 3.2799999999999998 110.82 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 32.3 m -80.45 118.35 21.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.651 -0.704 . . . . 2.1899999999999999 109.564 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.53 17.65 32.97 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.788 -0.925 . . . . 0.42999999999999999 110.788 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 179' ' ' ASP . 18.3 t -128.38 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.179 -0.51 . . . . 1.46 110.351 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.456 ' OG1' ' HG3' ' A' ' 178' ' ' ARG . 32.7 p -70.62 148.8 47.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.903 -0.59 . . . . 0.78000000000000003 109.872 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 181' ' ' LEU . 14.5 p -49.51 -37.71 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.888 -0.412 . . . . 2.04 109.888 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.628 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -57.94 -34.8 70.27 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.489 -0.778 . . . . 4.25 112.174 -173.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -77.02 -49.91 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.9 0.857 . . . . 1.1899999999999999 109.714 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -53.25 59.44 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.714 -1.13 . . . . 1.76 110.716 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -88.96 0.69 56.42 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.0 -1.08 . . . . 1.5 112.887 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.628 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 17.3 ptpt -69.05 -35.56 76.71 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.257 -1.377 . . . . 1.6399999999999999 107.736 167.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.495 ' HD2' ' HE1' ' A' ' 187' ' ' MET . 25.3 ttpt -65.15 -38.23 89.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.666 -0.814 . . . . 2.2599999999999998 109.26 171.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -48.92 -54.69 14.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.946 -0.301 . . . . 0.79000000000000004 110.631 172.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.76 -53.75 54.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.466 -0.334 . . . . 2.2400000000000002 111.045 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.89 -24.63 64.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.086 -0.506 . . . . 2.1299999999999999 112.291 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.495 ' HE1' ' HD2' ' A' ' 183' ' ' LYS . 12.4 mmt -78.19 -41.22 35.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.515 -0.55 . . . . 1.3 109.515 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.522 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 15.2 tpt180 -71.0 -18.12 62.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.695 -0.684 . . . . 2.5600000000000001 109.802 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.28 4.08 44.18 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.687 -0.688 . . . . 0.53000000000000003 112.824 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 190' ' ' LEU . 5.4 mp -102.18 175.29 5.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.94 0.4 . . . . 2.0499999999999998 111.543 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.439 HD11 ' HB2' ' A' ' 193' ' ' GLU . 46.5 pt -119.31 139.89 28.26 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.944 -0.571 . . . . 0.58999999999999997 110.381 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.457 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 55.6 Cg_endo -69.15 -14.3 37.77 Favored 'Trans proline' 0 N--CA 1.47 0.113 0 C-N-CA 123.348 2.699 . . . . 0.63 112.469 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.439 ' HB2' HD11 ' A' ' 191' ' ' ILE . 29.4 mt-10 -63.09 -37.04 85.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 1.74 110.846 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 75.7 m -101.42 17.3 23.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.954 -0.566 . . . . 2.3999999999999999 110.764 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.421 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 85.2 m -128.99 156.91 43.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.163 -0.471 . . . . 1.03 110.784 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -124.96 158.33 33.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.389 -0.597 . . . . 0.67000000000000004 109.389 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.43 HG23 ' CE2' ' A' ' 210' ' ' TRP . 96.1 t -106.88 139.09 29.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.782 0.801 . . . . 1.6200000000000001 111.792 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 114.229 -1.35 . . . . 2.8399999999999999 109.899 -178.615 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.887 0.375 . . . . 1.6100000000000001 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 141.47 17.7 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.719 -0.753 . . . . 0.46000000000000002 111.244 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.59 ' HA ' ' CG1' ' A' ' 177' ' ' VAL . 61.2 m95 -70.5 -12.91 61.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.731 0.301 . . . . 0.37 111.148 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.98 -12.91 40.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.492 . . . . 2.2999999999999998 110.116 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.6 m -60.8 127.97 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.68999999999999995 111.09 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 215' ' ' SER . 13.6 t70 -68.05 127.98 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 1.73 110.038 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.49 ' CD1' HG11 ' A' ' 169' ' ' VAL . 7.8 tt -68.53 -20.53 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.132 -0.486 . . . . 0.51000000000000001 112.153 -172.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.439 ' HB3' ' OD2' ' A' ' 213' ' ' ASP . 34.8 t -69.29 -11.73 61.06 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.112 -0.367 . . . . 1.5800000000000001 111.244 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -89.76 -17.97 27.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 4.6299999999999999 110.083 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 220' ' ' GLU . 33.4 mt -94.84 3.99 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 1.75 109.999 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 155' ' ' PRO . 58.4 m -43.07 139.78 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.55000000000000004 113.331 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.42 -8.67 46.03 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.368 -0.833 . . . . 0.53000000000000003 112.088 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 34.5 mm-40 -102.6 154.96 18.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.279 0.562 . . . . 2.1600000000000001 111.168 -175.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 35.5 mt-10 -101.39 124.09 46.51 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.342 -0.845 . . . . 2.0299999999999998 109.379 174.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.407 ' HB3' HG11 ' A' ' 159' ' ' VAL . 7.0 mp -96.01 173.38 7.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.948 -0.569 . . . . 1.97 110.218 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -137.99 135.21 35.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.15 -0.685 . . . . 3.3599999999999999 109.15 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.441 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 86.8 t -103.52 124.9 58.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.101 -0.64 . . . . 1.55 110.264 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -109.62 119.11 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.39 -0.823 . . . . 1.9399999999999999 108.801 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.324 -0.537 0 N-CA-C 109.718 -0.475 . . . . 1.8600000000000001 109.718 177.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.442 ' HB2' HG23 ' A' ' 218' ' ' THR . 71.6 Cg_endo . . . . . 0 N--CA 1.464 -0.224 0 N-CA-C 111.843 -0.099 . . . . 0.48999999999999999 111.843 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 20.7 pt -138.19 152.93 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 1.3700000000000001 111.628 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.3 t -124.69 129.82 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.734 -0.839 . . . . 1.5900000000000001 108.734 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.577 ' CG ' HG13 ' A' ' 168' ' ' VAL . 38.6 mtm-85 -101.51 123.01 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.855 -0.611 . . . . 3.4199999999999999 110.477 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 222' ' ' LEU . 40.8 t -108.23 127.77 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.415 -0.357 . . . . 1.1000000000000001 111.722 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -80.51 99.45 8.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.205 -0.665 . . . . 0.76000000000000001 109.205 170.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.7 OUTLIER -61.78 167.85 4.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.655 0.983 . . . . 1.95 113.655 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 73.7 Cg_exo -49.96 152.82 6.93 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.787 2.991 . . . . 0.56000000000000005 111.842 167.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.69 13.8 7.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.296 1.046 . . . . 2.4199999999999999 109.047 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.629 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 57.82 44.83 19.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.89 -1.505 . . . . 3.1299999999999999 112.108 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -82.44 178.16 8.37 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.819 -1.549 . . . . 2.02 106.819 166.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.403 ' HE ' ' HB3' ' A' ' 166' ' ' ARG . 12.2 ttp180 -148.6 129.75 14.55 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.542 -0.863 . . . . 2.8300000000000001 111.06 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.552 HG22 ' CB ' ' A' ' 184' ' ' ALA . 12.6 t -118.67 177.92 4.66 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.129 -0.942 . . . . 0.92000000000000004 109.494 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.577 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.4 t -142.81 129.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.702 -0.481 . . . . 1.1899999999999999 109.702 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.542 HG21 ' CD1' ' A' ' 214' ' ' ILE . 5.2 m -124.06 131.63 24.24 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.391 -0.822 . . . . 1.77 109.72 173.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 78.1 Cg_exo -49.4 146.36 14.23 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.634 2.223 . . . . 0.82999999999999996 112.143 175.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -66.81 80.21 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.34999999999999998 110.222 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 175' ' ' VAL . 26.8 mmm180 -64.64 112.22 3.09 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.055 -0.975 . . . . 3.2799999999999998 111.131 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.6 136.59 36.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.933 -0.576 . . . . 2.1899999999999999 110.333 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.84 14.69 82.32 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.016 -0.834 . . . . 0.42999999999999999 111.016 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 172' ' ' ARG . 55.3 t -126.78 135.11 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.038 0.447 . . . . 1.46 110.763 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.7 p -83.13 167.09 18.12 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.817 -0.629 . . . . 0.78000000000000003 110.326 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.677 ' O ' HD12 ' A' ' 181' ' ' LEU . 2.4 m -53.4 -37.73 30.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 108.487 -0.931 . . . . 2.04 108.487 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.8 tmm_? -44.56 -62.72 1.09 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.174 -0.921 . . . . 4.25 112.619 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.679 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 30.1 t70 -68.05 -44.37 76.55 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.394 0.616 . . . . 1.1899999999999999 111.034 -174.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.8 p -62.13 -54.65 38.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.462 -0.79 . . . . 1.76 110.656 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.705 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -91.52 -2.66 57.11 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.396 -0.922 . . . . 1.5 112.848 -175.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 13.6 ptmm? -68.34 -36.04 78.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.68 -1.23 . . . . 1.6399999999999999 107.68 168.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.89 -36.38 83.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.24 -0.891 . . . . 2.2599999999999998 109.345 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -53.63 -55.78 22.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.525 -0.307 . . . . 0.79000000000000004 111.097 173.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 190' ' ' LEU . 3.5 mm? -53.83 -50.48 66.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.376 -0.375 . . . . 2.2400000000000002 110.774 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 37.2 mtt -70.31 -21.69 62.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.342 0.497 . . . . 2.1299999999999999 112.342 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 16.4 mmt -76.3 -18.98 58.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 1.3 110.119 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.464 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 7.3 tpm_? -97.33 -11.83 23.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.439 -0.8 . . . . 2.5600000000000001 109.768 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 94.85 19.71 30.72 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.53000000000000003 111.955 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.442 ' HB2' HD11 ' A' ' 185' ' ' LEU . 7.7 mt -116.83 172.24 7.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.642 0.258 . . . . 2.0499999999999998 110.437 -176.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.7 pt -121.57 142.76 36.39 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.497 . . . . 0.58999999999999997 110.683 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.413 ' HG3' ' CB ' ' A' ' 182' ' ' LYS . 73.9 Cg_endo -75.15 -13.1 21.21 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 123.258 2.639 . . . . 0.63 112.968 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.37 -41.41 93.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 1.74 110.952 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 37.9 t -94.36 8.0 43.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.945 -0.571 . . . . 2.3999999999999999 110.785 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.424 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 73.1 m -116.29 158.18 23.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.65 0.262 . . . . 1.03 110.878 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.11 157.55 40.45 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.67000000000000004 110.053 174.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.404 HG23 ' CE2' ' A' ' 210' ' ' TRP . 13.9 t -118.89 124.1 72.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.136 0.493 . . . . 1.6200000000000001 110.717 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.529 ' HA ' HG12 ' A' ' 208' ' ' ILE . 55.1 p90 . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.672 -0.694 . . . . 2.8399999999999999 110.597 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 198' ' ' TYR . 2.6 mm . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.845 -0.798 . . . . 1.6100000000000001 108.845 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.419 ' H ' HG23 ' A' ' 208' ' ' ILE . . . -98.2 138.2 13.74 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.563 -0.827 . . . . 0.46000000000000002 111.205 176.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.648 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 62.3 m95 -68.06 -18.62 64.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.137 0.494 . . . . 0.37 110.244 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -95.08 6.67 48.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.553 -0.748 . . . . 2.2999999999999998 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 99.9 m -86.33 144.3 27.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.68999999999999995 110.354 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.96 128.02 34.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.03 -0.532 . . . . 1.73 111.184 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.542 ' CD1' HG21 ' A' ' 169' ' ' VAL . 6.5 tt -72.7 -26.95 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.51000000000000001 110.683 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 44.3 t -68.06 -14.96 63.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 1.5800000000000001 110.596 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -86.16 -13.06 48.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.446 0.641 . . . . 4.6299999999999999 109.615 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 mt -105.71 8.28 32.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.495 -0.775 . . . . 1.75 109.868 -176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.442 HG23 ' HB2' ' A' ' 155' ' ' PRO . 67.7 m -40.56 134.57 1.74 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.772 1.027 . . . . 0.55000000000000004 113.772 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.5 4.5 61.04 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.522 -0.763 . . . . 0.53000000000000003 112.281 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.63 162.58 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.714 -0.476 . . . . 2.1600000000000001 109.714 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 41.2 mt-10 -111.9 129.45 56.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.589 0.709 . . . . 2.0299999999999998 111.456 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 159' ' ' VAL . 66.3 mt -97.77 155.41 17.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.455 -1.248 . . . . 1.97 109.81 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.83 116.0 16.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.702 0.763 . . . . 3.3599999999999999 109.904 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.441 HG22 HD23 ' A' ' 181' ' ' LEU . 79.4 t -100.83 137.77 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 1.55 110.997 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.5 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 17.8 mm-40 -131.74 135.5 46.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.855 -1.066 . . . . 1.9399999999999999 109.694 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 19.5 t . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 110.054 -0.35 . . . . 1.8600000000000001 110.054 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.445 ' HB2' HG23 ' A' ' 218' ' ' THR . 88.5 Cg_endo . . . . . 0 N--CA 1.463 -0.273 0 CA-C-O 120.808 0.253 . . . . 0.48999999999999999 112.264 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.438 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 1.5 pp -141.78 147.07 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.892 0.377 . . . . 1.3700000000000001 111.295 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 220' ' ' GLU . 99.4 t -116.99 123.32 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.037 -0.727 . . . . 1.5900000000000001 109.037 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.557 ' CG ' HG13 ' A' ' 168' ' ' VAL . 42.6 mtp180 -98.81 114.31 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.464 -0.789 . . . . 3.4199999999999999 110.868 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.7 125.9 59.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.373 -0.376 . . . . 1.1000000000000001 111.537 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -76.23 101.96 5.63 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.611 -0.515 . . . . 0.76000000000000001 109.611 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.2 OUTLIER -67.09 158.03 82.79 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 1.95 111.136 176.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.539 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 50.2 Cg_exo -56.31 144.62 81.68 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 123.387 2.724 . . . . 0.56000000000000005 112.514 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 92.6 m-20 74.03 30.02 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.618 0.574 . . . . 2.4199999999999999 111.054 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.619 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 66.37 32.37 7.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.252 -0.885 . . . . 3.1299999999999999 112.774 173.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -90.47 167.07 12.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.462 -1.681 . . . . 2.02 106.462 171.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -148.86 136.44 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.672 -0.811 . . . . 2.8300000000000001 110.343 176.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.539 HG22 ' CB ' ' A' ' 184' ' ' ALA . 10.1 t -123.94 172.59 8.82 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.241 -0.891 . . . . 0.92000000000000004 109.852 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.557 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.6 t -142.12 128.07 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 109.249 -0.649 . . . . 1.1899999999999999 109.249 172.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' ' 214' ' ' ILE . 3.2 m -118.63 135.26 23.59 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.157 -0.929 . . . . 1.77 108.884 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' A' ' 172' ' ' ARG . 61.5 Cg_exo -51.26 146.06 25.08 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 121.872 1.714 . . . . 0.82999999999999996 110.532 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.23 81.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.373 -0.602 . . . . 0.34999999999999998 109.373 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 35.6 mmt180 -65.11 111.24 2.83 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.695 -1.139 . . . . 3.2799999999999998 109.974 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 26.9 p -78.43 130.41 36.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.877 0.37 . . . . 2.1899999999999999 110.782 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.2 22.61 44.04 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.628 -0.796 . . . . 0.42999999999999999 112.539 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 179' ' ' ASP . 1.4 p -137.58 153.44 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 1.46 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 40.3 p -91.05 164.64 13.88 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 116.024 -0.535 . . . . 0.78000000000000003 110.834 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.741 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 5.2 m -55.4 -32.93 30.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.268 0.556 . . . . 2.04 109.608 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.6 tpt180 -53.29 -48.23 68.53 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 115.202 -0.908 . . . . 4.25 112.171 -175.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.0 t70 -75.96 -49.93 16.34 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.377 0.608 . . . . 1.1899999999999999 110.564 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.1 p -59.61 -55.77 30.33 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.951 -1.022 . . . . 1.76 110.689 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.56 HD21 ' O ' ' A' ' 177' ' ' VAL . 0.1 OUTLIER -92.28 -5.33 52.55 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.069 -1.052 . . . . 1.5 112.659 -176.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.654 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 17.6 ptpt -61.2 -40.03 92.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 116.85 -1.94 . . . . 1.6399999999999999 107.716 167.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.496 ' HD2' ' HE1' ' A' ' 187' ' ' MET . 6.4 ttpm? -66.24 -38.27 87.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.976 -0.556 . . . . 2.2599999999999998 109.92 174.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.539 ' CB ' HG22 ' A' ' 167' ' ' THR . . . -49.96 -54.19 21.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.226 0.536 . . . . 0.79000000000000004 110.467 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.64 -51.05 68.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.519 -0.764 . . . . 2.2400000000000002 111.251 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.647 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 67.5 mtp -67.58 -21.82 65.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.509 -0.314 . . . . 2.1299999999999999 111.846 -173.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.496 ' HE1' ' HD2' ' A' ' 183' ' ' LYS . 26.4 mtt -77.84 -25.92 49.08 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.535 -0.542 . . . . 1.3 109.535 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.442 ' HB2' HD23 ' A' ' 161' ' ' LEU . 11.1 tpt180 -87.6 -11.28 49.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.511 -0.768 . . . . 2.5600000000000001 109.356 174.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.26 4.43 44.09 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.731 -0.668 . . . . 0.53000000000000003 113.251 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.421 HD11 ' N ' ' A' ' 190' ' ' LEU . 5.3 mp -97.43 176.87 5.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 2.0499999999999998 111.599 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.39 146.88 63.88 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.58999999999999997 110.293 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -4.61 15.59 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.354 2.703 . . . . 0.63 113.303 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.169 0.509 . . . . 1.74 110.029 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.7 t -107.49 28.41 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.615 -0.72 . . . . 2.3999999999999999 110.388 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.481 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.2 m -151.25 155.44 38.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.231 -0.441 . . . . 1.03 110.189 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.491 ' HA ' ' CZ2' ' A' ' 210' ' ' TRP . . . -131.33 173.34 11.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.148 -1.056 . . . . 0.67000000000000004 108.148 169.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.499 HG22 HD23 ' A' ' 181' ' ' LEU . 13.1 t -114.44 136.73 50.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.276 0.56 . . . . 1.6200000000000001 111.343 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--N 1.318 -0.776 0 CA-C-N 115.218 -0.901 . . . . 2.8399999999999999 110.139 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 6.9 mm . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.595 -0.52 . . . . 1.6100000000000001 109.595 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.78 140.31 14.94 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.847 -0.901 . . . . 0.46000000000000002 110.847 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.741 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 90.2 m95 -68.02 -14.37 62.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.277 0.539 . . . . 0.37 110.619 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -99.32 0.39 42.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.2999999999999998 110.388 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.7 m -75.07 140.78 43.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.754 -0.657 . . . . 0.68999999999999995 110.106 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.27 121.19 20.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.451 . . . . 1.73 110.193 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.503 ' CD1' HG21 ' A' ' 169' ' ' VAL . 4.1 tt -67.97 -28.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.51000000000000001 111.733 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -72.87 -8.39 55.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.228 0.537 . . . . 1.5800000000000001 110.342 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -83.62 -17.08 42.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.67 0.748 . . . . 4.6299999999999999 109.568 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -101.82 9.84 40.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.344 -0.843 . . . . 1.75 110.007 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.445 HG23 ' HB2' ' A' ' 155' ' ' PRO . 63.0 m -39.92 130.7 2.01 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.747 1.018 . . . . 0.55000000000000004 113.747 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.42 -1.18 61.88 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.508 -0.769 . . . . 0.53000000000000003 112.347 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.55 ' O ' HG11 ' A' ' 157' ' ' VAL . 38.7 mt-10 -105.61 138.26 42.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.8 0.333 . . . . 2.1600000000000001 110.205 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -84.46 128.9 34.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.294 0.569 . . . . 2.0299999999999998 110.598 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 48.9 mt -103.61 169.43 8.53 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.265 -0.88 . . . . 1.97 109.957 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -147.16 136.55 22.69 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.104 -0.702 . . . . 3.3599999999999999 109.104 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 72.3 t -99.32 144.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.935 0.398 . . . . 1.55 110.944 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 224' ' ' VAL . 68.8 mm-40 -109.64 145.8 35.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.865 -0.791 . . . . 1.9399999999999999 108.865 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.312 -1.022 0 CA-C-O 121.381 0.61 . . . . 1.8600000000000001 110.399 177.035 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.538 ' HB2' HG23 ' A' ' 218' ' ' THR . 83.4 Cg_endo . . . . . 0 N--CA 1.459 -0.521 0 N-CA-C 111.737 -0.14 . . . . 0.48999999999999999 111.737 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 17.4 pt -134.62 144.74 34.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 1.3700000000000001 110.965 176.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.678 HG21 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -124.41 117.05 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.806 0.812 . . . . 1.5900000000000001 108.977 173.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.567 ' CG ' HG13 ' A' ' 168' ' ' VAL . 18.1 mtm-85 -83.59 130.57 34.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.557 -1.201 . . . . 3.4199999999999999 110.506 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.457 ' HB ' ' CG2' ' A' ' 167' ' ' THR . 7.5 t -120.64 117.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.201 -0.909 . . . . 1.1000000000000001 111.215 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 10.2 m-85 -71.77 102.83 2.93 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.991 0.424 . . . . 0.76000000000000001 110.392 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 27.8 mt -55.46 151.04 21.49 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 124.294 1.038 . . . . 1.95 111.5 173.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.542 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 60.5 Cg_exo -54.06 161.69 4.76 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.022 2.481 . . . . 0.56000000000000005 111.869 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 67.76 14.78 9.55 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.206 -1.035 . . . . 2.4199999999999999 108.206 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 63.01 40.22 9.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 113.645 -1.616 . . . . 3.1299999999999999 112.235 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.666 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 3.0 mm-40 -96.7 -176.55 3.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.378 -1.342 . . . . 2.02 107.378 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 30.1 ttp180 -145.81 127.11 14.86 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.232 -0.987 . . . . 2.8300000000000001 111.66 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.53 ' HB ' HD12 ' A' ' 161' ' ' LEU . 12.1 t -109.55 176.66 4.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.611 -1.177 . . . . 0.92000000000000004 108.544 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.567 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.1 t -141.32 126.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.676 -0.861 . . . . 1.1899999999999999 108.676 168.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 214' ' ' ILE . 9.2 m -107.53 127.54 27.61 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.764 -0.653 . . . . 1.77 109.956 167.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 71.9 Cg_exo -50.51 142.51 30.42 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.163 1.909 . . . . 0.82999999999999996 110.461 169.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.431 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -64.7 88.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.34999999999999998 110.228 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 175' ' ' VAL . 29.0 mmt180 -70.87 110.98 5.94 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.085 -0.961 . . . . 3.2799999999999998 109.181 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.2 p -82.38 126.54 32.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.246 -0.434 . . . . 2.1899999999999999 110.904 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.14 22.51 29.8 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.539 -0.839 . . . . 0.42999999999999999 111.944 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 179' ' ' ASP . 1.3 p -138.1 154.59 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.061 0.457 . . . . 1.46 110.151 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.4 p -86.23 158.87 19.62 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.94 -0.573 . . . . 0.78000000000000003 110.72 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.677 ' O ' HD12 ' A' ' 181' ' ' LEU . 42.0 t -45.84 -49.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.224 -0.658 . . . . 2.04 109.224 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 11.8 tpt180 -41.57 -56.18 2.65 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 124.743 1.277 . . . . 4.25 113.239 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.5 t70 -67.5 -47.66 69.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.255 0.55 . . . . 1.1899999999999999 110.622 -176.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.8 t -64.28 -47.74 78.36 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.047 -0.661 . . . . 1.76 110.183 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.677 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -93.03 -2.58 55.54 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.271 -0.971 . . . . 1.5 112.464 -175.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 14.5 ptmm? -69.95 -31.4 69.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.27 -1.382 . . . . 1.6399999999999999 107.27 167.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.0 OUTLIER -65.94 -41.73 90.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.08 -0.964 . . . . 2.2599999999999998 109.418 168.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -50.61 -55.95 13.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.55 -0.295 . . . . 0.79000000000000004 110.983 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 185' ' ' LEU . 3.4 mm? -53.96 -51.9 62.37 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.494 -0.321 . . . . 2.2400000000000002 110.911 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -25.29 67.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 2.1299999999999999 112.363 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.55 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 24.2 mmt -78.48 -31.52 47.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.812 0.339 . . . . 1.3 110.222 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.531 ' HD3' HD13 ' A' ' 161' ' ' LEU . 15.4 tpt180 -77.52 -14.86 59.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.458 0.647 . . . . 2.5600000000000001 109.975 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.03 55.86 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.53000000000000003 111.543 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.7 mt -108.68 176.89 4.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.079 -0.341 . . . . 2.0499999999999998 110.079 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 193' ' ' GLU . 46.1 pt -122.63 140.96 34.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.58999999999999997 111.489 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.52 -10.55 26.99 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.55 2.833 . . . . 0.63 112.739 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' A' ' 191' ' ' ILE . 38.0 mt-10 -62.38 -44.19 97.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.336 0.589 . . . . 1.74 110.505 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.4 m -97.04 20.17 11.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.403 -0.817 . . . . 2.3999999999999999 110.989 -176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.549 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 72.8 m -128.39 156.66 42.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.542 -0.299 . . . . 1.03 110.713 -175.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -130.03 152.93 48.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.67000000000000004 109.995 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.517 HG13 ' CE2' ' A' ' 210' ' ' TRP . 3.5 m -110.68 126.96 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.791 0.805 . . . . 1.6200000000000001 111.108 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.531 ' CZ ' ' HG3' ' A' ' 225' ' ' GLU . 51.7 p90 . . . . . 0 C--N 1.311 -1.1 0 CA-C-N 115.51 -0.768 . . . . 2.8399999999999999 109.456 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' A' ' 198' ' ' TYR . 1.2 mm . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.216 -1.031 . . . . 1.6100000000000001 108.216 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.62 151.26 18.58 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.467 -1.349 . . . . 0.46000000000000002 113.004 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.543 ' CZ3' HD13 ' A' ' 181' ' ' LEU . 69.1 m95 -70.52 -18.43 62.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.872 0.368 . . . . 0.37 110.598 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -97.82 -1.96 42.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 2.2999999999999998 110.564 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.582 ' O ' HG22 ' A' ' 177' ' ' VAL . 89.3 m -70.34 142.02 52.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.829 -0.623 . . . . 0.68999999999999995 109.788 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.99 119.16 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.265 -0.642 . . . . 1.73 109.265 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 169' ' ' VAL . 4.4 tt -71.24 -27.01 27.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.51000000000000001 111.377 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.0 t -70.84 -7.78 47.88 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.479 0.656 . . . . 1.5800000000000001 109.717 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -88.37 -6.99 57.37 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.498 0.666 . . . . 4.6299999999999999 109.487 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.8 mt -112.61 7.48 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.431 -0.804 . . . . 1.75 110.038 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 155' ' ' PRO . 61.0 m -42.29 134.5 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.916 -1.038 . . . . 0.55000000000000004 113.7 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.4 57.64 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.53000000000000003 112.335 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.678 ' O ' HG21 ' A' ' 157' ' ' VAL . 41.6 mt-10 -113.36 148.92 34.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.864 0.364 . . . . 2.1600000000000001 110.391 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.6 mp0 -92.26 126.61 37.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.217 0.532 . . . . 2.0299999999999998 111.448 -176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 80.8 mt -99.56 155.13 17.74 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.22 -0.9 . . . . 1.97 110.144 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . 0.448 ' HA ' ' HB2' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -119.34 124.72 47.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.743 0.306 . . . . 3.3599999999999999 110.219 173.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.549 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 72.6 t -105.7 116.93 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.569 0.7 . . . . 1.55 109.408 172.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.531 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 54.0 mm-40 -119.55 133.02 55.86 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.921 -1.036 . . . . 1.9399999999999999 109.19 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.542 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 41.3 t . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 1.8600000000000001 111.187 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 55.1 Cg_endo . . . . . 0 N--CA 1.456 -0.695 0 N-CA-C 111.64 -0.177 . . . . 0.48999999999999999 111.64 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.572 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 39.5 pt -140.63 139.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.745 0.307 . . . . 1.3700000000000001 111.081 -178.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 88.4 t -112.53 118.76 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.149 -0.685 . . . . 1.5900000000000001 109.149 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.604 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 66.1 mtm180 -97.02 115.74 27.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.632 -0.713 . . . . 3.4199999999999999 110.538 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.49 ' CG1' HG23 ' A' ' 224' ' ' VAL . 13.5 t -105.85 127.02 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.233 -0.44 . . . . 1.1000000000000001 111.653 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 27.3 m-85 -74.22 103.09 4.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.302 -0.408 . . . . 0.76000000000000001 110.161 173.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.2 mm? -55.04 163.27 1.58 Allowed Pre-proline 0 N--CA 1.474 0.737 0 CA-C-O 121.331 0.586 . . . . 1.95 112.013 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.404 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 77.2 Cg_exo -51.24 160.48 2.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.964 2.443 . . . . 0.56000000000000005 111.047 163.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 67.89 6.99 5.46 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.069 0.462 . . . . 2.4199999999999999 110.213 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.509 ' HE2' ' HA ' ' A' ' 164' ' ' LYS . 8.1 mmpt? 70.2 39.39 1.31 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.134 -0.939 . . . . 3.1299999999999999 111.88 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.626 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 4.1 mm-40 -91.02 -178.89 5.32 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.549 -0.908 . . . . 2.02 108.549 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 33.0 ttp180 -147.38 132.89 18.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.006 -0.677 . . . . 2.8300000000000001 111.541 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.56 ' HB ' HD23 ' A' ' 161' ' ' LEU . 12.6 t -120.64 -177.74 3.54 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.459 -1.246 . . . . 0.92000000000000004 108.743 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.604 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.39 129.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.321 0.581 . . . . 1.1899999999999999 111.127 170.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.563 HG21 ' CD1' ' A' ' 214' ' ' ILE . 5.1 m -112.26 131.86 22.37 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.964 -1.016 . . . . 1.77 109.551 172.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 74.0 Cg_exo -48.35 141.86 18.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.504 2.136 . . . . 0.82999999999999996 111.859 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 155' ' ' PRO . . . -65.81 83.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.34999999999999998 110.44 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 175' ' ' VAL . 31.1 mmt180 -72.55 113.65 9.81 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 3.2799999999999998 110.041 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.416 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 41.9 t -82.81 124.75 30.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 2.1899999999999999 110.757 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.06 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.72 -0.752 . . . . 0.42999999999999999 111.915 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 179' ' ' ASP . 8.5 p -135.27 150.92 29.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.746 -0.464 . . . . 1.46 109.746 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 57.4 p -81.38 155.49 25.9 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.165 -0.471 . . . . 0.78000000000000003 110.777 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.619 ' O ' HD12 ' A' ' 181' ' ' LEU . 53.0 t -46.46 -46.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.18 -0.674 . . . . 2.04 109.18 173.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 9.5 tpt180 -41.51 -54.98 2.99 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 124.319 1.012 . . . . 4.25 113.125 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.6 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.8 t70 -68.6 -48.95 62.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.502 0.668 . . . . 1.1899999999999999 110.772 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.3 m -64.59 -46.79 81.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.325 -0.852 . . . . 1.76 111.02 -173.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.667 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -93.25 -4.49 51.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.928 -1.109 . . . . 1.5 112.529 -177.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.3 ptpt -67.23 -34.41 77.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 118.123 -1.431 . . . . 1.6399999999999999 107.697 168.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.56 -36.57 81.2 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.571 -0.741 . . . . 2.2599999999999998 109.48 171.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -51.94 -52.1 52.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.662 -0.245 . . . . 0.79000000000000004 110.825 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.62 -50.97 71.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.435 -0.348 . . . . 2.2400000000000002 111.067 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.488 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 49.2 mtt -68.47 -20.99 64.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.515 0.561 . . . . 2.1299999999999999 112.515 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 18.4 mmt -80.97 -20.32 42.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 1.3 109.722 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.508 ' HB3' ' CD1' ' A' ' 190' ' ' LEU . 10.2 tpt180 -91.09 -17.03 26.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.695 0.76 . . . . 2.5600000000000001 109.144 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.56 6.32 41.24 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 114.785 -1.098 . . . . 0.53000000000000003 112.835 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 188' ' ' ARG . 5.2 mp -104.96 174.64 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.112 0.482 . . . . 2.0499999999999998 111.718 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.1 pt -119.74 144.17 36.53 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.58999999999999997 110.53 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.76 -4.44 15.36 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.53 2.82 . . . . 0.63 113.593 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -69.38 -42.13 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 1.74 111.095 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 25.5 p -97.17 15.47 22.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 2.3999999999999999 110.609 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.614 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.6 m -123.1 149.6 44.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.07 -0.514 . . . . 1.03 110.661 -175.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -118.49 152.23 36.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.813 -0.44 . . . . 0.67000000000000004 109.813 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.56 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 13.6 t -118.88 124.54 73.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.097 0.475 . . . . 1.6200000000000001 110.867 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.525 ' HA ' HG12 ' A' ' 208' ' ' ILE . 51.9 p90 . . . . . 0 C--N 1.313 -1.021 0 CA-C-N 115.483 -0.78 . . . . 2.8399999999999999 109.764 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 198' ' ' TYR . 14.7 mm . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 109.61 -0.515 . . . . 1.6100000000000001 109.61 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 212' ' ' THR . . . -85.31 131.06 10.21 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.675 -1.37 . . . . 0.46000000000000002 109.675 171.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.56 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 57.6 m95 -65.38 -21.08 66.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.037 0.446 . . . . 0.37 110.194 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.02 1.7 52.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.533 0.683 . . . . 2.2999999999999998 110.086 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.603 ' O ' HG22 ' A' ' 177' ' ' VAL . 54.5 m -72.37 145.75 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.906 -0.588 . . . . 0.68999999999999995 110.282 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.61 115.02 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.497 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.563 ' CD1' HG21 ' A' ' 169' ' ' VAL . 2.4 tt -62.58 -29.4 46.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.51000000000000001 111.505 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -73.24 -8.25 55.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.857 -0.61 . . . . 1.5800000000000001 110.563 -173.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -82.27 -21.69 36.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.52 0.676 . . . . 4.6299999999999999 109.815 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.64 11.79 35.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.476 -0.783 . . . . 1.75 110.031 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.447 HG23 ' CB ' ' A' ' 155' ' ' PRO . 94.9 m -37.68 129.66 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.497 0.925 . . . . 0.55000000000000004 113.497 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.16 -14.03 29.64 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.816 -0.629 . . . . 0.53000000000000003 112.302 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.31 158.31 26.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.954 0.407 . . . . 2.1600000000000001 110.306 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.5 mt-10 -109.48 115.48 30.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.596 0.712 . . . . 2.0299999999999998 109.933 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 36.4 mt -95.6 164.67 12.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.644 -1.162 . . . . 1.97 110.989 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 2.1 m-70 -126.64 123.62 38.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 3.3599999999999999 110.614 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 98.4 t -101.61 112.37 34.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.666 0.746 . . . . 1.55 109.631 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 57.9 mm-40 -116.09 124.92 51.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.833 -1.076 . . . . 1.9399999999999999 109.082 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 47.9 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 1.8600000000000001 111.871 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB2' HG23 ' A' ' 218' ' ' THR . 65.1 Cg_endo . . . . . 0 N--CA 1.461 -0.422 0 CA-C-O 120.574 0.156 . . . . 0.48999999999999999 112.19 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.567 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 2.0 pp -146.42 147.43 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.888 0.375 . . . . 1.3700000000000001 111.682 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.4 t -119.72 125.69 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.818 -0.808 . . . . 1.5900000000000001 108.818 174.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.575 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 62.5 mtm180 -99.05 116.84 32.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.756 -0.656 . . . . 3.4199999999999999 110.678 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.413 ' O ' HG21 ' A' ' 167' ' ' THR . 2.0 t -106.11 120.56 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.282 -0.417 . . . . 1.1000000000000001 111.411 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 33.7 m-85 -72.6 103.27 3.51 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.039 -0.356 . . . . 0.76000000000000001 110.039 174.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.569 HD22 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -66.07 156.44 84.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 120.892 0.377 . . . . 1.95 110.749 176.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 93.0 Cg_exo -43.75 150.54 0.53 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.785 2.99 . . . . 0.56000000000000005 112.97 171.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 74.69 10.86 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.554 -0.748 . . . . 2.4199999999999999 110.037 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 76.03 32.36 0.63 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.144 -0.935 . . . . 3.1299999999999999 112.558 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.1 mm100 -86.11 173.39 9.88 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.32 -0.993 . . . . 2.02 108.32 171.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 19.3 ttp180 -147.48 130.76 16.53 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.738 -0.785 . . . . 2.8300000000000001 111.487 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.569 ' HB ' HD22 ' A' ' 161' ' ' LEU . 6.2 t -113.79 179.07 4.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.608 -1.178 . . . . 0.92000000000000004 108.837 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.575 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.25 128.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.53 0.681 . . . . 1.1899999999999999 110.756 165.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.7 m -108.95 145.26 31.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.58 -1.191 . . . . 1.77 109.61 174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.42 145.05 29.57 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.05 1.833 . . . . 0.82999999999999996 111.313 171.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 155' ' ' PRO . . . -68.43 79.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.333 0.587 . . . . 0.34999999999999998 109.996 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.421 ' O ' HG13 ' A' ' 175' ' ' VAL . 15.1 mmm180 -64.27 111.79 2.77 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.081 -0.963 . . . . 3.2799999999999998 110.72 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 76.3 m -77.72 126.54 31.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.572 -0.74 . . . . 2.1899999999999999 110.935 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.18 21.93 39.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.777 -0.725 . . . . 0.42999999999999999 112.174 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 172' ' ' ARG . 1.7 p -131.69 150.93 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.082 0.468 . . . . 1.46 110.368 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 51.4 p -87.18 158.95 19.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.786 -0.643 . . . . 0.78000000000000003 111.121 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.647 ' O ' HD12 ' A' ' 181' ' ' LEU . 59.6 t -48.4 -44.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 2.04 109.704 173.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.559 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 12.0 tpt180 -43.77 -51.28 7.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.217 -0.902 . . . . 4.25 113.224 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 12.2 t70 -72.77 -50.93 21.32 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.743 0.782 . . . . 1.1899999999999999 110.609 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.4 p -59.69 -51.89 67.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.606 -1.179 . . . . 1.76 110.568 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.657 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -90.86 -3.67 57.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 118.812 -1.155 . . . . 1.5 112.994 -177.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.0 ptpt -66.35 -33.69 76.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 118.195 -1.402 . . . . 1.6399999999999999 107.755 170.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.2 OUTLIER -70.6 -39.57 73.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.393 -0.822 . . . . 2.2599999999999998 109.49 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.536 ' CB ' HG22 ' A' ' 167' ' ' THR . . . -50.58 -52.61 37.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.975 0.417 . . . . 0.79000000000000004 111.116 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.4 HD23 HG13 ' A' ' 224' ' ' VAL . 5.5 mt -61.58 -51.05 70.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 2.2400000000000002 111.261 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -26.67 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.531 . . . . 2.1299999999999999 112.432 -174.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.5 mmt -75.6 -18.73 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.058 0.456 . . . . 1.3 110.954 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.45 ' HG3' ' HG ' ' A' ' 161' ' ' LEU . 4.2 mmp_? -96.04 -12.11 25.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.487 0.66 . . . . 2.5600000000000001 110.05 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.05 19.13 40.63 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.179 -0.918 . . . . 0.53000000000000003 111.675 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.8 mt -102.62 168.55 9.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.168 -0.308 . . . . 2.0499999999999998 110.168 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 193' ' ' GLU . 46.7 pt -127.39 143.43 47.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 121.317 0.58 . . . . 0.58999999999999997 111.777 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 -4.37 15.31 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.521 2.814 . . . . 0.63 112.854 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.404 ' HB2' HD11 ' A' ' 191' ' ' ILE . 24.7 mt-10 -75.46 -34.71 60.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 1.74 110.657 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 60.4 m -107.3 7.56 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 2.3999999999999999 111.74 -175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.506 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 83.9 m -127.49 145.48 50.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.919 -0.313 . . . . 1.03 111.248 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -111.52 160.79 16.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.67000000000000004 109.835 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.415 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 12.7 t -117.21 125.05 73.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.001 0.429 . . . . 1.6200000000000001 110.124 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.588 ' HH ' ' HG3' ' A' ' 225' ' ' GLU . 52.4 p90 . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 115.777 -0.647 . . . . 2.8399999999999999 110.4 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 198' ' ' TYR . 7.6 mm . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 109.253 -0.647 . . . . 1.6100000000000001 109.253 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -97.74 140.76 15.22 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.386 -1.086 . . . . 0.46000000000000002 110.386 174.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.583 ' CZ3' HD13 ' A' ' 181' ' ' LEU . 56.7 m95 -68.75 -13.16 62.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.074 0.464 . . . . 0.37 110.451 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.75 5.54 43.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 2.2999999999999998 110.333 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.507 ' O ' HG22 ' A' ' 177' ' ' VAL . 49.3 m -72.0 137.89 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.072 -0.513 . . . . 0.68999999999999995 110.051 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.499 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 13.0 t70 -74.05 112.88 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.73 109.995 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 4.2 tt -62.04 -26.02 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.181 -0.463 . . . . 0.51000000000000001 112.141 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.554 ' CB ' ' HA ' ' A' ' 173' ' ' CYS . 2.0 t -70.11 -8.65 51.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.708 0.289 . . . . 1.5800000000000001 111.157 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.432 ' HB3' HD13 ' A' ' 217' ' ' LEU . 1.7 t90 -87.11 -20.85 26.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.737 0.78 . . . . 4.6299999999999999 109.29 175.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.576 ' N ' HD13 ' A' ' 217' ' ' LEU . 6.9 mp -100.07 12.83 35.97 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 1.75 110.674 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 155' ' ' PRO . 90.8 m -39.21 129.73 1.69 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.764 -1.562 . . . . 0.55000000000000004 113.059 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.61 -7.86 51.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.698 -0.683 . . . . 0.53000000000000003 112.356 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -96.64 164.11 12.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.86 0.362 . . . . 2.1600000000000001 110.92 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 38.2 mt-10 -113.87 122.8 48.13 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.328 0.585 . . . . 2.0299999999999998 110.87 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.482 HD23 HD23 ' A' ' 217' ' ' LEU . 26.1 mt -99.29 161.49 13.59 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 1.97 111.081 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 26.3 m-70 -124.64 127.2 46.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.425 . . . . 3.3599999999999999 110.138 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 75.5 t -104.98 130.31 56.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.221 0.534 . . . . 1.55 109.66 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.588 ' HG3' ' HH ' ' A' ' 198' ' ' TYR . 6.7 mm-40 -128.65 130.06 46.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.162 -0.926 . . . . 1.9399999999999999 110.466 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 162' ' ' PRO . 99.6 t . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 109.622 -0.51 . . . . 1.8600000000000001 109.622 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 218' ' ' THR . 40.8 Cg_endo . . . . . 0 N--CA 1.464 -0.213 0 N-CA-C 111.665 -0.167 . . . . 0.48999999999999999 111.665 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.405 HD11 HG12 ' A' ' 168' ' ' VAL . 22.0 pt -141.37 158.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.453 0.644 . . . . 1.3700000000000001 111.861 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 130.27 48.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.903 -1.044 . . . . 1.5900000000000001 108.934 169.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.577 ' CG ' HG13 ' A' ' 168' ' ' VAL . 9.0 mtm180 -99.6 130.23 45.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.089 -0.959 . . . . 3.4199999999999999 110.337 -169.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 222' ' ' LEU . 6.0 t -115.54 125.73 72.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.453 -0.339 . . . . 1.1000000000000001 111.581 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -77.15 103.38 7.05 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.223 -0.298 . . . . 0.76000000000000001 110.236 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 2.0 mm? -51.97 162.84 0.74 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 121.12 0.486 . . . . 1.95 111.429 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.435 ' HB3' HG21 ' A' ' 226' ' ' VAL . 78.5 Cg_exo -52.71 154.56 12.13 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.807 2.338 . . . . 0.56000000000000005 111.889 166.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 64.91 15.48 9.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.688 0.756 . . . . 2.4199999999999999 110.091 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.646 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 70.05 37.34 1.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.776 -1.102 . . . . 3.1299999999999999 113.396 171.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.67 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.7 mm-40 -86.23 176.44 7.95 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.621 -1.251 . . . . 2.02 107.621 168.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -144.91 126.23 14.83 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.463 -0.895 . . . . 2.8300000000000001 111.54 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.442 HG22 ' HB2' ' A' ' 184' ' ' ALA . 8.1 t -107.72 172.68 6.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.068 -1.424 . . . . 0.92000000000000004 108.441 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.577 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.4 t -142.97 129.04 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 121.014 0.435 . . . . 1.1899999999999999 110.081 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.12 131.38 24.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.329 -0.851 . . . . 1.77 109.751 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.75 140.13 47.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.102 1.868 . . . . 0.82999999999999996 110.548 169.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' A' ' 218' ' ' THR . . . -61.2 101.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 0.34999999999999998 110.221 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.505 ' HB3' HG22 ' A' ' 175' ' ' VAL . 35.9 mmt180 -81.03 111.13 17.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.011 -0.995 . . . . 3.2799999999999998 110.386 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 p -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.436 -0.347 . . . . 2.1899999999999999 110.911 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.54 19.82 57.64 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.718 -0.953 . . . . 0.42999999999999999 110.718 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 172' ' ' ARG . 46.8 t -129.53 132.12 66.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.952 -0.624 . . . . 1.46 110.137 -175.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.5 p -78.02 162.15 26.94 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.907 -0.405 . . . . 0.78000000000000003 109.907 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.71 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 5.9 m -52.09 -36.5 20.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.616 -0.883 . . . . 2.04 108.616 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 54.2 ttt180 -43.75 -58.84 2.5 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.807 -1.088 . . . . 4.25 112.729 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.528 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -71.61 -46.1 60.17 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 1.1899999999999999 110.598 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.5 p -62.46 -57.25 11.89 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.946 -1.025 . . . . 1.76 110.887 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.669 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -90.16 0.0 57.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 118.889 -1.124 . . . . 1.5 112.486 -176.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 17.9 ptpt -67.95 -33.96 75.68 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 117.559 -1.656 . . . . 1.6399999999999999 107.427 165.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 187' ' ' MET . 12.8 tptt -60.79 -43.67 97.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.161 -0.927 . . . . 2.2599999999999998 108.921 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -48.05 -58.95 3.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.388 0.43 . . . . 0.79000000000000004 111.432 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 185' ' ' LEU . 2.9 mm? -52.95 -51.3 61.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.338 -0.392 . . . . 2.2400000000000002 110.463 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 16.4 mtt -67.99 -21.29 65.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.29 0.478 . . . . 2.1299999999999999 112.29 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.3 mmt -77.54 -27.3 51.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.207 0.527 . . . . 1.3 109.622 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 188' ' ' ARG . 25.8 tpt180 -85.88 -19.73 30.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.522 -0.763 . . . . 2.5600000000000001 109.929 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.06 14.88 29.86 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.744 -0.662 . . . . 0.53000000000000003 111.756 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 12.9 mt -108.07 177.13 4.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.07 -0.344 . . . . 2.0499999999999998 110.07 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 193' ' ' GLU . 43.8 pt -124.64 146.51 52.89 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 121.179 0.514 . . . . 0.58999999999999997 111.022 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.434 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 96.6 Cg_endo -77.86 -12.37 16.37 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.275 2.65 . . . . 0.63 112.597 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.44 ' HB2' HD11 ' A' ' 191' ' ' ILE . 24.0 mt-10 -65.74 -26.62 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 1.74 110.819 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 20.0 t -114.43 19.34 16.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.317 -0.401 . . . . 2.3999999999999999 110.779 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.4 m -125.99 157.62 37.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.719 -0.219 . . . . 1.03 110.887 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.13 154.42 45.76 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.67000000000000004 109.966 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.2 t -117.71 126.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.533 0.682 . . . . 1.6200000000000001 111.536 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.534 ' HH ' ' HG3' ' A' ' 225' ' ' GLU . 54.9 p90 . . . . . 0 C--N 1.313 -1.008 0 CA-C-N 115.087 -0.961 . . . . 2.8399999999999999 109.073 173.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.492 ' CD1' HD22 ' A' ' 222' ' ' LEU . 6.3 mt . . . . . 0 N--CA 1.444 -0.763 0 CA-C-O 120.757 0.313 . . . . 1.6100000000000001 110.36 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.11 146.82 18.9 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.492 -0.861 . . . . 0.46000000000000002 111.58 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.71 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 69.0 m95 -70.15 -13.71 62.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.37 110.704 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -94.79 1.02 55.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.2999999999999998 110.206 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.8 m -74.03 129.24 37.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.925 -0.579 . . . . 0.68999999999999995 110.684 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.89 117.22 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.564 -0.532 . . . . 1.73 109.564 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 tt -66.75 -21.14 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.593 0.59 . . . . 0.51000000000000001 112.593 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 172' ' ' ARG . 67.8 p -71.04 -6.85 42.2 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.28 -0.262 . . . . 1.5800000000000001 111.646 -175.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -90.01 -10.6 44.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.461 0.648 . . . . 4.6299999999999999 109.977 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.553 ' N ' HD13 ' A' ' 217' ' ' LEU . 6.3 mp -106.41 14.13 27.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.065 0.936 . . . . 1.75 110.291 -174.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 155' ' ' PRO . 3.3 m -53.83 142.69 23.2 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.673 -1.603 . . . . 0.55000000000000004 111.869 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 74.68 -3.21 44.27 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.026 -0.534 . . . . 0.53000000000000003 112.387 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -104.96 171.2 7.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.602 -0.518 . . . . 2.1600000000000001 109.602 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.1 mt-10 -121.18 125.88 48.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.744 0.783 . . . . 2.0299999999999998 110.845 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' A' ' 208' ' ' ILE . 27.6 mt -101.14 166.07 10.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.44 -1.255 . . . . 1.97 109.325 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.81 119.8 10.68 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.802 0.811 . . . . 3.3599999999999999 110.914 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 88.8 t -101.46 134.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 1.55 110.923 -175.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.534 ' HG3' ' HH ' ' A' ' 198' ' ' TYR . 27.3 mm-40 -129.32 132.9 47.22 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 1.9399999999999999 109.669 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 162' ' ' PRO . 92.4 t . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.8600000000000001 110.718 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.571 ' HB2' HG23 ' A' ' 218' ' ' THR . 39.0 Cg_endo . . . . . 0 N--CA 1.462 -0.359 0 CA-C-O 120.655 0.19 . . . . 0.48999999999999999 112.056 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.421 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 1.9 pp -139.44 150.85 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.237 0.541 . . . . 1.3700000000000001 111.697 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 220' ' ' GLU . 0.3 OUTLIER -131.42 132.92 62.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.405 -0.816 . . . . 1.5900000000000001 108.928 175.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.484 ' HG2' HG13 ' A' ' 168' ' ' VAL . 36.0 mtm-85 -102.77 129.75 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.753 -0.658 . . . . 3.4199999999999999 111.155 -168.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.468 ' HB ' HG21 ' A' ' 167' ' ' THR . 25.9 t -112.13 122.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.267 -0.424 . . . . 1.1000000000000001 111.828 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 223' ' ' HIS . 30.8 m-85 -74.71 103.53 5.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.023 -0.362 . . . . 0.76000000000000001 110.023 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.3 OUTLIER -63.7 160.78 41.79 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.89 0.376 . . . . 1.95 110.379 173.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.502 ' HD3' HG23 ' A' ' 224' ' ' VAL . 82.1 Cg_exo -45.06 152.17 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.364 2.709 . . . . 0.56000000000000005 112.316 167.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.1 m120 68.63 25.44 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 2.4199999999999999 111.176 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.603 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 68.75 28.13 5.62 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.398 0.888 . . . . 3.1299999999999999 113.398 171.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 1.7 mm-40 -89.7 169.48 11.26 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.392 -0.966 . . . . 2.02 108.392 173.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 33.4 ttp180 -146.68 135.07 21.88 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 120.264 -0.574 . . . . 2.8300000000000001 110.155 175.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.625 HG22 ' CB ' ' A' ' 184' ' ' ALA . 2.1 t -109.73 174.4 5.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.866 -1.061 . . . . 0.92000000000000004 108.845 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.484 HG13 ' HG2' ' A' ' 158' ' ' ARG . 2.9 t -138.97 127.19 27.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.823 -0.806 . . . . 1.1899999999999999 108.823 168.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.538 HG21 ' CD1' ' A' ' 214' ' ' ILE . 11.0 m -119.8 137.08 25.27 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 115.661 -0.699 . . . . 1.77 109.598 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.64 142.77 59.89 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.912 1.742 . . . . 0.82999999999999996 110.527 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.481 ' HB1' HG23 ' A' ' 218' ' ' THR . . . -68.78 80.36 0.29 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.515 0.674 . . . . 0.34999999999999998 109.196 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.446 ' O ' HG13 ' A' ' 175' ' ' VAL . 21.4 mmm180 -69.37 110.76 4.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.544 -1.207 . . . . 3.2799999999999998 109.886 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.1 p -85.48 116.68 23.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.011 -0.54 . . . . 2.1899999999999999 110.36 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.06 23.89 7.16 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.491 -0.861 . . . . 0.42999999999999999 111.497 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 179' ' ' ASP . 3.4 p -143.35 156.45 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.217 0.532 . . . . 1.46 110.838 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.5 p -93.31 161.49 14.38 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.517 -0.765 . . . . 0.78000000000000003 110.933 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.54 ' O ' HD12 ' A' ' 181' ' ' LEU . 16.0 t -48.86 -49.51 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.185 -0.461 . . . . 2.04 109.966 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -48.7 -44.75 38.37 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 113.276 0.843 . . . . 4.25 113.276 -172.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 15.7 t70 -71.5 -50.55 30.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.602 0.715 . . . . 1.1899999999999999 110.208 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.9 m -62.1 -46.29 89.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.083 -0.962 . . . . 1.76 110.925 -175.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.66 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -95.43 -3.97 45.99 Favored 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 119.429 -0.908 . . . . 1.5 112.826 -175.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.9 ptpt -67.51 -35.34 78.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 118.098 -1.441 . . . . 1.6399999999999999 107.294 167.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.102 -0.953 . . . . 2.2599999999999998 109.563 170.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -49.9 -56.19 11.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.699 0.285 . . . . 0.79000000000000004 111.026 172.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -56.3 -50.09 72.41 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.033 -0.531 . . . . 2.2400000000000002 110.678 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 50.6 mtt -70.1 -20.91 63.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.326 0.491 . . . . 2.1299999999999999 112.326 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 19.1 mmt -75.32 -20.33 59.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.479 . . . . 1.3 109.878 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.4 ' HG2' ' HG3' ' A' ' 165' ' ' GLN . 11.5 tpt180 -97.9 -11.56 23.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.653 -0.703 . . . . 2.5600000000000001 109.623 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.39 46.45 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.277 -0.874 . . . . 0.53000000000000003 112.061 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.1 mt -104.74 175.78 5.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.79 0.328 . . . . 2.0499999999999998 110.21 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -125.86 145.18 50.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.058 0.456 . . . . 0.58999999999999997 110.694 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.455 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 86.4 Cg_endo -76.27 -4.96 15.73 Favored 'Trans proline' 0 C--O 1.23 0.084 0 C-N-CA 123.239 2.626 . . . . 0.63 112.752 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.39 -45.35 76.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.572 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.72 29.75 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 2.3999999999999999 110.091 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.513 ' HB3' HG21 ' A' ' 224' ' ' VAL . 74.1 m -135.25 150.54 50.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 1.03 110.229 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 224' ' ' VAL . . . -133.24 147.93 51.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.352 -0.981 . . . . 0.67000000000000004 108.352 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.561 ' HA ' ' HB ' ' A' ' 224' ' ' VAL . 84.9 t -99.74 135.6 34.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.742 -0.783 . . . . 1.6200000000000001 111.797 -170.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 223' ' ' HIS . 35.7 m-85 . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 114.575 -1.193 . . . . 2.8399999999999999 110.959 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 209' ' ' GLY . 5.1 mm . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.088 0.47 . . . . 1.6100000000000001 110.239 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -90.72 131.9 11.0 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.521 -0.763 . . . . 0.46000000000000002 111.4 175.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.567 ' CZ3' HD13 ' A' ' 181' ' ' LEU . 51.9 m95 -67.5 -17.95 64.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 0.37 111.245 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -99.44 6.37 46.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.615 0.721 . . . . 2.2999999999999998 110.045 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 86.7 m -74.34 143.6 44.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.68999999999999995 109.855 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.54 ' HB2' ' CE3' ' A' ' 216' ' ' TRP . 1.1 m-20 -70.5 115.11 9.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.904 0.383 . . . . 1.73 110.329 177.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.538 ' CD1' HG21 ' A' ' 169' ' ' VAL . 2.6 tt -64.6 -30.49 50.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.51000000000000001 111.819 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 172' ' ' ARG . 30.3 t -66.18 -6.49 13.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.141 -0.481 . . . . 1.5800000000000001 111.702 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.54 ' CE3' ' HB2' ' A' ' 213' ' ' ASP . 31.6 m0 -90.95 -12.22 36.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.012 -0.43 . . . . 4.6299999999999999 110.703 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.0 mt -102.01 9.6 40.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 1.75 110.387 -175.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 155' ' ' PRO . 4.0 m -46.41 139.04 5.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.55000000000000004 113.519 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.34 7.71 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.769 -0.65 . . . . 0.53000000000000003 112.362 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.444 ' O ' HG21 ' A' ' 157' ' ' VAL . 47.7 mt-10 -93.44 168.69 10.89 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.607 -0.516 . . . . 2.1600000000000001 109.607 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -117.63 124.05 47.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.081 0.944 . . . . 2.0299999999999998 111.591 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.429 ' HB2' HG21 ' A' ' 159' ' ' VAL . 78.9 mt -96.14 160.83 14.24 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.038 -1.437 . . . . 1.97 108.975 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 160' ' ' PHE . 1.5 t60 -151.32 115.18 4.94 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.947 -0.76 . . . . 3.3599999999999999 108.947 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 197' ' ' VAL . 0.9 OUTLIER -102.19 153.68 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.686 0.755 . . . . 1.55 111.882 -177.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -113.43 172.78 6.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.199 -1.364 . . . . 1.9399999999999999 108.654 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.314 -0.948 0 CA-C-O 120.911 0.386 . . . . 1.8600000000000001 111.142 -179.483 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.431 -0.211 . . . . 5.9500000000000002 110.431 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.93 72.6 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.172 2.582 . . . . 3.96 112.847 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.41 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 77.4 mt-30 -84.45 154.36 22.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.983 -0.553 . . . . 3.8799999999999999 110.294 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -101.92 93.69 3.9 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.638 0.256 . . . . 2.7400000000000002 110.344 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.531 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 23.2 Cg_endo -85.38 157.75 10.95 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.797 2.331 . . . . 0.48999999999999999 111.504 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.456 HG22 ' C13' ' A' ' 301' ' ' 6FS . 2.1 pp -141.28 153.05 19.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.423 0.63 . . . . 1.3700000000000001 112.321 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -130.34 126.98 62.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.079 -0.964 . . . . 1.5900000000000001 109.248 173.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.626 ' HG2' HG13 ' A' ' 168' ' ' VAL . 52.8 mtm-85 -94.68 126.29 39.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.516 -0.766 . . . . 3.4199999999999999 110.739 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 222' ' ' LEU . 3.5 t -108.86 124.27 65.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.842 -0.617 . . . . 1.1000000000000001 111.15 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 25.3 m-85 -76.62 102.9 6.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 110.147 -0.316 . . . . 0.76000000000000001 110.147 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.542 HD22 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -63.02 161.36 31.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 121.071 0.463 . . . . 1.95 111.515 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 77.0 Cg_exo -47.71 153.19 2.43 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.291 2.661 . . . . 0.56000000000000005 111.783 168.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 4.6 m-20 70.76 18.15 6.31 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.78 0.432 . . . . 2.4199999999999999 110.804 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 67.48 36.46 3.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.941 -0.572 . . . . 3.1299999999999999 111.996 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -95.18 174.47 7.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.458 -0.942 . . . . 2.02 108.458 174.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.7 ttp180 -147.39 129.47 15.49 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.811 -0.755 . . . . 2.8300000000000001 111.953 175.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.542 ' HB ' HD22 ' A' ' 161' ' ' LEU . 12.5 t -107.99 175.9 5.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.48 -1.237 . . . . 0.92000000000000004 109.41 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.626 HG13 ' HG2' ' A' ' 158' ' ' ARG . 5.7 t -141.27 128.97 22.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.022 -0.733 . . . . 1.1899999999999999 109.022 172.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.416 HG21 ' CD1' ' A' ' 214' ' ' ILE . 6.4 m -124.94 137.45 29.64 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.892 -0.594 . . . . 1.77 109.619 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 50.0 Cg_exo -53.99 142.96 63.38 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.902 1.734 . . . . 0.82999999999999996 110.175 171.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.531 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -67.26 83.09 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.615 0.721 . . . . 0.34999999999999998 109.771 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.561 ' HB3' HG22 ' A' ' 175' ' ' VAL . 18.5 mmm180 -66.73 111.03 3.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.358 -1.292 . . . . 3.2799999999999998 111.134 -174.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 14.3 p -77.67 132.86 38.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 2.1899999999999999 110.43 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.42 17.75 79.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.608 -0.806 . . . . 0.42999999999999999 111.129 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 172' ' ' ARG . 34.2 t -121.89 133.19 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.247 0.546 . . . . 1.46 110.708 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.7 p -83.73 155.93 22.84 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.543 -0.753 . . . . 0.78000000000000003 110.593 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.672 ' O ' HD12 ' A' ' 181' ' ' LEU . 67.2 t -45.09 -47.37 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 123.33 0.394 . . . . 2.04 110.709 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 0.7 OUTLIER -49.6 -43.55 46.54 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 113.165 0.802 . . . . 4.25 113.165 -174.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.6 t70 -72.34 -50.76 24.4 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.803 0.811 . . . . 1.1899999999999999 109.824 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.4 p -61.56 -50.53 72.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.301 -1.318 . . . . 1.76 110.474 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.15 -5.75 54.55 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.28 -0.968 . . . . 1.5 113.174 -175.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.558 ' N ' HD11 ' A' ' 181' ' ' LEU . 18.0 ptpt -69.18 -31.31 69.84 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 117.845 -1.542 . . . . 1.6399999999999999 107.864 169.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.437 ' HD2' ' HE1' ' A' ' 187' ' ' MET . 0.0 OUTLIER -62.79 -44.49 96.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.466 -0.788 . . . . 2.2599999999999998 109.008 168.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -50.05 -50.32 48.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.639 -0.709 . . . . 0.79000000000000004 111.892 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.88 -52.06 67.37 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 2.2400000000000002 110.524 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.7 mmt -60.69 -25.8 66.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.935 -0.575 . . . . 2.1299999999999999 112.371 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.437 ' HE1' ' HD2' ' A' ' 183' ' ' LYS . 20.0 mmt -75.15 -18.01 60.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.126 0.489 . . . . 1.3 110.862 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.434 ' HD3' ' CB ' ' A' ' 165' ' ' GLN . 10.9 mmm180 -95.25 -21.11 18.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.579 0.704 . . . . 2.5600000000000001 109.679 171.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.95 10.86 36.04 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.897 -1.047 . . . . 0.53000000000000003 111.143 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.98 177.21 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 2.0499999999999998 110.685 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 16.5 pt -129.08 145.26 55.92 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.028 -0.533 . . . . 0.58999999999999997 111.079 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.777 ' HA ' ' SG ' ' A' ' 195' ' ' CYS . 61.4 Cg_endo -72.54 -4.19 14.83 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.381 2.721 . . . . 0.63 113.759 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.31 -49.76 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.939 0.4 . . . . 1.74 111.725 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 77.2 m -96.34 16.42 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.734 0.642 . . . . 2.3999999999999999 112.734 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.777 ' SG ' ' HA ' ' A' ' 192' ' ' PRO . 1.3 p -115.88 160.52 20.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 1.03 111.981 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.46 ' HB2' ' CG ' ' A' ' 227' ' ' LEU . . . -125.38 155.16 40.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.398 -0.819 . . . . 0.67000000000000004 109.292 169.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.494 HG23 ' CE2' ' A' ' 210' ' ' TRP . 17.6 t -117.39 122.07 69.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.372 0.606 . . . . 1.6200000000000001 111.097 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.737 ' CE1' ' HE3' ' A' ' 205' ' ' LYS . 50.6 p90 -155.55 147.69 23.58 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.222 -0.899 . . . . 2.8399999999999999 109.405 175.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.435 ' HG2' HD11 ' A' ' 208' ' ' ILE . 14.7 ptm180 -114.12 137.21 52.03 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.168 -0.332 . . . . 1.8799999999999999 111.084 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.443 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 20.2 mm -82.35 122.78 37.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.705 0.764 . . . . 1.01 110.905 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.555 ' NE2' ' HE2' ' A' ' 206' ' ' LYS . 0.8 OUTLIER -99.44 -149.28 0.36 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.452 -1.249 . . . . 2.98 108.295 175.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -52.88 81.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.432 0.693 . . . . 1.9099999999999999 112.427 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.79 11.6 24.39 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.494 -0.384 . . . . 1.2 112.791 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.431 ' O ' HG21 ' A' ' 200' ' ' ILE . 13.3 pt-20 -130.85 -177.75 4.5 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 120.872 0.367 . . . . 1.54 110.679 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.737 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 11.2 mtpt -121.25 129.35 53.12 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.135 -0.484 . . . . 2.0499999999999998 110.585 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.555 ' HE2' ' NE2' ' A' ' 201' ' ' GLN . 61.7 mmtt -109.98 97.36 29.17 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.455 -0.943 . . . . 2.0800000000000001 108.455 173.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.715 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 15.2 Cg_exo -68.22 118.22 5.48 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.934 1.756 . . . . 0.68000000000000005 112.685 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.435 HD11 ' HG2' ' A' ' 199' ' ' ARG . 5.4 mt -89.16 163.75 2.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.182 -0.917 . . . . 1.6100000000000001 110.291 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.42 145.81 17.91 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.694 -0.765 . . . . 0.46000000000000002 111.229 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.656 ' CZ3' HD13 ' A' ' 181' ' ' LEU . 48.7 m95 -66.76 -16.05 63.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.166 0.508 . . . . 0.37 110.29 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 2.2999999999999998 110.769 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.59 ' O ' HG22 ' A' ' 177' ' ' VAL . 24.1 m -70.18 137.29 50.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.398 -0.364 . . . . 0.68999999999999995 110.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.03 116.16 10.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.432 -0.581 . . . . 1.73 109.432 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.416 ' CD1' HG21 ' A' ' 169' ' ' VAL . 7.7 tt -69.68 -20.86 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.292 0.479 . . . . 0.51000000000000001 112.292 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 81.6 p -71.0 -6.57 39.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 1.5800000000000001 111.261 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -91.73 -16.42 26.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.262 0.553 . . . . 4.6299999999999999 110.975 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.5 mp -99.41 11.93 37.75 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.077 0.941 . . . . 1.75 111.035 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.51 ' CG2' ' HB2' ' A' ' 155' ' ' PRO . 4.3 m -50.0 138.67 15.15 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.516 -1.674 . . . . 0.55000000000000004 113.293 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.41 -2.63 28.48 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.53000000000000003 112.798 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.561 ' O ' HG21 ' A' ' 157' ' ' VAL . 48.2 mt-10 -115.1 131.77 56.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.885 -0.413 . . . . 2.1600000000000001 109.885 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.7 mt-10 -83.4 136.08 34.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.717 0.77 . . . . 2.0299999999999998 111.032 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.489 ' HB2' HG11 ' A' ' 159' ' ' VAL . 54.1 mt -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.552 -1.204 . . . . 1.97 110.58 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -127.33 134.52 49.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.241 0.544 . . . . 3.3599999999999999 110.815 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.511 ' CG2' HD23 ' A' ' 181' ' ' LEU . 86.5 t -114.76 116.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.555 -0.748 . . . . 1.55 109.145 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.526 ' HG3' ' HH ' ' A' ' 198' ' ' TYR . 66.0 mm-40 -120.16 133.66 55.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.542 -0.754 . . . . 1.9399999999999999 109.925 -172.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.8 t -64.05 130.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.135 -0.484 . . . . 1.8600000000000001 111.092 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.46 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 52.1 mt -81.6 83.78 6.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.842 -0.617 . . . . 2.3399999999999999 110.495 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.57 114.88 29.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.798 -0.637 . . . . 2.1200000000000001 110.452 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.9 41.41 32.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.674 -0.694 . . . . 4.4199999999999999 111.124 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 55.2 t 50.49 86.93 0.14 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.127 -1.397 . . . . 6.3700000000000001 112.519 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.91 135.5 12.58 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.282 1.988 . . . . 7.2599999999999998 111.713 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.397 -0.811 . . . . 9.2200000000000006 110.072 178.958 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.59 ' O3 ' ' H11' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 110.27 -0.27 . . . . 5.9500000000000002 110.27 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -67.85 -25.7 38.96 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.434 2.09 . . . . 3.96 111.339 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.422 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 24.7 tp60 -121.06 121.1 37.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.235 -0.893 . . . . 3.8799999999999999 108.89 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -69.72 110.54 6.69 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 123.276 0.36 . . . . 2.7400000000000002 110.152 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.52 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 42.3 Cg_endo -85.29 146.92 9.98 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.495 2.13 . . . . 0.48999999999999999 111.736 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.417 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 16.6 pt -143.13 143.94 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.175 0.512 . . . . 1.3700000000000001 111.545 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 220' ' ' GLU . 89.3 t -117.59 117.73 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.627 -0.879 . . . . 1.5900000000000001 108.627 170.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.544 ' HG2' HG13 ' A' ' 168' ' ' VAL . 87.4 mtm180 -97.28 113.62 25.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.039 -0.528 . . . . 3.4199999999999999 110.867 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 222' ' ' LEU . 24.3 t -99.04 126.54 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.214 -0.448 . . . . 1.1000000000000001 111.456 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 25.1 m-85 -78.25 101.05 6.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.647 -0.501 . . . . 0.76000000000000001 109.647 171.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 165' ' ' GLN . 0.4 OUTLIER -58.72 168.36 1.45 Allowed Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 122.553 0.341 . . . . 1.95 111.789 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 81.7 Cg_exo -47.12 149.44 3.63 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.915 2.41 . . . . 0.56000000000000005 111.449 167.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.83 8.22 6.65 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.709 0.766 . . . . 2.4199999999999999 109.22 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.671 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.83 48.44 16.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.153 -1.385 . . . . 3.1299999999999999 112.022 178.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.581 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 11.9 mm-40 -80.39 -176.91 5.91 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.628 -1.619 . . . . 2.02 106.628 166.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -147.56 131.09 16.75 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.56 -1.256 . . . . 2.8300000000000001 112.052 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.529 HG22 ' CB ' ' A' ' 184' ' ' ALA . 5.5 t -112.18 173.0 6.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.125 -1.398 . . . . 0.92000000000000004 108.988 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.544 HG13 ' HG2' ' A' ' 158' ' ' ARG . 3.3 t -139.37 129.08 30.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.818 -0.438 . . . . 1.1899999999999999 109.818 172.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.27 120.95 22.42 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.461 -0.79 . . . . 1.77 109.615 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 52.1 Cg_exo -50.22 135.28 38.35 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.008 2.472 . . . . 0.82999999999999996 111.454 174.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.88 105.96 0.52 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.34999999999999998 110.243 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.67 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 3.6 mmp_? -100.7 111.04 23.21 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 3.2799999999999998 111.31 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.83 123.82 26.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.76 -0.654 . . . . 2.1899999999999999 109.886 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 -7.69 59.29 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.683 -0.967 . . . . 0.42999999999999999 110.683 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 172' ' ' ARG . 53.7 t -103.7 128.54 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.215 0.531 . . . . 1.46 110.047 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 178' ' ' ARG . 25.5 p -78.08 156.63 29.89 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.528 -0.76 . . . . 0.78000000000000003 110.062 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.659 ' O ' HD12 ' A' ' 181' ' ' LEU . 23.3 t -48.39 -43.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.851 -0.425 . . . . 2.04 109.851 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 1.3 ptm180 -53.56 -47.01 70.45 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 112.726 0.639 . . . . 4.25 112.726 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.479 ' HB3' HG11 ' A' ' 175' ' ' VAL . 21.0 t70 -68.12 -50.25 55.91 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.698 0.761 . . . . 1.1899999999999999 109.875 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.1 p -59.62 -55.53 33.3 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.091 -1.413 . . . . 1.76 110.732 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.691 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -91.93 -2.5 56.75 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 118.78 -1.168 . . . . 1.5 113.334 -174.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.514 ' N ' HD11 ' A' ' 181' ' ' LEU . 18.5 ptpt -70.95 -32.76 69.74 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 117.989 -1.485 . . . . 1.6399999999999999 107.909 169.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -37.55 87.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.169 -0.678 . . . . 2.2599999999999998 109.169 169.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -52.04 -52.52 50.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.694 -0.23 . . . . 0.79000000000000004 111.283 173.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.74 -52.23 65.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.798 0.333 . . . . 2.2400000000000002 110.59 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 17.6 mmt -62.79 -22.37 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.667 0.617 . . . . 2.1299999999999999 112.667 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 18.1 mmt -71.65 -38.22 70.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.823 0.345 . . . . 1.3 110.207 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.504 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 11.8 mmm180 -73.85 -23.6 59.64 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.519 0.676 . . . . 2.5600000000000001 109.685 172.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.77 9.52 37.43 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.022 -0.99 . . . . 0.53000000000000003 111.468 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.99 177.0 5.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.937 0.398 . . . . 2.0499999999999998 110.666 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 193' ' ' GLU . 41.1 pt -124.8 141.77 39.05 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.58999999999999997 110.776 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.415 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 60.9 Cg_endo -72.26 -10.01 25.13 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 123.242 2.628 . . . . 0.63 112.472 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.518 ' HB3' HD11 ' A' ' 191' ' ' ILE . 15.4 tt0 -54.57 -48.01 72.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.825 -0.625 . . . . 1.74 111.301 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 83.7 m -102.3 25.78 8.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.49 -0.777 . . . . 2.3999999999999999 111.173 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.547 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 78.0 m -131.79 151.41 51.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.555 -0.293 . . . . 1.03 110.764 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.35 158.67 30.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.402 -0.592 . . . . 0.67000000000000004 109.402 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.404 HG11 HD13 ' A' ' 208' ' ' ILE . 41.4 t -112.22 134.67 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.895 0.855 . . . . 1.6200000000000001 112.474 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -134.72 174.74 10.24 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.17 -1.377 . . . . 2.8399999999999999 109.913 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.443 ' NE ' ' HG2' ' A' ' 220' ' ' GLU . 9.0 ptm180 -150.03 136.23 18.81 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.364 -0.976 . . . . 1.8799999999999999 108.364 169.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.554 HG12 ' CD2' ' A' ' 223' ' ' HIS . 27.6 mm -86.62 122.61 38.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.817 0.818 . . . . 1.01 110.814 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 203' ' ' GLY . 2.1 tp-100 -102.32 -145.31 0.36 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 113.985 -1.461 . . . . 2.98 108.733 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.85 81.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.745 0.418 . . . . 1.9099999999999999 111.876 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.59 8.85 10.53 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.537 -0.363 . . . . 1.2 112.697 -177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.72 -179.71 5.22 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.319 0.581 . . . . 1.54 111.397 -172.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.466 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 36.7 mtpt -116.98 134.68 54.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.405 -0.816 . . . . 2.0499999999999998 110.957 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -117.57 112.44 39.04 Favored Pre-proline 0 C--N 1.315 -0.926 0 N-CA-C 109.227 -0.657 . . . . 2.0800000000000001 109.227 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.77 118.48 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.2 1.933 . . . . 0.68000000000000005 111.458 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 209' ' ' GLY . 16.3 mt -93.49 160.05 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.125 0.488 . . . . 1.6100000000000001 111.304 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -97.51 145.53 17.86 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.884 -0.887 . . . . 0.46000000000000002 110.884 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.573 ' CZ3' HD13 ' A' ' 181' ' ' LEU . 62.0 m95 -70.73 -18.39 62.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.951 0.405 . . . . 0.37 110.791 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -89.58 -5.78 56.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 2.2999999999999998 110.387 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.436 ' O ' HG21 ' A' ' 177' ' ' VAL . 98.0 m -69.34 146.6 52.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.68999999999999995 110.071 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.455 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 12.1 t70 -79.1 129.8 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.851 -0.426 . . . . 1.73 109.851 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.87 -21.68 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.832 0.348 . . . . 0.51000000000000001 111.759 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 44.6 t -75.85 -7.75 55.24 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.098 -0.376 . . . . 1.5800000000000001 110.399 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 13.0 m0 -82.36 -11.12 58.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.385 0.612 . . . . 4.6299999999999999 109.586 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 220' ' ' GLU . 18.8 mt -114.54 6.87 15.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.468 -0.787 . . . . 1.75 110.385 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.457 HG23 ' HB2' ' A' ' 155' ' ' PRO . 21.1 m -42.94 134.71 3.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.091 0.774 . . . . 0.55000000000000004 113.091 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 71.36 12.68 73.14 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.87 -0.605 . . . . 0.53000000000000003 112.266 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.46 ' O ' HG11 ' A' ' 157' ' ' VAL . 7.5 tp10 -115.33 141.21 48.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.956 -0.387 . . . . 2.1600000000000001 109.956 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.9 123.07 33.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 2.0299999999999998 110.123 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.402 ' HB2' HG21 ' A' ' 159' ' ' VAL . 8.7 mp -99.29 170.5 8.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.625 -0.716 . . . . 1.97 110.121 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.554 ' CD2' HG12 ' A' ' 200' ' ' ILE . 12.1 p80 -149.0 130.25 14.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.509 -0.552 . . . . 3.3599999999999999 109.509 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 47.3 t -98.57 135.37 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.105 -0.498 . . . . 1.55 110.794 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -118.95 126.22 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.091 -0.958 . . . . 1.9399999999999999 110.231 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.69 129.83 26.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.421 . . . . 1.8600000000000001 111.384 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 79.1 mt -89.18 101.73 14.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.752 -0.658 . . . . 2.3399999999999999 110.391 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.84 97.57 3.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.998 -0.546 . . . . 2.1200000000000001 110.448 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -91.74 60.64 4.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.313 0.577 . . . . 4.4199999999999999 110.476 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.0 m -71.76 125.9 91.57 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.783 -0.644 . . . . 6.3700000000000001 110.592 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.66 39.06 0.81 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.892 2.395 . . . . 7.2599999999999998 112.44 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.2 tp . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.605 -0.712 . . . . 9.2200000000000006 109.787 -177.228 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.611 ' O3 ' ' H11' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 120.836 0.351 . . . . 5.9500000000000002 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.08 141.47 47.6 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.34 2.693 . . . . 3.96 112.543 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -79.9 112.95 17.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.201 -0.454 . . . . 3.8799999999999999 110.336 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -108.87 98.18 28.26 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.23 -0.441 . . . . 2.7400000000000002 109.811 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.491 ' HB2' HG23 ' A' ' 218' ' ' THR . 95.9 Cg_endo -73.29 145.13 38.11 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.443 2.095 . . . . 0.48999999999999999 112.977 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.8 pt -140.13 154.75 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.696 -0.684 . . . . 1.3700000000000001 110.701 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.4 t -121.2 126.86 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 108.814 -0.81 . . . . 1.5900000000000001 108.814 172.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.499 ' CG ' HG13 ' A' ' 168' ' ' VAL . 11.1 mtp180 -102.9 107.03 17.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.401 -0.818 . . . . 3.4199999999999999 110.879 -174.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' A' ' 222' ' ' LEU . 3.5 t -97.44 125.56 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.471 -0.331 . . . . 1.1000000000000001 111.441 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -72.63 103.23 3.51 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.189 0.518 . . . . 0.76000000000000001 110.232 173.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.681 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 28.3 mt -56.86 155.02 16.24 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 1.95 110.963 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 62.8 Cg_exo -53.17 153.8 15.5 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.8 2.333 . . . . 0.56000000000000005 111.421 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 5.2 m-20 71.79 18.48 5.14 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.428 0.632 . . . . 2.4199999999999999 110.474 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.26 35.4 5.96 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.985 -1.007 . . . . 3.1299999999999999 112.558 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.681 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.5 mm100 -94.49 -179.62 4.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.602 -1.258 . . . . 2.02 107.602 171.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -147.24 138.33 23.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.871 -0.732 . . . . 2.8300000000000001 110.704 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.5 ' HA ' ' C1 ' ' A' ' 301' ' ' 6FS . 13.5 t -119.17 171.96 7.92 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.854 -1.066 . . . . 0.92000000000000004 109.042 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.499 HG13 ' CG ' ' A' ' 158' ' ' ARG . 3.1 t -141.17 129.82 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.748 -0.464 . . . . 1.1899999999999999 109.748 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.49 HG11 ' CD1' ' A' ' 214' ' ' ILE . 3.3 p -131.75 130.39 22.29 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.274 -0.875 . . . . 1.77 109.251 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -49.24 144.01 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.359 2.706 . . . . 0.82999999999999996 112.014 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.73 82.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.29 0.567 . . . . 0.34999999999999998 109.76 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.505 ' HB3' HG22 ' A' ' 175' ' ' VAL . 36.9 mmt180 -70.76 110.65 5.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.282 -0.872 . . . . 3.2799999999999998 110.82 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 32.3 m -80.45 118.35 21.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.651 -0.704 . . . . 2.1899999999999999 109.564 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.53 17.65 32.97 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.788 -0.925 . . . . 0.42999999999999999 110.788 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 179' ' ' ASP . 18.3 t -128.38 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.179 -0.51 . . . . 1.46 110.351 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.456 ' OG1' ' HG3' ' A' ' 178' ' ' ARG . 32.7 p -70.62 148.8 47.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.903 -0.59 . . . . 0.78000000000000003 109.872 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 181' ' ' LEU . 14.5 p -49.51 -37.71 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.888 -0.412 . . . . 2.04 109.888 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.628 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -57.94 -34.8 70.27 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.489 -0.778 . . . . 4.25 112.174 -173.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -77.02 -49.91 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.9 0.857 . . . . 1.1899999999999999 109.714 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -53.25 59.44 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.714 -1.13 . . . . 1.76 110.716 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -88.96 0.69 56.42 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.0 -1.08 . . . . 1.5 112.887 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.628 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 17.3 ptpt -69.05 -35.56 76.71 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.257 -1.377 . . . . 1.6399999999999999 107.736 167.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.495 ' HD2' ' HE1' ' A' ' 187' ' ' MET . 25.3 ttpt -65.15 -38.23 89.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.666 -0.814 . . . . 2.2599999999999998 109.26 171.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -48.92 -54.69 14.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.946 -0.301 . . . . 0.79000000000000004 110.631 172.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.76 -53.75 54.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.466 -0.334 . . . . 2.2400000000000002 111.045 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.89 -24.63 64.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.086 -0.506 . . . . 2.1299999999999999 112.291 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.495 ' HE1' ' HD2' ' A' ' 183' ' ' LYS . 12.4 mmt -78.19 -41.22 35.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.515 -0.55 . . . . 1.3 109.515 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.522 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 15.2 tpt180 -71.0 -18.12 62.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.695 -0.684 . . . . 2.5600000000000001 109.802 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.28 4.08 44.18 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.687 -0.688 . . . . 0.53000000000000003 112.824 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 190' ' ' LEU . 5.4 mp -102.18 175.29 5.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.94 0.4 . . . . 2.0499999999999998 111.543 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.439 HD11 ' HB2' ' A' ' 193' ' ' GLU . 46.5 pt -119.31 139.89 28.26 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.944 -0.571 . . . . 0.58999999999999997 110.381 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.457 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 55.6 Cg_endo -69.15 -14.3 37.77 Favored 'Trans proline' 0 N--CA 1.47 0.113 0 C-N-CA 123.348 2.699 . . . . 0.63 112.469 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.439 ' HB2' HD11 ' A' ' 191' ' ' ILE . 29.4 mt-10 -63.09 -37.04 85.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 1.74 110.846 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 75.7 m -101.42 17.3 23.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.954 -0.566 . . . . 2.3999999999999999 110.764 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.421 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 85.2 m -128.99 156.91 43.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.163 -0.471 . . . . 1.03 110.784 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.401 ' HB2' HD23 ' A' ' 227' ' ' LEU . . . -124.96 158.33 33.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.389 -0.597 . . . . 0.67000000000000004 109.389 173.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.43 HG23 ' CE2' ' A' ' 210' ' ' TRP . 96.1 t -106.88 139.09 29.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.782 0.801 . . . . 1.6200000000000001 111.792 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -136.86 173.48 11.65 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.229 -1.35 . . . . 2.8399999999999999 109.899 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.414 ' HB3' HD11 ' A' ' 208' ' ' ILE . 11.2 ptm180 -152.36 141.16 21.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.132 -1.062 . . . . 1.8799999999999999 108.132 168.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.613 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 18.5 mm -89.4 121.28 39.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.764 0.792 . . . . 1.01 110.492 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.764 ' OE1' ' HE3' ' A' ' 206' ' ' LYS . 8.7 tt0 -105.88 -142.66 0.37 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.315 -1.311 . . . . 2.98 107.554 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.55 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.663 0.616 . . . . 1.9099999999999999 112.663 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.58 5.17 6.27 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 116.121 -0.491 . . . . 1.2 113.643 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.17 176.98 8.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.73 0.765 . . . . 1.54 111.842 -171.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 46.3 mtpt -109.59 131.62 54.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.249 -0.887 . . . . 2.0499999999999998 111.443 -171.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.764 ' HE3' ' OE1' ' A' ' 201' ' ' GLN . 5.4 mptp? -118.51 118.47 33.68 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.62 -0.718 . . . . 2.0800000000000001 110.35 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.1 117.36 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.05 1.834 . . . . 0.68000000000000005 111.511 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.414 HD11 ' HB3' ' A' ' 199' ' ' ARG . 6.4 mt -91.31 162.05 2.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.129 -0.487 . . . . 1.6100000000000001 110.883 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 141.47 17.7 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.719 -0.753 . . . . 0.46000000000000002 111.244 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.59 ' HA ' ' CG1' ' A' ' 177' ' ' VAL . 61.2 m95 -70.5 -12.91 61.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.731 0.301 . . . . 0.37 111.148 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.98 -12.91 40.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.492 . . . . 2.2999999999999998 110.116 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.6 m -60.8 127.97 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.68999999999999995 111.09 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 215' ' ' SER . 13.6 t70 -68.05 127.98 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 1.73 110.038 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.49 ' CD1' HG11 ' A' ' 169' ' ' VAL . 7.8 tt -68.53 -20.53 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.132 -0.486 . . . . 0.51000000000000001 112.153 -172.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.439 ' HB3' ' OD2' ' A' ' 213' ' ' ASP . 34.8 t -69.29 -11.73 61.06 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.112 -0.367 . . . . 1.5800000000000001 111.244 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -89.76 -17.97 27.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 4.6299999999999999 110.083 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 220' ' ' GLU . 33.4 mt -94.84 3.99 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 1.75 109.999 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 155' ' ' PRO . 58.4 m -43.07 139.78 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.55000000000000004 113.331 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.42 -8.67 46.03 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.368 -0.833 . . . . 0.53000000000000003 112.088 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 34.5 mm-40 -102.6 154.96 18.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.279 0.562 . . . . 2.1600000000000001 111.168 -175.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 35.5 mt-10 -101.39 124.09 46.51 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.342 -0.845 . . . . 2.0299999999999998 109.379 174.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.407 ' HB3' HG11 ' A' ' 159' ' ' VAL . 7.0 mp -96.01 173.38 7.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.948 -0.569 . . . . 1.97 110.218 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -137.99 135.21 35.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.15 -0.685 . . . . 3.3599999999999999 109.15 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.441 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 86.8 t -103.52 124.9 58.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.101 -0.64 . . . . 1.55 110.264 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -109.62 119.11 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.39 -0.823 . . . . 1.9399999999999999 108.801 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.08 126.75 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.718 -0.475 . . . . 1.8600000000000001 109.718 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 196' ' ' ALA . 63.2 mt -79.45 88.68 5.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.728 -0.669 . . . . 2.3399999999999999 109.699 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -94.17 97.66 10.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.178 -0.919 . . . . 2.1200000000000001 111.058 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -82.08 67.7 8.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.556 -0.747 . . . . 4.4199999999999999 109.061 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.5 m 44.29 71.67 1.43 Allowed Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.448 1.092 . . . . 6.3700000000000001 112.599 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.11 152.0 56.11 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.134 2.556 . . . . 7.2599999999999998 112.338 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 232' ' ' LEU . 1.3 pt? . . . . . 0 C--O 1.248 1.013 0 CA-C-N 116.191 -0.458 . . . . 9.2200000000000006 110.273 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.581 ' O3 ' ' H11' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.839 -0.43 . . . . 5.9500000000000002 109.839 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.19 -38.82 33.75 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.913 2.409 . . . . 3.96 112.649 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -132.15 120.39 22.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.847 0.356 . . . . 3.8799999999999999 110.888 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -120.87 96.28 48.72 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.694 -0.484 . . . . 2.7400000000000002 109.694 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.442 ' HB2' HG23 ' A' ' 218' ' ' THR . 71.6 Cg_endo -70.8 148.29 58.02 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.507 2.138 . . . . 0.48999999999999999 111.843 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 20.7 pt -138.19 152.93 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 1.3700000000000001 111.628 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.3 t -124.69 129.82 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.734 -0.839 . . . . 1.5900000000000001 108.734 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.577 ' CG ' HG13 ' A' ' 168' ' ' VAL . 38.6 mtm-85 -101.51 123.01 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.855 -0.611 . . . . 3.4199999999999999 110.477 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 222' ' ' LEU . 40.8 t -108.23 127.77 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.415 -0.357 . . . . 1.1000000000000001 111.722 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -80.51 99.45 8.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.205 -0.665 . . . . 0.76000000000000001 109.205 170.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.7 OUTLIER -61.78 167.85 4.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.655 0.983 . . . . 1.95 113.655 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 73.7 Cg_exo -49.96 152.82 6.93 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.787 2.991 . . . . 0.56000000000000005 111.842 167.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.69 13.8 7.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.296 1.046 . . . . 2.4199999999999999 109.047 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.629 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 57.82 44.83 19.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.89 -1.505 . . . . 3.1299999999999999 112.108 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -82.44 178.16 8.37 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.819 -1.549 . . . . 2.02 106.819 166.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.403 ' HE ' ' HB3' ' A' ' 166' ' ' ARG . 12.2 ttp180 -148.6 129.75 14.55 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.542 -0.863 . . . . 2.8300000000000001 111.06 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.552 HG22 ' CB ' ' A' ' 184' ' ' ALA . 12.6 t -118.67 177.92 4.66 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.129 -0.942 . . . . 0.92000000000000004 109.494 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.577 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.4 t -142.81 129.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.702 -0.481 . . . . 1.1899999999999999 109.702 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.542 HG21 ' CD1' ' A' ' 214' ' ' ILE . 5.2 m -124.06 131.63 24.24 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.391 -0.822 . . . . 1.77 109.72 173.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 78.1 Cg_exo -49.4 146.36 14.23 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.634 2.223 . . . . 0.82999999999999996 112.143 175.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -66.81 80.21 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.34999999999999998 110.222 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 175' ' ' VAL . 26.8 mmm180 -64.64 112.22 3.09 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.055 -0.975 . . . . 3.2799999999999998 111.131 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.6 136.59 36.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.933 -0.576 . . . . 2.1899999999999999 110.333 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.84 14.69 82.32 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.016 -0.834 . . . . 0.42999999999999999 111.016 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 172' ' ' ARG . 55.3 t -126.78 135.11 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.038 0.447 . . . . 1.46 110.763 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.7 p -83.13 167.09 18.12 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.817 -0.629 . . . . 0.78000000000000003 110.326 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.677 ' O ' HD12 ' A' ' 181' ' ' LEU . 2.4 m -53.4 -37.73 30.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 108.487 -0.931 . . . . 2.04 108.487 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.8 tmm_? -44.56 -62.72 1.09 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.174 -0.921 . . . . 4.25 112.619 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.679 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 30.1 t70 -68.05 -44.37 76.55 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.394 0.616 . . . . 1.1899999999999999 111.034 -174.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.8 p -62.13 -54.65 38.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.462 -0.79 . . . . 1.76 110.656 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.705 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -91.52 -2.66 57.11 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.396 -0.922 . . . . 1.5 112.848 -175.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 13.6 ptmm? -68.34 -36.04 78.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.68 -1.23 . . . . 1.6399999999999999 107.68 168.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.89 -36.38 83.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.24 -0.891 . . . . 2.2599999999999998 109.345 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -53.63 -55.78 22.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.525 -0.307 . . . . 0.79000000000000004 111.097 173.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 190' ' ' LEU . 3.5 mm? -53.83 -50.48 66.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.376 -0.375 . . . . 2.2400000000000002 110.774 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 37.2 mtt -70.31 -21.69 62.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.342 0.497 . . . . 2.1299999999999999 112.342 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 16.4 mmt -76.3 -18.98 58.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 1.3 110.119 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.464 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 7.3 tpm_? -97.33 -11.83 23.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.439 -0.8 . . . . 2.5600000000000001 109.768 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 94.85 19.71 30.72 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.53000000000000003 111.955 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.442 ' HB2' HD11 ' A' ' 185' ' ' LEU . 7.7 mt -116.83 172.24 7.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.642 0.258 . . . . 2.0499999999999998 110.437 -176.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.7 pt -121.57 142.76 36.39 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.497 . . . . 0.58999999999999997 110.683 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.413 ' HG3' ' CB ' ' A' ' 182' ' ' LYS . 73.9 Cg_endo -75.15 -13.1 21.21 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 123.258 2.639 . . . . 0.63 112.968 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.37 -41.41 93.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 1.74 110.952 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 37.9 t -94.36 8.0 43.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.945 -0.571 . . . . 2.3999999999999999 110.785 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.424 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 73.1 m -116.29 158.18 23.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.65 0.262 . . . . 1.03 110.878 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.431 ' HB2' ' CG ' ' A' ' 227' ' ' LEU . . . -128.11 157.55 40.45 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.67000000000000004 110.053 174.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.404 HG23 ' CE2' ' A' ' 210' ' ' TRP . 13.9 t -118.89 124.1 72.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.136 0.493 . . . . 1.6200000000000001 110.717 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.73 ' CB ' ' HA ' ' A' ' 207' ' ' PRO . 55.1 p90 -154.66 154.65 33.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.672 -0.694 . . . . 2.8399999999999999 110.597 175.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.582 ' HG3' HD11 ' A' ' 208' ' ' ILE . 81.4 mtp180 -106.44 130.3 54.27 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.021 -0.424 . . . . 1.8799999999999999 111.272 -175.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.411 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 20.0 mm -82.57 123.03 38.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.972 0.892 . . . . 1.01 110.516 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 201' ' ' GLN . 1.5 tp60 -105.06 -143.2 0.37 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.957 -1.474 . . . . 2.98 108.707 177.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.84 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.076 0.399 . . . . 1.9099999999999999 112.076 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.61 9.83 20.68 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.381 -0.438 . . . . 1.2 112.467 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -130.01 -177.78 4.44 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 120.841 0.353 . . . . 1.54 110.807 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.633 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 7.9 mtpt -122.54 122.3 38.56 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.011 -0.54 . . . . 2.0499999999999998 110.942 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.08 97.08 10.63 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.153 -1.054 . . . . 2.0800000000000001 108.153 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.73 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 23.2 Cg_exo -65.85 129.82 23.05 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.509 2.139 . . . . 0.68000000000000005 113.035 -175.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.582 HD11 ' HG3' ' A' ' 199' ' ' ARG . 2.6 mm -90.81 164.06 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.845 -0.798 . . . . 1.6100000000000001 108.845 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.419 ' H ' HG23 ' A' ' 208' ' ' ILE . . . -98.2 138.2 13.74 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.563 -0.827 . . . . 0.46000000000000002 111.205 176.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.648 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 62.3 m95 -68.06 -18.62 64.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.137 0.494 . . . . 0.37 110.244 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -95.08 6.67 48.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.553 -0.748 . . . . 2.2999999999999998 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 99.9 m -86.33 144.3 27.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.68999999999999995 110.354 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.96 128.02 34.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.03 -0.532 . . . . 1.73 111.184 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.542 ' CD1' HG21 ' A' ' 169' ' ' VAL . 6.5 tt -72.7 -26.95 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.51000000000000001 110.683 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 44.3 t -68.06 -14.96 63.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 1.5800000000000001 110.596 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -86.16 -13.06 48.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.446 0.641 . . . . 4.6299999999999999 109.615 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 mt -105.71 8.28 32.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.495 -0.775 . . . . 1.75 109.868 -176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.442 HG23 ' HB2' ' A' ' 155' ' ' PRO . 67.7 m -40.56 134.57 1.74 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.772 1.027 . . . . 0.55000000000000004 113.772 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.5 4.5 61.04 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.522 -0.763 . . . . 0.53000000000000003 112.281 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.63 162.58 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.714 -0.476 . . . . 2.1600000000000001 109.714 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 41.2 mt-10 -111.9 129.45 56.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.589 0.709 . . . . 2.0299999999999998 111.456 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 159' ' ' VAL . 66.3 mt -97.77 155.41 17.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.455 -1.248 . . . . 1.97 109.81 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.83 116.0 16.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.702 0.763 . . . . 3.3599999999999999 109.904 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.441 HG22 HD23 ' A' ' 181' ' ' LEU . 79.4 t -100.83 137.77 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 1.55 110.997 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.5 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 17.8 mm-40 -131.74 135.5 46.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.855 -1.066 . . . . 1.9399999999999999 109.694 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 19.5 t -68.11 126.36 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 110.054 -0.35 . . . . 1.8600000000000001 110.054 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 44.5 mt -75.98 82.6 2.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.347 0.594 . . . . 2.3399999999999999 110.712 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -110.04 97.63 7.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.652 -0.704 . . . . 2.1200000000000001 110.434 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.22 59.59 5.66 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.972 -0.558 . . . . 4.4199999999999999 110.144 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.405 HG11 ' O ' ' A' ' 230' ' ' VAL . 75.5 t 55.62 80.74 0.28 Allowed Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 114.506 -1.225 . . . . 6.3700000000000001 111.071 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.74 -11.29 8.01 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.063 2.509 . . . . 7.2599999999999998 112.071 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.6 tp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.673 -0.679 . . . . 9.2200000000000006 110.032 -177.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.647 ' O3 ' ' H11' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.593 0.235 . . . . 5.9500000000000002 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -54.1 -37.03 86.89 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.067 2.511 . . . . 3.96 112.134 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -89.29 107.96 19.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.064 -0.516 . . . . 3.8799999999999999 109.697 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -74.93 115.48 44.87 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.752 -0.462 . . . . 2.7400000000000002 109.752 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.445 ' HB2' HG23 ' A' ' 218' ' ' THR . 88.5 Cg_endo -76.09 144.02 26.36 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.342 2.028 . . . . 0.48999999999999999 112.264 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.438 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 1.5 pp -141.78 147.07 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.892 0.377 . . . . 1.3700000000000001 111.295 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 220' ' ' GLU . 99.4 t -116.99 123.32 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.037 -0.727 . . . . 1.5900000000000001 109.037 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.557 ' CG ' HG13 ' A' ' 168' ' ' VAL . 42.6 mtp180 -98.81 114.31 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.464 -0.789 . . . . 3.4199999999999999 110.868 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.7 125.9 59.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.373 -0.376 . . . . 1.1000000000000001 111.537 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -76.23 101.96 5.63 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.611 -0.515 . . . . 0.76000000000000001 109.611 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.2 OUTLIER -67.09 158.03 82.79 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 1.95 111.136 176.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.539 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 50.2 Cg_exo -56.31 144.62 81.68 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 123.387 2.724 . . . . 0.56000000000000005 112.514 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 92.6 m-20 74.03 30.02 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.618 0.574 . . . . 2.4199999999999999 111.054 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.619 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 66.37 32.37 7.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.252 -0.885 . . . . 3.1299999999999999 112.774 173.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -90.47 167.07 12.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.462 -1.681 . . . . 2.02 106.462 171.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -148.86 136.44 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.672 -0.811 . . . . 2.8300000000000001 110.343 176.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.539 HG22 ' CB ' ' A' ' 184' ' ' ALA . 10.1 t -123.94 172.59 8.82 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.241 -0.891 . . . . 0.92000000000000004 109.852 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.557 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.6 t -142.12 128.07 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 109.249 -0.649 . . . . 1.1899999999999999 109.249 172.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' ' 214' ' ' ILE . 3.2 m -118.63 135.26 23.59 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.157 -0.929 . . . . 1.77 108.884 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' A' ' 172' ' ' ARG . 61.5 Cg_exo -51.26 146.06 25.08 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 121.872 1.714 . . . . 0.82999999999999996 110.532 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.23 81.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.373 -0.602 . . . . 0.34999999999999998 109.373 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 35.6 mmt180 -65.11 111.24 2.83 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.695 -1.139 . . . . 3.2799999999999998 109.974 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 26.9 p -78.43 130.41 36.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.877 0.37 . . . . 2.1899999999999999 110.782 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.2 22.61 44.04 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.628 -0.796 . . . . 0.42999999999999999 112.539 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 179' ' ' ASP . 1.4 p -137.58 153.44 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 1.46 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 40.3 p -91.05 164.64 13.88 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 116.024 -0.535 . . . . 0.78000000000000003 110.834 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.741 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 5.2 m -55.4 -32.93 30.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.268 0.556 . . . . 2.04 109.608 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.6 tpt180 -53.29 -48.23 68.53 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 115.202 -0.908 . . . . 4.25 112.171 -175.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.0 t70 -75.96 -49.93 16.34 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.377 0.608 . . . . 1.1899999999999999 110.564 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.1 p -59.61 -55.77 30.33 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.951 -1.022 . . . . 1.76 110.689 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.56 HD21 ' O ' ' A' ' 177' ' ' VAL . 0.1 OUTLIER -92.28 -5.33 52.55 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.069 -1.052 . . . . 1.5 112.659 -176.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.654 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 17.6 ptpt -61.2 -40.03 92.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 116.85 -1.94 . . . . 1.6399999999999999 107.716 167.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.496 ' HD2' ' HE1' ' A' ' 187' ' ' MET . 6.4 ttpm? -66.24 -38.27 87.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.976 -0.556 . . . . 2.2599999999999998 109.92 174.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.539 ' CB ' HG22 ' A' ' 167' ' ' THR . . . -49.96 -54.19 21.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.226 0.536 . . . . 0.79000000000000004 110.467 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.64 -51.05 68.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.519 -0.764 . . . . 2.2400000000000002 111.251 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.647 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 67.5 mtp -67.58 -21.82 65.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.509 -0.314 . . . . 2.1299999999999999 111.846 -173.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.496 ' HE1' ' HD2' ' A' ' 183' ' ' LYS . 26.4 mtt -77.84 -25.92 49.08 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.535 -0.542 . . . . 1.3 109.535 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.442 ' HB2' HD23 ' A' ' 161' ' ' LEU . 11.1 tpt180 -87.6 -11.28 49.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.511 -0.768 . . . . 2.5600000000000001 109.356 174.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.26 4.43 44.09 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.731 -0.668 . . . . 0.53000000000000003 113.251 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.421 HD11 ' N ' ' A' ' 190' ' ' LEU . 5.3 mp -97.43 176.87 5.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 2.0499999999999998 111.599 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.39 146.88 63.88 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.58999999999999997 110.293 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -4.61 15.59 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.354 2.703 . . . . 0.63 113.303 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.169 0.509 . . . . 1.74 110.029 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 227' ' ' LEU . 48.7 t -107.49 28.41 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.615 -0.72 . . . . 2.3999999999999999 110.388 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.481 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.2 m -151.25 155.44 38.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.231 -0.441 . . . . 1.03 110.189 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.538 ' N ' HD21 ' A' ' 227' ' ' LEU . . . -131.33 173.34 11.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.148 -1.056 . . . . 0.67000000000000004 108.148 169.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.499 HG22 HD23 ' A' ' 181' ' ' LEU . 13.1 t -114.44 136.73 50.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.276 0.56 . . . . 1.6200000000000001 111.343 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -135.36 168.53 19.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.218 -0.901 . . . . 2.8399999999999999 110.139 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.423 ' HG2' HD11 ' A' ' 208' ' ' ILE . 10.1 ptm180 -138.6 136.26 35.79 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.447 -0.945 . . . . 1.8799999999999999 108.447 168.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.622 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 21.7 mm -87.82 119.56 35.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.971 0.891 . . . . 1.01 110.963 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.559 ' NE2' ' HA ' ' A' ' 201' ' ' GLN . 0.4 OUTLIER -98.14 -146.86 0.32 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.952 -1.476 . . . . 2.98 108.809 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.15 80.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.079 0.399 . . . . 1.9099999999999999 112.079 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.3 13.03 27.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.324 -0.465 . . . . 1.2 112.125 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -132.14 -178.35 4.86 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.084 0.469 . . . . 1.54 110.96 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.622 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 42.6 mtpt -120.78 136.1 54.98 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.859 -0.61 . . . . 2.0499999999999998 111.195 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -122.35 112.99 31.06 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.079 -0.712 . . . . 2.0800000000000001 109.079 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.18 125.97 11.92 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.003 1.802 . . . . 0.68000000000000005 112.944 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.423 HD11 ' HG2' ' A' ' 199' ' ' ARG . 6.9 mm -84.09 162.2 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.421 -0.809 . . . . 1.6100000000000001 109.595 177.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.78 140.31 14.94 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.847 -0.901 . . . . 0.46000000000000002 110.847 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.741 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 90.2 m95 -68.02 -14.37 62.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.277 0.539 . . . . 0.37 110.619 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -99.32 0.39 42.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.2999999999999998 110.388 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.7 m -75.07 140.78 43.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.754 -0.657 . . . . 0.68999999999999995 110.106 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.27 121.19 20.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.451 . . . . 1.73 110.193 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.503 ' CD1' HG21 ' A' ' 169' ' ' VAL . 4.1 tt -67.97 -28.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.51000000000000001 111.733 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -72.87 -8.39 55.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.228 0.537 . . . . 1.5800000000000001 110.342 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -83.62 -17.08 42.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.67 0.748 . . . . 4.6299999999999999 109.568 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -101.82 9.84 40.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.344 -0.843 . . . . 1.75 110.007 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.445 HG23 ' HB2' ' A' ' 155' ' ' PRO . 63.0 m -39.92 130.7 2.01 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.747 1.018 . . . . 0.55000000000000004 113.747 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.42 -1.18 61.88 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.508 -0.769 . . . . 0.53000000000000003 112.347 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.55 ' O ' HG11 ' A' ' 157' ' ' VAL . 38.7 mt-10 -105.61 138.26 42.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.8 0.333 . . . . 2.1600000000000001 110.205 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -84.46 128.9 34.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.294 0.569 . . . . 2.0299999999999998 110.598 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 48.9 mt -103.61 169.43 8.53 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.265 -0.88 . . . . 1.97 109.957 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -147.16 136.55 22.69 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.104 -0.702 . . . . 3.3599999999999999 109.104 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 72.3 t -99.32 144.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.935 0.398 . . . . 1.55 110.944 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 224' ' ' VAL . 68.8 mm-40 -109.64 145.8 35.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.865 -0.791 . . . . 1.9399999999999999 108.865 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 8.3 t -83.52 114.77 24.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.381 0.61 . . . . 1.8600000000000001 110.399 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.538 HD21 ' N ' ' A' ' 196' ' ' ALA . 4.2 mm? -104.85 90.81 3.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.162 -0.926 . . . . 2.3399999999999999 110.401 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -94.14 133.03 38.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.22 -0.9 . . . . 2.1200000000000001 111.207 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 20.8 m120 58.84 56.21 4.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.629 0.728 . . . . 4.4199999999999999 111.527 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.424 HG11 ' H ' ' A' ' 232' ' ' LEU . 9.1 t -65.67 117.33 40.29 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.733 -1.121 . . . . 6.3700000000000001 110.998 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.09 20.46 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.935 2.423 . . . . 7.2599999999999998 112.817 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.424 ' H ' HG11 ' A' ' 230' ' ' VAL . 93.0 mt . . . . . 0 C--O 1.246 0.916 0 CA-C-N 115.666 -0.697 . . . . 9.2200000000000006 110.861 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.841 ' H15' ' C19' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.639 0.256 . . . . 5.9500000000000002 110.725 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.23 108.74 0.53 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.868 2.378 . . . . 3.96 111.905 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -75.2 120.74 21.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.357 -0.383 . . . . 3.8799999999999999 110.25 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -116.12 91.16 31.04 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 2.7400000000000002 110.361 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.538 ' HB2' HG23 ' A' ' 218' ' ' THR . 83.4 Cg_endo -77.52 144.59 22.74 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.387 2.058 . . . . 0.48999999999999999 111.737 175.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 17.4 pt -134.62 144.74 34.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 1.3700000000000001 110.965 176.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.678 HG21 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -124.41 117.05 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.806 0.812 . . . . 1.5900000000000001 108.977 173.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.567 ' CG ' HG13 ' A' ' 168' ' ' VAL . 18.1 mtm-85 -83.59 130.57 34.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.557 -1.201 . . . . 3.4199999999999999 110.506 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.457 ' HB ' ' CG2' ' A' ' 167' ' ' THR . 7.5 t -120.64 117.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.201 -0.909 . . . . 1.1000000000000001 111.215 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 10.2 m-85 -71.77 102.83 2.93 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.991 0.424 . . . . 0.76000000000000001 110.392 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 27.8 mt -55.46 151.04 21.49 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 124.294 1.038 . . . . 1.95 111.5 173.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.542 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 60.5 Cg_exo -54.06 161.69 4.76 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.022 2.481 . . . . 0.56000000000000005 111.869 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 67.76 14.78 9.55 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.206 -1.035 . . . . 2.4199999999999999 108.206 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 63.01 40.22 9.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 113.645 -1.616 . . . . 3.1299999999999999 112.235 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.666 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 3.0 mm-40 -96.7 -176.55 3.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.378 -1.342 . . . . 2.02 107.378 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 30.1 ttp180 -145.81 127.11 14.86 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.232 -0.987 . . . . 2.8300000000000001 111.66 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.553 ' HA ' ' C1 ' ' A' ' 301' ' ' 6FS . 12.1 t -109.55 176.66 4.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.611 -1.177 . . . . 0.92000000000000004 108.544 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.567 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.1 t -141.32 126.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.676 -0.861 . . . . 1.1899999999999999 108.676 168.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 214' ' ' ILE . 9.2 m -107.53 127.54 27.61 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.764 -0.653 . . . . 1.77 109.956 167.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 71.9 Cg_exo -50.51 142.51 30.42 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.163 1.909 . . . . 0.82999999999999996 110.461 169.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.431 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -64.7 88.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.34999999999999998 110.228 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 175' ' ' VAL . 29.0 mmt180 -70.87 110.98 5.94 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.085 -0.961 . . . . 3.2799999999999998 109.181 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.2 p -82.38 126.54 32.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.246 -0.434 . . . . 2.1899999999999999 110.904 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.14 22.51 29.8 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.539 -0.839 . . . . 0.42999999999999999 111.944 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 179' ' ' ASP . 1.3 p -138.1 154.59 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.061 0.457 . . . . 1.46 110.151 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.4 p -86.23 158.87 19.62 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.94 -0.573 . . . . 0.78000000000000003 110.72 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.677 ' O ' HD12 ' A' ' 181' ' ' LEU . 42.0 t -45.84 -49.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.224 -0.658 . . . . 2.04 109.224 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 11.8 tpt180 -41.57 -56.18 2.65 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 124.743 1.277 . . . . 4.25 113.239 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.734 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.5 t70 -67.5 -47.66 69.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.255 0.55 . . . . 1.1899999999999999 110.622 -176.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.8 t -64.28 -47.74 78.36 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.047 -0.661 . . . . 1.76 110.183 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.677 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -93.03 -2.58 55.54 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.271 -0.971 . . . . 1.5 112.464 -175.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 14.5 ptmm? -69.95 -31.4 69.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.27 -1.382 . . . . 1.6399999999999999 107.27 167.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.0 OUTLIER -65.94 -41.73 90.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.08 -0.964 . . . . 2.2599999999999998 109.418 168.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -50.61 -55.95 13.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.55 -0.295 . . . . 0.79000000000000004 110.983 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 185' ' ' LEU . 3.4 mm? -53.96 -51.9 62.37 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.494 -0.321 . . . . 2.2400000000000002 110.911 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -25.29 67.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 2.1299999999999999 112.363 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.55 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 24.2 mmt -78.48 -31.52 47.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.812 0.339 . . . . 1.3 110.222 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.531 ' HD3' HD13 ' A' ' 161' ' ' LEU . 15.4 tpt180 -77.52 -14.86 59.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.458 0.647 . . . . 2.5600000000000001 109.975 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.03 55.86 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.53000000000000003 111.543 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.7 mt -108.68 176.89 4.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.079 -0.341 . . . . 2.0499999999999998 110.079 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 193' ' ' GLU . 46.1 pt -122.63 140.96 34.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.58999999999999997 111.489 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.52 -10.55 26.99 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.55 2.833 . . . . 0.63 112.739 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' A' ' 191' ' ' ILE . 38.0 mt-10 -62.38 -44.19 97.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.336 0.589 . . . . 1.74 110.505 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.4 m -97.04 20.17 11.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.403 -0.817 . . . . 2.3999999999999999 110.989 -176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.549 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 72.8 m -128.39 156.66 42.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.542 -0.299 . . . . 1.03 110.713 -175.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -130.03 152.93 48.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.67000000000000004 109.995 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.517 HG13 ' CE2' ' A' ' 210' ' ' TRP . 3.5 m -110.68 126.96 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.791 0.805 . . . . 1.6200000000000001 111.108 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.664 ' CE1' ' HE3' ' A' ' 205' ' ' LYS . 51.7 p90 -158.23 156.04 30.04 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.51 -0.768 . . . . 2.8399999999999999 109.456 173.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.546 ' HG3' HD11 ' A' ' 208' ' ' ILE . 81.7 mtp180 -103.61 159.06 15.93 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.931 -0.308 . . . . 1.8799999999999999 111.133 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 20.5 mm -108.06 124.35 64.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.908 0.861 . . . . 1.01 111.202 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.473 ' CD ' ' HE3' ' A' ' 206' ' ' LYS . 5.6 tt0 -99.52 -148.72 0.35 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.968 -1.469 . . . . 2.98 107.473 174.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -54.27 82.08 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.164 0.586 . . . . 1.9099999999999999 112.433 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 60.81 7.81 8.98 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 121.612 -0.328 . . . . 1.2 112.621 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -126.12 179.88 5.04 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 120.707 0.289 . . . . 1.54 110.458 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.664 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 14.8 mtpt -120.65 137.75 54.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.243 0.544 . . . . 2.0499999999999998 111.616 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.473 ' HE3' ' CD ' ' A' ' 201' ' ' GLN . 70.9 mmtt -121.12 96.53 48.31 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 107.983 -1.118 . . . . 2.0800000000000001 107.983 173.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.659 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 26.8 Cg_exo -64.78 124.1 12.67 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.676 2.25 . . . . 0.68000000000000005 113.531 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.546 HD11 ' HG3' ' A' ' 199' ' ' ARG . 1.2 mm -97.13 161.55 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 108.216 -1.031 . . . . 1.6100000000000001 108.216 175.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.62 151.26 18.58 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.467 -1.349 . . . . 0.46000000000000002 113.004 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.543 ' CZ3' HD13 ' A' ' 181' ' ' LEU . 69.1 m95 -70.52 -18.43 62.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.872 0.368 . . . . 0.37 110.598 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -97.82 -1.96 42.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 2.2999999999999998 110.564 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.582 ' O ' HG22 ' A' ' 177' ' ' VAL . 89.3 m -70.34 142.02 52.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.829 -0.623 . . . . 0.68999999999999995 109.788 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.99 119.16 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.265 -0.642 . . . . 1.73 109.265 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 169' ' ' VAL . 4.4 tt -71.24 -27.01 27.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.51000000000000001 111.377 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.0 t -70.84 -7.78 47.88 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.479 0.656 . . . . 1.5800000000000001 109.717 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -88.37 -6.99 57.37 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.498 0.666 . . . . 4.6299999999999999 109.487 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.8 mt -112.61 7.48 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.431 -0.804 . . . . 1.75 110.038 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 155' ' ' PRO . 61.0 m -42.29 134.5 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.916 -1.038 . . . . 0.55000000000000004 113.7 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.4 57.64 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.53000000000000003 112.335 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.678 ' O ' HG21 ' A' ' 157' ' ' VAL . 41.6 mt-10 -113.36 148.92 34.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.864 0.364 . . . . 2.1600000000000001 110.391 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.6 mp0 -92.26 126.61 37.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.217 0.532 . . . . 2.0299999999999998 111.448 -176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 80.8 mt -99.56 155.13 17.74 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.22 -0.9 . . . . 1.97 110.144 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.448 ' HA ' ' HB2' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -119.34 124.72 47.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.743 0.306 . . . . 3.3599999999999999 110.219 173.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.549 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 72.6 t -105.7 116.93 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.569 0.7 . . . . 1.55 109.408 172.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.531 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 54.0 mm-40 -119.55 133.02 55.86 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.921 -1.036 . . . . 1.9399999999999999 109.19 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.542 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 41.3 t -67.29 128.54 30.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 1.8600000000000001 111.187 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 196' ' ' ALA . 79.2 mt -86.1 88.08 7.53 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.708 -0.678 . . . . 2.3399999999999999 110.774 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.35 139.4 31.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.167 -0.47 . . . . 2.1200000000000001 109.865 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.48 59.52 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.621 0.576 . . . . 4.4199999999999999 110.466 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.02 142.68 83.04 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.624 -0.716 . . . . 6.3700000000000001 111.165 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.29 133.38 55.65 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.079 2.52 . . . . 7.2599999999999998 112.176 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.405 ' N ' HD21 ' A' ' 232' ' ' LEU . 2.0 pt? . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.395 -0.812 . . . . 9.2200000000000006 110.355 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.621 ' O3 ' ' H11' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.233 -0.284 . . . . 5.9500000000000002 110.233 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.02 89.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.186 2.591 . . . . 3.96 112.399 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -121.46 146.54 46.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.878 -0.601 . . . . 3.8799999999999999 109.535 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.543 ' HE2' ' N1 ' ' A' ' 301' ' ' 6FS . 0.7 OUTLIER -105.73 91.07 4.76 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.322 -0.621 . . . . 2.7400000000000002 109.322 175.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 55.1 Cg_endo -81.42 138.97 11.25 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.527 2.152 . . . . 0.48999999999999999 111.64 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.572 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 39.5 pt -140.63 139.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.745 0.307 . . . . 1.3700000000000001 111.081 -178.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 88.4 t -112.53 118.76 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.149 -0.685 . . . . 1.5900000000000001 109.149 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.604 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 66.1 mtm180 -97.02 115.74 27.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.632 -0.713 . . . . 3.4199999999999999 110.538 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.49 ' CG1' HG23 ' A' ' 224' ' ' VAL . 13.5 t -105.85 127.02 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.233 -0.44 . . . . 1.1000000000000001 111.653 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 27.3 m-85 -74.22 103.09 4.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.302 -0.408 . . . . 0.76000000000000001 110.161 173.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.2 mm? -55.04 163.27 1.58 Allowed Pre-proline 0 N--CA 1.474 0.737 0 CA-C-O 121.331 0.586 . . . . 1.95 112.013 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.404 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 77.2 Cg_exo -51.24 160.48 2.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.964 2.443 . . . . 0.56000000000000005 111.047 163.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 67.89 6.99 5.46 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.069 0.462 . . . . 2.4199999999999999 110.213 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.509 ' HE2' ' HA ' ' A' ' 164' ' ' LYS . 8.1 mmpt? 70.2 39.39 1.31 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.134 -0.939 . . . . 3.1299999999999999 111.88 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.626 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 4.1 mm-40 -91.02 -178.89 5.32 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.549 -0.908 . . . . 2.02 108.549 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 33.0 ttp180 -147.38 132.89 18.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.006 -0.677 . . . . 2.8300000000000001 111.541 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.56 ' HB ' HD23 ' A' ' 161' ' ' LEU . 12.6 t -120.64 -177.74 3.54 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.459 -1.246 . . . . 0.92000000000000004 108.743 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.604 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.39 129.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.321 0.581 . . . . 1.1899999999999999 111.127 170.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.563 HG21 ' CD1' ' A' ' 214' ' ' ILE . 5.1 m -112.26 131.86 22.37 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.964 -1.016 . . . . 1.77 109.551 172.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 74.0 Cg_exo -48.35 141.86 18.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.504 2.136 . . . . 0.82999999999999996 111.859 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 155' ' ' PRO . . . -65.81 83.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.34999999999999998 110.44 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 175' ' ' VAL . 31.1 mmt180 -72.55 113.65 9.81 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 3.2799999999999998 110.041 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.416 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 41.9 t -82.81 124.75 30.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 2.1899999999999999 110.757 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.06 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.72 -0.752 . . . . 0.42999999999999999 111.915 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 179' ' ' ASP . 8.5 p -135.27 150.92 29.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.746 -0.464 . . . . 1.46 109.746 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 57.4 p -81.38 155.49 25.9 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.165 -0.471 . . . . 0.78000000000000003 110.777 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.619 ' O ' HD12 ' A' ' 181' ' ' LEU . 53.0 t -46.46 -46.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.18 -0.674 . . . . 2.04 109.18 173.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 9.5 tpt180 -41.51 -54.98 2.99 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 124.319 1.012 . . . . 4.25 113.125 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.6 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.8 t70 -68.6 -48.95 62.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.502 0.668 . . . . 1.1899999999999999 110.772 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.3 m -64.59 -46.79 81.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.325 -0.852 . . . . 1.76 111.02 -173.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.667 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -93.25 -4.49 51.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.928 -1.109 . . . . 1.5 112.529 -177.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.3 ptpt -67.23 -34.41 77.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 118.123 -1.431 . . . . 1.6399999999999999 107.697 168.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.56 -36.57 81.2 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.571 -0.741 . . . . 2.2599999999999998 109.48 171.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -51.94 -52.1 52.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.662 -0.245 . . . . 0.79000000000000004 110.825 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.62 -50.97 71.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.435 -0.348 . . . . 2.2400000000000002 111.067 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.488 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 49.2 mtt -68.47 -20.99 64.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.515 0.561 . . . . 2.1299999999999999 112.515 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 18.4 mmt -80.97 -20.32 42.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 1.3 109.722 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.508 ' HB3' ' CD1' ' A' ' 190' ' ' LEU . 10.2 tpt180 -91.09 -17.03 26.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.695 0.76 . . . . 2.5600000000000001 109.144 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.56 6.32 41.24 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 114.785 -1.098 . . . . 0.53000000000000003 112.835 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 188' ' ' ARG . 5.2 mp -104.96 174.64 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.112 0.482 . . . . 2.0499999999999998 111.718 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.1 pt -119.74 144.17 36.53 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.58999999999999997 110.53 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.76 -4.44 15.36 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.53 2.82 . . . . 0.63 113.593 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -69.38 -42.13 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 1.74 111.095 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 25.5 p -97.17 15.47 22.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 2.3999999999999999 110.609 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.614 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.6 m -123.1 149.6 44.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.07 -0.514 . . . . 1.03 110.661 -175.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -118.49 152.23 36.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.813 -0.44 . . . . 0.67000000000000004 109.813 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.56 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 13.6 t -118.88 124.54 73.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.097 0.475 . . . . 1.6200000000000001 110.867 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.741 ' CB ' ' HA ' ' A' ' 207' ' ' PRO . 51.9 p90 -155.23 149.61 26.09 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.483 -0.78 . . . . 2.8399999999999999 109.764 174.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.422 ' HG2' HD11 ' A' ' 208' ' ' ILE . 6.8 ptm180 -106.41 152.11 24.04 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.062 -0.347 . . . . 1.8799999999999999 110.062 -172.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.442 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 22.2 mm -98.37 122.42 50.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.84 0.829 . . . . 1.01 110.532 174.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 203' ' ' GLY . 4.6 tt0 -99.78 -146.6 0.34 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.19 -1.368 . . . . 2.98 107.885 175.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -55.78 80.54 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.292 0.637 . . . . 1.9099999999999999 112.386 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.02 9.04 12.29 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.508 -0.377 . . . . 1.2 112.524 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -127.87 -178.98 4.72 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 120.797 0.332 . . . . 1.54 110.354 -172.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.626 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 9.3 mtpt -124.19 129.76 51.36 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.952 0.406 . . . . 2.0499999999999998 110.925 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 24.5 mmtp -113.71 98.96 48.87 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.298 -1.001 . . . . 2.0800000000000001 108.298 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.741 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 31.4 Cg_exo -62.27 121.79 9.96 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.184 1.923 . . . . 0.68000000000000005 112.295 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 198' ' ' TYR . 14.7 mm -77.24 148.02 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 115.937 -0.574 . . . . 1.6100000000000001 109.61 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 212' ' ' THR . . . -85.31 131.06 10.21 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.675 -1.37 . . . . 0.46000000000000002 109.675 171.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.56 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 57.6 m95 -65.38 -21.08 66.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.037 0.446 . . . . 0.37 110.194 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.02 1.7 52.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.533 0.683 . . . . 2.2999999999999998 110.086 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.603 ' O ' HG22 ' A' ' 177' ' ' VAL . 54.5 m -72.37 145.75 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.906 -0.588 . . . . 0.68999999999999995 110.282 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.61 115.02 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.497 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.563 ' CD1' HG21 ' A' ' 169' ' ' VAL . 2.4 tt -62.58 -29.4 46.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.51000000000000001 111.505 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -73.24 -8.25 55.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.857 -0.61 . . . . 1.5800000000000001 110.563 -173.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -82.27 -21.69 36.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.52 0.676 . . . . 4.6299999999999999 109.815 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.64 11.79 35.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.476 -0.783 . . . . 1.75 110.031 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.447 HG23 ' CB ' ' A' ' 155' ' ' PRO . 94.9 m -37.68 129.66 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.497 0.925 . . . . 0.55000000000000004 113.497 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.16 -14.03 29.64 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.816 -0.629 . . . . 0.53000000000000003 112.302 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.31 158.31 26.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.954 0.407 . . . . 2.1600000000000001 110.306 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.5 mt-10 -109.48 115.48 30.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.596 0.712 . . . . 2.0299999999999998 109.933 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 36.4 mt -95.6 164.67 12.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.644 -1.162 . . . . 1.97 110.989 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 2.1 m-70 -126.64 123.62 38.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 3.3599999999999999 110.614 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 98.4 t -101.61 112.37 34.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.666 0.746 . . . . 1.55 109.631 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 57.9 mm-40 -116.09 124.92 51.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.833 -1.076 . . . . 1.9399999999999999 109.082 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 47.9 t -55.75 134.05 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 1.8600000000000001 111.871 -173.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 38.7 mt -78.9 89.02 4.7 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.686 -0.688 . . . . 2.3399999999999999 110.336 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -109.48 97.59 7.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.479 -0.782 . . . . 2.1200000000000001 109.874 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -155.02 53.61 0.64 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.749 -0.659 . . . . 4.4199999999999999 109.235 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 43.6 t 57.27 90.1 0.09 OUTLIER Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 114.517 -1.22 . . . . 6.3700000000000001 111.258 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.36 -60.7 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.617 2.211 . . . . 7.2599999999999998 111.609 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.4 mt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.287 -0.863 . . . . 9.2200000000000006 110.022 179.526 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.651 ' O3 ' ' H11' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.3 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.663 0.268 . . . . 5.9500000000000002 110.402 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.19 -21.44 23.58 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.1 2.533 . . . . 3.96 112.797 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -123.98 152.09 42.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.337 -0.392 . . . . 3.8799999999999999 110.33 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -113.87 96.41 41.19 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.434 -0.348 . . . . 2.7400000000000002 110.143 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB2' HG23 ' A' ' 218' ' ' THR . 65.1 Cg_endo -79.95 149.6 20.34 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.621 2.214 . . . . 0.48999999999999999 112.19 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.567 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 2.0 pp -146.42 147.43 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.888 0.375 . . . . 1.3700000000000001 111.682 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.4 t -119.72 125.69 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.818 -0.808 . . . . 1.5900000000000001 108.818 174.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.575 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 62.5 mtm180 -99.05 116.84 32.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.756 -0.656 . . . . 3.4199999999999999 110.678 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.413 ' O ' HG21 ' A' ' 167' ' ' THR . 2.0 t -106.11 120.56 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.282 -0.417 . . . . 1.1000000000000001 111.411 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 33.7 m-85 -72.6 103.27 3.51 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.039 -0.356 . . . . 0.76000000000000001 110.039 174.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.569 HD22 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -66.07 156.44 84.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 120.892 0.377 . . . . 1.95 110.749 176.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 93.0 Cg_exo -43.75 150.54 0.53 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.785 2.99 . . . . 0.56000000000000005 112.97 171.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 74.69 10.86 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.554 -0.748 . . . . 2.4199999999999999 110.037 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 76.03 32.36 0.63 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.144 -0.935 . . . . 3.1299999999999999 112.558 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.1 mm100 -86.11 173.39 9.88 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.32 -0.993 . . . . 2.02 108.32 171.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 19.3 ttp180 -147.48 130.76 16.53 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.738 -0.785 . . . . 2.8300000000000001 111.487 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.569 ' HB ' HD22 ' A' ' 161' ' ' LEU . 6.2 t -113.79 179.07 4.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.608 -1.178 . . . . 0.92000000000000004 108.837 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.575 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.25 128.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.53 0.681 . . . . 1.1899999999999999 110.756 165.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.7 m -108.95 145.26 31.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.58 -1.191 . . . . 1.77 109.61 174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.42 145.05 29.57 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.05 1.833 . . . . 0.82999999999999996 111.313 171.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 155' ' ' PRO . . . -68.43 79.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.333 0.587 . . . . 0.34999999999999998 109.996 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.421 ' O ' HG13 ' A' ' 175' ' ' VAL . 15.1 mmm180 -64.27 111.79 2.77 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.081 -0.963 . . . . 3.2799999999999998 110.72 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 76.3 m -77.72 126.54 31.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.572 -0.74 . . . . 2.1899999999999999 110.935 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.18 21.93 39.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.777 -0.725 . . . . 0.42999999999999999 112.174 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 172' ' ' ARG . 1.7 p -131.69 150.93 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.082 0.468 . . . . 1.46 110.368 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 51.4 p -87.18 158.95 19.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.786 -0.643 . . . . 0.78000000000000003 111.121 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.647 ' O ' HD12 ' A' ' 181' ' ' LEU . 59.6 t -48.4 -44.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 2.04 109.704 173.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.559 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 12.0 tpt180 -43.77 -51.28 7.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.217 -0.902 . . . . 4.25 113.224 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 12.2 t70 -72.77 -50.93 21.32 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.743 0.782 . . . . 1.1899999999999999 110.609 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.4 p -59.69 -51.89 67.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.606 -1.179 . . . . 1.76 110.568 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.657 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -90.86 -3.67 57.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 118.812 -1.155 . . . . 1.5 112.994 -177.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.0 ptpt -66.35 -33.69 76.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 118.195 -1.402 . . . . 1.6399999999999999 107.755 170.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.2 OUTLIER -70.6 -39.57 73.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.393 -0.822 . . . . 2.2599999999999998 109.49 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.536 ' CB ' HG22 ' A' ' 167' ' ' THR . . . -50.58 -52.61 37.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.975 0.417 . . . . 0.79000000000000004 111.116 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.4 HD23 HG13 ' A' ' 224' ' ' VAL . 5.5 mt -61.58 -51.05 70.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 2.2400000000000002 111.261 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -26.67 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.531 . . . . 2.1299999999999999 112.432 -174.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.5 mmt -75.6 -18.73 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.058 0.456 . . . . 1.3 110.954 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.45 ' HG3' ' HG ' ' A' ' 161' ' ' LEU . 4.2 mmp_? -96.04 -12.11 25.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.487 0.66 . . . . 2.5600000000000001 110.05 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.05 19.13 40.63 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.179 -0.918 . . . . 0.53000000000000003 111.675 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.8 mt -102.62 168.55 9.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.168 -0.308 . . . . 2.0499999999999998 110.168 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 193' ' ' GLU . 46.7 pt -127.39 143.43 47.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 121.317 0.58 . . . . 0.58999999999999997 111.777 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 -4.37 15.31 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.521 2.814 . . . . 0.63 112.854 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.404 ' HB2' HD11 ' A' ' 191' ' ' ILE . 24.7 mt-10 -75.46 -34.71 60.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 1.74 110.657 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 60.4 m -107.3 7.56 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 2.3999999999999999 111.74 -175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.506 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 83.9 m -127.49 145.48 50.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.919 -0.313 . . . . 1.03 111.248 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.785 ' N ' HD23 ' A' ' 227' ' ' LEU . . . -111.52 160.79 16.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.67000000000000004 109.835 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.415 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 12.7 t -117.21 125.05 73.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.001 0.429 . . . . 1.6200000000000001 110.124 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.78 ' CE1' ' HE3' ' A' ' 205' ' ' LYS . 52.4 p90 -152.86 150.31 29.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.777 -0.647 . . . . 2.8399999999999999 110.4 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.499 ' CG ' HD11 ' A' ' 208' ' ' ILE . 15.1 ptm180 -105.97 145.19 31.65 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.057 -0.349 . . . . 1.8799999999999999 110.057 -171.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 24.3 mm -91.44 123.75 43.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.98 0.895 . . . . 1.01 110.918 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 201' ' ' GLN . 1.9 tp60 -103.27 -142.84 0.36 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.944 -1.48 . . . . 2.98 109.012 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.38 77.59 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.841 0.456 . . . . 1.9099999999999999 112.046 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.77 9.85 15.69 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.559 -0.353 . . . . 1.2 112.282 -175.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -127.38 -176.14 3.65 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.791 0.329 . . . . 1.54 110.646 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.78 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 10.3 mtpt -121.14 129.15 53.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.055 0.455 . . . . 2.0499999999999998 111.21 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 34.3 mmtp -114.29 98.23 48.07 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.145 -1.057 . . . . 2.0800000000000001 108.145 173.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.706 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 28.4 Cg_exo -63.2 124.73 14.39 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.372 2.048 . . . . 0.68000000000000005 113.222 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 198' ' ' TYR . 7.6 mm -82.84 161.78 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.253 -0.647 . . . . 1.6100000000000001 109.253 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -97.74 140.76 15.22 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.386 -1.086 . . . . 0.46000000000000002 110.386 174.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.583 ' CZ3' HD13 ' A' ' 181' ' ' LEU . 56.7 m95 -68.75 -13.16 62.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.074 0.464 . . . . 0.37 110.451 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.75 5.54 43.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 2.2999999999999998 110.333 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.507 ' O ' HG22 ' A' ' 177' ' ' VAL . 49.3 m -72.0 137.89 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.072 -0.513 . . . . 0.68999999999999995 110.051 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.499 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 13.0 t70 -74.05 112.88 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.73 109.995 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 4.2 tt -62.04 -26.02 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.181 -0.463 . . . . 0.51000000000000001 112.141 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.554 ' CB ' ' HA ' ' A' ' 173' ' ' CYS . 2.0 t -70.11 -8.65 51.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.708 0.289 . . . . 1.5800000000000001 111.157 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.432 ' HB3' HD13 ' A' ' 217' ' ' LEU . 1.7 t90 -87.11 -20.85 26.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.737 0.78 . . . . 4.6299999999999999 109.29 175.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.576 ' N ' HD13 ' A' ' 217' ' ' LEU . 6.9 mp -100.07 12.83 35.97 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 1.75 110.674 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 155' ' ' PRO . 90.8 m -39.21 129.73 1.69 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.764 -1.562 . . . . 0.55000000000000004 113.059 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.61 -7.86 51.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.698 -0.683 . . . . 0.53000000000000003 112.356 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -96.64 164.11 12.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.86 0.362 . . . . 2.1600000000000001 110.92 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 38.2 mt-10 -113.87 122.8 48.13 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.328 0.585 . . . . 2.0299999999999998 110.87 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.482 HD23 HD23 ' A' ' 217' ' ' LEU . 26.1 mt -99.29 161.49 13.59 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 1.97 111.081 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 26.3 m-70 -124.64 127.2 46.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.425 . . . . 3.3599999999999999 110.138 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 75.5 t -104.98 130.31 56.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.221 0.534 . . . . 1.55 109.66 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.588 ' HG3' ' HH ' ' A' ' 198' ' ' TYR . 6.7 mm-40 -128.65 130.06 46.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.162 -0.926 . . . . 1.9399999999999999 110.466 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 162' ' ' PRO . 99.6 t -68.01 126.43 27.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.622 -0.51 . . . . 1.8600000000000001 109.622 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 196' ' ' ALA . 1.0 OUTLIER -85.43 82.81 8.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.494 -0.558 . . . . 2.3399999999999999 109.494 -178.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -84.6 95.87 9.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.56 -0.746 . . . . 2.1200000000000001 109.896 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -133.3 59.41 1.74 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.604 0.716 . . . . 4.4199999999999999 109.39 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.17 114.96 35.97 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.723 -1.126 . . . . 6.3700000000000001 110.785 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -90.19 26.97 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.07 2.513 . . . . 7.2599999999999998 112.879 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 41.4 tp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.324 -0.846 . . . . 9.2200000000000006 110.382 179.052 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.628 ' O3 ' ' H11' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.123 -0.325 . . . . 5.9500000000000002 110.123 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.74 -26.49 79.83 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.204 2.603 . . . . 3.96 112.818 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -85.36 139.14 31.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.633 -0.506 . . . . 3.8799999999999999 109.633 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.525 ' HZ1' ' HB2' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -83.87 114.7 55.74 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.328 -0.396 . . . . 2.7400000000000002 110.129 178.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 218' ' ' THR . 40.8 Cg_endo -80.64 158.16 21.83 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.52 2.147 . . . . 0.48999999999999999 111.665 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.437 HG22 ' C13' ' A' ' 301' ' ' 6FS . 22.0 pt -141.37 158.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.453 0.644 . . . . 1.3700000000000001 111.861 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 130.27 48.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.903 -1.044 . . . . 1.5900000000000001 108.934 169.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.577 ' CG ' HG13 ' A' ' 168' ' ' VAL . 9.0 mtm180 -99.6 130.23 45.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.089 -0.959 . . . . 3.4199999999999999 110.337 -169.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 222' ' ' LEU . 6.0 t -115.54 125.73 72.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.453 -0.339 . . . . 1.1000000000000001 111.581 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -77.15 103.38 7.05 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.223 -0.298 . . . . 0.76000000000000001 110.236 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 2.0 mm? -51.97 162.84 0.74 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 121.12 0.486 . . . . 1.95 111.429 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.435 ' HB3' HG21 ' A' ' 226' ' ' VAL . 78.5 Cg_exo -52.71 154.56 12.13 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.807 2.338 . . . . 0.56000000000000005 111.889 166.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 64.91 15.48 9.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.688 0.756 . . . . 2.4199999999999999 110.091 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.646 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 70.05 37.34 1.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.776 -1.102 . . . . 3.1299999999999999 113.396 171.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.67 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.7 mm-40 -86.23 176.44 7.95 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.621 -1.251 . . . . 2.02 107.621 168.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -144.91 126.23 14.83 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.463 -0.895 . . . . 2.8300000000000001 111.54 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.492 ' HA ' ' C1 ' ' A' ' 301' ' ' 6FS . 8.1 t -107.72 172.68 6.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.068 -1.424 . . . . 0.92000000000000004 108.441 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.577 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.4 t -142.97 129.04 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 121.014 0.435 . . . . 1.1899999999999999 110.081 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.12 131.38 24.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.329 -0.851 . . . . 1.77 109.751 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.75 140.13 47.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.102 1.868 . . . . 0.82999999999999996 110.548 169.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' A' ' 218' ' ' THR . . . -61.2 101.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 0.34999999999999998 110.221 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.505 ' HB3' HG22 ' A' ' 175' ' ' VAL . 35.9 mmt180 -81.03 111.13 17.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.011 -0.995 . . . . 3.2799999999999998 110.386 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 p -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.436 -0.347 . . . . 2.1899999999999999 110.911 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.54 19.82 57.64 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.718 -0.953 . . . . 0.42999999999999999 110.718 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 172' ' ' ARG . 46.8 t -129.53 132.12 66.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.952 -0.624 . . . . 1.46 110.137 -175.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.5 p -78.02 162.15 26.94 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.907 -0.405 . . . . 0.78000000000000003 109.907 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.71 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 5.9 m -52.09 -36.5 20.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.616 -0.883 . . . . 2.04 108.616 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 54.2 ttt180 -43.75 -58.84 2.5 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.807 -1.088 . . . . 4.25 112.729 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.528 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -71.61 -46.1 60.17 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 1.1899999999999999 110.598 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.5 p -62.46 -57.25 11.89 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.946 -1.025 . . . . 1.76 110.887 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.669 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -90.16 0.0 57.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 118.889 -1.124 . . . . 1.5 112.486 -176.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 17.9 ptpt -67.95 -33.96 75.68 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 117.559 -1.656 . . . . 1.6399999999999999 107.427 165.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 187' ' ' MET . 12.8 tptt -60.79 -43.67 97.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.161 -0.927 . . . . 2.2599999999999998 108.921 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -48.05 -58.95 3.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.388 0.43 . . . . 0.79000000000000004 111.432 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 185' ' ' LEU . 2.9 mm? -52.95 -51.3 61.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.338 -0.392 . . . . 2.2400000000000002 110.463 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 16.4 mtt -67.99 -21.29 65.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.29 0.478 . . . . 2.1299999999999999 112.29 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.3 mmt -77.54 -27.3 51.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.207 0.527 . . . . 1.3 109.622 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 188' ' ' ARG . 25.8 tpt180 -85.88 -19.73 30.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.522 -0.763 . . . . 2.5600000000000001 109.929 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.06 14.88 29.86 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.744 -0.662 . . . . 0.53000000000000003 111.756 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 12.9 mt -108.07 177.13 4.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.07 -0.344 . . . . 2.0499999999999998 110.07 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 193' ' ' GLU . 43.8 pt -124.64 146.51 52.89 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 121.179 0.514 . . . . 0.58999999999999997 111.022 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.434 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 96.6 Cg_endo -77.86 -12.37 16.37 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.275 2.65 . . . . 0.63 112.597 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.44 ' HB2' HD11 ' A' ' 191' ' ' ILE . 24.0 mt-10 -65.74 -26.62 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 1.74 110.819 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 20.0 t -114.43 19.34 16.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.317 -0.401 . . . . 2.3999999999999999 110.779 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.4 m -125.99 157.62 37.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.719 -0.219 . . . . 1.03 110.887 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.431 ' HB2' ' CG ' ' A' ' 227' ' ' LEU . . . -128.13 154.42 45.76 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.67000000000000004 109.966 174.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.2 t -117.71 126.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.533 0.682 . . . . 1.6200000000000001 111.536 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.736 ' CB ' ' HA ' ' A' ' 207' ' ' PRO . 54.9 p90 -154.71 150.86 28.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.087 -0.961 . . . . 2.8399999999999999 109.073 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.403 ' CG ' HD11 ' A' ' 208' ' ' ILE . 13.3 ptm180 -115.09 131.36 56.95 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.531 -0.731 . . . . 1.8799999999999999 111.507 -170.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.534 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 14.2 mm -84.88 122.79 38.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.728 0.775 . . . . 1.01 111.638 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.583 ' CD ' ' HE3' ' A' ' 206' ' ' LYS . 8.3 mt-30 -95.62 -153.05 0.38 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.154 -1.385 . . . . 2.98 108.517 173.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 201' ' ' GLN . 20.6 t70 -54.66 85.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.668 0.27 . . . . 1.9099999999999999 111.623 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 62.16 7.87 15.24 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 116.247 -0.433 . . . . 1.2 113.18 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.405 ' O ' HG21 ' A' ' 200' ' ' ILE . 15.3 pt-20 -123.97 176.24 6.46 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 117.616 0.708 . . . . 1.54 111.039 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.593 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 12.8 mtpt -123.48 127.14 47.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.047 0.451 . . . . 2.0499999999999998 110.792 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.583 ' HE3' ' CD ' ' A' ' 201' ' ' GLN . 70.6 mmtt -110.72 98.29 36.9 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 108.643 -0.873 . . . . 2.0800000000000001 108.643 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.736 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 6.6 Cg_exo -72.25 117.73 5.28 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.844 1.696 . . . . 0.68000000000000005 112.89 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.492 ' CD1' HD22 ' A' ' 222' ' ' LEU . 6.3 mt -91.02 152.04 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.241 -0.891 . . . . 1.6100000000000001 110.36 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.11 146.82 18.9 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.492 -0.861 . . . . 0.46000000000000002 111.58 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.71 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 69.0 m95 -70.15 -13.71 62.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.37 110.704 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -94.79 1.02 55.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.2999999999999998 110.206 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.8 m -74.03 129.24 37.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.925 -0.579 . . . . 0.68999999999999995 110.684 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.89 117.22 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.564 -0.532 . . . . 1.73 109.564 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 tt -66.75 -21.14 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.593 0.59 . . . . 0.51000000000000001 112.593 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 172' ' ' ARG . 67.8 p -71.04 -6.85 42.2 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.28 -0.262 . . . . 1.5800000000000001 111.646 -175.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -90.01 -10.6 44.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.461 0.648 . . . . 4.6299999999999999 109.977 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.553 ' N ' HD13 ' A' ' 217' ' ' LEU . 6.3 mp -106.41 14.13 27.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.065 0.936 . . . . 1.75 110.291 -174.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 155' ' ' PRO . 3.3 m -53.83 142.69 23.2 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.673 -1.603 . . . . 0.55000000000000004 111.869 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 74.68 -3.21 44.27 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.026 -0.534 . . . . 0.53000000000000003 112.387 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -104.96 171.2 7.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.602 -0.518 . . . . 2.1600000000000001 109.602 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.1 mt-10 -121.18 125.88 48.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.744 0.783 . . . . 2.0299999999999998 110.845 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' A' ' 208' ' ' ILE . 27.6 mt -101.14 166.07 10.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.44 -1.255 . . . . 1.97 109.325 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.81 119.8 10.68 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.802 0.811 . . . . 3.3599999999999999 110.914 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 88.8 t -101.46 134.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 1.55 110.923 -175.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.534 ' HG3' ' HH ' ' A' ' 198' ' ' TYR . 27.3 mm-40 -129.32 132.9 47.22 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 1.9399999999999999 109.669 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 162' ' ' PRO . 92.4 t -67.0 130.38 32.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.8600000000000001 110.718 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 61.1 mt -83.96 81.85 8.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.377 0.608 . . . . 2.3399999999999999 109.676 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -88.43 98.18 11.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.033 -0.985 . . . . 2.1200000000000001 111.138 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -126.7 54.24 1.62 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.974 0.892 . . . . 4.4199999999999999 109.156 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 7.9 t -78.49 120.9 82.75 Favored Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 114.393 -1.276 . . . . 6.3700000000000001 110.366 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.06 83.58 0.26 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.674 2.249 . . . . 7.2599999999999998 111.971 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.382 -0.818 . . . . 9.2200000000000006 109.942 178.594 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.618 ' O3 ' ' H11' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.314 -0.254 . . . . 5.9500000000000002 110.314 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.81 78.42 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.652 2.235 . . . . 3.96 111.531 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -78.57 136.58 37.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.5 . . . . 3.8799999999999999 111.024 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -119.47 85.44 31.81 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 109.369 -0.604 . . . . 2.7400000000000002 109.369 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.571 ' HB2' HG23 ' A' ' 218' ' ' THR . 39.0 Cg_endo -82.04 147.81 14.99 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.43 2.086 . . . . 0.48999999999999999 112.056 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.421 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 1.9 pp -139.44 150.85 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.237 0.541 . . . . 1.3700000000000001 111.697 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 220' ' ' GLU . 0.3 OUTLIER -131.42 132.92 62.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.405 -0.816 . . . . 1.5900000000000001 108.928 175.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.484 ' HG2' HG13 ' A' ' 168' ' ' VAL . 36.0 mtm-85 -102.77 129.75 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.753 -0.658 . . . . 3.4199999999999999 111.155 -168.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.468 ' HB ' HG21 ' A' ' 167' ' ' THR . 25.9 t -112.13 122.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.267 -0.424 . . . . 1.1000000000000001 111.828 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 223' ' ' HIS . 30.8 m-85 -74.71 103.53 5.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.023 -0.362 . . . . 0.76000000000000001 110.023 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.3 OUTLIER -63.7 160.78 41.79 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.89 0.376 . . . . 1.95 110.379 173.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.502 ' HD3' HG23 ' A' ' 224' ' ' VAL . 82.1 Cg_exo -45.06 152.17 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.364 2.709 . . . . 0.56000000000000005 112.316 167.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.1 m120 68.63 25.44 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 2.4199999999999999 111.176 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.603 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 68.75 28.13 5.62 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.398 0.888 . . . . 3.1299999999999999 113.398 171.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 1.7 mm-40 -89.7 169.48 11.26 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.392 -0.966 . . . . 2.02 108.392 173.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 33.4 ttp180 -146.68 135.07 21.88 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 120.264 -0.574 . . . . 2.8300000000000001 110.155 175.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.625 HG22 ' CB ' ' A' ' 184' ' ' ALA . 2.1 t -109.73 174.4 5.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.866 -1.061 . . . . 0.92000000000000004 108.845 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.484 HG13 ' HG2' ' A' ' 158' ' ' ARG . 2.9 t -138.97 127.19 27.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.823 -0.806 . . . . 1.1899999999999999 108.823 168.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.538 HG21 ' CD1' ' A' ' 214' ' ' ILE . 11.0 m -119.8 137.08 25.27 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 115.661 -0.699 . . . . 1.77 109.598 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.64 142.77 59.89 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.912 1.742 . . . . 0.82999999999999996 110.527 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.481 ' HB1' HG23 ' A' ' 218' ' ' THR . . . -68.78 80.36 0.29 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.515 0.674 . . . . 0.34999999999999998 109.196 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.446 ' O ' HG13 ' A' ' 175' ' ' VAL . 21.4 mmm180 -69.37 110.76 4.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.544 -1.207 . . . . 3.2799999999999998 109.886 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.1 p -85.48 116.68 23.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.011 -0.54 . . . . 2.1899999999999999 110.36 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.06 23.89 7.16 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.491 -0.861 . . . . 0.42999999999999999 111.497 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 179' ' ' ASP . 3.4 p -143.35 156.45 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.217 0.532 . . . . 1.46 110.838 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.5 p -93.31 161.49 14.38 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.517 -0.765 . . . . 0.78000000000000003 110.933 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.54 ' O ' HD12 ' A' ' 181' ' ' LEU . 16.0 t -48.86 -49.51 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.185 -0.461 . . . . 2.04 109.966 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -48.7 -44.75 38.37 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 113.276 0.843 . . . . 4.25 113.276 -172.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 15.7 t70 -71.5 -50.55 30.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.602 0.715 . . . . 1.1899999999999999 110.208 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.9 m -62.1 -46.29 89.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.083 -0.962 . . . . 1.76 110.925 -175.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.66 ' C ' HD11 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -95.43 -3.97 45.99 Favored 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 119.429 -0.908 . . . . 1.5 112.826 -175.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.9 ptpt -67.51 -35.34 78.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 118.098 -1.441 . . . . 1.6399999999999999 107.294 167.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.102 -0.953 . . . . 2.2599999999999998 109.563 170.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -49.9 -56.19 11.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.699 0.285 . . . . 0.79000000000000004 111.026 172.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -56.3 -50.09 72.41 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.033 -0.531 . . . . 2.2400000000000002 110.678 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 50.6 mtt -70.1 -20.91 63.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.326 0.491 . . . . 2.1299999999999999 112.326 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 19.1 mmt -75.32 -20.33 59.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.479 . . . . 1.3 109.878 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.4 ' HG2' ' HG3' ' A' ' 165' ' ' GLN . 11.5 tpt180 -97.9 -11.56 23.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.653 -0.703 . . . . 2.5600000000000001 109.623 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.39 46.45 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.277 -0.874 . . . . 0.53000000000000003 112.061 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.1 mt -104.74 175.78 5.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.79 0.328 . . . . 2.0499999999999998 110.21 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -125.86 145.18 50.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.058 0.456 . . . . 0.58999999999999997 110.694 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.455 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 86.4 Cg_endo -76.27 -4.96 15.73 Favored 'Trans proline' 0 C--O 1.23 0.084 0 C-N-CA 123.239 2.626 . . . . 0.63 112.752 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.39 -45.35 76.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.572 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.72 29.75 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 2.3999999999999999 110.091 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.513 ' HB3' HG21 ' A' ' 224' ' ' VAL . 74.1 m -135.25 150.54 50.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 1.03 110.229 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 224' ' ' VAL . . . -133.24 147.93 51.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.352 -0.981 . . . . 0.67000000000000004 108.352 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.561 ' HA ' ' HB ' ' A' ' 224' ' ' VAL . 84.9 t -99.74 135.6 34.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.742 -0.783 . . . . 1.6200000000000001 111.797 -170.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 223' ' ' HIS . 35.7 m-85 -135.05 166.74 22.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.575 -1.193 . . . . 2.8399999999999999 110.959 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.605 ' HG3' HD11 ' A' ' 208' ' ' ILE . 48.3 mtp180 -130.3 124.05 31.46 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.993 -1.003 . . . . 1.8799999999999999 109.055 164.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.586 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 21.0 mm -81.81 115.71 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 C-N-CA 119.405 -0.918 . . . . 1.01 110.123 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.488 ' NE2' ' HA ' ' A' ' 201' ' ' GLN . 0.6 OUTLIER -98.72 -145.69 0.32 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.176 -1.375 . . . . 2.98 108.739 179.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.54 79.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.7 0.625 . . . . 1.9099999999999999 112.439 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.58 13.23 30.1 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.463 -0.399 . . . . 1.2 112.53 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.55 177.86 7.28 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.172 0.511 . . . . 1.54 111.055 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.586 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 45.8 mtpt -115.09 136.13 53.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.595 -0.729 . . . . 2.0499999999999998 111.087 -175.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -119.32 108.45 39.97 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.508 -0.769 . . . . 2.0800000000000001 108.981 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.91 118.92 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.732 1.622 . . . . 0.68000000000000005 111.994 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.605 HD11 ' HG3' ' A' ' 199' ' ' ARG . 5.1 mm -87.16 162.57 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 1.6100000000000001 110.239 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -90.72 131.9 11.0 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.521 -0.763 . . . . 0.46000000000000002 111.4 175.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.567 ' CZ3' HD13 ' A' ' 181' ' ' LEU . 51.9 m95 -67.5 -17.95 64.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 0.37 111.245 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -99.44 6.37 46.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.615 0.721 . . . . 2.2999999999999998 110.045 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 86.7 m -74.34 143.6 44.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.68999999999999995 109.855 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.54 ' HB2' ' CE3' ' A' ' 216' ' ' TRP . 1.1 m-20 -70.5 115.11 9.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.904 0.383 . . . . 1.73 110.329 177.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.538 ' CD1' HG21 ' A' ' 169' ' ' VAL . 2.6 tt -64.6 -30.49 50.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.51000000000000001 111.819 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 172' ' ' ARG . 30.3 t -66.18 -6.49 13.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.141 -0.481 . . . . 1.5800000000000001 111.702 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.54 ' CE3' ' HB2' ' A' ' 213' ' ' ASP . 31.6 m0 -90.95 -12.22 36.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.012 -0.43 . . . . 4.6299999999999999 110.703 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.0 mt -102.01 9.6 40.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 1.75 110.387 -175.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 155' ' ' PRO . 4.0 m -46.41 139.04 5.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.55000000000000004 113.519 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.34 7.71 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.769 -0.65 . . . . 0.53000000000000003 112.362 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.444 ' O ' HG21 ' A' ' 157' ' ' VAL . 47.7 mt-10 -93.44 168.69 10.89 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.607 -0.516 . . . . 2.1600000000000001 109.607 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -117.63 124.05 47.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.081 0.944 . . . . 2.0299999999999998 111.591 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.429 ' HB2' HG21 ' A' ' 159' ' ' VAL . 78.9 mt -96.14 160.83 14.24 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.038 -1.437 . . . . 1.97 108.975 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 160' ' ' PHE . 1.5 t60 -151.32 115.18 4.94 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.947 -0.76 . . . . 3.3599999999999999 108.947 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 197' ' ' VAL . 0.9 OUTLIER -102.19 153.68 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.686 0.755 . . . . 1.55 111.882 -177.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -113.43 172.78 6.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.199 -1.364 . . . . 1.9399999999999999 108.654 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.9 123.4 50.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 120.911 0.386 . . . . 1.8600000000000001 111.142 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.452 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 82.9 mt -81.5 83.27 7.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.742 -0.663 . . . . 2.3399999999999999 109.578 175.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.26 120.59 20.03 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.462 -0.79 . . . . 2.1200000000000001 109.743 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -79.42 54.61 1.76 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.564 0.697 . . . . 4.4199999999999999 110.991 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.486 ' HB ' ' HD3' ' A' ' 231' ' ' PRO . 7.0 t -67.12 -48.93 47.68 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.902 -1.045 . . . . 6.3700000000000001 110.825 172.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.486 ' HD3' ' HB ' ' A' ' 230' ' ' VAL . 8.8 Cg_exo -71.53 106.73 2.01 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.715 1.61 . . . . 7.2599999999999998 111.057 173.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.483 -0.77 . . . . 9.2200000000000006 109.77 178.693 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.645 ' O3 ' ' H11' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.535 ' HB2' ' CG2' ' A' ' 218' ' ' THR . 23.2 Cg_endo . . . . . 0 N--CA 1.462 -0.372 0 N-CA-C 111.504 -0.229 . . . . 0.43 111.504 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.28 153.05 19.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.423 0.63 . . . . 0.79 112.321 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -130.34 126.98 62.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.079 -0.964 . . . . 1.05 109.248 173.575 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.584 ' HG2' HG22 ' A' ' 168' ' ' VAL . 52.8 mtm-85 -94.68 126.29 39.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.516 -0.766 . . . . 2.87 110.739 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 222' ' ' LEU . 3.5 t -108.86 124.27 65.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.842 -0.617 . . . . 0.42 111.15 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 25.3 m-85 -76.62 102.9 6.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 110.147 -0.316 . . . . 0.58 110.147 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.573 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -63.02 161.36 31.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 121.071 0.463 . . . . 1.46 111.515 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.522 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 77.0 Cg_exo -47.71 153.19 2.43 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.291 2.661 . . . . 0.5 111.783 168.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 4.6 m-20 70.76 18.15 6.31 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.78 0.432 . . . . 2.08 110.804 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 67.48 36.46 3.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.941 -0.572 . . . . 2.74 111.996 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 162' ' ' PRO . 1.7 mm-40 -95.18 174.47 7.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.458 -0.942 . . . . 1.33 108.458 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.7 ttp180 -147.39 129.47 15.49 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.811 -0.755 . . . . 2.49 111.953 175.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.592 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.5 t -107.99 175.9 5.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.48 -1.237 . . . . 0.52 109.41 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.584 HG22 ' HG2' ' A' ' 158' ' ' ARG . 5.7 t -141.27 128.97 22.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.022 -0.733 . . . . 0.88 109.022 172.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.94 137.45 29.64 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.892 -0.594 . . . . 1.31 109.619 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 50.0 Cg_exo -53.99 142.96 63.38 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.902 1.734 . . . . 0.59 110.175 171.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.542 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -67.26 83.09 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.615 0.721 . . . . 0.35 109.771 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 172' ' ' ARG . 18.5 mmm180 -66.73 111.03 3.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.358 -1.292 . . . . 2.81 111.134 -174.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 14.3 p -77.67 132.86 38.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 1.44 110.43 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.42 17.75 79.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.608 -0.806 . . . . 0.43 111.129 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 179' ' ' ASP . 34.2 t -121.89 133.19 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.247 0.546 . . . . 0.97 110.708 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.7 p -83.73 155.93 22.84 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.543 -0.753 . . . . 0.47 110.593 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.783 ' O ' HD12 ' A' ' 181' ' ' LEU . 67.2 t -45.09 -47.37 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 123.33 0.394 . . . . 1.39 110.709 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 0.7 OUTLIER -49.6 -43.55 46.54 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 113.165 0.802 . . . . 3.53 113.165 -174.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.6 t70 -72.34 -50.76 24.4 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.803 0.811 . . . . 1.19 109.824 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.4 p -61.56 -50.53 72.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.301 -1.318 . . . . 1.34 110.474 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.783 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.15 -5.75 54.55 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.28 -0.968 . . . . 1.08 113.174 -175.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.503 ' N ' HD13 ' A' ' 181' ' ' LEU . 18.0 ptpt -69.18 -31.31 69.84 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 117.845 -1.542 . . . . 1.15 107.864 169.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -44.49 96.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.466 -0.788 . . . . 1.8 109.008 168.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.05 -50.32 48.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.639 -0.709 . . . . 0.3 111.892 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.497 ' CD2' HD22 ' A' ' 181' ' ' LEU . 2.1 mm? -58.88 -52.06 67.37 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 1.46 110.524 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.7 mmt -60.69 -25.8 66.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.935 -0.575 . . . . 1.45 112.371 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 20.0 mmt -75.15 -18.01 60.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.126 0.489 . . . . 0.85 110.862 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.434 ' HD3' ' CB ' ' A' ' 165' ' ' GLN . 10.9 mmm180 -95.25 -21.11 18.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.579 0.704 . . . . 2.12 109.679 171.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.95 10.86 36.04 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.897 -1.047 . . . . 0.53 111.143 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.98 177.21 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 1.28 110.685 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 16.5 pt -129.08 145.26 55.92 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.028 -0.533 . . . . 0.52 111.079 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.84 ' HA ' ' SG ' ' A' ' 195' ' ' CYS . 61.4 Cg_endo -72.54 -4.19 14.83 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.381 2.721 . . . . 0.52 113.759 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.31 -49.76 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.939 0.4 . . . . 1.74 111.725 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 77.2 m -96.34 16.42 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.734 0.642 . . . . 1.69 112.734 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.84 ' SG ' ' HA ' ' A' ' 192' ' ' PRO . 1.3 p -115.88 160.52 20.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 0.52 111.981 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.492 ' HA ' ' HE1' ' A' ' 210' ' ' TRP . . . -125.38 155.16 40.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.398 -0.819 . . . . 0.39 109.292 169.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.524 HG23 ' CE2' ' A' ' 210' ' ' TRP . 17.6 t -117.39 122.07 69.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.372 0.606 . . . . 1.06 111.097 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.491 ' CZ ' ' HG3' ' A' ' 225' ' ' GLU . 50.6 p90 . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.222 -0.899 . . . . 2.49 109.405 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.419 ' CD1' HD22 ' A' ' 222' ' ' LEU . 5.4 mt . . . . . 0 N--CA 1.447 -0.582 0 N-CA-C 110.291 -0.262 . . . . 0.9 110.291 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.42 145.81 17.91 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.694 -0.765 . . . . 0.37 111.229 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.595 ' CZ3' HD11 ' A' ' 181' ' ' LEU . 48.7 m95 -66.76 -16.05 63.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.166 0.508 . . . . 0.31 110.29 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 2.3 110.769 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 177' ' ' VAL . 24.1 m -70.18 137.29 50.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.398 -0.364 . . . . 0.31 110.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.03 116.16 10.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.432 -0.581 . . . . 1.73 109.432 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 175' ' ' VAL . 7.7 tt -69.68 -20.86 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.292 0.479 . . . . 0.29 112.292 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.503 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 81.6 p -71.0 -6.57 39.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 1.07 111.261 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -91.73 -16.42 26.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.262 0.553 . . . . 3.87 110.975 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.5 mp -99.41 11.93 37.75 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.077 0.941 . . . . 1.21 111.035 -175.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.542 HG23 ' HB2' ' A' ' 171' ' ' ALA . 4.3 m -50.0 138.67 15.15 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.516 -1.674 . . . . 0.39 113.293 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.41 -2.63 28.48 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.53 112.798 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 157' ' ' VAL . 48.2 mt-10 -115.1 131.77 56.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.885 -0.413 . . . . 2.16 109.885 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.7 mt-10 -83.4 136.08 34.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.717 0.77 . . . . 2.03 111.032 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.542 ' HB2' HG13 ' A' ' 159' ' ' VAL . 54.1 mt -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.552 -1.204 . . . . 1.19 110.58 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -127.33 134.52 49.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.241 0.544 . . . . 2.63 110.815 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.706 HG21 HD23 ' A' ' 181' ' ' LEU . 86.5 t -114.76 116.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.555 -0.748 . . . . 0.97 109.145 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 66.0 mm-40 -120.16 133.66 55.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.542 -0.754 . . . . 1.94 109.925 -172.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 116.135 -0.484 . . . . 1.12 111.092 -176.145 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.528 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 42.3 Cg_endo . . . . . 0 N--CA 1.458 -0.565 0 N-CA-C 111.736 -0.14 . . . . 0.43 111.736 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.426 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 16.6 pt -143.13 143.94 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.175 0.512 . . . . 0.79 111.545 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 220' ' ' GLU . 89.3 t -117.59 117.73 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.627 -0.879 . . . . 1.05 108.627 170.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.618 ' HG2' HG22 ' A' ' 168' ' ' VAL . 87.4 mtm180 -97.28 113.62 25.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.039 -0.528 . . . . 2.87 110.867 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.493 ' CG1' HG23 ' A' ' 224' ' ' VAL . 24.3 t -99.04 126.54 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.214 -0.448 . . . . 0.42 111.456 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 25.1 m-85 -78.25 101.05 6.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.647 -0.501 . . . . 0.58 109.647 171.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.669 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.4 OUTLIER -58.72 168.36 1.45 Allowed Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 122.553 0.341 . . . . 1.46 111.789 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 81.7 Cg_exo -47.12 149.44 3.63 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.915 2.41 . . . . 0.5 111.449 167.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.83 8.22 6.65 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.709 0.766 . . . . 2.08 109.22 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.83 48.44 16.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.153 -1.385 . . . . 2.74 112.022 178.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 11.9 mm-40 -80.39 -176.91 5.91 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.628 -1.619 . . . . 1.33 106.628 166.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.409 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 30.5 ttp180 -147.56 131.09 16.75 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.56 -1.256 . . . . 2.49 112.052 175.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.669 ' HB ' HD21 ' A' ' 161' ' ' LEU . 5.5 t -112.18 173.0 6.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.125 -1.398 . . . . 0.52 108.988 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.618 HG22 ' HG2' ' A' ' 158' ' ' ARG . 3.3 t -139.37 129.08 30.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.818 -0.438 . . . . 0.88 109.818 172.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 180' ' ' SER . 73.1 t -127.27 120.95 22.42 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.461 -0.79 . . . . 1.31 109.615 175.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 52.1 Cg_exo -50.22 135.28 38.35 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.008 2.472 . . . . 0.59 111.454 174.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.88 105.96 0.52 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.35 110.243 -177.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.656 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 3.6 mmp_? -100.7 111.04 23.21 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 2.81 111.31 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.83 123.82 26.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.76 -0.654 . . . . 1.44 109.886 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 -7.69 59.29 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.683 -0.967 . . . . 0.43 110.683 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 179' ' ' ASP . 53.7 t -103.7 128.54 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.215 0.531 . . . . 0.97 110.047 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 178' ' ' ARG . 25.5 p -78.08 156.63 29.89 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.528 -0.76 . . . . 0.47 110.062 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.765 ' O ' HD12 ' A' ' 181' ' ' LEU . 23.3 t -48.39 -43.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.851 -0.425 . . . . 1.39 109.851 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 1.3 ptm180 -53.56 -47.01 70.45 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 112.726 0.639 . . . . 3.53 112.726 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.495 ' HB3' HG13 ' A' ' 175' ' ' VAL . 21.0 t70 -68.12 -50.25 55.91 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.698 0.761 . . . . 1.19 109.875 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 169' ' ' VAL . 2.1 p -59.62 -55.53 33.3 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.091 -1.413 . . . . 1.34 110.732 -175.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.93 -2.5 56.75 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 118.78 -1.168 . . . . 1.08 113.334 -174.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.447 ' HB2' ' HG3' ' A' ' 192' ' ' PRO . 18.5 ptpt -70.95 -32.76 69.74 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 117.989 -1.485 . . . . 1.15 107.909 169.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -37.55 87.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.169 -0.678 . . . . 1.8 109.169 169.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -52.04 -52.52 50.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.694 -0.23 . . . . 0.3 111.283 173.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.457 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -56.74 -52.23 65.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.798 0.333 . . . . 1.46 110.59 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 17.6 mmt -62.79 -22.37 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.667 0.617 . . . . 1.45 112.667 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 18.1 mmt -71.65 -38.22 70.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.823 0.345 . . . . 0.85 110.207 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.508 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 11.8 mmm180 -73.85 -23.6 59.64 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.519 0.676 . . . . 2.12 109.685 172.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.77 9.52 37.43 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.022 -0.99 . . . . 0.53 111.468 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.99 177.0 5.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.937 0.398 . . . . 1.28 110.666 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.1 pt -124.8 141.77 39.05 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.52 110.776 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 60.9 Cg_endo -72.26 -10.01 25.13 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 123.242 2.628 . . . . 0.52 112.472 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -54.57 -48.01 72.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.825 -0.625 . . . . 1.74 111.301 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 83.7 m -102.3 25.78 8.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.49 -0.777 . . . . 1.69 111.173 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.549 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 78.0 m -131.79 151.41 51.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.555 -0.293 . . . . 0.52 110.764 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.35 158.67 30.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.402 -0.592 . . . . 0.39 109.402 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.504 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 41.4 t -112.22 134.67 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.895 0.855 . . . . 1.06 112.474 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--N 1.316 -0.855 0 CA-C-N 114.17 -1.377 . . . . 2.49 109.913 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 209' ' ' GLY . 16.3 mt . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.125 0.488 . . . . 0.9 111.304 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -97.51 145.53 17.86 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.884 -0.887 . . . . 0.37 110.884 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.578 ' O ' ' HD2' ' A' ' 178' ' ' ARG . 62.0 m95 -70.73 -18.39 62.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.951 0.405 . . . . 0.31 110.791 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -89.58 -5.78 56.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 2.3 110.387 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 177' ' ' VAL . 98.0 m -69.34 146.6 52.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.31 110.071 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.459 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 12.1 t70 -79.1 129.8 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.851 -0.426 . . . . 1.73 109.851 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.87 -21.68 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.832 0.348 . . . . 0.29 111.759 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.439 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 44.6 t -75.85 -7.75 55.24 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.098 -0.376 . . . . 1.07 110.399 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 13.0 m0 -82.36 -11.12 58.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.385 0.612 . . . . 3.87 109.586 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 220' ' ' GLU . 18.8 mt -114.54 6.87 15.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.468 -0.787 . . . . 1.21 110.385 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 155' ' ' PRO . 21.1 m -42.94 134.71 3.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.091 0.774 . . . . 0.39 113.091 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 71.36 12.68 73.14 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.87 -0.605 . . . . 0.53 112.266 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 217' ' ' LEU . 7.5 tp10 -115.33 141.21 48.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.956 -0.387 . . . . 2.16 109.956 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.9 123.07 33.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 2.03 110.123 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 159' ' ' VAL . 8.7 mp -99.29 170.5 8.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.625 -0.716 . . . . 1.19 110.121 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -149.0 130.25 14.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.509 -0.552 . . . . 2.63 109.509 174.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.549 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 47.3 t -98.57 135.37 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.105 -0.498 . . . . 0.97 110.794 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -118.95 126.22 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.091 -0.958 . . . . 1.94 110.231 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.421 . . . . 1.12 111.384 -179.234 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 C--O 1.236 0.384 0 N-CA-C 112.977 0.337 . . . . 0.43 112.977 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.469 HD12 HG11 ' A' ' 168' ' ' VAL . 14.8 pt -140.13 154.75 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.696 -0.684 . . . . 0.79 110.701 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 218' ' ' THR . 98.4 t -121.2 126.86 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 108.814 -0.81 . . . . 1.05 108.814 172.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 11.1 mtp180 -102.9 107.03 17.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.401 -0.818 . . . . 2.87 110.879 -174.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 222' ' ' LEU . 3.5 t -97.44 125.56 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.471 -0.331 . . . . 0.42 111.441 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -72.63 103.23 3.51 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.189 0.518 . . . . 0.58 110.232 173.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.735 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 28.3 mt -56.86 155.02 16.24 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 1.46 110.963 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 62.8 Cg_exo -53.17 153.8 15.5 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.8 2.333 . . . . 0.5 111.421 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 5.2 m-20 71.79 18.48 5.14 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.428 0.632 . . . . 2.08 110.474 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.26 35.4 5.96 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.985 -1.007 . . . . 2.74 112.558 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.735 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.5 mm100 -94.49 -179.62 4.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.602 -1.258 . . . . 1.33 107.602 171.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -147.24 138.33 23.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.871 -0.732 . . . . 2.49 110.704 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.621 HG21 ' HB1' ' A' ' 184' ' ' ALA . 13.5 t -119.17 171.96 7.92 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.854 -1.066 . . . . 0.52 109.042 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.469 HG11 HD12 ' A' ' 156' ' ' ILE . 3.1 t -141.17 129.82 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.748 -0.464 . . . . 0.88 109.748 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.409 HG13 HD11 ' A' ' 214' ' ' ILE . 3.3 p -131.75 130.39 22.29 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.274 -0.875 . . . . 1.31 109.251 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.446 ' HA ' HG22 ' A' ' 156' ' ' ILE . 10.2 Cg_exo -49.24 144.01 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.359 2.706 . . . . 0.59 112.014 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.73 82.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.29 0.567 . . . . 0.35 109.76 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -70.76 110.65 5.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.282 -0.872 . . . . 2.81 110.82 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 32.3 m -80.45 118.35 21.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.651 -0.704 . . . . 1.44 109.564 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.53 17.65 32.97 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.788 -0.925 . . . . 0.43 110.788 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 179' ' ' ASP . 18.3 t -128.38 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.179 -0.51 . . . . 0.97 110.351 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.474 ' OG1' ' HG3' ' A' ' 178' ' ' ARG . 32.7 p -70.62 148.8 47.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.903 -0.59 . . . . 0.47 109.872 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.823 ' O ' HD12 ' A' ' 181' ' ' LEU . 14.5 p -49.51 -37.71 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.888 -0.412 . . . . 1.39 109.888 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -57.94 -34.8 70.27 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.489 -0.778 . . . . 3.53 112.174 -173.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.651 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -77.02 -49.91 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.9 0.857 . . . . 1.19 109.714 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -53.25 59.44 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.714 -1.13 . . . . 1.34 110.716 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -88.96 0.69 56.42 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.0 -1.08 . . . . 1.08 112.887 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.651 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 17.3 ptpt -69.05 -35.56 76.71 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.257 -1.377 . . . . 1.15 107.736 167.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -65.15 -38.23 89.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.666 -0.814 . . . . 1.8 109.26 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.621 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -48.92 -54.69 14.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.946 -0.301 . . . . 0.3 110.631 172.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.478 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -58.76 -53.75 54.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.466 -0.334 . . . . 1.46 111.045 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.89 -24.63 64.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.086 -0.506 . . . . 1.45 112.291 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 12.4 mmt -78.19 -41.22 35.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.515 -0.55 . . . . 0.85 109.515 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.533 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 15.2 tpt180 -71.0 -18.12 62.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.695 -0.684 . . . . 2.12 109.802 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.28 4.08 44.18 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.687 -0.688 . . . . 0.53 112.824 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 190' ' ' LEU . 5.4 mp -102.18 175.29 5.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.94 0.4 . . . . 1.28 111.543 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.5 pt -119.31 139.89 28.26 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.944 -0.571 . . . . 0.52 110.381 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 55.6 Cg_endo -69.15 -14.3 37.77 Favored 'Trans proline' 0 N--CA 1.47 0.113 0 C-N-CA 123.348 2.699 . . . . 0.52 112.469 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -63.09 -37.04 85.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 1.74 110.846 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 75.7 m -101.42 17.3 23.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.954 -0.566 . . . . 1.69 110.764 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.415 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 85.2 m -128.99 156.91 43.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.163 -0.471 . . . . 0.52 110.784 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -124.96 158.33 33.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.389 -0.597 . . . . 0.39 109.389 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.637 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 96.1 t -106.88 139.09 29.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.782 0.801 . . . . 1.06 111.792 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 114.229 -1.35 . . . . 2.49 109.899 -178.615 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.9 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 141.47 17.7 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.719 -0.753 . . . . 0.37 111.244 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.637 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 61.2 m95 -70.5 -12.91 61.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.731 0.301 . . . . 0.31 111.148 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.98 -12.91 40.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.492 . . . . 2.3 110.116 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.6 m -60.8 127.97 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.31 111.09 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 215' ' ' SER . 13.6 t70 -68.05 127.98 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 1.73 110.038 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.409 HD11 HG13 ' A' ' 169' ' ' VAL . 7.8 tt -68.53 -20.53 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.132 -0.486 . . . . 0.29 112.153 -172.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.476 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 34.8 t -69.29 -11.73 61.06 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.112 -0.367 . . . . 1.07 111.244 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -89.76 -17.97 27.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 3.87 110.083 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 220' ' ' GLU . 33.4 mt -94.84 3.99 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 1.21 109.999 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.44 ' HA ' HG22 ' A' ' 157' ' ' VAL . 58.4 m -43.07 139.78 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.39 113.331 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.42 -8.67 46.03 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.368 -0.833 . . . . 0.53 112.088 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 34.5 mm-40 -102.6 154.96 18.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.279 0.562 . . . . 2.16 111.168 -175.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 35.5 mt-10 -101.39 124.09 46.51 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.342 -0.845 . . . . 2.03 109.379 174.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 217' ' ' LEU . 7.0 mp -96.01 173.38 7.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.948 -0.569 . . . . 1.19 110.218 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -137.99 135.21 35.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.15 -0.685 . . . . 2.63 109.15 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.439 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 86.8 t -103.52 124.9 58.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.101 -0.64 . . . . 0.97 110.264 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -109.62 119.11 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.39 -0.823 . . . . 1.94 108.801 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.324 -0.537 0 N-CA-C 109.718 -0.475 . . . . 1.12 109.718 177.982 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 71.6 Cg_endo . . . . . 0 N--CA 1.464 -0.224 0 N-CA-C 111.843 -0.099 . . . . 0.43 111.843 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.545 HD12 HG11 ' A' ' 168' ' ' VAL . 20.7 pt -138.19 152.93 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 0.79 111.628 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.403 ' HB ' HD11 ' A' ' 214' ' ' ILE . 90.3 t -124.69 129.82 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.734 -0.839 . . . . 1.05 108.734 172.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 168' ' ' VAL . 38.6 mtm-85 -101.51 123.01 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.855 -0.611 . . . . 2.87 110.477 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 222' ' ' LEU . 40.8 t -108.23 127.77 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.415 -0.357 . . . . 0.42 111.722 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -80.51 99.45 8.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.205 -0.665 . . . . 0.58 109.205 170.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.7 OUTLIER -61.78 167.85 4.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.655 0.983 . . . . 1.46 113.655 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 73.7 Cg_exo -49.96 152.82 6.93 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.787 2.991 . . . . 0.5 111.842 167.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.69 13.8 7.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.296 1.046 . . . . 2.08 109.047 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.648 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 57.82 44.83 19.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.89 -1.505 . . . . 2.74 112.108 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 4.1 mm-40 -82.44 178.16 8.37 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.819 -1.549 . . . . 1.33 106.819 166.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 166' ' ' ARG . 12.2 ttp180 -148.6 129.75 14.55 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.542 -0.863 . . . . 2.49 111.06 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.79 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.6 t -118.67 177.92 4.66 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.129 -0.942 . . . . 0.52 109.494 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.545 HG11 HD12 ' A' ' 156' ' ' ILE . 2.4 t -142.81 129.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.702 -0.481 . . . . 0.88 109.702 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 214' ' ' ILE . 5.2 m -124.06 131.63 24.24 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.391 -0.822 . . . . 1.31 109.72 173.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 78.1 Cg_exo -49.4 146.36 14.23 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.634 2.223 . . . . 0.59 112.143 175.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.559 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -66.81 80.21 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.35 110.222 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -64.64 112.22 3.09 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.055 -0.975 . . . . 2.81 111.131 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.6 136.59 36.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.933 -0.576 . . . . 1.44 110.333 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.84 14.69 82.32 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.016 -0.834 . . . . 0.43 111.016 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 179' ' ' ASP . 55.3 t -126.78 135.11 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.038 0.447 . . . . 0.97 110.763 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.7 p -83.13 167.09 18.12 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.817 -0.629 . . . . 0.47 110.326 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.837 ' O ' HD12 ' A' ' 181' ' ' LEU . 2.4 m -53.4 -37.73 30.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 108.487 -0.931 . . . . 1.39 108.487 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.8 tmm_? -44.56 -62.72 1.09 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.174 -0.921 . . . . 3.53 112.619 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.696 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 30.1 t70 -68.05 -44.37 76.55 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.394 0.616 . . . . 1.19 111.034 -174.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.8 p -62.13 -54.65 38.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.462 -0.79 . . . . 1.34 110.656 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.52 -2.66 57.11 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.396 -0.922 . . . . 1.08 112.848 -175.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 13.6 ptmm? -68.34 -36.04 78.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.68 -1.23 . . . . 1.15 107.68 168.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.89 -36.38 83.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.24 -0.891 . . . . 1.8 109.345 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.79 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.63 -55.78 22.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.525 -0.307 . . . . 0.3 111.097 173.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.564 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.5 mm? -53.83 -50.48 66.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.376 -0.375 . . . . 1.46 110.774 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 37.2 mtt -70.31 -21.69 62.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.342 0.497 . . . . 1.45 112.342 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 16.4 mmt -76.3 -18.98 58.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 0.85 110.119 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.47 ' HB2' HD23 ' A' ' 161' ' ' LEU . 7.3 tpm_? -97.33 -11.83 23.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.439 -0.8 . . . . 2.12 109.768 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 94.85 19.71 30.72 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.53 111.955 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.502 ' HB2' HD12 ' A' ' 185' ' ' LEU . 7.7 mt -116.83 172.24 7.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.642 0.258 . . . . 1.28 110.437 -176.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.7 pt -121.57 142.76 36.39 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.497 . . . . 0.52 110.683 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 73.9 Cg_endo -75.15 -13.1 21.21 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 123.258 2.639 . . . . 0.52 112.968 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.37 -41.41 93.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 1.74 110.952 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 37.9 t -94.36 8.0 43.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.945 -0.571 . . . . 1.69 110.785 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.427 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 73.1 m -116.29 158.18 23.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.65 0.262 . . . . 0.52 110.878 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.11 157.55 40.45 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.39 110.053 174.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 224' ' ' VAL . 13.9 t -118.89 124.1 72.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.136 0.493 . . . . 1.06 110.717 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.55 ' HA ' HG12 ' A' ' 208' ' ' ILE . 55.1 p90 . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.672 -0.694 . . . . 2.49 110.597 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.55 HG12 ' HA ' ' A' ' 198' ' ' TYR . 2.6 mm . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.845 -0.798 . . . . 0.9 108.845 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.2 138.2 13.74 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.563 -0.827 . . . . 0.37 111.205 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.677 ' HA ' HG22 ' A' ' 177' ' ' VAL . 62.3 m95 -68.06 -18.62 64.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.137 0.494 . . . . 0.31 110.244 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -95.08 6.67 48.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.553 -0.748 . . . . 2.3 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 99.9 m -86.33 144.3 27.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.31 110.354 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.96 128.02 34.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.03 -0.532 . . . . 1.73 111.184 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.447 HD11 HG23 ' A' ' 169' ' ' VAL . 6.5 tt -72.7 -26.95 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.683 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.559 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 44.3 t -68.06 -14.96 63.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 1.07 110.596 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -86.16 -13.06 48.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.446 0.641 . . . . 3.87 109.615 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.483 HD13 HD21 ' A' ' 222' ' ' LEU . 10.3 mt -105.71 8.28 32.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.495 -0.775 . . . . 1.21 109.868 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.7 m -40.56 134.57 1.74 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.772 1.027 . . . . 0.39 113.772 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.5 4.5 61.04 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.522 -0.763 . . . . 0.53 112.281 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.63 162.58 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.714 -0.476 . . . . 2.16 109.714 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 41.2 mt-10 -111.9 129.45 56.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.589 0.709 . . . . 2.03 111.456 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 217' ' ' LEU . 66.3 mt -97.77 155.41 17.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.455 -1.248 . . . . 1.19 109.81 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.83 116.0 16.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.702 0.763 . . . . 2.63 109.904 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 197' ' ' VAL . 79.4 t -100.83 137.77 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 0.97 110.997 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.504 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 17.8 mm-40 -131.74 135.5 46.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.855 -1.066 . . . . 1.94 109.694 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 19.5 t . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 110.054 -0.35 . . . . 1.12 110.054 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.434 ' HB2' HG23 ' A' ' 218' ' ' THR . 88.5 Cg_endo . . . . . 0 N--CA 1.463 -0.273 0 CA-C-O 120.808 0.253 . . . . 0.43 112.264 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 170' ' ' PRO . 1.5 pp -141.78 147.07 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.892 0.377 . . . . 0.79 111.295 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 220' ' ' GLU . 99.4 t -116.99 123.32 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.037 -0.727 . . . . 1.05 109.037 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 168' ' ' VAL . 42.6 mtp180 -98.81 114.31 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.464 -0.789 . . . . 2.87 110.868 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 222' ' ' LEU . 2.7 t -104.7 125.9 59.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.373 -0.376 . . . . 0.42 111.537 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.413 ' CZ ' ' HD3' ' A' ' 166' ' ' ARG . 20.2 m-85 -76.23 101.96 5.63 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.611 -0.515 . . . . 0.58 109.611 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.2 OUTLIER -67.09 158.03 82.79 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 1.46 111.136 176.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.558 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 50.2 Cg_exo -56.31 144.62 81.68 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 123.387 2.724 . . . . 0.5 112.514 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 92.6 m-20 74.03 30.02 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.618 0.574 . . . . 2.08 111.054 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.603 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 66.37 32.37 7.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.252 -0.885 . . . . 2.74 112.774 173.298 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.642 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -90.47 167.07 12.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.462 -1.681 . . . . 1.33 106.462 171.078 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 38.7 ttp180 -148.86 136.44 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.672 -0.811 . . . . 2.49 110.343 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.805 HG21 ' HB1' ' A' ' 184' ' ' ALA . 10.1 t -123.94 172.59 8.82 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.241 -0.891 . . . . 0.52 109.852 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.549 HG22 ' HG2' ' A' ' 158' ' ' ARG . 2.6 t -142.12 128.07 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 109.249 -0.649 . . . . 0.88 109.249 172.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.477 HG23 HD11 ' A' ' 214' ' ' ILE . 3.2 m -118.63 135.26 23.59 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.157 -0.929 . . . . 1.31 108.884 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.485 ' HA ' HG22 ' A' ' 156' ' ' ILE . 61.5 Cg_exo -51.26 146.06 25.08 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 121.872 1.714 . . . . 0.59 110.532 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.23 81.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.373 -0.602 . . . . 0.35 109.373 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 35.6 mmt180 -65.11 111.24 2.83 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.695 -1.139 . . . . 2.81 109.974 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 26.9 p -78.43 130.41 36.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.877 0.37 . . . . 1.44 110.782 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.2 22.61 44.04 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.628 -0.796 . . . . 0.43 112.539 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 1.4 p -137.58 153.44 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 0.97 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 40.3 p -91.05 164.64 13.88 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.834 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.736 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 5.2 m -55.4 -32.93 30.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.268 0.556 . . . . 1.39 109.608 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.649 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.6 tpt180 -53.29 -48.23 68.53 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 115.202 -0.908 . . . . 3.53 112.171 -175.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.0 t70 -75.96 -49.93 16.34 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.377 0.608 . . . . 1.19 110.564 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.1 p -59.61 -55.77 30.33 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.951 -1.022 . . . . 1.34 110.689 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 177' ' ' VAL . 0.1 OUTLIER -92.28 -5.33 52.55 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.069 -1.052 . . . . 1.08 112.659 -176.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 17.6 ptpt -61.2 -40.03 92.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 116.85 -1.94 . . . . 1.15 107.716 167.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 182' ' ' LYS . 6.4 ttpm? -66.24 -38.27 87.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.976 -0.556 . . . . 1.8 109.92 174.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.805 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -49.96 -54.19 21.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.226 0.536 . . . . 0.3 110.467 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.545 HD21 HG11 ' A' ' 224' ' ' VAL . 6.0 mt -62.64 -51.05 68.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.519 -0.764 . . . . 1.46 111.251 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 67.5 mtp -67.58 -21.82 65.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.509 -0.314 . . . . 1.45 111.846 -173.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.4 mtt -77.84 -25.92 49.08 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.535 -0.542 . . . . 0.85 109.535 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.476 ' HB2' HD23 ' A' ' 161' ' ' LEU . 11.1 tpt180 -87.6 -11.28 49.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.511 -0.768 . . . . 2.12 109.356 174.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.26 4.43 44.09 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.731 -0.668 . . . . 0.53 113.251 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 186' ' ' MET . 5.3 mp -97.43 176.87 5.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 1.28 111.599 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.39 146.88 63.88 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.52 110.293 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -4.61 15.59 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.354 2.703 . . . . 0.52 113.303 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.169 0.509 . . . . 1.74 110.029 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.7 t -107.49 28.41 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.615 -0.72 . . . . 1.69 110.388 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.48 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.2 m -151.25 155.44 38.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.231 -0.441 . . . . 0.52 110.189 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HA ' ' CZ2' ' A' ' 210' ' ' TRP . . . -131.33 173.34 11.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.148 -1.056 . . . . 0.39 108.148 169.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.571 HG21 HD21 ' A' ' 181' ' ' LEU . 13.1 t -114.44 136.73 50.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.276 0.56 . . . . 1.06 111.343 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--N 1.318 -0.776 0 CA-C-N 115.218 -0.901 . . . . 2.49 110.139 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 6.9 mm . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.595 -0.52 . . . . 0.9 109.595 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.78 140.31 14.94 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.847 -0.901 . . . . 0.37 110.847 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.736 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 90.2 m95 -68.02 -14.37 62.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.277 0.539 . . . . 0.31 110.619 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -99.32 0.39 42.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.3 110.388 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.7 m -75.07 140.78 43.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.754 -0.657 . . . . 0.31 110.106 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.27 121.19 20.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.451 . . . . 1.73 110.193 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 169' ' ' VAL . 4.1 tt -67.97 -28.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.29 111.733 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -72.87 -8.39 55.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.228 0.537 . . . . 1.07 110.342 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -83.62 -17.08 42.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.67 0.748 . . . . 3.87 109.568 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -101.82 9.84 40.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.344 -0.843 . . . . 1.21 110.007 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' HB2' ' A' ' 155' ' ' PRO . 63.0 m -39.92 130.7 2.01 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.747 1.018 . . . . 0.39 113.747 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.42 -1.18 61.88 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.508 -0.769 . . . . 0.53 112.347 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 157' ' ' VAL . 38.7 mt-10 -105.61 138.26 42.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.8 0.333 . . . . 2.16 110.205 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -84.46 128.9 34.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.294 0.569 . . . . 2.03 110.598 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 159' ' ' VAL . 48.9 mt -103.61 169.43 8.53 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.265 -0.88 . . . . 1.19 109.957 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -147.16 136.55 22.69 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.104 -0.702 . . . . 2.63 109.104 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.545 HG11 HD21 ' A' ' 185' ' ' LEU . 72.3 t -99.32 144.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.935 0.398 . . . . 0.97 110.944 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -109.64 145.8 35.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.865 -0.791 . . . . 1.94 108.865 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.312 -1.022 0 CA-C-O 121.381 0.61 . . . . 1.12 110.399 177.035 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 83.4 Cg_endo . . . . . 0 N--CA 1.459 -0.521 0 N-CA-C 111.737 -0.14 . . . . 0.43 111.737 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 17.4 pt -134.62 144.74 34.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 0.79 110.965 176.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -124.41 117.05 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.806 0.812 . . . . 1.05 108.977 173.253 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 18.1 mtm-85 -83.59 130.57 34.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.557 -1.201 . . . . 2.87 110.506 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 167' ' ' THR . 7.5 t -120.64 117.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.201 -0.909 . . . . 0.42 111.215 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.48 ' HB2' ' HA ' ' A' ' 223' ' ' HIS . 10.2 m-85 -71.77 102.83 2.93 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.991 0.424 . . . . 0.58 110.392 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 27.8 mt -55.46 151.04 21.49 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 124.294 1.038 . . . . 1.46 111.5 173.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.562 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 60.5 Cg_exo -54.06 161.69 4.76 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.022 2.481 . . . . 0.5 111.869 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 67.76 14.78 9.55 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.206 -1.035 . . . . 2.08 108.206 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 63.01 40.22 9.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 113.645 -1.616 . . . . 2.74 112.235 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.711 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 3.0 mm-40 -96.7 -176.55 3.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.378 -1.342 . . . . 1.33 107.378 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 30.1 ttp180 -145.81 127.11 14.86 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.232 -0.987 . . . . 2.49 111.66 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.675 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.1 t -109.55 176.66 4.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.611 -1.177 . . . . 0.52 108.544 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.458 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.1 t -141.32 126.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.676 -0.861 . . . . 0.88 108.676 168.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.475 HG23 HD11 ' A' ' 214' ' ' ILE . 9.2 m -107.53 127.54 27.61 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.764 -0.653 . . . . 1.31 109.956 167.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 71.9 Cg_exo -50.51 142.51 30.42 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.163 1.909 . . . . 0.59 110.461 169.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.432 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -64.7 88.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.35 110.228 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.448 ' O ' HG12 ' A' ' 175' ' ' VAL . 29.0 mmt180 -70.87 110.98 5.94 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.085 -0.961 . . . . 2.81 109.181 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.2 p -82.38 126.54 32.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.246 -0.434 . . . . 1.44 110.904 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.14 22.51 29.8 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.539 -0.839 . . . . 0.43 111.944 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 172' ' ' ARG . 1.3 p -138.1 154.59 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.061 0.457 . . . . 0.97 110.151 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.4 p -86.23 158.87 19.62 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.94 -0.573 . . . . 0.47 110.72 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.777 ' O ' HD12 ' A' ' 181' ' ' LEU . 42.0 t -45.84 -49.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.224 -0.658 . . . . 1.39 109.224 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 11.8 tpt180 -41.57 -56.18 2.65 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 124.743 1.277 . . . . 3.53 113.239 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.747 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.5 t70 -67.5 -47.66 69.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.255 0.55 . . . . 1.19 110.622 -176.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.8 t -64.28 -47.74 78.36 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.047 -0.661 . . . . 1.34 110.183 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -93.03 -2.58 55.54 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.271 -0.971 . . . . 1.08 112.464 -175.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 14.5 ptmm? -69.95 -31.4 69.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.27 -1.382 . . . . 1.15 107.27 167.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.56 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.0 OUTLIER -65.94 -41.73 90.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.08 -0.964 . . . . 1.8 109.418 168.234 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.675 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.61 -55.95 13.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.55 -0.295 . . . . 0.3 110.983 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -53.96 -51.9 62.37 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.494 -0.321 . . . . 1.46 110.911 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -25.29 67.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 1.45 112.363 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 24.2 mmt -78.48 -31.52 47.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.812 0.339 . . . . 0.85 110.222 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.706 ' HD3' HD13 ' A' ' 161' ' ' LEU . 15.4 tpt180 -77.52 -14.86 59.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.458 0.647 . . . . 2.12 109.975 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.03 55.86 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.53 111.543 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.414 ' HB2' HD12 ' A' ' 185' ' ' LEU . 13.7 mt -108.68 176.89 4.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.079 -0.341 . . . . 1.28 110.079 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 193' ' ' GLU . 46.1 pt -122.63 140.96 34.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.52 111.489 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.52 -10.55 26.99 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.55 2.833 . . . . 0.52 112.739 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.421 ' HB2' HD12 ' A' ' 191' ' ' ILE . 38.0 mt-10 -62.38 -44.19 97.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.336 0.589 . . . . 1.74 110.505 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.4 m -97.04 20.17 11.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.403 -0.817 . . . . 1.69 110.989 -176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.545 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 72.8 m -128.39 156.66 42.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.542 -0.299 . . . . 0.52 110.713 -175.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -130.03 152.93 48.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.39 109.995 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.522 HG13 ' CE2' ' A' ' 210' ' ' TRP . 3.5 m -110.68 126.96 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.791 0.805 . . . . 1.06 111.108 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.539 ' CZ ' ' HG3' ' A' ' 225' ' ' GLU . 51.7 p90 . . . . . 0 C--N 1.311 -1.1 0 CA-C-N 115.51 -0.768 . . . . 2.49 109.456 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' A' ' 198' ' ' TYR . 1.2 mm . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.216 -1.031 . . . . 0.9 108.216 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.62 151.26 18.58 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.467 -1.349 . . . . 0.37 113.004 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.522 ' CE2' HG13 ' A' ' 197' ' ' VAL . 69.1 m95 -70.52 -18.43 62.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.872 0.368 . . . . 0.31 110.598 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -97.82 -1.96 42.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 2.3 110.564 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.3 m -70.34 142.02 52.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.829 -0.623 . . . . 0.31 109.788 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.99 119.16 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.265 -0.642 . . . . 1.73 109.265 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 177' ' ' VAL . 4.4 tt -71.24 -27.01 27.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.29 111.377 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.0 t -70.84 -7.78 47.88 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.479 0.656 . . . . 1.07 109.717 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -88.37 -6.99 57.37 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.498 0.666 . . . . 3.87 109.487 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.423 HD13 HD21 ' A' ' 222' ' ' LEU . 22.8 mt -112.61 7.48 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.431 -0.804 . . . . 1.21 110.038 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 61.0 m -42.29 134.5 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.916 -1.038 . . . . 0.39 113.7 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.4 57.64 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.53 112.335 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 157' ' ' VAL . 41.6 mt-10 -113.36 148.92 34.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.864 0.364 . . . . 2.16 110.391 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.6 mp0 -92.26 126.61 37.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.217 0.532 . . . . 2.03 111.448 -176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.446 ' HB2' HG13 ' A' ' 159' ' ' VAL . 80.8 mt -99.56 155.13 17.74 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.22 -0.9 . . . . 1.19 110.144 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' HIS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -119.34 124.72 47.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.743 0.306 . . . . 2.63 110.219 173.359 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.575 HG21 HD23 ' A' ' 181' ' ' LEU . 72.6 t -105.7 116.93 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.569 0.7 . . . . 0.97 109.408 172.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.539 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 54.0 mm-40 -119.55 133.02 55.86 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.921 -1.036 . . . . 1.94 109.19 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.562 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 41.3 t . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 1.12 111.187 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.463 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 55.1 Cg_endo . . . . . 0 N--CA 1.456 -0.695 0 N-CA-C 111.64 -0.177 . . . . 0.43 111.64 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.587 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 39.5 pt -140.63 139.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.745 0.307 . . . . 0.79 111.081 -178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 217' ' ' LEU . 88.4 t -112.53 118.76 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.149 -0.685 . . . . 1.05 109.149 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.627 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 66.1 mtm180 -97.02 115.74 27.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.632 -0.713 . . . . 2.87 110.538 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.67 ' CG1' HG23 ' A' ' 224' ' ' VAL . 13.5 t -105.85 127.02 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.233 -0.44 . . . . 0.42 111.653 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 27.3 m-85 -74.22 103.09 4.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.302 -0.408 . . . . 0.58 110.161 173.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.2 mm? -55.04 163.27 1.58 Allowed Pre-proline 0 N--CA 1.474 0.737 0 CA-C-O 121.331 0.586 . . . . 1.46 112.013 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.417 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 77.2 Cg_exo -51.24 160.48 2.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.964 2.443 . . . . 0.5 111.047 163.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 67.89 6.99 5.46 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.069 0.462 . . . . 2.08 110.213 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 164' ' ' LYS . 8.1 mmpt? 70.2 39.39 1.31 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.134 -0.939 . . . . 2.74 111.88 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 4.1 mm-40 -91.02 -178.89 5.32 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.549 -0.908 . . . . 1.33 108.549 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 33.0 ttp180 -147.38 132.89 18.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.006 -0.677 . . . . 2.49 111.541 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.784 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.6 t -120.64 -177.74 3.54 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.459 -1.246 . . . . 0.52 108.743 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.627 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.39 129.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.321 0.581 . . . . 0.88 111.127 170.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.535 HG23 HD11 ' A' ' 214' ' ' ILE . 5.1 m -112.26 131.86 22.37 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.964 -1.016 . . . . 1.31 109.551 172.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 74.0 Cg_exo -48.35 141.86 18.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.504 2.136 . . . . 0.59 111.859 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.81 83.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.35 110.44 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.565 ' O ' HG12 ' A' ' 175' ' ' VAL . 31.1 mmt180 -72.55 113.65 9.81 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 2.81 110.041 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 41.9 t -82.81 124.75 30.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 1.44 110.757 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.06 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.72 -0.752 . . . . 0.43 111.915 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 172' ' ' ARG . 8.5 p -135.27 150.92 29.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.746 -0.464 . . . . 0.97 109.746 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 57.4 p -81.38 155.49 25.9 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.165 -0.471 . . . . 0.47 110.777 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.744 ' O ' HD12 ' A' ' 181' ' ' LEU . 53.0 t -46.46 -46.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.18 -0.674 . . . . 1.39 109.18 173.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 9.5 tpt180 -41.51 -54.98 2.99 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 124.319 1.012 . . . . 3.53 113.125 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.8 t70 -68.6 -48.95 62.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.502 0.668 . . . . 1.19 110.772 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.469 ' O ' HG11 ' A' ' 169' ' ' VAL . 3.3 m -64.59 -46.79 81.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.325 -0.852 . . . . 1.34 111.02 -173.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -93.25 -4.49 51.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.928 -1.109 . . . . 1.08 112.529 -177.611 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.3 ptpt -67.23 -34.41 77.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 118.123 -1.431 . . . . 1.15 107.697 168.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.7 OUTLIER -67.56 -36.57 81.2 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.571 -0.741 . . . . 1.8 109.48 171.581 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.784 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.94 -52.1 52.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.662 -0.245 . . . . 0.3 110.825 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.507 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.2 mm? -58.62 -50.97 71.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.435 -0.348 . . . . 1.46 111.067 176.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.48 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 49.2 mtt -68.47 -20.99 64.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.515 0.561 . . . . 1.45 112.515 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 18.4 mmt -80.97 -20.32 42.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 0.85 109.722 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.496 ' HB3' ' CD1' ' A' ' 190' ' ' LEU . 10.2 tpt180 -91.09 -17.03 26.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.695 0.76 . . . . 2.12 109.144 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.56 6.32 41.24 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 114.785 -1.098 . . . . 0.53 112.835 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.496 ' CD1' ' HB3' ' A' ' 188' ' ' ARG . 5.2 mp -104.96 174.64 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.112 0.482 . . . . 1.28 111.718 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.1 pt -119.74 144.17 36.53 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.52 110.53 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.76 -4.44 15.36 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.53 2.82 . . . . 0.52 113.593 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -69.38 -42.13 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 1.74 111.095 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 25.5 p -97.17 15.47 22.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 1.69 110.609 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.619 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.6 m -123.1 149.6 44.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.07 -0.514 . . . . 0.52 110.661 -175.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -118.49 152.23 36.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.813 -0.44 . . . . 0.39 109.813 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.692 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 13.6 t -118.88 124.54 73.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.097 0.475 . . . . 1.06 110.867 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.53 ' HA ' HG12 ' A' ' 208' ' ' ILE . 51.9 p90 . . . . . 0 C--N 1.313 -1.021 0 CA-C-N 115.483 -0.78 . . . . 2.49 109.764 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 198' ' ' TYR . 14.7 mm . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 109.61 -0.515 . . . . 0.9 109.61 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 212' ' ' THR . . . -85.31 131.06 10.21 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.675 -1.37 . . . . 0.37 109.675 171.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.692 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 57.6 m95 -65.38 -21.08 66.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.037 0.446 . . . . 0.31 110.194 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.02 1.7 52.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.533 0.683 . . . . 2.3 110.086 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.5 m -72.37 145.75 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.906 -0.588 . . . . 0.31 110.282 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.61 115.02 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.497 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.535 HD11 HG23 ' A' ' 169' ' ' VAL . 2.4 tt -62.58 -29.4 46.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.29 111.505 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.479 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -73.24 -8.25 55.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.857 -0.61 . . . . 1.07 110.563 -173.326 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -82.27 -21.69 36.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.52 0.676 . . . . 3.87 109.815 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 157' ' ' VAL . 13.0 mt -97.64 11.79 35.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.476 -0.783 . . . . 1.21 110.031 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.459 HG23 ' HB2' ' A' ' 155' ' ' PRO . 94.9 m -37.68 129.66 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.497 0.925 . . . . 0.39 113.497 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.16 -14.03 29.64 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.816 -0.629 . . . . 0.53 112.302 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.31 158.31 26.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.954 0.407 . . . . 2.16 110.306 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.5 mt-10 -109.48 115.48 30.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.596 0.712 . . . . 2.03 109.933 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.443 ' HB2' HG22 ' A' ' 159' ' ' VAL . 36.4 mt -95.6 164.67 12.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.644 -1.162 . . . . 1.19 110.989 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 2.1 m-70 -126.64 123.62 38.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 2.63 110.614 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.67 HG23 ' CG1' ' A' ' 159' ' ' VAL . 98.4 t -101.61 112.37 34.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.666 0.746 . . . . 0.97 109.631 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.501 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 57.9 mm-40 -116.09 124.92 51.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.833 -1.076 . . . . 1.94 109.082 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.417 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 47.9 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 1.12 111.871 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.494 ' HB2' HG23 ' A' ' 218' ' ' THR . 65.1 Cg_endo . . . . . 0 N--CA 1.461 -0.422 0 CA-C-O 120.574 0.156 . . . . 0.43 112.19 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.573 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 2.0 pp -146.42 147.43 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.888 0.375 . . . . 0.79 111.682 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 217' ' ' LEU . 98.4 t -119.72 125.69 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.818 -0.808 . . . . 1.05 108.818 174.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.597 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 62.5 mtm180 -99.05 116.84 32.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.756 -0.656 . . . . 2.87 110.678 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.415 HG12 HG23 ' A' ' 224' ' ' VAL . 2.0 t -106.11 120.56 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.282 -0.417 . . . . 0.42 111.411 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 33.7 m-85 -72.6 103.27 3.51 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.039 -0.356 . . . . 0.58 110.039 174.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.705 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -66.07 156.44 84.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 120.892 0.377 . . . . 1.46 110.749 176.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.578 ' HB3' HG23 ' A' ' 226' ' ' VAL . 93.0 Cg_exo -43.75 150.54 0.53 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.785 2.99 . . . . 0.5 112.97 171.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 74.69 10.86 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.554 -0.748 . . . . 2.08 110.037 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 76.03 32.36 0.63 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.144 -0.935 . . . . 2.74 112.558 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.1 mm100 -86.11 173.39 9.88 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.32 -0.993 . . . . 1.33 108.32 171.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 19.3 ttp180 -147.48 130.76 16.53 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.738 -0.785 . . . . 2.49 111.487 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.748 HG21 ' HB1' ' A' ' 184' ' ' ALA . 6.2 t -113.79 179.07 4.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.608 -1.178 . . . . 0.52 108.837 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.597 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.25 128.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.53 0.681 . . . . 0.88 110.756 165.579 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.485 HG23 HD11 ' A' ' 214' ' ' ILE . 2.7 m -108.95 145.26 31.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.58 -1.191 . . . . 1.31 109.61 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.42 145.05 29.57 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.05 1.833 . . . . 0.59 111.313 171.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -68.43 79.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.333 0.587 . . . . 0.35 109.996 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.464 ' O ' HG12 ' A' ' 175' ' ' VAL . 15.1 mmm180 -64.27 111.79 2.77 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.081 -0.963 . . . . 2.81 110.72 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.559 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 76.3 m -77.72 126.54 31.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.572 -0.74 . . . . 1.44 110.935 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.18 21.93 39.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.777 -0.725 . . . . 0.43 112.174 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 172' ' ' ARG . 1.7 p -131.69 150.93 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.082 0.468 . . . . 0.97 110.368 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 51.4 p -87.18 158.95 19.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.786 -0.643 . . . . 0.47 111.121 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.756 ' O ' HD12 ' A' ' 181' ' ' LEU . 59.6 t -48.4 -44.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 1.39 109.704 173.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 12.0 tpt180 -43.77 -51.28 7.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.217 -0.902 . . . . 3.53 113.224 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.626 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 12.2 t70 -72.77 -50.93 21.32 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.743 0.782 . . . . 1.19 110.609 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.4 p -59.69 -51.89 67.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.606 -1.179 . . . . 1.34 110.568 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -90.86 -3.67 57.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 118.812 -1.155 . . . . 1.08 112.994 -177.222 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.0 ptpt -66.35 -33.69 76.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 118.195 -1.402 . . . . 1.15 107.755 170.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.2 OUTLIER -70.6 -39.57 73.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.393 -0.822 . . . . 1.8 109.49 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.748 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.58 -52.61 37.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.975 0.417 . . . . 0.3 111.116 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.511 HD21 HG11 ' A' ' 224' ' ' VAL . 5.5 mt -61.58 -51.05 70.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 1.46 111.261 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -26.67 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.531 . . . . 1.45 112.432 -174.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.5 mmt -75.6 -18.73 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.058 0.456 . . . . 0.85 110.954 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.48 ' HG3' ' HG ' ' A' ' 161' ' ' LEU . 4.2 mmp_? -96.04 -12.11 25.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.487 0.66 . . . . 2.12 110.05 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.05 19.13 40.63 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.179 -0.918 . . . . 0.53 111.675 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 188' ' ' ARG . 14.8 mt -102.62 168.55 9.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.168 -0.308 . . . . 1.28 110.168 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.7 pt -127.39 143.43 47.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 121.317 0.58 . . . . 0.52 111.777 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 -4.37 15.31 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.521 2.814 . . . . 0.52 112.854 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -75.46 -34.71 60.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 1.74 110.657 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 60.4 m -107.3 7.56 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 1.69 111.74 -175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.506 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 83.9 m -127.49 145.48 50.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.919 -0.313 . . . . 0.52 111.248 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -111.52 160.79 16.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.39 109.835 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 224' ' ' VAL . 12.7 t -117.21 125.05 73.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.001 0.429 . . . . 1.06 110.124 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.586 ' CZ ' ' HG3' ' A' ' 225' ' ' GLU . 52.4 p90 . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 115.777 -0.647 . . . . 2.49 110.4 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 198' ' ' TYR . 7.6 mm . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 109.253 -0.647 . . . . 0.9 109.253 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.74 140.76 15.22 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.386 -1.086 . . . . 0.37 110.386 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.598 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 56.7 m95 -68.75 -13.16 62.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.074 0.464 . . . . 0.31 110.451 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.75 5.54 43.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 2.3 110.333 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 177' ' ' VAL . 49.3 m -72.0 137.89 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.072 -0.513 . . . . 0.31 110.051 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.502 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 13.0 t70 -74.05 112.88 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.73 109.995 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.485 HD11 HG23 ' A' ' 169' ' ' VAL . 4.2 tt -62.04 -26.02 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.181 -0.463 . . . . 0.29 112.141 -175.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 173' ' ' CYS . 2.0 t -70.11 -8.65 51.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.708 0.289 . . . . 1.07 111.157 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.501 ' HB3' HD12 ' A' ' 217' ' ' LEU . 1.7 t90 -87.11 -20.85 26.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.737 0.78 . . . . 3.87 109.29 175.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.597 HD23 HD21 ' A' ' 222' ' ' LEU . 6.9 mp -100.07 12.83 35.97 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 1.21 110.674 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 155' ' ' PRO . 90.8 m -39.21 129.73 1.69 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.764 -1.562 . . . . 0.39 113.059 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.61 -7.86 51.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.698 -0.683 . . . . 0.53 112.356 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -96.64 164.11 12.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.86 0.362 . . . . 2.16 110.92 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 38.2 mt-10 -113.87 122.8 48.13 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.328 0.585 . . . . 2.03 110.87 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.597 HD21 HD23 ' A' ' 217' ' ' LEU . 26.1 mt -99.29 161.49 13.59 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 1.19 111.081 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 26.3 m-70 -124.64 127.2 46.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.425 . . . . 2.63 110.138 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 197' ' ' VAL . 75.5 t -104.98 130.31 56.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.221 0.534 . . . . 0.97 109.66 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 6.7 mm-40 -128.65 130.06 46.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.162 -0.926 . . . . 1.94 110.466 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.578 HG23 ' HB3' ' A' ' 162' ' ' PRO . 99.6 t . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 109.622 -0.51 . . . . 1.12 109.622 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.53 ' HB2' HG21 ' A' ' 218' ' ' THR . 40.8 Cg_endo . . . . . 0 N--CA 1.464 -0.213 0 N-CA-C 111.665 -0.167 . . . . 0.43 111.665 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.464 HD12 HG11 ' A' ' 168' ' ' VAL . 22.0 pt -141.37 158.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.453 0.644 . . . . 0.79 111.861 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 130.27 48.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.903 -1.044 . . . . 1.05 108.934 169.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 9.0 mtm180 -99.6 130.23 45.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.089 -0.959 . . . . 2.87 110.337 -169.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' A' ' 222' ' ' LEU . 6.0 t -115.54 125.73 72.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.453 -0.339 . . . . 0.42 111.581 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -77.15 103.38 7.05 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.223 -0.298 . . . . 0.58 110.236 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.743 HD22 ' H ' ' A' ' 161' ' ' LEU . 2.0 mm? -51.97 162.84 0.74 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 121.12 0.486 . . . . 1.46 111.429 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.468 ' HB3' HG23 ' A' ' 226' ' ' VAL . 78.5 Cg_exo -52.71 154.56 12.13 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.807 2.338 . . . . 0.5 111.889 166.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 64.91 15.48 9.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.688 0.756 . . . . 2.08 110.091 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 70.05 37.34 1.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.776 -1.102 . . . . 2.74 113.396 171.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.7 mm-40 -86.23 176.44 7.95 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.621 -1.251 . . . . 1.33 107.621 168.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -144.91 126.23 14.83 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.463 -0.895 . . . . 2.49 111.54 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.707 HG21 ' HB1' ' A' ' 184' ' ' ALA . 8.1 t -107.72 172.68 6.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.068 -1.424 . . . . 0.52 108.441 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 156' ' ' ILE . 2.4 t -142.97 129.04 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 121.014 0.435 . . . . 0.88 110.081 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.12 131.38 24.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.329 -0.851 . . . . 1.31 109.751 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 73.0 Cg_exo -51.75 140.13 47.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.102 1.868 . . . . 0.59 110.548 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.557 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -61.2 101.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 0.35 110.221 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 215' ' ' SER . 35.9 mmt180 -81.03 111.13 17.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.011 -0.995 . . . . 2.81 110.386 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 p -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.436 -0.347 . . . . 1.44 110.911 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.54 19.82 57.64 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.718 -0.953 . . . . 0.43 110.718 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 179' ' ' ASP . 46.8 t -129.53 132.12 66.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.952 -0.624 . . . . 0.97 110.137 -175.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.5 p -78.02 162.15 26.94 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.907 -0.405 . . . . 0.47 109.907 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.785 ' O ' HD12 ' A' ' 181' ' ' LEU . 5.9 m -52.09 -36.5 20.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.616 -0.883 . . . . 1.39 108.616 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 54.2 ttt180 -43.75 -58.84 2.5 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.807 -1.088 . . . . 3.53 112.729 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.556 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -71.61 -46.1 60.17 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 1.19 110.598 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.5 p -62.46 -57.25 11.89 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.946 -1.025 . . . . 1.34 110.887 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -90.16 0.0 57.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 118.889 -1.124 . . . . 1.08 112.486 -176.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 17.9 ptpt -67.95 -33.96 75.68 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 117.559 -1.656 . . . . 1.15 107.427 165.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 187' ' ' MET . 12.8 tptt -60.79 -43.67 97.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.161 -0.927 . . . . 1.8 108.921 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.707 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -48.05 -58.95 3.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.388 0.43 . . . . 0.3 111.432 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 181' ' ' LEU . 2.9 mm? -52.95 -51.3 61.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.338 -0.392 . . . . 1.46 110.463 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 16.4 mtt -67.99 -21.29 65.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.29 0.478 . . . . 1.45 112.29 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.3 mmt -77.54 -27.3 51.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.207 0.527 . . . . 0.85 109.622 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 188' ' ' ARG . 25.8 tpt180 -85.88 -19.73 30.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.522 -0.763 . . . . 2.12 109.929 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.06 14.88 29.86 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.744 -0.662 . . . . 0.53 111.756 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.45 ' HB2' HD12 ' A' ' 185' ' ' LEU . 12.9 mt -108.07 177.13 4.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.07 -0.344 . . . . 1.28 110.07 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 193' ' ' GLU . 43.8 pt -124.64 146.51 52.89 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 121.179 0.514 . . . . 0.52 111.022 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.467 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 96.6 Cg_endo -77.86 -12.37 16.37 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.275 2.65 . . . . 0.52 112.597 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.449 ' HB2' HD12 ' A' ' 191' ' ' ILE . 24.0 mt-10 -65.74 -26.62 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 1.74 110.819 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 20.0 t -114.43 19.34 16.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.317 -0.401 . . . . 1.69 110.779 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.456 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.4 m -125.99 157.62 37.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.719 -0.219 . . . . 0.52 110.887 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.13 154.42 45.76 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.39 109.966 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.534 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 19.2 t -117.71 126.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.533 0.682 . . . . 1.06 111.536 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.494 ' OH ' ' HG3' ' A' ' 225' ' ' GLU . 54.9 p90 . . . . . 0 C--N 1.313 -1.008 0 CA-C-N 115.087 -0.961 . . . . 2.49 109.073 173.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.496 ' CD1' HD22 ' A' ' 222' ' ' LEU . 6.3 mt . . . . . 0 N--CA 1.444 -0.763 0 CA-C-O 120.757 0.313 . . . . 0.9 110.36 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.11 146.82 18.9 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.492 -0.861 . . . . 0.37 111.58 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.712 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 69.0 m95 -70.15 -13.71 62.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.31 110.704 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -94.79 1.02 55.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.3 110.206 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.8 m -74.03 129.24 37.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.925 -0.579 . . . . 0.31 110.684 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.89 117.22 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.564 -0.532 . . . . 1.73 109.564 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 tt -66.75 -21.14 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.593 0.59 . . . . 0.29 112.593 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 172' ' ' ARG . 67.8 p -71.04 -6.85 42.2 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.28 -0.262 . . . . 1.07 111.646 -175.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -90.01 -10.6 44.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.461 0.648 . . . . 3.87 109.977 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 217' ' ' LEU . 6.3 mp -106.41 14.13 27.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.065 0.936 . . . . 1.21 110.291 -174.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.557 HG23 ' HB2' ' A' ' 171' ' ' ALA . 3.3 m -53.83 142.69 23.2 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.673 -1.603 . . . . 0.39 111.869 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 74.68 -3.21 44.27 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.026 -0.534 . . . . 0.53 112.387 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -104.96 171.2 7.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.602 -0.518 . . . . 2.16 109.602 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.1 mt-10 -121.18 125.88 48.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.744 0.783 . . . . 2.03 110.845 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.535 ' HB2' HG13 ' A' ' 159' ' ' VAL . 27.6 mt -101.14 166.07 10.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.44 -1.255 . . . . 1.19 109.325 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.81 119.8 10.68 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.802 0.811 . . . . 2.63 110.914 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 197' ' ' VAL . 88.8 t -101.46 134.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.97 110.923 -175.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.494 ' HG3' ' OH ' ' A' ' 198' ' ' TYR . 27.3 mm-40 -129.32 132.9 47.22 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 1.94 109.669 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 162' ' ' PRO . 92.4 t . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.12 110.718 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.487 ' HB2' ' CG2' ' A' ' 218' ' ' THR . 39.0 Cg_endo . . . . . 0 N--CA 1.462 -0.359 0 CA-C-O 120.655 0.19 . . . . 0.43 112.056 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.525 ' HB ' HG12 ' A' ' 168' ' ' VAL . 1.9 pp -139.44 150.85 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.237 0.541 . . . . 0.79 111.697 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.3 OUTLIER -131.42 132.92 62.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.405 -0.816 . . . . 1.05 108.928 175.404 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.613 ' HG2' HG13 ' A' ' 168' ' ' VAL . 36.0 mtm-85 -102.77 129.75 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.753 -0.658 . . . . 2.87 111.155 -168.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 167' ' ' THR . 25.9 t -112.13 122.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.267 -0.424 . . . . 0.42 111.828 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 223' ' ' HIS . 30.8 m-85 -74.71 103.53 5.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.023 -0.362 . . . . 0.58 110.023 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.523 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -63.7 160.78 41.79 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.89 0.376 . . . . 1.46 110.379 173.08 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.797 ' HD3' HG22 ' A' ' 224' ' ' VAL . 82.1 Cg_exo -45.06 152.17 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.364 2.709 . . . . 0.5 112.316 167.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.1 m120 68.63 25.44 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 2.08 111.176 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 68.75 28.13 5.62 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.398 0.888 . . . . 2.74 113.398 171.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 1.7 mm-40 -89.7 169.48 11.26 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.392 -0.966 . . . . 1.33 108.392 173.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 33.4 ttp180 -146.68 135.07 21.88 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 120.264 -0.574 . . . . 2.49 110.155 175.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.62 HG21 ' CB ' ' A' ' 184' ' ' ALA . 2.1 t -109.73 174.4 5.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.866 -1.061 . . . . 0.52 108.845 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' A' ' 158' ' ' ARG . 2.9 t -138.97 127.19 27.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.823 -0.806 . . . . 0.88 108.823 168.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.444 HG23 HD11 ' A' ' 214' ' ' ILE . 11.0 m -119.8 137.08 25.27 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 115.661 -0.699 . . . . 1.31 109.598 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.64 142.77 59.89 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.912 1.742 . . . . 0.59 110.527 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -68.78 80.36 0.29 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.515 0.674 . . . . 0.35 109.196 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 175' ' ' VAL . 21.4 mmm180 -69.37 110.76 4.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.544 -1.207 . . . . 2.81 109.886 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.1 p -85.48 116.68 23.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.011 -0.54 . . . . 1.44 110.36 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.06 23.89 7.16 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.491 -0.861 . . . . 0.43 111.497 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 172' ' ' ARG . 3.4 p -143.35 156.45 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.217 0.532 . . . . 0.97 110.838 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.5 p -93.31 161.49 14.38 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.517 -0.765 . . . . 0.47 110.933 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.664 ' O ' HD12 ' A' ' 181' ' ' LEU . 16.0 t -48.86 -49.51 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.185 -0.461 . . . . 1.39 109.966 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 3.6 ptm180 -48.7 -44.75 38.37 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 113.276 0.843 . . . . 3.53 113.276 -172.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.564 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 15.7 t70 -71.5 -50.55 30.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.602 0.715 . . . . 1.19 110.208 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.414 ' O ' HG11 ' A' ' 169' ' ' VAL . 2.9 m -62.1 -46.29 89.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.083 -0.962 . . . . 1.34 110.925 -175.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -95.43 -3.97 45.99 Favored 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 119.429 -0.908 . . . . 1.08 112.826 -175.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.9 ptpt -67.51 -35.34 78.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 118.098 -1.441 . . . . 1.15 107.294 167.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.102 -0.953 . . . . 1.8 109.563 170.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -49.9 -56.19 11.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.699 0.285 . . . . 0.3 111.026 172.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.428 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.3 mm? -56.3 -50.09 72.41 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.033 -0.531 . . . . 1.46 110.678 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 50.6 mtt -70.1 -20.91 63.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.326 0.491 . . . . 1.45 112.326 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 19.1 mmt -75.32 -20.33 59.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.479 . . . . 0.85 109.878 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.416 ' HG2' ' HG3' ' A' ' 165' ' ' GLN . 11.5 tpt180 -97.9 -11.56 23.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.653 -0.703 . . . . 2.12 109.623 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.39 46.45 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.277 -0.874 . . . . 0.53 112.061 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.1 mt -104.74 175.78 5.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.79 0.328 . . . . 1.28 110.21 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -125.86 145.18 50.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.058 0.456 . . . . 0.52 110.694 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 86.4 Cg_endo -76.27 -4.96 15.73 Favored 'Trans proline' 0 C--O 1.23 0.084 0 C-N-CA 123.239 2.626 . . . . 0.52 112.752 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.39 -45.35 76.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.572 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.72 29.75 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 1.69 110.091 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 74.1 m -135.25 150.54 50.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.52 110.229 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.55 ' O ' ' HB ' ' A' ' 224' ' ' VAL . . . -133.24 147.93 51.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.352 -0.981 . . . . 0.39 108.352 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.59 ' HA ' ' HB ' ' A' ' 224' ' ' VAL . 84.9 t -99.74 135.6 34.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.742 -0.783 . . . . 1.06 111.797 -170.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 223' ' ' HIS . 35.7 m-85 . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 114.575 -1.193 . . . . 2.49 110.959 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 5.1 mm . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.088 0.47 . . . . 0.9 110.239 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.72 131.9 11.0 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.521 -0.763 . . . . 0.37 111.4 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.516 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 51.9 m95 -67.5 -17.95 64.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 0.31 111.245 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -99.44 6.37 46.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.615 0.721 . . . . 2.3 110.045 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 177' ' ' VAL . 86.7 m -74.34 143.6 44.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.31 109.855 174.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.55 ' HB2' ' CE3' ' A' ' 216' ' ' TRP . 1.1 m-20 -70.5 115.11 9.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.904 0.383 . . . . 1.73 110.329 177.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.444 HD11 HG23 ' A' ' 169' ' ' VAL . 2.6 tt -64.6 -30.49 50.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.29 111.819 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 172' ' ' ARG . 30.3 t -66.18 -6.49 13.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.141 -0.481 . . . . 1.07 111.702 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 213' ' ' ASP . 31.6 m0 -90.95 -12.22 36.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.012 -0.43 . . . . 3.87 110.703 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.0 mt -102.01 9.6 40.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 1.21 110.387 -175.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.568 HG23 ' HB2' ' A' ' 171' ' ' ALA . 4.0 m -46.41 139.04 5.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.39 113.519 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.34 7.71 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.769 -0.65 . . . . 0.53 112.362 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 157' ' ' VAL . 47.7 mt-10 -93.44 168.69 10.89 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.607 -0.516 . . . . 2.16 109.607 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -117.63 124.05 47.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.081 0.944 . . . . 2.03 111.591 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.466 ' HB2' HG22 ' A' ' 159' ' ' VAL . 78.9 mt -96.14 160.83 14.24 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.038 -1.437 . . . . 1.19 108.975 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 160' ' ' PHE . 1.5 t60 -151.32 115.18 4.94 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.947 -0.76 . . . . 2.63 108.947 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.797 HG22 ' HD3' ' A' ' 162' ' ' PRO . 0.9 OUTLIER -102.19 153.68 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.686 0.755 . . . . 0.97 111.882 -177.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -113.43 172.78 6.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.199 -1.364 . . . . 1.94 108.654 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.314 -0.948 0 CA-C-O 120.911 0.386 . . . . 1.12 111.142 -179.483 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.431 -0.211 . . . . 5.63 110.431 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.93 72.6 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.172 2.582 . . . . 3.38 112.847 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 77.4 mt-30 -84.45 154.36 22.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.983 -0.553 . . . . 3.3 110.294 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -101.92 93.69 3.9 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.638 0.256 . . . . 2.33 110.344 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.535 ' HB2' ' CG2' ' A' ' 218' ' ' THR . 23.2 Cg_endo -85.38 157.75 10.95 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.797 2.331 . . . . 0.43 111.504 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.453 HG21 ' C13' ' A' ' 301' ' ' 6FS . 2.1 pp -141.28 153.05 19.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.423 0.63 . . . . 0.79 112.321 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -130.34 126.98 62.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.079 -0.964 . . . . 1.05 109.248 173.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.584 ' HG2' HG22 ' A' ' 168' ' ' VAL . 52.8 mtm-85 -94.68 126.29 39.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.516 -0.766 . . . . 2.87 110.739 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 222' ' ' LEU . 3.5 t -108.86 124.27 65.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.842 -0.617 . . . . 0.42 111.15 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 25.3 m-85 -76.62 102.9 6.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 110.147 -0.316 . . . . 0.58 110.147 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.573 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -63.02 161.36 31.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 121.071 0.463 . . . . 1.46 111.515 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.522 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 77.0 Cg_exo -47.71 153.19 2.43 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.291 2.661 . . . . 0.5 111.783 168.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 4.6 m-20 70.76 18.15 6.31 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.78 0.432 . . . . 2.08 110.804 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 67.48 36.46 3.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.941 -0.572 . . . . 2.74 111.996 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 162' ' ' PRO . 1.7 mm-40 -95.18 174.47 7.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.458 -0.942 . . . . 1.33 108.458 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.7 ttp180 -147.39 129.47 15.49 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.811 -0.755 . . . . 2.49 111.953 175.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.592 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.5 t -107.99 175.9 5.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.48 -1.237 . . . . 0.52 109.41 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.584 HG22 ' HG2' ' A' ' 158' ' ' ARG . 5.7 t -141.27 128.97 22.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.022 -0.733 . . . . 0.88 109.022 172.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.94 137.45 29.64 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.892 -0.594 . . . . 1.31 109.619 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 50.0 Cg_exo -53.99 142.96 63.38 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.902 1.734 . . . . 0.59 110.175 171.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.542 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -67.26 83.09 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.615 0.721 . . . . 0.35 109.771 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 172' ' ' ARG . 18.5 mmm180 -66.73 111.03 3.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.358 -1.292 . . . . 2.81 111.134 -174.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 14.3 p -77.67 132.86 38.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 1.44 110.43 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.42 17.75 79.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.608 -0.806 . . . . 0.43 111.129 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 179' ' ' ASP . 34.2 t -121.89 133.19 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.247 0.546 . . . . 0.97 110.708 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.7 p -83.73 155.93 22.84 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.543 -0.753 . . . . 0.47 110.593 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.783 ' O ' HD12 ' A' ' 181' ' ' LEU . 67.2 t -45.09 -47.37 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 123.33 0.394 . . . . 1.39 110.709 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 0.7 OUTLIER -49.6 -43.55 46.54 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 113.165 0.802 . . . . 3.53 113.165 -174.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.6 t70 -72.34 -50.76 24.4 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.803 0.811 . . . . 1.19 109.824 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.4 p -61.56 -50.53 72.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.301 -1.318 . . . . 1.34 110.474 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.783 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.15 -5.75 54.55 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.28 -0.968 . . . . 1.08 113.174 -175.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.503 ' N ' HD13 ' A' ' 181' ' ' LEU . 18.0 ptpt -69.18 -31.31 69.84 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 117.845 -1.542 . . . . 1.15 107.864 169.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -44.49 96.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.466 -0.788 . . . . 1.8 109.008 168.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.05 -50.32 48.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.639 -0.709 . . . . 0.3 111.892 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.497 ' CD2' HD22 ' A' ' 181' ' ' LEU . 2.1 mm? -58.88 -52.06 67.37 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 1.46 110.524 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.7 mmt -60.69 -25.8 66.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.935 -0.575 . . . . 1.45 112.371 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 20.0 mmt -75.15 -18.01 60.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.126 0.489 . . . . 0.85 110.862 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.434 ' HD3' ' CB ' ' A' ' 165' ' ' GLN . 10.9 mmm180 -95.25 -21.11 18.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.579 0.704 . . . . 2.12 109.679 171.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.95 10.86 36.04 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.897 -1.047 . . . . 0.53 111.143 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.98 177.21 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 1.28 110.685 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 16.5 pt -129.08 145.26 55.92 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.028 -0.533 . . . . 0.52 111.079 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.84 ' HA ' ' SG ' ' A' ' 195' ' ' CYS . 61.4 Cg_endo -72.54 -4.19 14.83 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.381 2.721 . . . . 0.52 113.759 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.31 -49.76 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.939 0.4 . . . . 1.74 111.725 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 77.2 m -96.34 16.42 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.734 0.642 . . . . 1.69 112.734 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.84 ' SG ' ' HA ' ' A' ' 192' ' ' PRO . 1.3 p -115.88 160.52 20.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 0.52 111.981 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.492 ' HA ' ' HE1' ' A' ' 210' ' ' TRP . . . -125.38 155.16 40.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.398 -0.819 . . . . 0.39 109.292 169.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.524 HG23 ' CE2' ' A' ' 210' ' ' TRP . 17.6 t -117.39 122.07 69.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.372 0.606 . . . . 1.06 111.097 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.756 ' CE1' ' HE3' ' A' ' 205' ' ' LYS . 50.6 p90 -155.55 147.69 23.58 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.222 -0.899 . . . . 2.49 109.405 175.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.432 ' HG2' HD11 ' A' ' 208' ' ' ILE . 14.7 ptm180 -114.12 137.21 52.03 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.168 -0.332 . . . . 1.57 111.084 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.463 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 20.2 mm -82.35 122.78 37.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.705 0.764 . . . . 0.88 110.905 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.438 ' HB2' ' HG2' ' A' ' 206' ' ' LYS . 5.1 tt0 -99.44 -149.28 0.36 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.452 -1.249 . . . . 2.41 108.295 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -52.88 81.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.432 0.693 . . . . 1.91 112.427 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.79 11.6 24.39 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.494 -0.384 . . . . 1.12 112.791 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 200' ' ' ILE . 13.3 pt-20 -130.85 -177.75 4.5 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 120.872 0.367 . . . . 1.54 110.679 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.756 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 11.2 mtpt -121.25 129.35 53.12 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.135 -0.484 . . . . 1.69 110.585 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 201' ' ' GLN . 61.7 mmtt -109.98 97.36 29.17 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.455 -0.943 . . . . 1.66 108.455 173.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.711 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 15.2 Cg_exo -68.22 118.22 5.48 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.934 1.756 . . . . 0.58 112.685 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.432 HD11 ' HG2' ' A' ' 199' ' ' ARG . 5.4 mt -89.16 163.75 2.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.182 -0.917 . . . . 0.9 110.291 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.42 145.81 17.91 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.694 -0.765 . . . . 0.37 111.229 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.595 ' CZ3' HD11 ' A' ' 181' ' ' LEU . 48.7 m95 -66.76 -16.05 63.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.166 0.508 . . . . 0.31 110.29 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 2.3 110.769 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 177' ' ' VAL . 24.1 m -70.18 137.29 50.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.398 -0.364 . . . . 0.31 110.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.03 116.16 10.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.432 -0.581 . . . . 1.73 109.432 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 175' ' ' VAL . 7.7 tt -69.68 -20.86 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.292 0.479 . . . . 0.29 112.292 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.503 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 81.6 p -71.0 -6.57 39.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 1.07 111.261 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -91.73 -16.42 26.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.262 0.553 . . . . 3.87 110.975 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.5 mp -99.41 11.93 37.75 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.077 0.941 . . . . 1.21 111.035 -175.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.542 HG23 ' HB2' ' A' ' 171' ' ' ALA . 4.3 m -50.0 138.67 15.15 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.516 -1.674 . . . . 0.39 113.293 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.41 -2.63 28.48 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.53 112.798 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 157' ' ' VAL . 48.2 mt-10 -115.1 131.77 56.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.885 -0.413 . . . . 2.16 109.885 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.7 mt-10 -83.4 136.08 34.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.717 0.77 . . . . 2.03 111.032 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.542 ' HB2' HG13 ' A' ' 159' ' ' VAL . 54.1 mt -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.552 -1.204 . . . . 1.19 110.58 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -127.33 134.52 49.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.241 0.544 . . . . 2.63 110.815 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.706 HG21 HD23 ' A' ' 181' ' ' LEU . 86.5 t -114.76 116.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.555 -0.748 . . . . 0.97 109.145 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 66.0 mm-40 -120.16 133.66 55.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.542 -0.754 . . . . 1.94 109.925 -172.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.8 t -64.05 130.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.135 -0.484 . . . . 1.12 111.092 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 196' ' ' ALA . 52.1 mt -81.6 83.78 6.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.842 -0.617 . . . . 1.69 110.495 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.57 114.88 29.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.798 -0.637 . . . . 2.12 110.452 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 53.9 41.41 32.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.674 -0.694 . . . . 4.42 111.124 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 55.2 t 50.49 86.93 0.14 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.127 -1.397 . . . . 5.77 112.519 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.91 135.5 12.58 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.282 1.988 . . . . 7.15 111.713 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.397 -0.811 . . . . 9.01 110.072 178.958 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.513 ' C11' ' O3 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 110.27 -0.27 . . . . 5.63 110.27 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -67.85 -25.7 38.96 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.434 2.09 . . . . 3.38 111.339 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.426 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 24.7 tp60 -121.06 121.1 37.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.235 -0.893 . . . . 3.3 108.89 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.4 ' CE ' ' HA ' ' A' ' 154' ' ' LYS . 2.2 tpmt? -69.72 110.54 6.69 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 123.276 0.36 . . . . 2.33 110.152 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.528 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 42.3 Cg_endo -85.29 146.92 9.98 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.495 2.13 . . . . 0.43 111.736 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.426 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 16.6 pt -143.13 143.94 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.175 0.512 . . . . 0.79 111.545 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 220' ' ' GLU . 89.3 t -117.59 117.73 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.627 -0.879 . . . . 1.05 108.627 170.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.618 ' HG2' HG22 ' A' ' 168' ' ' VAL . 87.4 mtm180 -97.28 113.62 25.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.039 -0.528 . . . . 2.87 110.867 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.493 ' CG1' HG23 ' A' ' 224' ' ' VAL . 24.3 t -99.04 126.54 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.214 -0.448 . . . . 0.42 111.456 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 25.1 m-85 -78.25 101.05 6.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.647 -0.501 . . . . 0.58 109.647 171.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.669 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.4 OUTLIER -58.72 168.36 1.45 Allowed Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 122.553 0.341 . . . . 1.46 111.789 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 81.7 Cg_exo -47.12 149.44 3.63 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.915 2.41 . . . . 0.5 111.449 167.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.83 8.22 6.65 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.709 0.766 . . . . 2.08 109.22 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.83 48.44 16.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.153 -1.385 . . . . 2.74 112.022 178.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 11.9 mm-40 -80.39 -176.91 5.91 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.628 -1.619 . . . . 1.33 106.628 166.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.409 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 30.5 ttp180 -147.56 131.09 16.75 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.56 -1.256 . . . . 2.49 112.052 175.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.669 ' HB ' HD21 ' A' ' 161' ' ' LEU . 5.5 t -112.18 173.0 6.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.125 -1.398 . . . . 0.52 108.988 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.618 HG22 ' HG2' ' A' ' 158' ' ' ARG . 3.3 t -139.37 129.08 30.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.818 -0.438 . . . . 0.88 109.818 172.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 180' ' ' SER . 73.1 t -127.27 120.95 22.42 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.461 -0.79 . . . . 1.31 109.615 175.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 52.1 Cg_exo -50.22 135.28 38.35 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.008 2.472 . . . . 0.59 111.454 174.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.88 105.96 0.52 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.35 110.243 -177.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.656 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 3.6 mmp_? -100.7 111.04 23.21 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 2.81 111.31 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.83 123.82 26.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.76 -0.654 . . . . 1.44 109.886 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 -7.69 59.29 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.683 -0.967 . . . . 0.43 110.683 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 179' ' ' ASP . 53.7 t -103.7 128.54 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.215 0.531 . . . . 0.97 110.047 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 178' ' ' ARG . 25.5 p -78.08 156.63 29.89 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.528 -0.76 . . . . 0.47 110.062 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.765 ' O ' HD12 ' A' ' 181' ' ' LEU . 23.3 t -48.39 -43.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.851 -0.425 . . . . 1.39 109.851 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 1.3 ptm180 -53.56 -47.01 70.45 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 112.726 0.639 . . . . 3.53 112.726 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.495 ' HB3' HG13 ' A' ' 175' ' ' VAL . 21.0 t70 -68.12 -50.25 55.91 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.698 0.761 . . . . 1.19 109.875 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 169' ' ' VAL . 2.1 p -59.62 -55.53 33.3 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.091 -1.413 . . . . 1.34 110.732 -175.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.93 -2.5 56.75 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 118.78 -1.168 . . . . 1.08 113.334 -174.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.447 ' HB2' ' HG3' ' A' ' 192' ' ' PRO . 18.5 ptpt -70.95 -32.76 69.74 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 117.989 -1.485 . . . . 1.15 107.909 169.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -37.55 87.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.169 -0.678 . . . . 1.8 109.169 169.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -52.04 -52.52 50.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.694 -0.23 . . . . 0.3 111.283 173.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.457 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -56.74 -52.23 65.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.798 0.333 . . . . 1.46 110.59 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 17.6 mmt -62.79 -22.37 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.667 0.617 . . . . 1.45 112.667 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 18.1 mmt -71.65 -38.22 70.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.823 0.345 . . . . 0.85 110.207 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.508 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 11.8 mmm180 -73.85 -23.6 59.64 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.519 0.676 . . . . 2.12 109.685 172.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.77 9.52 37.43 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.022 -0.99 . . . . 0.53 111.468 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.99 177.0 5.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.937 0.398 . . . . 1.28 110.666 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.1 pt -124.8 141.77 39.05 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.52 110.776 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 60.9 Cg_endo -72.26 -10.01 25.13 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 123.242 2.628 . . . . 0.52 112.472 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -54.57 -48.01 72.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.825 -0.625 . . . . 1.74 111.301 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 83.7 m -102.3 25.78 8.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.49 -0.777 . . . . 1.69 111.173 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.549 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 78.0 m -131.79 151.41 51.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.555 -0.293 . . . . 0.52 110.764 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.446 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -123.35 158.67 30.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.402 -0.592 . . . . 0.39 109.402 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.504 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 41.4 t -112.22 134.67 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.895 0.855 . . . . 1.06 112.474 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -134.72 174.74 10.24 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.17 -1.377 . . . . 2.49 109.913 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.454 ' NE ' ' HG2' ' A' ' 220' ' ' GLU . 9.0 ptm180 -150.03 136.23 18.81 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.364 -0.976 . . . . 1.57 108.364 169.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.561 HG12 ' CD2' ' A' ' 223' ' ' HIS . 27.6 mm -86.62 122.61 38.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.817 0.818 . . . . 0.88 110.814 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 203' ' ' GLY . 2.1 tp-100 -102.32 -145.31 0.36 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 113.985 -1.461 . . . . 2.41 108.733 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.85 81.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.745 0.418 . . . . 1.91 111.876 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.59 8.85 10.53 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.537 -0.363 . . . . 1.12 112.697 -177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.72 -179.71 5.22 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.319 0.581 . . . . 1.54 111.397 -172.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.49 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 36.7 mtpt -116.98 134.68 54.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.405 -0.816 . . . . 1.69 110.957 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.419 ' HB2' ' HG3' ' A' ' 199' ' ' ARG . 72.5 mmtt -117.57 112.44 39.04 Favored Pre-proline 0 C--N 1.315 -0.926 0 N-CA-C 109.227 -0.657 . . . . 1.66 109.227 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.77 118.48 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.2 1.933 . . . . 0.58 111.458 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.431 HD11 ' CG ' ' A' ' 199' ' ' ARG . 16.3 mt -93.49 160.05 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.125 0.488 . . . . 0.9 111.304 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -97.51 145.53 17.86 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.884 -0.887 . . . . 0.37 110.884 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.578 ' O ' ' HD2' ' A' ' 178' ' ' ARG . 62.0 m95 -70.73 -18.39 62.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.951 0.405 . . . . 0.31 110.791 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -89.58 -5.78 56.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 2.3 110.387 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 177' ' ' VAL . 98.0 m -69.34 146.6 52.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.31 110.071 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.459 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 12.1 t70 -79.1 129.8 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.851 -0.426 . . . . 1.73 109.851 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.87 -21.68 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.832 0.348 . . . . 0.29 111.759 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.439 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 44.6 t -75.85 -7.75 55.24 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.098 -0.376 . . . . 1.07 110.399 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 13.0 m0 -82.36 -11.12 58.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.385 0.612 . . . . 3.87 109.586 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 220' ' ' GLU . 18.8 mt -114.54 6.87 15.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.468 -0.787 . . . . 1.21 110.385 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 155' ' ' PRO . 21.1 m -42.94 134.71 3.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.091 0.774 . . . . 0.39 113.091 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 71.36 12.68 73.14 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.87 -0.605 . . . . 0.53 112.266 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.454 ' HG2' ' NE ' ' A' ' 199' ' ' ARG . 7.5 tp10 -115.33 141.21 48.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.956 -0.387 . . . . 2.16 109.956 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.9 123.07 33.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 2.03 110.123 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 159' ' ' VAL . 8.7 mp -99.29 170.5 8.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.625 -0.716 . . . . 1.19 110.121 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.561 ' CD2' HG12 ' A' ' 200' ' ' ILE . 12.1 p80 -149.0 130.25 14.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.509 -0.552 . . . . 2.63 109.509 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.549 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 47.3 t -98.57 135.37 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.105 -0.498 . . . . 0.97 110.794 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -118.95 126.22 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.091 -0.958 . . . . 1.94 110.231 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.69 129.83 26.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.421 . . . . 1.12 111.384 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 196' ' ' ALA . 79.1 mt -89.18 101.73 14.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.752 -0.658 . . . . 1.69 110.391 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.84 97.57 3.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.998 -0.546 . . . . 2.12 110.448 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -91.74 60.64 4.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.313 0.577 . . . . 4.42 110.476 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.0 m -71.76 125.9 91.57 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.783 -0.644 . . . . 5.77 110.592 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.66 39.06 0.81 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.892 2.395 . . . . 7.15 112.44 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.2 tp . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.605 -0.712 . . . . 9.01 109.787 -177.228 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.534 ' C1 ' ' HA ' ' A' ' 167' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 120.836 0.351 . . . . 5.63 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.08 141.47 47.6 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.34 2.693 . . . . 3.38 112.543 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -79.9 112.95 17.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.201 -0.454 . . . . 3.3 110.336 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -108.87 98.18 28.26 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.23 -0.441 . . . . 2.33 109.811 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.29 145.13 38.11 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.443 2.095 . . . . 0.43 112.977 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.469 HD12 HG11 ' A' ' 168' ' ' VAL . 14.8 pt -140.13 154.75 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.696 -0.684 . . . . 0.79 110.701 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 218' ' ' THR . 98.4 t -121.2 126.86 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 108.814 -0.81 . . . . 1.05 108.814 172.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 11.1 mtp180 -102.9 107.03 17.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.401 -0.818 . . . . 2.87 110.879 -174.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 222' ' ' LEU . 3.5 t -97.44 125.56 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.471 -0.331 . . . . 0.42 111.441 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -72.63 103.23 3.51 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.189 0.518 . . . . 0.58 110.232 173.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.735 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 28.3 mt -56.86 155.02 16.24 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 1.46 110.963 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 62.8 Cg_exo -53.17 153.8 15.5 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.8 2.333 . . . . 0.5 111.421 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 5.2 m-20 71.79 18.48 5.14 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.428 0.632 . . . . 2.08 110.474 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.26 35.4 5.96 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.985 -1.007 . . . . 2.74 112.558 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.735 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.5 mm100 -94.49 -179.62 4.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.602 -1.258 . . . . 1.33 107.602 171.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -147.24 138.33 23.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.871 -0.732 . . . . 2.49 110.704 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.621 HG21 ' HB1' ' A' ' 184' ' ' ALA . 13.5 t -119.17 171.96 7.92 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.854 -1.066 . . . . 0.52 109.042 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.469 HG11 HD12 ' A' ' 156' ' ' ILE . 3.1 t -141.17 129.82 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.748 -0.464 . . . . 0.88 109.748 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.409 HG13 HD11 ' A' ' 214' ' ' ILE . 3.3 p -131.75 130.39 22.29 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.274 -0.875 . . . . 1.31 109.251 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.446 ' HA ' HG22 ' A' ' 156' ' ' ILE . 10.2 Cg_exo -49.24 144.01 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.359 2.706 . . . . 0.59 112.014 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.73 82.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.29 0.567 . . . . 0.35 109.76 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -70.76 110.65 5.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.282 -0.872 . . . . 2.81 110.82 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 32.3 m -80.45 118.35 21.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.651 -0.704 . . . . 1.44 109.564 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.53 17.65 32.97 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.788 -0.925 . . . . 0.43 110.788 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 179' ' ' ASP . 18.3 t -128.38 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.179 -0.51 . . . . 0.97 110.351 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.474 ' OG1' ' HG3' ' A' ' 178' ' ' ARG . 32.7 p -70.62 148.8 47.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.903 -0.59 . . . . 0.47 109.872 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.823 ' O ' HD12 ' A' ' 181' ' ' LEU . 14.5 p -49.51 -37.71 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.888 -0.412 . . . . 1.39 109.888 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -57.94 -34.8 70.27 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.489 -0.778 . . . . 3.53 112.174 -173.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.651 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -77.02 -49.91 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.9 0.857 . . . . 1.19 109.714 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -53.25 59.44 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.714 -1.13 . . . . 1.34 110.716 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -88.96 0.69 56.42 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.0 -1.08 . . . . 1.08 112.887 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.651 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 17.3 ptpt -69.05 -35.56 76.71 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.257 -1.377 . . . . 1.15 107.736 167.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -65.15 -38.23 89.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.666 -0.814 . . . . 1.8 109.26 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.621 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -48.92 -54.69 14.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.946 -0.301 . . . . 0.3 110.631 172.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.478 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -58.76 -53.75 54.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.466 -0.334 . . . . 1.46 111.045 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.89 -24.63 64.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.086 -0.506 . . . . 1.45 112.291 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 12.4 mmt -78.19 -41.22 35.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.515 -0.55 . . . . 0.85 109.515 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.533 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 15.2 tpt180 -71.0 -18.12 62.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.695 -0.684 . . . . 2.12 109.802 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.28 4.08 44.18 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.687 -0.688 . . . . 0.53 112.824 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 190' ' ' LEU . 5.4 mp -102.18 175.29 5.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.94 0.4 . . . . 1.28 111.543 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.5 pt -119.31 139.89 28.26 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.944 -0.571 . . . . 0.52 110.381 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 55.6 Cg_endo -69.15 -14.3 37.77 Favored 'Trans proline' 0 N--CA 1.47 0.113 0 C-N-CA 123.348 2.699 . . . . 0.52 112.469 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -63.09 -37.04 85.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 1.74 110.846 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 75.7 m -101.42 17.3 23.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.954 -0.566 . . . . 1.69 110.764 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.415 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 85.2 m -128.99 156.91 43.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.163 -0.471 . . . . 0.52 110.784 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -124.96 158.33 33.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.389 -0.597 . . . . 0.39 109.389 173.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.637 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 96.1 t -106.88 139.09 29.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.782 0.801 . . . . 1.06 111.792 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -136.86 173.48 11.65 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.229 -1.35 . . . . 2.49 109.899 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.457 ' CG ' HD11 ' A' ' 208' ' ' ILE . 11.2 ptm180 -152.36 141.16 21.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.132 -1.062 . . . . 1.57 108.132 168.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.636 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 18.5 mm -89.4 121.28 39.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.764 0.792 . . . . 0.88 110.492 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.771 ' OE1' ' HE3' ' A' ' 206' ' ' LYS . 8.7 tt0 -105.88 -142.66 0.37 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.315 -1.311 . . . . 2.41 107.554 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.55 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.663 0.616 . . . . 1.91 112.663 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.58 5.17 6.27 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 116.121 -0.491 . . . . 1.12 113.643 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.17 176.98 8.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.73 0.765 . . . . 1.54 111.842 -171.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.636 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 46.3 mtpt -109.59 131.62 54.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.249 -0.887 . . . . 1.69 111.443 -171.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.771 ' HE3' ' OE1' ' A' ' 201' ' ' GLN . 5.4 mptp? -118.51 118.47 33.68 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.62 -0.718 . . . . 1.66 110.35 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 3.7 Cg_exo -79.1 117.36 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.05 1.834 . . . . 0.58 111.511 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.457 HD11 ' CG ' ' A' ' 199' ' ' ARG . 6.4 mt -91.31 162.05 2.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.129 -0.487 . . . . 0.9 110.883 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 141.47 17.7 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.719 -0.753 . . . . 0.37 111.244 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.637 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 61.2 m95 -70.5 -12.91 61.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.731 0.301 . . . . 0.31 111.148 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.98 -12.91 40.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.492 . . . . 2.3 110.116 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.6 m -60.8 127.97 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.31 111.09 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 215' ' ' SER . 13.6 t70 -68.05 127.98 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 1.73 110.038 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.409 HD11 HG13 ' A' ' 169' ' ' VAL . 7.8 tt -68.53 -20.53 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.132 -0.486 . . . . 0.29 112.153 -172.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.476 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 34.8 t -69.29 -11.73 61.06 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.112 -0.367 . . . . 1.07 111.244 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -89.76 -17.97 27.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 3.87 110.083 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 220' ' ' GLU . 33.4 mt -94.84 3.99 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 1.21 109.999 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.44 ' HA ' HG22 ' A' ' 157' ' ' VAL . 58.4 m -43.07 139.78 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.39 113.331 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.42 -8.67 46.03 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.368 -0.833 . . . . 0.53 112.088 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 34.5 mm-40 -102.6 154.96 18.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.279 0.562 . . . . 2.16 111.168 -175.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 35.5 mt-10 -101.39 124.09 46.51 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.342 -0.845 . . . . 2.03 109.379 174.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 217' ' ' LEU . 7.0 mp -96.01 173.38 7.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.948 -0.569 . . . . 1.19 110.218 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -137.99 135.21 35.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.15 -0.685 . . . . 2.63 109.15 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.439 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 86.8 t -103.52 124.9 58.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.101 -0.64 . . . . 0.97 110.264 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -109.62 119.11 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.39 -0.823 . . . . 1.94 108.801 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.08 126.75 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.718 -0.475 . . . . 1.12 109.718 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 196' ' ' ALA . 63.2 mt -79.45 88.68 5.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.728 -0.669 . . . . 1.69 109.699 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -94.17 97.66 10.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.178 -0.919 . . . . 2.12 111.058 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -82.08 67.7 8.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.556 -0.747 . . . . 4.42 109.061 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.5 m 44.29 71.67 1.43 Allowed Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.448 1.092 . . . . 5.77 112.599 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.11 152.0 56.11 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.134 2.556 . . . . 7.15 112.338 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 232' ' ' LEU . 1.3 pt? . . . . . 0 C--O 1.248 1.013 0 CA-C-N 116.191 -0.458 . . . . 9.01 110.273 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.543 ' C11' ' O3 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.839 -0.43 . . . . 5.63 109.839 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.19 -38.82 33.75 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.913 2.409 . . . . 3.38 112.649 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -132.15 120.39 22.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.847 0.356 . . . . 3.3 110.888 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -120.87 96.28 48.72 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.694 -0.484 . . . . 2.33 109.694 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 71.6 Cg_endo -70.8 148.29 58.02 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.507 2.138 . . . . 0.43 111.843 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.545 HD12 HG11 ' A' ' 168' ' ' VAL . 20.7 pt -138.19 152.93 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 0.79 111.628 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.403 ' HB ' HD11 ' A' ' 214' ' ' ILE . 90.3 t -124.69 129.82 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.734 -0.839 . . . . 1.05 108.734 172.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 168' ' ' VAL . 38.6 mtm-85 -101.51 123.01 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.855 -0.611 . . . . 2.87 110.477 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 222' ' ' LEU . 40.8 t -108.23 127.77 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.415 -0.357 . . . . 0.42 111.722 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -80.51 99.45 8.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.205 -0.665 . . . . 0.58 109.205 170.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.7 OUTLIER -61.78 167.85 4.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.655 0.983 . . . . 1.46 113.655 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 73.7 Cg_exo -49.96 152.82 6.93 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.787 2.991 . . . . 0.5 111.842 167.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.69 13.8 7.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.296 1.046 . . . . 2.08 109.047 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.648 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 57.82 44.83 19.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.89 -1.505 . . . . 2.74 112.108 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 4.1 mm-40 -82.44 178.16 8.37 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.819 -1.549 . . . . 1.33 106.819 166.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 166' ' ' ARG . 12.2 ttp180 -148.6 129.75 14.55 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.542 -0.863 . . . . 2.49 111.06 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.79 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.6 t -118.67 177.92 4.66 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.129 -0.942 . . . . 0.52 109.494 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.545 HG11 HD12 ' A' ' 156' ' ' ILE . 2.4 t -142.81 129.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.702 -0.481 . . . . 0.88 109.702 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 214' ' ' ILE . 5.2 m -124.06 131.63 24.24 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.391 -0.822 . . . . 1.31 109.72 173.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 78.1 Cg_exo -49.4 146.36 14.23 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.634 2.223 . . . . 0.59 112.143 175.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.559 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -66.81 80.21 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.35 110.222 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -64.64 112.22 3.09 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.055 -0.975 . . . . 2.81 111.131 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.6 136.59 36.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.933 -0.576 . . . . 1.44 110.333 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.84 14.69 82.32 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.016 -0.834 . . . . 0.43 111.016 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 179' ' ' ASP . 55.3 t -126.78 135.11 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.038 0.447 . . . . 0.97 110.763 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.7 p -83.13 167.09 18.12 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.817 -0.629 . . . . 0.47 110.326 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.837 ' O ' HD12 ' A' ' 181' ' ' LEU . 2.4 m -53.4 -37.73 30.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 108.487 -0.931 . . . . 1.39 108.487 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.8 tmm_? -44.56 -62.72 1.09 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.174 -0.921 . . . . 3.53 112.619 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.696 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 30.1 t70 -68.05 -44.37 76.55 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.394 0.616 . . . . 1.19 111.034 -174.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.8 p -62.13 -54.65 38.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.462 -0.79 . . . . 1.34 110.656 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.52 -2.66 57.11 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.396 -0.922 . . . . 1.08 112.848 -175.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 13.6 ptmm? -68.34 -36.04 78.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.68 -1.23 . . . . 1.15 107.68 168.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.89 -36.38 83.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.24 -0.891 . . . . 1.8 109.345 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.79 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.63 -55.78 22.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.525 -0.307 . . . . 0.3 111.097 173.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.564 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.5 mm? -53.83 -50.48 66.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.376 -0.375 . . . . 1.46 110.774 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 37.2 mtt -70.31 -21.69 62.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.342 0.497 . . . . 1.45 112.342 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 16.4 mmt -76.3 -18.98 58.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 0.85 110.119 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.47 ' HB2' HD23 ' A' ' 161' ' ' LEU . 7.3 tpm_? -97.33 -11.83 23.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.439 -0.8 . . . . 2.12 109.768 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 94.85 19.71 30.72 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.53 111.955 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.502 ' HB2' HD12 ' A' ' 185' ' ' LEU . 7.7 mt -116.83 172.24 7.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.642 0.258 . . . . 1.28 110.437 -176.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.7 pt -121.57 142.76 36.39 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.497 . . . . 0.52 110.683 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 73.9 Cg_endo -75.15 -13.1 21.21 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 123.258 2.639 . . . . 0.52 112.968 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.37 -41.41 93.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 1.74 110.952 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 37.9 t -94.36 8.0 43.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.945 -0.571 . . . . 1.69 110.785 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.427 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 73.1 m -116.29 158.18 23.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.65 0.262 . . . . 0.52 110.878 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -128.11 157.55 40.45 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.39 110.053 174.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 224' ' ' VAL . 13.9 t -118.89 124.1 72.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.136 0.493 . . . . 1.06 110.717 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.73 ' CB ' ' HA ' ' A' ' 207' ' ' PRO . 55.1 p90 -154.66 154.65 33.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.672 -0.694 . . . . 2.49 110.597 175.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.664 ' HG3' HD11 ' A' ' 208' ' ' ILE . 81.4 mtp180 -106.44 130.3 54.27 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.021 -0.424 . . . . 1.57 111.272 -175.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.432 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 20.0 mm -82.57 123.03 38.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.972 0.892 . . . . 0.88 110.516 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.452 ' NE2' ' HA ' ' A' ' 201' ' ' GLN . 1.5 tp60 -105.06 -143.2 0.37 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.957 -1.474 . . . . 2.41 108.707 177.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.84 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.076 0.399 . . . . 1.91 112.076 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.61 9.83 20.68 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.381 -0.438 . . . . 1.12 112.467 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -130.01 -177.78 4.44 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 120.841 0.353 . . . . 1.54 110.807 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.645 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 7.9 mtpt -122.54 122.3 38.56 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.011 -0.54 . . . . 1.69 110.942 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.08 97.08 10.63 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.153 -1.054 . . . . 1.66 108.153 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.73 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 23.2 Cg_exo -65.85 129.82 23.05 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.509 2.139 . . . . 0.58 113.035 -175.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.664 HD11 ' HG3' ' A' ' 199' ' ' ARG . 2.6 mm -90.81 164.06 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.845 -0.798 . . . . 0.9 108.845 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.2 138.2 13.74 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.563 -0.827 . . . . 0.37 111.205 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.677 ' HA ' HG22 ' A' ' 177' ' ' VAL . 62.3 m95 -68.06 -18.62 64.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.137 0.494 . . . . 0.31 110.244 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -95.08 6.67 48.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.553 -0.748 . . . . 2.3 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 99.9 m -86.33 144.3 27.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.31 110.354 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.96 128.02 34.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.03 -0.532 . . . . 1.73 111.184 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.447 HD11 HG23 ' A' ' 169' ' ' VAL . 6.5 tt -72.7 -26.95 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.683 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.559 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 44.3 t -68.06 -14.96 63.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 1.07 110.596 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -86.16 -13.06 48.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.446 0.641 . . . . 3.87 109.615 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.483 HD13 HD21 ' A' ' 222' ' ' LEU . 10.3 mt -105.71 8.28 32.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.495 -0.775 . . . . 1.21 109.868 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.7 m -40.56 134.57 1.74 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.772 1.027 . . . . 0.39 113.772 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.5 4.5 61.04 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.522 -0.763 . . . . 0.53 112.281 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.63 162.58 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.714 -0.476 . . . . 2.16 109.714 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 41.2 mt-10 -111.9 129.45 56.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.589 0.709 . . . . 2.03 111.456 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 217' ' ' LEU . 66.3 mt -97.77 155.41 17.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.455 -1.248 . . . . 1.19 109.81 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.83 116.0 16.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.702 0.763 . . . . 2.63 109.904 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 197' ' ' VAL . 79.4 t -100.83 137.77 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 0.97 110.997 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.504 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 17.8 mm-40 -131.74 135.5 46.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.855 -1.066 . . . . 1.94 109.694 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 19.5 t -68.11 126.36 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 110.054 -0.35 . . . . 1.12 110.054 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 196' ' ' ALA . 44.5 mt -75.98 82.6 2.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.347 0.594 . . . . 1.69 110.712 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.4 ' HG3' HG12 ' A' ' 226' ' ' VAL . 42.3 mt-10 -110.04 97.63 7.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.652 -0.704 . . . . 2.12 110.434 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.22 59.59 5.66 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.972 -0.558 . . . . 4.42 110.144 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 75.5 t 55.62 80.74 0.28 Allowed Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 114.506 -1.225 . . . . 5.77 111.071 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.74 -11.29 8.01 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.063 2.509 . . . . 7.15 112.071 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.6 tp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.673 -0.679 . . . . 9.01 110.032 -177.853 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.505 ' C1 ' ' HA ' ' A' ' 167' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.593 0.235 . . . . 5.63 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -54.1 -37.03 86.89 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.067 2.511 . . . . 3.38 112.134 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -89.29 107.96 19.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.064 -0.516 . . . . 3.3 109.697 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -74.93 115.48 44.87 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.752 -0.462 . . . . 2.33 109.752 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.434 ' HB2' HG23 ' A' ' 218' ' ' THR . 88.5 Cg_endo -76.09 144.02 26.36 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.342 2.028 . . . . 0.43 112.264 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 170' ' ' PRO . 1.5 pp -141.78 147.07 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.892 0.377 . . . . 0.79 111.295 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 220' ' ' GLU . 99.4 t -116.99 123.32 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.037 -0.727 . . . . 1.05 109.037 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 168' ' ' VAL . 42.6 mtp180 -98.81 114.31 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.464 -0.789 . . . . 2.87 110.868 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 222' ' ' LEU . 2.7 t -104.7 125.9 59.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.373 -0.376 . . . . 0.42 111.537 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.413 ' CZ ' ' HD3' ' A' ' 166' ' ' ARG . 20.2 m-85 -76.23 101.96 5.63 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.611 -0.515 . . . . 0.58 109.611 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.2 OUTLIER -67.09 158.03 82.79 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 1.46 111.136 176.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.558 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 50.2 Cg_exo -56.31 144.62 81.68 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 123.387 2.724 . . . . 0.5 112.514 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 92.6 m-20 74.03 30.02 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.618 0.574 . . . . 2.08 111.054 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.603 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 66.37 32.37 7.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.252 -0.885 . . . . 2.74 112.774 173.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.642 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -90.47 167.07 12.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.462 -1.681 . . . . 1.33 106.462 171.078 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 38.7 ttp180 -148.86 136.44 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.672 -0.811 . . . . 2.49 110.343 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.805 HG21 ' HB1' ' A' ' 184' ' ' ALA . 10.1 t -123.94 172.59 8.82 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.241 -0.891 . . . . 0.52 109.852 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.549 HG22 ' HG2' ' A' ' 158' ' ' ARG . 2.6 t -142.12 128.07 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 109.249 -0.649 . . . . 0.88 109.249 172.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.477 HG23 HD11 ' A' ' 214' ' ' ILE . 3.2 m -118.63 135.26 23.59 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.157 -0.929 . . . . 1.31 108.884 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.485 ' HA ' HG22 ' A' ' 156' ' ' ILE . 61.5 Cg_exo -51.26 146.06 25.08 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 121.872 1.714 . . . . 0.59 110.532 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.23 81.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.373 -0.602 . . . . 0.35 109.373 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 35.6 mmt180 -65.11 111.24 2.83 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.695 -1.139 . . . . 2.81 109.974 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 26.9 p -78.43 130.41 36.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.877 0.37 . . . . 1.44 110.782 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.2 22.61 44.04 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.628 -0.796 . . . . 0.43 112.539 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 1.4 p -137.58 153.44 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 0.97 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 40.3 p -91.05 164.64 13.88 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.834 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.736 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 5.2 m -55.4 -32.93 30.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.268 0.556 . . . . 1.39 109.608 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.649 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.6 tpt180 -53.29 -48.23 68.53 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 115.202 -0.908 . . . . 3.53 112.171 -175.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.0 t70 -75.96 -49.93 16.34 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.377 0.608 . . . . 1.19 110.564 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.1 p -59.61 -55.77 30.33 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.951 -1.022 . . . . 1.34 110.689 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 177' ' ' VAL . 0.1 OUTLIER -92.28 -5.33 52.55 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.069 -1.052 . . . . 1.08 112.659 -176.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 17.6 ptpt -61.2 -40.03 92.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 116.85 -1.94 . . . . 1.15 107.716 167.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 182' ' ' LYS . 6.4 ttpm? -66.24 -38.27 87.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.976 -0.556 . . . . 1.8 109.92 174.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.805 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -49.96 -54.19 21.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.226 0.536 . . . . 0.3 110.467 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.545 HD21 HG11 ' A' ' 224' ' ' VAL . 6.0 mt -62.64 -51.05 68.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.519 -0.764 . . . . 1.46 111.251 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 67.5 mtp -67.58 -21.82 65.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.509 -0.314 . . . . 1.45 111.846 -173.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.4 mtt -77.84 -25.92 49.08 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.535 -0.542 . . . . 0.85 109.535 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.476 ' HB2' HD23 ' A' ' 161' ' ' LEU . 11.1 tpt180 -87.6 -11.28 49.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.511 -0.768 . . . . 2.12 109.356 174.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.26 4.43 44.09 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.731 -0.668 . . . . 0.53 113.251 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 186' ' ' MET . 5.3 mp -97.43 176.87 5.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 1.28 111.599 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.39 146.88 63.88 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.52 110.293 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -4.61 15.59 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.354 2.703 . . . . 0.52 113.303 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.169 0.509 . . . . 1.74 110.029 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 227' ' ' LEU . 48.7 t -107.49 28.41 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.615 -0.72 . . . . 1.69 110.388 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.48 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.2 m -151.25 155.44 38.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.231 -0.441 . . . . 0.52 110.189 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.571 ' HB2' ' HG ' ' A' ' 227' ' ' LEU . . . -131.33 173.34 11.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.148 -1.056 . . . . 0.39 108.148 169.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.571 HG21 HD21 ' A' ' 181' ' ' LEU . 13.1 t -114.44 136.73 50.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.276 0.56 . . . . 1.06 111.343 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -135.36 168.53 19.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.218 -0.901 . . . . 2.49 110.139 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -138.6 136.26 35.79 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.447 -0.945 . . . . 1.57 108.447 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.64 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 21.7 mm -87.82 119.56 35.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.971 0.891 . . . . 0.88 110.963 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.58 ' HA ' ' NE2' ' A' ' 201' ' ' GLN . 0.4 OUTLIER -98.14 -146.86 0.32 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.952 -1.476 . . . . 2.41 108.809 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.15 80.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.079 0.399 . . . . 1.91 112.079 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.3 13.03 27.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.324 -0.465 . . . . 1.12 112.125 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -132.14 -178.35 4.86 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.084 0.469 . . . . 1.54 110.96 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.64 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 42.6 mtpt -120.78 136.1 54.98 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.859 -0.61 . . . . 1.69 111.195 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -122.35 112.99 31.06 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.079 -0.712 . . . . 1.66 109.079 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.18 125.97 11.92 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.003 1.802 . . . . 0.58 112.944 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 6.9 mm -84.09 162.2 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.421 -0.809 . . . . 0.9 109.595 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.78 140.31 14.94 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.847 -0.901 . . . . 0.37 110.847 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.736 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 90.2 m95 -68.02 -14.37 62.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.277 0.539 . . . . 0.31 110.619 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -99.32 0.39 42.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.3 110.388 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.7 m -75.07 140.78 43.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.754 -0.657 . . . . 0.31 110.106 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.27 121.19 20.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.451 . . . . 1.73 110.193 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 169' ' ' VAL . 4.1 tt -67.97 -28.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.29 111.733 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -72.87 -8.39 55.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.228 0.537 . . . . 1.07 110.342 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -83.62 -17.08 42.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.67 0.748 . . . . 3.87 109.568 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -101.82 9.84 40.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.344 -0.843 . . . . 1.21 110.007 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' HB2' ' A' ' 155' ' ' PRO . 63.0 m -39.92 130.7 2.01 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.747 1.018 . . . . 0.39 113.747 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.42 -1.18 61.88 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.508 -0.769 . . . . 0.53 112.347 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 157' ' ' VAL . 38.7 mt-10 -105.61 138.26 42.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.8 0.333 . . . . 2.16 110.205 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -84.46 128.9 34.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.294 0.569 . . . . 2.03 110.598 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 159' ' ' VAL . 48.9 mt -103.61 169.43 8.53 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.265 -0.88 . . . . 1.19 109.957 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -147.16 136.55 22.69 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.104 -0.702 . . . . 2.63 109.104 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.545 HG11 HD21 ' A' ' 185' ' ' LEU . 72.3 t -99.32 144.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.935 0.398 . . . . 0.97 110.944 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -109.64 145.8 35.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.865 -0.791 . . . . 1.94 108.865 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 8.3 t -83.52 114.77 24.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.381 0.61 . . . . 1.12 110.399 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' A' ' 196' ' ' ALA . 4.2 mm? -104.85 90.81 3.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.162 -0.926 . . . . 1.69 110.401 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -94.14 133.03 38.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.22 -0.9 . . . . 2.12 111.207 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 20.8 m120 58.84 56.21 4.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.629 0.728 . . . . 4.42 111.527 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 232' ' ' LEU . 9.1 t -65.67 117.33 40.29 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.733 -1.121 . . . . 5.77 110.998 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.09 20.46 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.935 2.423 . . . . 7.15 112.817 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.544 ' H ' HG12 ' A' ' 230' ' ' VAL . 93.0 mt . . . . . 0 C--O 1.246 0.916 0 CA-C-N 115.666 -0.697 . . . . 9.01 110.861 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.71 ' C19' ' N1 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.639 0.256 . . . . 5.63 110.725 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.23 108.74 0.53 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.868 2.378 . . . . 3.38 111.905 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -75.2 120.74 21.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.357 -0.383 . . . . 3.3 110.25 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -116.12 91.16 31.04 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 2.33 110.361 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 83.4 Cg_endo -77.52 144.59 22.74 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.387 2.058 . . . . 0.43 111.737 175.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 17.4 pt -134.62 144.74 34.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 0.79 110.965 176.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -124.41 117.05 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.806 0.812 . . . . 1.05 108.977 173.253 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 18.1 mtm-85 -83.59 130.57 34.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.557 -1.201 . . . . 2.87 110.506 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 167' ' ' THR . 7.5 t -120.64 117.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.201 -0.909 . . . . 0.42 111.215 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.48 ' HB2' ' HA ' ' A' ' 223' ' ' HIS . 10.2 m-85 -71.77 102.83 2.93 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.991 0.424 . . . . 0.58 110.392 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 27.8 mt -55.46 151.04 21.49 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 124.294 1.038 . . . . 1.46 111.5 173.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.562 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 60.5 Cg_exo -54.06 161.69 4.76 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.022 2.481 . . . . 0.5 111.869 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 67.76 14.78 9.55 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.206 -1.035 . . . . 2.08 108.206 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 63.01 40.22 9.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 113.645 -1.616 . . . . 2.74 112.235 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.711 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 3.0 mm-40 -96.7 -176.55 3.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.378 -1.342 . . . . 1.33 107.378 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 30.1 ttp180 -145.81 127.11 14.86 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.232 -0.987 . . . . 2.49 111.66 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.675 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.1 t -109.55 176.66 4.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.611 -1.177 . . . . 0.52 108.544 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.458 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.1 t -141.32 126.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.676 -0.861 . . . . 0.88 108.676 168.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.475 HG23 HD11 ' A' ' 214' ' ' ILE . 9.2 m -107.53 127.54 27.61 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.764 -0.653 . . . . 1.31 109.956 167.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 71.9 Cg_exo -50.51 142.51 30.42 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.163 1.909 . . . . 0.59 110.461 169.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.432 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -64.7 88.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.35 110.228 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.448 ' O ' HG12 ' A' ' 175' ' ' VAL . 29.0 mmt180 -70.87 110.98 5.94 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.085 -0.961 . . . . 2.81 109.181 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.2 p -82.38 126.54 32.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.246 -0.434 . . . . 1.44 110.904 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.14 22.51 29.8 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.539 -0.839 . . . . 0.43 111.944 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 172' ' ' ARG . 1.3 p -138.1 154.59 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.061 0.457 . . . . 0.97 110.151 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.4 p -86.23 158.87 19.62 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.94 -0.573 . . . . 0.47 110.72 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.777 ' O ' HD12 ' A' ' 181' ' ' LEU . 42.0 t -45.84 -49.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.224 -0.658 . . . . 1.39 109.224 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 11.8 tpt180 -41.57 -56.18 2.65 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 124.743 1.277 . . . . 3.53 113.239 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.747 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.5 t70 -67.5 -47.66 69.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.255 0.55 . . . . 1.19 110.622 -176.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.8 t -64.28 -47.74 78.36 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.047 -0.661 . . . . 1.34 110.183 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -93.03 -2.58 55.54 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.271 -0.971 . . . . 1.08 112.464 -175.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 14.5 ptmm? -69.95 -31.4 69.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.27 -1.382 . . . . 1.15 107.27 167.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.56 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.0 OUTLIER -65.94 -41.73 90.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.08 -0.964 . . . . 1.8 109.418 168.234 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.675 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.61 -55.95 13.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.55 -0.295 . . . . 0.3 110.983 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -53.96 -51.9 62.37 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.494 -0.321 . . . . 1.46 110.911 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -25.29 67.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 1.45 112.363 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 24.2 mmt -78.48 -31.52 47.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.812 0.339 . . . . 0.85 110.222 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.706 ' HD3' HD13 ' A' ' 161' ' ' LEU . 15.4 tpt180 -77.52 -14.86 59.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.458 0.647 . . . . 2.12 109.975 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.03 55.86 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.53 111.543 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.414 ' HB2' HD12 ' A' ' 185' ' ' LEU . 13.7 mt -108.68 176.89 4.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.079 -0.341 . . . . 1.28 110.079 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 193' ' ' GLU . 46.1 pt -122.63 140.96 34.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.52 111.489 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.52 -10.55 26.99 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.55 2.833 . . . . 0.52 112.739 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.421 ' HB2' HD12 ' A' ' 191' ' ' ILE . 38.0 mt-10 -62.38 -44.19 97.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.336 0.589 . . . . 1.74 110.505 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.4 m -97.04 20.17 11.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.403 -0.817 . . . . 1.69 110.989 -176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.545 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 72.8 m -128.39 156.66 42.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.542 -0.299 . . . . 0.52 110.713 -175.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -130.03 152.93 48.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.39 109.995 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.522 HG13 ' CE2' ' A' ' 210' ' ' TRP . 3.5 m -110.68 126.96 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.791 0.805 . . . . 1.06 111.108 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.678 ' CE1' ' HE3' ' A' ' 205' ' ' LYS . 51.7 p90 -158.23 156.04 30.04 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.51 -0.768 . . . . 2.49 109.456 173.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.619 ' HG3' HD11 ' A' ' 208' ' ' ILE . 81.7 mtp180 -103.61 159.06 15.93 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.931 -0.308 . . . . 1.57 111.133 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 20.5 mm -108.06 124.35 64.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.908 0.861 . . . . 0.88 111.202 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.482 ' CD ' ' HE3' ' A' ' 206' ' ' LYS . 5.6 tt0 -99.52 -148.72 0.35 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.968 -1.469 . . . . 2.41 107.473 174.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -54.27 82.08 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.164 0.586 . . . . 1.91 112.433 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 60.81 7.81 8.98 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 121.612 -0.328 . . . . 1.12 112.621 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -126.12 179.88 5.04 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 120.707 0.289 . . . . 1.54 110.458 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.678 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 14.8 mtpt -120.65 137.75 54.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.243 0.544 . . . . 1.69 111.616 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.482 ' HE3' ' CD ' ' A' ' 201' ' ' GLN . 70.9 mmtt -121.12 96.53 48.31 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 107.983 -1.118 . . . . 1.66 107.983 173.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.651 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 26.8 Cg_exo -64.78 124.1 12.67 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.676 2.25 . . . . 0.58 113.531 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.619 HD11 ' HG3' ' A' ' 199' ' ' ARG . 1.2 mm -97.13 161.55 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 108.216 -1.031 . . . . 0.9 108.216 175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.62 151.26 18.58 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.467 -1.349 . . . . 0.37 113.004 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.522 ' CE2' HG13 ' A' ' 197' ' ' VAL . 69.1 m95 -70.52 -18.43 62.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.872 0.368 . . . . 0.31 110.598 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -97.82 -1.96 42.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 2.3 110.564 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.3 m -70.34 142.02 52.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.829 -0.623 . . . . 0.31 109.788 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.99 119.16 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.265 -0.642 . . . . 1.73 109.265 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 177' ' ' VAL . 4.4 tt -71.24 -27.01 27.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.29 111.377 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.0 t -70.84 -7.78 47.88 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.479 0.656 . . . . 1.07 109.717 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -88.37 -6.99 57.37 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.498 0.666 . . . . 3.87 109.487 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.423 HD13 HD21 ' A' ' 222' ' ' LEU . 22.8 mt -112.61 7.48 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.431 -0.804 . . . . 1.21 110.038 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 61.0 m -42.29 134.5 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.916 -1.038 . . . . 0.39 113.7 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.4 57.64 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.53 112.335 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 157' ' ' VAL . 41.6 mt-10 -113.36 148.92 34.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.864 0.364 . . . . 2.16 110.391 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.6 mp0 -92.26 126.61 37.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.217 0.532 . . . . 2.03 111.448 -176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.446 ' HB2' HG13 ' A' ' 159' ' ' VAL . 80.8 mt -99.56 155.13 17.74 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.22 -0.9 . . . . 1.19 110.144 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -119.34 124.72 47.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.743 0.306 . . . . 2.63 110.219 173.359 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.575 HG21 HD23 ' A' ' 181' ' ' LEU . 72.6 t -105.7 116.93 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.569 0.7 . . . . 0.97 109.408 172.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.539 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 54.0 mm-40 -119.55 133.02 55.86 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.921 -1.036 . . . . 1.94 109.19 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.562 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 41.3 t -67.29 128.54 30.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 1.12 111.187 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 196' ' ' ALA . 79.2 mt -86.1 88.08 7.53 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.708 -0.678 . . . . 1.69 110.774 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.35 139.4 31.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.167 -0.47 . . . . 2.12 109.865 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 61.48 59.52 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.621 0.576 . . . . 4.42 110.466 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.02 142.68 83.04 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.624 -0.716 . . . . 5.77 111.165 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.29 133.38 55.65 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.079 2.52 . . . . 7.15 112.176 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 232' ' ' LEU . 2.0 pt? . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.395 -0.812 . . . . 9.01 110.355 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.57 ' C1 ' ' HA ' ' A' ' 167' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 19.1 m . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.233 -0.284 . . . . 5.63 110.233 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 32.3 Cg_exo -61.02 89.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.186 2.591 . . . . 3.38 112.399 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -121.46 146.54 46.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.878 -0.601 . . . . 3.3 109.535 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.559 ' HE2' ' N1 ' ' A' ' 301' ' ' 6FS . 0.7 OUTLIER -105.73 91.07 4.76 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.322 -0.621 . . . . 2.33 109.322 175.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.463 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 55.1 Cg_endo -81.42 138.97 11.25 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.527 2.152 . . . . 0.43 111.64 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.587 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 39.5 pt -140.63 139.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.745 0.307 . . . . 0.79 111.081 -178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 217' ' ' LEU . 88.4 t -112.53 118.76 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.149 -0.685 . . . . 1.05 109.149 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.627 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 66.1 mtm180 -97.02 115.74 27.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.632 -0.713 . . . . 2.87 110.538 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.67 ' CG1' HG23 ' A' ' 224' ' ' VAL . 13.5 t -105.85 127.02 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.233 -0.44 . . . . 0.42 111.653 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 27.3 m-85 -74.22 103.09 4.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.302 -0.408 . . . . 0.58 110.161 173.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.2 mm? -55.04 163.27 1.58 Allowed Pre-proline 0 N--CA 1.474 0.737 0 CA-C-O 121.331 0.586 . . . . 1.46 112.013 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.417 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 77.2 Cg_exo -51.24 160.48 2.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.964 2.443 . . . . 0.5 111.047 163.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 67.89 6.99 5.46 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.069 0.462 . . . . 2.08 110.213 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 164' ' ' LYS . 8.1 mmpt? 70.2 39.39 1.31 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.134 -0.939 . . . . 2.74 111.88 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 4.1 mm-40 -91.02 -178.89 5.32 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.549 -0.908 . . . . 1.33 108.549 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 33.0 ttp180 -147.38 132.89 18.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.006 -0.677 . . . . 2.49 111.541 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.784 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.6 t -120.64 -177.74 3.54 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.459 -1.246 . . . . 0.52 108.743 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.627 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.39 129.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.321 0.581 . . . . 0.88 111.127 170.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.535 HG23 HD11 ' A' ' 214' ' ' ILE . 5.1 m -112.26 131.86 22.37 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.964 -1.016 . . . . 1.31 109.551 172.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 74.0 Cg_exo -48.35 141.86 18.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.504 2.136 . . . . 0.59 111.859 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.81 83.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.35 110.44 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.565 ' O ' HG12 ' A' ' 175' ' ' VAL . 31.1 mmt180 -72.55 113.65 9.81 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 2.81 110.041 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 41.9 t -82.81 124.75 30.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 1.44 110.757 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.06 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.72 -0.752 . . . . 0.43 111.915 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 172' ' ' ARG . 8.5 p -135.27 150.92 29.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.746 -0.464 . . . . 0.97 109.746 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 57.4 p -81.38 155.49 25.9 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.165 -0.471 . . . . 0.47 110.777 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.744 ' O ' HD12 ' A' ' 181' ' ' LEU . 53.0 t -46.46 -46.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.18 -0.674 . . . . 1.39 109.18 173.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 9.5 tpt180 -41.51 -54.98 2.99 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 124.319 1.012 . . . . 3.53 113.125 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.8 t70 -68.6 -48.95 62.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.502 0.668 . . . . 1.19 110.772 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.469 ' O ' HG11 ' A' ' 169' ' ' VAL . 3.3 m -64.59 -46.79 81.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.325 -0.852 . . . . 1.34 111.02 -173.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -93.25 -4.49 51.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.928 -1.109 . . . . 1.08 112.529 -177.611 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.3 ptpt -67.23 -34.41 77.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 118.123 -1.431 . . . . 1.15 107.697 168.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.7 OUTLIER -67.56 -36.57 81.2 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.571 -0.741 . . . . 1.8 109.48 171.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.784 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.94 -52.1 52.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.662 -0.245 . . . . 0.3 110.825 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.507 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.2 mm? -58.62 -50.97 71.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.435 -0.348 . . . . 1.46 111.067 176.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.48 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 49.2 mtt -68.47 -20.99 64.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.515 0.561 . . . . 1.45 112.515 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 18.4 mmt -80.97 -20.32 42.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 0.85 109.722 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.496 ' HB3' ' CD1' ' A' ' 190' ' ' LEU . 10.2 tpt180 -91.09 -17.03 26.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.695 0.76 . . . . 2.12 109.144 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.56 6.32 41.24 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 114.785 -1.098 . . . . 0.53 112.835 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.496 ' CD1' ' HB3' ' A' ' 188' ' ' ARG . 5.2 mp -104.96 174.64 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.112 0.482 . . . . 1.28 111.718 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.1 pt -119.74 144.17 36.53 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.52 110.53 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.76 -4.44 15.36 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.53 2.82 . . . . 0.52 113.593 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -69.38 -42.13 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 1.74 111.095 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 25.5 p -97.17 15.47 22.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 1.69 110.609 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.619 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.6 m -123.1 149.6 44.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.07 -0.514 . . . . 0.52 110.661 -175.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -118.49 152.23 36.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.813 -0.44 . . . . 0.39 109.813 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.692 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 13.6 t -118.88 124.54 73.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.097 0.475 . . . . 1.06 110.867 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.729 ' CB ' ' HA ' ' A' ' 207' ' ' PRO . 51.9 p90 -155.23 149.61 26.09 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.483 -0.78 . . . . 2.49 109.764 174.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 6.8 ptm180 -106.41 152.11 24.04 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.062 -0.347 . . . . 1.57 110.062 -172.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.46 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 22.2 mm -98.37 122.42 50.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.84 0.829 . . . . 0.88 110.532 174.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 203' ' ' GLY . 4.6 tt0 -99.78 -146.6 0.34 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.19 -1.368 . . . . 2.41 107.885 175.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -55.78 80.54 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.292 0.637 . . . . 1.91 112.386 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.02 9.04 12.29 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.508 -0.377 . . . . 1.12 112.524 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -127.87 -178.98 4.72 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 120.797 0.332 . . . . 1.54 110.354 -172.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.644 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 9.3 mtpt -124.19 129.76 51.36 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.952 0.406 . . . . 1.69 110.925 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 24.5 mmtp -113.71 98.96 48.87 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.298 -1.001 . . . . 1.66 108.298 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.729 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 31.4 Cg_exo -62.27 121.79 9.96 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.184 1.923 . . . . 0.58 112.295 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 198' ' ' TYR . 14.7 mm -77.24 148.02 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.9 109.61 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 212' ' ' THR . . . -85.31 131.06 10.21 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.675 -1.37 . . . . 0.37 109.675 171.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.692 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 57.6 m95 -65.38 -21.08 66.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.037 0.446 . . . . 0.31 110.194 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.02 1.7 52.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.533 0.683 . . . . 2.3 110.086 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.5 m -72.37 145.75 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.906 -0.588 . . . . 0.31 110.282 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.61 115.02 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.497 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.535 HD11 HG23 ' A' ' 169' ' ' VAL . 2.4 tt -62.58 -29.4 46.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.29 111.505 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.479 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -73.24 -8.25 55.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.857 -0.61 . . . . 1.07 110.563 -173.326 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -82.27 -21.69 36.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.52 0.676 . . . . 3.87 109.815 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 157' ' ' VAL . 13.0 mt -97.64 11.79 35.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.476 -0.783 . . . . 1.21 110.031 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.459 HG23 ' HB2' ' A' ' 155' ' ' PRO . 94.9 m -37.68 129.66 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.497 0.925 . . . . 0.39 113.497 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.16 -14.03 29.64 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.816 -0.629 . . . . 0.53 112.302 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.31 158.31 26.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.954 0.407 . . . . 2.16 110.306 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.5 mt-10 -109.48 115.48 30.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.596 0.712 . . . . 2.03 109.933 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.443 ' HB2' HG22 ' A' ' 159' ' ' VAL . 36.4 mt -95.6 164.67 12.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.644 -1.162 . . . . 1.19 110.989 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 2.1 m-70 -126.64 123.62 38.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 2.63 110.614 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.67 HG23 ' CG1' ' A' ' 159' ' ' VAL . 98.4 t -101.61 112.37 34.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.666 0.746 . . . . 0.97 109.631 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.501 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 57.9 mm-40 -116.09 124.92 51.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.833 -1.076 . . . . 1.94 109.082 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.417 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 47.9 t -55.75 134.05 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 1.12 111.871 -173.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 196' ' ' ALA . 38.7 mt -78.9 89.02 4.7 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.686 -0.688 . . . . 1.69 110.336 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -109.48 97.59 7.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.479 -0.782 . . . . 2.12 109.874 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -155.02 53.61 0.64 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.749 -0.659 . . . . 4.42 109.235 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 43.6 t 57.27 90.1 0.09 OUTLIER Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 114.517 -1.22 . . . . 5.77 111.258 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.36 -60.7 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.617 2.211 . . . . 7.15 111.609 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.4 mt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.287 -0.863 . . . . 9.01 110.022 179.526 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.559 ' N1 ' ' HE2' ' A' ' 154' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.3 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.663 0.268 . . . . 5.63 110.402 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.19 -21.44 23.58 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.1 2.533 . . . . 3.38 112.797 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -123.98 152.09 42.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.337 -0.392 . . . . 3.3 110.33 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -113.87 96.41 41.19 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.434 -0.348 . . . . 2.33 110.143 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.494 ' HB2' HG23 ' A' ' 218' ' ' THR . 65.1 Cg_endo -79.95 149.6 20.34 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.621 2.214 . . . . 0.43 112.19 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.573 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 2.0 pp -146.42 147.43 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.888 0.375 . . . . 0.79 111.682 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 217' ' ' LEU . 98.4 t -119.72 125.69 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.818 -0.808 . . . . 1.05 108.818 174.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.597 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 62.5 mtm180 -99.05 116.84 32.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.756 -0.656 . . . . 2.87 110.678 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.415 HG12 HG23 ' A' ' 224' ' ' VAL . 2.0 t -106.11 120.56 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.282 -0.417 . . . . 0.42 111.411 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 33.7 m-85 -72.6 103.27 3.51 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.039 -0.356 . . . . 0.58 110.039 174.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.705 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -66.07 156.44 84.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 120.892 0.377 . . . . 1.46 110.749 176.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.578 ' HB3' HG23 ' A' ' 226' ' ' VAL . 93.0 Cg_exo -43.75 150.54 0.53 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.785 2.99 . . . . 0.5 112.97 171.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 74.69 10.86 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.554 -0.748 . . . . 2.08 110.037 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 76.03 32.36 0.63 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.144 -0.935 . . . . 2.74 112.558 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.1 mm100 -86.11 173.39 9.88 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.32 -0.993 . . . . 1.33 108.32 171.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 19.3 ttp180 -147.48 130.76 16.53 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.738 -0.785 . . . . 2.49 111.487 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.748 HG21 ' HB1' ' A' ' 184' ' ' ALA . 6.2 t -113.79 179.07 4.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.608 -1.178 . . . . 0.52 108.837 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.597 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.25 128.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.53 0.681 . . . . 0.88 110.756 165.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.485 HG23 HD11 ' A' ' 214' ' ' ILE . 2.7 m -108.95 145.26 31.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.58 -1.191 . . . . 1.31 109.61 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.42 145.05 29.57 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.05 1.833 . . . . 0.59 111.313 171.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -68.43 79.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.333 0.587 . . . . 0.35 109.996 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.464 ' O ' HG12 ' A' ' 175' ' ' VAL . 15.1 mmm180 -64.27 111.79 2.77 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.081 -0.963 . . . . 2.81 110.72 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.559 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 76.3 m -77.72 126.54 31.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.572 -0.74 . . . . 1.44 110.935 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.18 21.93 39.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.777 -0.725 . . . . 0.43 112.174 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 172' ' ' ARG . 1.7 p -131.69 150.93 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.082 0.468 . . . . 0.97 110.368 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 51.4 p -87.18 158.95 19.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.786 -0.643 . . . . 0.47 111.121 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.756 ' O ' HD12 ' A' ' 181' ' ' LEU . 59.6 t -48.4 -44.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 1.39 109.704 173.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 12.0 tpt180 -43.77 -51.28 7.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.217 -0.902 . . . . 3.53 113.224 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.626 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 12.2 t70 -72.77 -50.93 21.32 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.743 0.782 . . . . 1.19 110.609 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.4 p -59.69 -51.89 67.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.606 -1.179 . . . . 1.34 110.568 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -90.86 -3.67 57.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 118.812 -1.155 . . . . 1.08 112.994 -177.222 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.0 ptpt -66.35 -33.69 76.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 118.195 -1.402 . . . . 1.15 107.755 170.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.2 OUTLIER -70.6 -39.57 73.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.393 -0.822 . . . . 1.8 109.49 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.748 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.58 -52.61 37.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.975 0.417 . . . . 0.3 111.116 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.511 HD21 HG11 ' A' ' 224' ' ' VAL . 5.5 mt -61.58 -51.05 70.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 1.46 111.261 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -26.67 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.531 . . . . 1.45 112.432 -174.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.5 mmt -75.6 -18.73 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.058 0.456 . . . . 0.85 110.954 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.48 ' HG3' ' HG ' ' A' ' 161' ' ' LEU . 4.2 mmp_? -96.04 -12.11 25.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.487 0.66 . . . . 2.12 110.05 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.05 19.13 40.63 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.179 -0.918 . . . . 0.53 111.675 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 188' ' ' ARG . 14.8 mt -102.62 168.55 9.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.168 -0.308 . . . . 1.28 110.168 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.7 pt -127.39 143.43 47.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 121.317 0.58 . . . . 0.52 111.777 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 -4.37 15.31 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.521 2.814 . . . . 0.52 112.854 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -75.46 -34.71 60.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 1.74 110.657 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 60.4 m -107.3 7.56 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 1.69 111.74 -175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.506 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 83.9 m -127.49 145.48 50.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.919 -0.313 . . . . 0.52 111.248 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.561 ' N ' HD21 ' A' ' 227' ' ' LEU . . . -111.52 160.79 16.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.39 109.835 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 224' ' ' VAL . 12.7 t -117.21 125.05 73.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.001 0.429 . . . . 1.06 110.124 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.791 ' CE1' ' HE3' ' A' ' 205' ' ' LYS . 52.4 p90 -152.86 150.31 29.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.777 -0.647 . . . . 2.49 110.4 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 15.1 ptm180 -105.97 145.19 31.65 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.057 -0.349 . . . . 1.57 110.057 -171.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 24.3 mm -91.44 123.75 43.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.98 0.895 . . . . 0.88 110.918 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.447 ' HB2' ' HG2' ' A' ' 206' ' ' LYS . 1.8 tp-100 -103.27 -142.84 0.36 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.944 -1.48 . . . . 2.41 109.012 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.38 77.59 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.841 0.456 . . . . 1.91 112.046 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.77 9.85 15.69 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.559 -0.353 . . . . 1.12 112.282 -175.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -127.38 -176.14 3.65 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.791 0.329 . . . . 1.54 110.646 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.791 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 10.3 mtpt -121.14 129.15 53.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.055 0.455 . . . . 1.69 111.21 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 34.3 mmtp -114.29 98.23 48.07 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.145 -1.057 . . . . 1.66 108.145 173.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.701 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 28.4 Cg_exo -63.2 124.73 14.39 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.372 2.048 . . . . 0.58 113.222 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 198' ' ' TYR . 7.6 mm -82.84 161.78 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.253 -0.647 . . . . 0.9 109.253 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.74 140.76 15.22 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.386 -1.086 . . . . 0.37 110.386 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.598 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 56.7 m95 -68.75 -13.16 62.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.074 0.464 . . . . 0.31 110.451 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.75 5.54 43.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 2.3 110.333 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 177' ' ' VAL . 49.3 m -72.0 137.89 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.072 -0.513 . . . . 0.31 110.051 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.502 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 13.0 t70 -74.05 112.88 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.73 109.995 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.485 HD11 HG23 ' A' ' 169' ' ' VAL . 4.2 tt -62.04 -26.02 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.181 -0.463 . . . . 0.29 112.141 -175.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 173' ' ' CYS . 2.0 t -70.11 -8.65 51.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.708 0.289 . . . . 1.07 111.157 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.501 ' HB3' HD12 ' A' ' 217' ' ' LEU . 1.7 t90 -87.11 -20.85 26.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.737 0.78 . . . . 3.87 109.29 175.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.597 HD23 HD21 ' A' ' 222' ' ' LEU . 6.9 mp -100.07 12.83 35.97 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 1.21 110.674 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 155' ' ' PRO . 90.8 m -39.21 129.73 1.69 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.764 -1.562 . . . . 0.39 113.059 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.61 -7.86 51.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.698 -0.683 . . . . 0.53 112.356 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -96.64 164.11 12.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.86 0.362 . . . . 2.16 110.92 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 38.2 mt-10 -113.87 122.8 48.13 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.328 0.585 . . . . 2.03 110.87 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.597 HD21 HD23 ' A' ' 217' ' ' LEU . 26.1 mt -99.29 161.49 13.59 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 1.19 111.081 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 26.3 m-70 -124.64 127.2 46.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.425 . . . . 2.63 110.138 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 197' ' ' VAL . 75.5 t -104.98 130.31 56.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.221 0.534 . . . . 0.97 109.66 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 6.7 mm-40 -128.65 130.06 46.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.162 -0.926 . . . . 1.94 110.466 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.578 HG23 ' HB3' ' A' ' 162' ' ' PRO . 99.6 t -68.01 126.43 27.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.622 -0.51 . . . . 1.12 109.622 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.561 HD21 ' N ' ' A' ' 196' ' ' ALA . 1.0 OUTLIER -85.43 82.81 8.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.494 -0.558 . . . . 1.69 109.494 -178.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -84.6 95.87 9.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.56 -0.746 . . . . 2.12 109.896 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -133.3 59.41 1.74 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.604 0.716 . . . . 4.42 109.39 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.17 114.96 35.97 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.723 -1.126 . . . . 5.77 110.785 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -90.19 26.97 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.07 2.513 . . . . 7.15 112.879 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 41.4 tp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.324 -0.846 . . . . 9.01 110.382 179.052 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.513 ' C1 ' ' HA ' ' A' ' 167' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.123 -0.325 . . . . 5.63 110.123 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.74 -26.49 79.83 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.204 2.603 . . . . 3.38 112.818 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -85.36 139.14 31.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.633 -0.506 . . . . 3.3 109.633 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.87 114.7 55.74 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.328 -0.396 . . . . 2.33 110.129 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.53 ' HB2' HG21 ' A' ' 218' ' ' THR . 40.8 Cg_endo -80.64 158.16 21.83 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.52 2.147 . . . . 0.43 111.665 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.476 HG21 ' C13' ' A' ' 301' ' ' 6FS . 22.0 pt -141.37 158.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.453 0.644 . . . . 0.79 111.861 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 130.27 48.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.903 -1.044 . . . . 1.05 108.934 169.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 9.0 mtm180 -99.6 130.23 45.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.089 -0.959 . . . . 2.87 110.337 -169.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' A' ' 222' ' ' LEU . 6.0 t -115.54 125.73 72.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.453 -0.339 . . . . 0.42 111.581 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -77.15 103.38 7.05 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.223 -0.298 . . . . 0.58 110.236 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.743 HD22 ' H ' ' A' ' 161' ' ' LEU . 2.0 mm? -51.97 162.84 0.74 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 121.12 0.486 . . . . 1.46 111.429 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.468 ' HB3' HG23 ' A' ' 226' ' ' VAL . 78.5 Cg_exo -52.71 154.56 12.13 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.807 2.338 . . . . 0.5 111.889 166.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 64.91 15.48 9.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.688 0.756 . . . . 2.08 110.091 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 70.05 37.34 1.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.776 -1.102 . . . . 2.74 113.396 171.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.7 mm-40 -86.23 176.44 7.95 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.621 -1.251 . . . . 1.33 107.621 168.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -144.91 126.23 14.83 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.463 -0.895 . . . . 2.49 111.54 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.707 HG21 ' HB1' ' A' ' 184' ' ' ALA . 8.1 t -107.72 172.68 6.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.068 -1.424 . . . . 0.52 108.441 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 156' ' ' ILE . 2.4 t -142.97 129.04 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 121.014 0.435 . . . . 0.88 110.081 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.12 131.38 24.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.329 -0.851 . . . . 1.31 109.751 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 73.0 Cg_exo -51.75 140.13 47.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.102 1.868 . . . . 0.59 110.548 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.557 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -61.2 101.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 0.35 110.221 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 215' ' ' SER . 35.9 mmt180 -81.03 111.13 17.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.011 -0.995 . . . . 2.81 110.386 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 p -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.436 -0.347 . . . . 1.44 110.911 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.54 19.82 57.64 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.718 -0.953 . . . . 0.43 110.718 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 179' ' ' ASP . 46.8 t -129.53 132.12 66.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.952 -0.624 . . . . 0.97 110.137 -175.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.5 p -78.02 162.15 26.94 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.907 -0.405 . . . . 0.47 109.907 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.785 ' O ' HD12 ' A' ' 181' ' ' LEU . 5.9 m -52.09 -36.5 20.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.616 -0.883 . . . . 1.39 108.616 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 54.2 ttt180 -43.75 -58.84 2.5 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.807 -1.088 . . . . 3.53 112.729 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.556 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -71.61 -46.1 60.17 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 1.19 110.598 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.5 p -62.46 -57.25 11.89 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.946 -1.025 . . . . 1.34 110.887 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -90.16 0.0 57.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 118.889 -1.124 . . . . 1.08 112.486 -176.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 17.9 ptpt -67.95 -33.96 75.68 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 117.559 -1.656 . . . . 1.15 107.427 165.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 187' ' ' MET . 12.8 tptt -60.79 -43.67 97.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.161 -0.927 . . . . 1.8 108.921 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.707 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -48.05 -58.95 3.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.388 0.43 . . . . 0.3 111.432 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 181' ' ' LEU . 2.9 mm? -52.95 -51.3 61.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.338 -0.392 . . . . 1.46 110.463 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 16.4 mtt -67.99 -21.29 65.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.29 0.478 . . . . 1.45 112.29 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.3 mmt -77.54 -27.3 51.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.207 0.527 . . . . 0.85 109.622 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 188' ' ' ARG . 25.8 tpt180 -85.88 -19.73 30.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.522 -0.763 . . . . 2.12 109.929 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.06 14.88 29.86 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.744 -0.662 . . . . 0.53 111.756 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.45 ' HB2' HD12 ' A' ' 185' ' ' LEU . 12.9 mt -108.07 177.13 4.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.07 -0.344 . . . . 1.28 110.07 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 193' ' ' GLU . 43.8 pt -124.64 146.51 52.89 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 121.179 0.514 . . . . 0.52 111.022 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.467 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 96.6 Cg_endo -77.86 -12.37 16.37 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.275 2.65 . . . . 0.52 112.597 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.449 ' HB2' HD12 ' A' ' 191' ' ' ILE . 24.0 mt-10 -65.74 -26.62 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 1.74 110.819 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 20.0 t -114.43 19.34 16.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.317 -0.401 . . . . 1.69 110.779 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.456 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.4 m -125.99 157.62 37.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.719 -0.219 . . . . 0.52 110.887 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -128.13 154.42 45.76 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.39 109.966 174.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.534 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 19.2 t -117.71 126.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.533 0.682 . . . . 1.06 111.536 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.734 ' CB ' ' HA ' ' A' ' 207' ' ' PRO . 54.9 p90 -154.71 150.86 28.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.087 -0.961 . . . . 2.49 109.073 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.435 ' CG ' HD11 ' A' ' 208' ' ' ILE . 13.3 ptm180 -115.09 131.36 56.95 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.531 -0.731 . . . . 1.57 111.507 -170.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.549 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 14.2 mm -84.88 122.79 38.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.728 0.775 . . . . 0.88 111.638 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.587 ' CD ' ' HE3' ' A' ' 206' ' ' LYS . 27.7 mt-30 -95.62 -153.05 0.38 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.154 -1.385 . . . . 2.41 108.517 173.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.411 ' H ' ' HB3' ' A' ' 201' ' ' GLN . 20.6 t70 -54.66 85.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.668 0.27 . . . . 1.91 111.623 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 62.16 7.87 15.24 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 116.247 -0.433 . . . . 1.12 113.18 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 200' ' ' ILE . 15.3 pt-20 -123.97 176.24 6.46 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 117.616 0.708 . . . . 1.54 111.039 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.616 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 12.8 mtpt -123.48 127.14 47.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.047 0.451 . . . . 1.69 110.792 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.587 ' HE3' ' CD ' ' A' ' 201' ' ' GLN . 70.6 mmtt -110.72 98.29 36.9 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 108.643 -0.873 . . . . 1.66 108.643 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.734 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 6.6 Cg_exo -72.25 117.73 5.28 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.844 1.696 . . . . 0.58 112.89 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.496 ' CD1' HD22 ' A' ' 222' ' ' LEU . 6.3 mt -91.02 152.04 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.241 -0.891 . . . . 0.9 110.36 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.11 146.82 18.9 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.492 -0.861 . . . . 0.37 111.58 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.712 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 69.0 m95 -70.15 -13.71 62.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.31 110.704 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -94.79 1.02 55.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.3 110.206 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.8 m -74.03 129.24 37.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.925 -0.579 . . . . 0.31 110.684 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.89 117.22 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.564 -0.532 . . . . 1.73 109.564 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 tt -66.75 -21.14 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.593 0.59 . . . . 0.29 112.593 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 172' ' ' ARG . 67.8 p -71.04 -6.85 42.2 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.28 -0.262 . . . . 1.07 111.646 -175.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -90.01 -10.6 44.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.461 0.648 . . . . 3.87 109.977 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 217' ' ' LEU . 6.3 mp -106.41 14.13 27.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.065 0.936 . . . . 1.21 110.291 -174.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.557 HG23 ' HB2' ' A' ' 171' ' ' ALA . 3.3 m -53.83 142.69 23.2 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.673 -1.603 . . . . 0.39 111.869 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 74.68 -3.21 44.27 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.026 -0.534 . . . . 0.53 112.387 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -104.96 171.2 7.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.602 -0.518 . . . . 2.16 109.602 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.1 mt-10 -121.18 125.88 48.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.744 0.783 . . . . 2.03 110.845 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.535 ' HB2' HG13 ' A' ' 159' ' ' VAL . 27.6 mt -101.14 166.07 10.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.44 -1.255 . . . . 1.19 109.325 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.81 119.8 10.68 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.802 0.811 . . . . 2.63 110.914 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 197' ' ' VAL . 88.8 t -101.46 134.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.97 110.923 -175.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.494 ' HG3' ' OH ' ' A' ' 198' ' ' TYR . 27.3 mm-40 -129.32 132.9 47.22 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 1.94 109.669 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 162' ' ' PRO . 92.4 t -67.0 130.38 32.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.12 110.718 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 196' ' ' ALA . 61.1 mt -83.96 81.85 8.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.377 0.608 . . . . 1.69 109.676 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -88.43 98.18 11.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.033 -0.985 . . . . 2.12 111.138 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -126.7 54.24 1.62 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.974 0.892 . . . . 4.42 109.156 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 7.9 t -78.49 120.9 82.75 Favored Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 114.393 -1.276 . . . . 5.77 110.366 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.06 83.58 0.26 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.674 2.249 . . . . 7.15 111.971 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.382 -0.818 . . . . 9.01 109.942 178.594 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.506 ' C1 ' ' HA ' ' A' ' 167' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.314 -0.254 . . . . 5.63 110.314 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.81 78.42 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.652 2.235 . . . . 3.38 111.531 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -78.57 136.58 37.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.5 . . . . 3.3 111.024 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -119.47 85.44 31.81 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 109.369 -0.604 . . . . 2.33 109.369 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.487 ' HB2' ' CG2' ' A' ' 218' ' ' THR . 39.0 Cg_endo -82.04 147.81 14.99 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.43 2.086 . . . . 0.43 112.056 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.525 ' HB ' HG12 ' A' ' 168' ' ' VAL . 1.9 pp -139.44 150.85 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.237 0.541 . . . . 0.79 111.697 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.3 OUTLIER -131.42 132.92 62.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.405 -0.816 . . . . 1.05 108.928 175.404 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.613 ' HG2' HG13 ' A' ' 168' ' ' VAL . 36.0 mtm-85 -102.77 129.75 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.753 -0.658 . . . . 2.87 111.155 -168.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 167' ' ' THR . 25.9 t -112.13 122.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.267 -0.424 . . . . 0.42 111.828 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 223' ' ' HIS . 30.8 m-85 -74.71 103.53 5.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.023 -0.362 . . . . 0.58 110.023 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.523 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -63.7 160.78 41.79 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.89 0.376 . . . . 1.46 110.379 173.08 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.797 ' HD3' HG22 ' A' ' 224' ' ' VAL . 82.1 Cg_exo -45.06 152.17 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.364 2.709 . . . . 0.5 112.316 167.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.1 m120 68.63 25.44 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 2.08 111.176 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 68.75 28.13 5.62 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.398 0.888 . . . . 2.74 113.398 171.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 1.7 mm-40 -89.7 169.48 11.26 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.392 -0.966 . . . . 1.33 108.392 173.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 33.4 ttp180 -146.68 135.07 21.88 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 120.264 -0.574 . . . . 2.49 110.155 175.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.62 HG21 ' CB ' ' A' ' 184' ' ' ALA . 2.1 t -109.73 174.4 5.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.866 -1.061 . . . . 0.52 108.845 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' A' ' 158' ' ' ARG . 2.9 t -138.97 127.19 27.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.823 -0.806 . . . . 0.88 108.823 168.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.444 HG23 HD11 ' A' ' 214' ' ' ILE . 11.0 m -119.8 137.08 25.27 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 115.661 -0.699 . . . . 1.31 109.598 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.64 142.77 59.89 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.912 1.742 . . . . 0.59 110.527 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -68.78 80.36 0.29 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.515 0.674 . . . . 0.35 109.196 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 175' ' ' VAL . 21.4 mmm180 -69.37 110.76 4.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.544 -1.207 . . . . 2.81 109.886 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.1 p -85.48 116.68 23.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.011 -0.54 . . . . 1.44 110.36 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.06 23.89 7.16 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.491 -0.861 . . . . 0.43 111.497 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 172' ' ' ARG . 3.4 p -143.35 156.45 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.217 0.532 . . . . 0.97 110.838 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.5 p -93.31 161.49 14.38 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.517 -0.765 . . . . 0.47 110.933 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.664 ' O ' HD12 ' A' ' 181' ' ' LEU . 16.0 t -48.86 -49.51 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.185 -0.461 . . . . 1.39 109.966 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 3.6 ptm180 -48.7 -44.75 38.37 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 113.276 0.843 . . . . 3.53 113.276 -172.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.564 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 15.7 t70 -71.5 -50.55 30.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.602 0.715 . . . . 1.19 110.208 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.414 ' O ' HG11 ' A' ' 169' ' ' VAL . 2.9 m -62.1 -46.29 89.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.083 -0.962 . . . . 1.34 110.925 -175.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -95.43 -3.97 45.99 Favored 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 119.429 -0.908 . . . . 1.08 112.826 -175.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.9 ptpt -67.51 -35.34 78.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 118.098 -1.441 . . . . 1.15 107.294 167.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.102 -0.953 . . . . 1.8 109.563 170.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -49.9 -56.19 11.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.699 0.285 . . . . 0.3 111.026 172.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.428 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.3 mm? -56.3 -50.09 72.41 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.033 -0.531 . . . . 1.46 110.678 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 50.6 mtt -70.1 -20.91 63.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.326 0.491 . . . . 1.45 112.326 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 19.1 mmt -75.32 -20.33 59.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.479 . . . . 0.85 109.878 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.416 ' HG2' ' HG3' ' A' ' 165' ' ' GLN . 11.5 tpt180 -97.9 -11.56 23.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.653 -0.703 . . . . 2.12 109.623 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.39 46.45 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.277 -0.874 . . . . 0.53 112.061 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.1 mt -104.74 175.78 5.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.79 0.328 . . . . 1.28 110.21 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -125.86 145.18 50.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.058 0.456 . . . . 0.52 110.694 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 86.4 Cg_endo -76.27 -4.96 15.73 Favored 'Trans proline' 0 C--O 1.23 0.084 0 C-N-CA 123.239 2.626 . . . . 0.52 112.752 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.39 -45.35 76.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.572 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.72 29.75 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 1.69 110.091 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 74.1 m -135.25 150.54 50.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.52 110.229 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.55 ' O ' ' HB ' ' A' ' 224' ' ' VAL . . . -133.24 147.93 51.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.352 -0.981 . . . . 0.39 108.352 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.59 ' HA ' ' HB ' ' A' ' 224' ' ' VAL . 84.9 t -99.74 135.6 34.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.742 -0.783 . . . . 1.06 111.797 -170.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 223' ' ' HIS . 35.7 m-85 -135.05 166.74 22.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.575 -1.193 . . . . 2.49 110.959 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.642 ' HG3' HD11 ' A' ' 208' ' ' ILE . 48.3 mtp180 -130.3 124.05 31.46 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.993 -1.003 . . . . 1.57 109.055 164.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.607 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 21.0 mm -81.81 115.71 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 C-N-CA 119.405 -0.918 . . . . 0.88 110.123 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.517 ' HA ' ' NE2' ' A' ' 201' ' ' GLN . 0.6 OUTLIER -98.72 -145.69 0.32 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.176 -1.375 . . . . 2.41 108.739 179.011 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.54 79.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.7 0.625 . . . . 1.91 112.439 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.58 13.23 30.1 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.463 -0.399 . . . . 1.12 112.53 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.55 177.86 7.28 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.172 0.511 . . . . 1.54 111.055 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 45.8 mtpt -115.09 136.13 53.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.595 -0.729 . . . . 1.69 111.087 -175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -119.32 108.45 39.97 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.508 -0.769 . . . . 1.66 108.981 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.91 118.92 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.732 1.622 . . . . 0.58 111.994 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.642 HD11 ' HG3' ' A' ' 199' ' ' ARG . 5.1 mm -87.16 162.57 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.9 110.239 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.72 131.9 11.0 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.521 -0.763 . . . . 0.37 111.4 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.516 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 51.9 m95 -67.5 -17.95 64.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 0.31 111.245 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -99.44 6.37 46.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.615 0.721 . . . . 2.3 110.045 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 177' ' ' VAL . 86.7 m -74.34 143.6 44.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.31 109.855 174.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.55 ' HB2' ' CE3' ' A' ' 216' ' ' TRP . 1.1 m-20 -70.5 115.11 9.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.904 0.383 . . . . 1.73 110.329 177.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.444 HD11 HG23 ' A' ' 169' ' ' VAL . 2.6 tt -64.6 -30.49 50.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.29 111.819 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 172' ' ' ARG . 30.3 t -66.18 -6.49 13.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.141 -0.481 . . . . 1.07 111.702 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 213' ' ' ASP . 31.6 m0 -90.95 -12.22 36.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.012 -0.43 . . . . 3.87 110.703 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.0 mt -102.01 9.6 40.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 1.21 110.387 -175.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.568 HG23 ' HB2' ' A' ' 171' ' ' ALA . 4.0 m -46.41 139.04 5.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.39 113.519 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.34 7.71 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.769 -0.65 . . . . 0.53 112.362 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 157' ' ' VAL . 47.7 mt-10 -93.44 168.69 10.89 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.607 -0.516 . . . . 2.16 109.607 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -117.63 124.05 47.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.081 0.944 . . . . 2.03 111.591 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.466 ' HB2' HG22 ' A' ' 159' ' ' VAL . 78.9 mt -96.14 160.83 14.24 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.038 -1.437 . . . . 1.19 108.975 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 160' ' ' PHE . 1.5 t60 -151.32 115.18 4.94 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.947 -0.76 . . . . 2.63 108.947 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.797 HG22 ' HD3' ' A' ' 162' ' ' PRO . 0.9 OUTLIER -102.19 153.68 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.686 0.755 . . . . 0.97 111.882 -177.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -113.43 172.78 6.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.199 -1.364 . . . . 1.94 108.654 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.9 123.4 50.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 120.911 0.386 . . . . 1.12 111.142 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 196' ' ' ALA . 82.9 mt -81.5 83.27 7.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.742 -0.663 . . . . 1.69 109.578 175.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.26 120.59 20.03 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.462 -0.79 . . . . 2.12 109.743 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.42 54.61 1.76 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.564 0.697 . . . . 4.42 110.991 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.513 ' HB ' ' HD3' ' A' ' 231' ' ' PRO . 7.0 t -67.12 -48.93 47.68 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.902 -1.045 . . . . 5.77 110.825 172.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.513 ' HD3' ' HB ' ' A' ' 230' ' ' VAL . 8.8 Cg_exo -71.53 106.73 2.01 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.715 1.61 . . . . 7.15 111.057 173.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.483 -0.77 . . . . 9.01 109.77 178.693 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.545 ' C11' ' O3 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.535 ' HB2' ' CG2' ' A' ' 218' ' ' THR . 23.2 Cg_endo . . . . . 0 N--CA 1.462 -0.372 0 N-CA-C 111.504 -0.229 . . . . 0.43 111.504 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.28 153.05 19.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.423 0.63 . . . . 0.79 112.321 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -130.34 126.98 62.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.079 -0.964 . . . . 1.05 109.248 173.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.584 ' HG2' HG22 ' A' ' 168' ' ' VAL . 52.8 mtm-85 -94.68 126.29 39.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.516 -0.766 . . . . 2.87 110.739 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 222' ' ' LEU . 3.5 t -108.86 124.27 65.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.842 -0.617 . . . . 0.42 111.15 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 25.3 m-85 -76.62 102.9 6.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 110.147 -0.316 . . . . 0.58 110.147 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.573 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -63.02 161.36 31.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 121.071 0.463 . . . . 1.46 111.515 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.522 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 77.0 Cg_exo -47.71 153.19 2.43 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.291 2.661 . . . . 0.5 111.783 168.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 4.6 m-20 70.76 18.15 6.31 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.78 0.432 . . . . 2.08 110.804 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 67.48 36.46 3.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.941 -0.572 . . . . 2.74 111.996 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.546 ' HA ' HE21 ' A' ' 165' ' ' GLN . 0.0 OUTLIER -95.18 174.47 7.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.458 -0.942 . . . . 1.33 108.458 174.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.7 ttp180 -147.39 129.47 15.49 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.811 -0.755 . . . . 2.49 111.953 175.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.592 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.5 t -107.99 175.9 5.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.48 -1.237 . . . . 0.52 109.41 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.584 HG22 ' HG2' ' A' ' 158' ' ' ARG . 5.7 t -141.27 128.97 22.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.022 -0.733 . . . . 0.88 109.022 172.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.94 137.45 29.64 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.892 -0.594 . . . . 1.31 109.619 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 50.0 Cg_exo -53.99 142.96 63.38 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.902 1.734 . . . . 0.59 110.175 171.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.542 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -67.26 83.09 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.615 0.721 . . . . 0.35 109.771 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 172' ' ' ARG . 18.5 mmm180 -66.73 111.03 3.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.358 -1.292 . . . . 2.81 111.134 -174.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 14.3 p -77.67 132.86 38.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 1.44 110.43 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.42 17.75 79.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.608 -0.806 . . . . 0.43 111.129 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 179' ' ' ASP . 34.2 t -121.89 133.19 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.247 0.546 . . . . 0.97 110.708 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.7 p -83.73 155.93 22.84 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.543 -0.753 . . . . 0.47 110.593 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.783 ' O ' HD12 ' A' ' 181' ' ' LEU . 67.2 t -45.09 -47.37 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 123.33 0.394 . . . . 1.39 110.709 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 0.7 OUTLIER -49.6 -43.55 46.54 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 113.165 0.802 . . . . 3.53 113.165 -174.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.6 t70 -72.34 -50.76 24.4 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.803 0.811 . . . . 1.19 109.824 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.4 p -61.56 -50.53 72.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.301 -1.318 . . . . 1.34 110.474 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.783 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.15 -5.75 54.55 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.28 -0.968 . . . . 1.08 113.174 -175.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.503 ' N ' HD13 ' A' ' 181' ' ' LEU . 18.0 ptpt -69.18 -31.31 69.84 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 117.845 -1.542 . . . . 1.15 107.864 169.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -44.49 96.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.466 -0.788 . . . . 1.8 109.008 168.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.05 -50.32 48.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.639 -0.709 . . . . 0.3 111.892 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.497 ' CD2' HD22 ' A' ' 181' ' ' LEU . 2.1 mm? -58.88 -52.06 67.37 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 1.46 110.524 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.7 mmt -60.69 -25.8 66.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.935 -0.575 . . . . 1.45 112.371 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 20.0 mmt -75.15 -18.01 60.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.126 0.489 . . . . 0.85 110.862 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.434 ' HD3' ' CB ' ' A' ' 165' ' ' GLN . 10.9 mmm180 -95.25 -21.11 18.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.579 0.704 . . . . 2.12 109.679 171.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.95 10.86 36.04 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.897 -1.047 . . . . 0.53 111.143 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.98 177.21 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 1.28 110.685 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 16.5 pt -129.08 145.26 55.92 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.028 -0.533 . . . . 0.52 111.079 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.84 ' HA ' ' SG ' ' A' ' 195' ' ' CYS . 61.4 Cg_endo -72.54 -4.19 14.83 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.381 2.721 . . . . 0.52 113.759 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.31 -49.76 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.939 0.4 . . . . 1.74 111.725 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 77.2 m -96.34 16.42 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.734 0.642 . . . . 1.69 112.734 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.84 ' SG ' ' HA ' ' A' ' 192' ' ' PRO . 1.3 p -115.88 160.52 20.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 0.52 111.981 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.492 ' HA ' ' HE1' ' A' ' 210' ' ' TRP . . . -125.38 155.16 40.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.398 -0.819 . . . . 0.39 109.292 169.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.524 HG23 ' CE2' ' A' ' 210' ' ' TRP . 17.6 t -117.39 122.07 69.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.372 0.606 . . . . 1.06 111.097 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.491 ' CZ ' ' HG3' ' A' ' 225' ' ' GLU . 50.6 p90 . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.222 -0.899 . . . . 2.49 109.405 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.419 ' CD1' HD22 ' A' ' 222' ' ' LEU . 5.4 mt . . . . . 0 N--CA 1.447 -0.582 0 N-CA-C 110.291 -0.262 . . . . 0.9 110.291 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.42 145.81 17.91 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.694 -0.765 . . . . 0.37 111.229 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.595 ' CZ3' HD11 ' A' ' 181' ' ' LEU . 48.7 m95 -66.76 -16.05 63.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.166 0.508 . . . . 0.31 110.29 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 2.3 110.769 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 177' ' ' VAL . 24.1 m -70.18 137.29 50.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.398 -0.364 . . . . 0.31 110.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.03 116.16 10.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.432 -0.581 . . . . 1.73 109.432 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 175' ' ' VAL . 7.7 tt -69.68 -20.86 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.292 0.479 . . . . 0.29 112.292 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.503 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 81.6 p -71.0 -6.57 39.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 1.07 111.261 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -91.73 -16.42 26.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.262 0.553 . . . . 3.87 110.975 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.5 mp -99.41 11.93 37.75 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.077 0.941 . . . . 1.21 111.035 -175.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.542 HG23 ' HB2' ' A' ' 171' ' ' ALA . 4.3 m -50.0 138.67 15.15 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.516 -1.674 . . . . 0.39 113.293 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.41 -2.63 28.48 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.53 112.798 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 157' ' ' VAL . 48.2 mt-10 -115.1 131.77 56.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.885 -0.413 . . . . 2.16 109.885 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.7 mt-10 -83.4 136.08 34.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.717 0.77 . . . . 2.03 111.032 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.542 ' HB2' HG13 ' A' ' 159' ' ' VAL . 54.1 mt -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.552 -1.204 . . . . 1.19 110.58 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -127.33 134.52 49.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.241 0.544 . . . . 2.63 110.815 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.706 HG21 HD23 ' A' ' 181' ' ' LEU . 86.5 t -114.76 116.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.555 -0.748 . . . . 0.97 109.145 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 66.0 mm-40 -120.16 133.66 55.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.542 -0.754 . . . . 1.94 109.925 -172.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 116.135 -0.484 . . . . 1.12 111.092 -176.145 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.528 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 42.3 Cg_endo . . . . . 0 N--CA 1.458 -0.565 0 N-CA-C 111.736 -0.14 . . . . 0.43 111.736 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.426 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 16.6 pt -143.13 143.94 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.175 0.512 . . . . 0.79 111.545 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 220' ' ' GLU . 89.3 t -117.59 117.73 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.627 -0.879 . . . . 1.05 108.627 170.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.618 ' HG2' HG22 ' A' ' 168' ' ' VAL . 87.4 mtm180 -97.28 113.62 25.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.039 -0.528 . . . . 2.87 110.867 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.493 ' CG1' HG23 ' A' ' 224' ' ' VAL . 24.3 t -99.04 126.54 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.214 -0.448 . . . . 0.42 111.456 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 25.1 m-85 -78.25 101.05 6.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.647 -0.501 . . . . 0.58 109.647 171.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.669 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.4 OUTLIER -58.72 168.36 1.45 Allowed Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 122.553 0.341 . . . . 1.46 111.789 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 81.7 Cg_exo -47.12 149.44 3.63 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.915 2.41 . . . . 0.5 111.449 167.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.83 8.22 6.65 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.709 0.766 . . . . 2.08 109.22 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.83 48.44 16.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.153 -1.385 . . . . 2.74 112.022 178.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 11.9 mm-40 -80.39 -176.91 5.91 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.628 -1.619 . . . . 1.33 106.628 166.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.409 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 30.5 ttp180 -147.56 131.09 16.75 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.56 -1.256 . . . . 2.49 112.052 175.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.669 ' HB ' HD21 ' A' ' 161' ' ' LEU . 5.5 t -112.18 173.0 6.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.125 -1.398 . . . . 0.52 108.988 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.618 HG22 ' HG2' ' A' ' 158' ' ' ARG . 3.3 t -139.37 129.08 30.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.818 -0.438 . . . . 0.88 109.818 172.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 180' ' ' SER . 73.1 t -127.27 120.95 22.42 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.461 -0.79 . . . . 1.31 109.615 175.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 52.1 Cg_exo -50.22 135.28 38.35 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.008 2.472 . . . . 0.59 111.454 174.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.88 105.96 0.52 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.35 110.243 -177.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.656 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 3.6 mmp_? -100.7 111.04 23.21 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 2.81 111.31 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.83 123.82 26.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.76 -0.654 . . . . 1.44 109.886 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 -7.69 59.29 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.683 -0.967 . . . . 0.43 110.683 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 179' ' ' ASP . 53.7 t -103.7 128.54 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.215 0.531 . . . . 0.97 110.047 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 178' ' ' ARG . 25.5 p -78.08 156.63 29.89 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.528 -0.76 . . . . 0.47 110.062 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.765 ' O ' HD12 ' A' ' 181' ' ' LEU . 23.3 t -48.39 -43.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.851 -0.425 . . . . 1.39 109.851 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 1.3 ptm180 -53.56 -47.01 70.45 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 112.726 0.639 . . . . 3.53 112.726 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.495 ' HB3' HG13 ' A' ' 175' ' ' VAL . 21.0 t70 -68.12 -50.25 55.91 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.698 0.761 . . . . 1.19 109.875 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 169' ' ' VAL . 2.1 p -59.62 -55.53 33.3 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.091 -1.413 . . . . 1.34 110.732 -175.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.93 -2.5 56.75 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 118.78 -1.168 . . . . 1.08 113.334 -174.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.447 ' HB2' ' HG3' ' A' ' 192' ' ' PRO . 18.5 ptpt -70.95 -32.76 69.74 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 117.989 -1.485 . . . . 1.15 107.909 169.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -37.55 87.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.169 -0.678 . . . . 1.8 109.169 169.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -52.04 -52.52 50.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.694 -0.23 . . . . 0.3 111.283 173.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.457 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -56.74 -52.23 65.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.798 0.333 . . . . 1.46 110.59 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 17.6 mmt -62.79 -22.37 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.667 0.617 . . . . 1.45 112.667 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 18.1 mmt -71.65 -38.22 70.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.823 0.345 . . . . 0.85 110.207 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.508 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 11.8 mmm180 -73.85 -23.6 59.64 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.519 0.676 . . . . 2.12 109.685 172.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.77 9.52 37.43 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.022 -0.99 . . . . 0.53 111.468 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.99 177.0 5.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.937 0.398 . . . . 1.28 110.666 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.1 pt -124.8 141.77 39.05 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.52 110.776 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 60.9 Cg_endo -72.26 -10.01 25.13 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 123.242 2.628 . . . . 0.52 112.472 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -54.57 -48.01 72.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.825 -0.625 . . . . 1.74 111.301 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 83.7 m -102.3 25.78 8.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.49 -0.777 . . . . 1.69 111.173 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.549 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 78.0 m -131.79 151.41 51.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.555 -0.293 . . . . 0.52 110.764 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.35 158.67 30.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.402 -0.592 . . . . 0.39 109.402 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.504 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 41.4 t -112.22 134.67 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.895 0.855 . . . . 1.06 112.474 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--N 1.316 -0.855 0 CA-C-N 114.17 -1.377 . . . . 2.49 109.913 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 209' ' ' GLY . 16.3 mt . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.125 0.488 . . . . 0.9 111.304 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -97.51 145.53 17.86 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.884 -0.887 . . . . 0.37 110.884 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.578 ' O ' ' HD2' ' A' ' 178' ' ' ARG . 62.0 m95 -70.73 -18.39 62.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.951 0.405 . . . . 0.31 110.791 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -89.58 -5.78 56.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 2.3 110.387 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 177' ' ' VAL . 98.0 m -69.34 146.6 52.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.31 110.071 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.459 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 12.1 t70 -79.1 129.8 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.851 -0.426 . . . . 1.73 109.851 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.87 -21.68 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.832 0.348 . . . . 0.29 111.759 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.439 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 44.6 t -75.85 -7.75 55.24 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.098 -0.376 . . . . 1.07 110.399 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 13.0 m0 -82.36 -11.12 58.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.385 0.612 . . . . 3.87 109.586 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 220' ' ' GLU . 18.8 mt -114.54 6.87 15.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.468 -0.787 . . . . 1.21 110.385 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 155' ' ' PRO . 21.1 m -42.94 134.71 3.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.091 0.774 . . . . 0.39 113.091 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 71.36 12.68 73.14 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.87 -0.605 . . . . 0.53 112.266 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 217' ' ' LEU . 7.5 tp10 -115.33 141.21 48.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.956 -0.387 . . . . 2.16 109.956 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.9 123.07 33.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 2.03 110.123 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 159' ' ' VAL . 8.7 mp -99.29 170.5 8.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.625 -0.716 . . . . 1.19 110.121 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -149.0 130.25 14.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.509 -0.552 . . . . 2.63 109.509 174.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.549 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 47.3 t -98.57 135.37 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.105 -0.498 . . . . 0.97 110.794 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -118.95 126.22 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.091 -0.958 . . . . 1.94 110.231 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.421 . . . . 1.12 111.384 -179.234 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 C--O 1.236 0.384 0 N-CA-C 112.977 0.337 . . . . 0.43 112.977 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.469 HD12 HG11 ' A' ' 168' ' ' VAL . 14.8 pt -140.13 154.75 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.696 -0.684 . . . . 0.79 110.701 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 218' ' ' THR . 98.4 t -121.2 126.86 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 108.814 -0.81 . . . . 1.05 108.814 172.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 11.1 mtp180 -102.9 107.03 17.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.401 -0.818 . . . . 2.87 110.879 -174.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 222' ' ' LEU . 3.5 t -97.44 125.56 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.471 -0.331 . . . . 0.42 111.441 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -72.63 103.23 3.51 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.189 0.518 . . . . 0.58 110.232 173.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.735 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 28.3 mt -56.86 155.02 16.24 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 1.46 110.963 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 62.8 Cg_exo -53.17 153.8 15.5 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.8 2.333 . . . . 0.5 111.421 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 5.2 m-20 71.79 18.48 5.14 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.428 0.632 . . . . 2.08 110.474 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.26 35.4 5.96 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.985 -1.007 . . . . 2.74 112.558 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.735 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.5 mm100 -94.49 -179.62 4.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.602 -1.258 . . . . 1.33 107.602 171.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -147.24 138.33 23.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.871 -0.732 . . . . 2.49 110.704 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.621 HG21 ' HB1' ' A' ' 184' ' ' ALA . 13.5 t -119.17 171.96 7.92 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.854 -1.066 . . . . 0.52 109.042 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.469 HG11 HD12 ' A' ' 156' ' ' ILE . 3.1 t -141.17 129.82 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.748 -0.464 . . . . 0.88 109.748 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.409 HG13 HD11 ' A' ' 214' ' ' ILE . 3.3 p -131.75 130.39 22.29 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.274 -0.875 . . . . 1.31 109.251 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.446 ' HA ' HG22 ' A' ' 156' ' ' ILE . 10.2 Cg_exo -49.24 144.01 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.359 2.706 . . . . 0.59 112.014 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.73 82.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.29 0.567 . . . . 0.35 109.76 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -70.76 110.65 5.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.282 -0.872 . . . . 2.81 110.82 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 32.3 m -80.45 118.35 21.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.651 -0.704 . . . . 1.44 109.564 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.53 17.65 32.97 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.788 -0.925 . . . . 0.43 110.788 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 179' ' ' ASP . 18.3 t -128.38 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.179 -0.51 . . . . 0.97 110.351 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.474 ' OG1' ' HG3' ' A' ' 178' ' ' ARG . 32.7 p -70.62 148.8 47.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.903 -0.59 . . . . 0.47 109.872 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.823 ' O ' HD12 ' A' ' 181' ' ' LEU . 14.5 p -49.51 -37.71 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.888 -0.412 . . . . 1.39 109.888 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -57.94 -34.8 70.27 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.489 -0.778 . . . . 3.53 112.174 -173.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.651 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -77.02 -49.91 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.9 0.857 . . . . 1.19 109.714 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -53.25 59.44 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.714 -1.13 . . . . 1.34 110.716 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -88.96 0.69 56.42 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.0 -1.08 . . . . 1.08 112.887 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.651 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 17.3 ptpt -69.05 -35.56 76.71 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.257 -1.377 . . . . 1.15 107.736 167.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -65.15 -38.23 89.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.666 -0.814 . . . . 1.8 109.26 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.621 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -48.92 -54.69 14.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.946 -0.301 . . . . 0.3 110.631 172.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.478 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -58.76 -53.75 54.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.466 -0.334 . . . . 1.46 111.045 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.89 -24.63 64.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.086 -0.506 . . . . 1.45 112.291 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 12.4 mmt -78.19 -41.22 35.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.515 -0.55 . . . . 0.85 109.515 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.533 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 15.2 tpt180 -71.0 -18.12 62.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.695 -0.684 . . . . 2.12 109.802 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.28 4.08 44.18 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.687 -0.688 . . . . 0.53 112.824 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 190' ' ' LEU . 5.4 mp -102.18 175.29 5.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.94 0.4 . . . . 1.28 111.543 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.5 pt -119.31 139.89 28.26 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.944 -0.571 . . . . 0.52 110.381 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 55.6 Cg_endo -69.15 -14.3 37.77 Favored 'Trans proline' 0 N--CA 1.47 0.113 0 C-N-CA 123.348 2.699 . . . . 0.52 112.469 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -63.09 -37.04 85.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 1.74 110.846 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 75.7 m -101.42 17.3 23.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.954 -0.566 . . . . 1.69 110.764 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.415 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 85.2 m -128.99 156.91 43.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.163 -0.471 . . . . 0.52 110.784 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -124.96 158.33 33.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.389 -0.597 . . . . 0.39 109.389 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.637 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 96.1 t -106.88 139.09 29.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.782 0.801 . . . . 1.06 111.792 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 114.229 -1.35 . . . . 2.49 109.899 -178.615 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.9 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 141.47 17.7 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.719 -0.753 . . . . 0.37 111.244 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.637 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 61.2 m95 -70.5 -12.91 61.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.731 0.301 . . . . 0.31 111.148 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.98 -12.91 40.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.492 . . . . 2.3 110.116 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.6 m -60.8 127.97 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.31 111.09 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 215' ' ' SER . 13.6 t70 -68.05 127.98 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 1.73 110.038 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.409 HD11 HG13 ' A' ' 169' ' ' VAL . 7.8 tt -68.53 -20.53 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.132 -0.486 . . . . 0.29 112.153 -172.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.476 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 34.8 t -69.29 -11.73 61.06 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.112 -0.367 . . . . 1.07 111.244 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -89.76 -17.97 27.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 3.87 110.083 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 220' ' ' GLU . 33.4 mt -94.84 3.99 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 1.21 109.999 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.44 ' HA ' HG22 ' A' ' 157' ' ' VAL . 58.4 m -43.07 139.78 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.39 113.331 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.42 -8.67 46.03 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.368 -0.833 . . . . 0.53 112.088 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 34.5 mm-40 -102.6 154.96 18.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.279 0.562 . . . . 2.16 111.168 -175.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 35.5 mt-10 -101.39 124.09 46.51 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.342 -0.845 . . . . 2.03 109.379 174.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 217' ' ' LEU . 7.0 mp -96.01 173.38 7.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.948 -0.569 . . . . 1.19 110.218 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -137.99 135.21 35.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.15 -0.685 . . . . 2.63 109.15 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.439 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 86.8 t -103.52 124.9 58.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.101 -0.64 . . . . 0.97 110.264 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -109.62 119.11 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.39 -0.823 . . . . 1.94 108.801 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.324 -0.537 0 N-CA-C 109.718 -0.475 . . . . 1.12 109.718 177.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 71.6 Cg_endo . . . . . 0 N--CA 1.464 -0.224 0 N-CA-C 111.843 -0.099 . . . . 0.43 111.843 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.545 HD12 HG11 ' A' ' 168' ' ' VAL . 20.7 pt -138.19 152.93 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 0.79 111.628 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.403 ' HB ' HD11 ' A' ' 214' ' ' ILE . 90.3 t -124.69 129.82 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.734 -0.839 . . . . 1.05 108.734 172.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 168' ' ' VAL . 38.6 mtm-85 -101.51 123.01 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.855 -0.611 . . . . 2.87 110.477 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 222' ' ' LEU . 40.8 t -108.23 127.77 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.415 -0.357 . . . . 0.42 111.722 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -80.51 99.45 8.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.205 -0.665 . . . . 0.58 109.205 170.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.7 OUTLIER -61.78 167.85 4.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.655 0.983 . . . . 1.46 113.655 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 73.7 Cg_exo -49.96 152.82 6.93 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.787 2.991 . . . . 0.5 111.842 167.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.69 13.8 7.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.296 1.046 . . . . 2.08 109.047 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.648 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 57.82 44.83 19.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.89 -1.505 . . . . 2.74 112.108 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -82.44 178.16 8.37 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.819 -1.549 . . . . 1.33 106.819 166.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 166' ' ' ARG . 12.2 ttp180 -148.6 129.75 14.55 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.542 -0.863 . . . . 2.49 111.06 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.79 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.6 t -118.67 177.92 4.66 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.129 -0.942 . . . . 0.52 109.494 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.545 HG11 HD12 ' A' ' 156' ' ' ILE . 2.4 t -142.81 129.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.702 -0.481 . . . . 0.88 109.702 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 214' ' ' ILE . 5.2 m -124.06 131.63 24.24 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.391 -0.822 . . . . 1.31 109.72 173.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 78.1 Cg_exo -49.4 146.36 14.23 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.634 2.223 . . . . 0.59 112.143 175.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.559 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -66.81 80.21 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.35 110.222 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -64.64 112.22 3.09 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.055 -0.975 . . . . 2.81 111.131 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.6 136.59 36.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.933 -0.576 . . . . 1.44 110.333 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.84 14.69 82.32 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.016 -0.834 . . . . 0.43 111.016 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 179' ' ' ASP . 55.3 t -126.78 135.11 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.038 0.447 . . . . 0.97 110.763 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.7 p -83.13 167.09 18.12 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.817 -0.629 . . . . 0.47 110.326 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.837 ' O ' HD12 ' A' ' 181' ' ' LEU . 2.4 m -53.4 -37.73 30.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 108.487 -0.931 . . . . 1.39 108.487 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.8 tmm_? -44.56 -62.72 1.09 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.174 -0.921 . . . . 3.53 112.619 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.696 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 30.1 t70 -68.05 -44.37 76.55 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.394 0.616 . . . . 1.19 111.034 -174.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.8 p -62.13 -54.65 38.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.462 -0.79 . . . . 1.34 110.656 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.52 -2.66 57.11 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.396 -0.922 . . . . 1.08 112.848 -175.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 13.6 ptmm? -68.34 -36.04 78.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.68 -1.23 . . . . 1.15 107.68 168.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.89 -36.38 83.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.24 -0.891 . . . . 1.8 109.345 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.79 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.63 -55.78 22.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.525 -0.307 . . . . 0.3 111.097 173.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.564 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.5 mm? -53.83 -50.48 66.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.376 -0.375 . . . . 1.46 110.774 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 37.2 mtt -70.31 -21.69 62.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.342 0.497 . . . . 1.45 112.342 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 16.4 mmt -76.3 -18.98 58.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 0.85 110.119 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.47 ' HB2' HD23 ' A' ' 161' ' ' LEU . 7.3 tpm_? -97.33 -11.83 23.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.439 -0.8 . . . . 2.12 109.768 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 94.85 19.71 30.72 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.53 111.955 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.502 ' HB2' HD12 ' A' ' 185' ' ' LEU . 7.7 mt -116.83 172.24 7.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.642 0.258 . . . . 1.28 110.437 -176.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.7 pt -121.57 142.76 36.39 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.497 . . . . 0.52 110.683 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 73.9 Cg_endo -75.15 -13.1 21.21 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 123.258 2.639 . . . . 0.52 112.968 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.37 -41.41 93.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 1.74 110.952 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 37.9 t -94.36 8.0 43.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.945 -0.571 . . . . 1.69 110.785 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.427 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 73.1 m -116.29 158.18 23.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.65 0.262 . . . . 0.52 110.878 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.11 157.55 40.45 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.39 110.053 174.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 224' ' ' VAL . 13.9 t -118.89 124.1 72.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.136 0.493 . . . . 1.06 110.717 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.55 ' HA ' HG12 ' A' ' 208' ' ' ILE . 55.1 p90 . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.672 -0.694 . . . . 2.49 110.597 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.55 HG12 ' HA ' ' A' ' 198' ' ' TYR . 2.6 mm . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.845 -0.798 . . . . 0.9 108.845 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.2 138.2 13.74 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.563 -0.827 . . . . 0.37 111.205 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.677 ' HA ' HG22 ' A' ' 177' ' ' VAL . 62.3 m95 -68.06 -18.62 64.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.137 0.494 . . . . 0.31 110.244 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -95.08 6.67 48.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.553 -0.748 . . . . 2.3 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 99.9 m -86.33 144.3 27.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.31 110.354 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.96 128.02 34.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.03 -0.532 . . . . 1.73 111.184 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.447 HD11 HG23 ' A' ' 169' ' ' VAL . 6.5 tt -72.7 -26.95 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.683 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.559 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 44.3 t -68.06 -14.96 63.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 1.07 110.596 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -86.16 -13.06 48.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.446 0.641 . . . . 3.87 109.615 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.483 HD13 HD21 ' A' ' 222' ' ' LEU . 10.3 mt -105.71 8.28 32.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.495 -0.775 . . . . 1.21 109.868 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.7 m -40.56 134.57 1.74 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.772 1.027 . . . . 0.39 113.772 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.5 4.5 61.04 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.522 -0.763 . . . . 0.53 112.281 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.63 162.58 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.714 -0.476 . . . . 2.16 109.714 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 41.2 mt-10 -111.9 129.45 56.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.589 0.709 . . . . 2.03 111.456 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 217' ' ' LEU . 66.3 mt -97.77 155.41 17.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.455 -1.248 . . . . 1.19 109.81 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.83 116.0 16.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.702 0.763 . . . . 2.63 109.904 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 197' ' ' VAL . 79.4 t -100.83 137.77 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 0.97 110.997 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.504 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 17.8 mm-40 -131.74 135.5 46.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.855 -1.066 . . . . 1.94 109.694 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 19.5 t . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 110.054 -0.35 . . . . 1.12 110.054 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.434 ' HB2' HG23 ' A' ' 218' ' ' THR . 88.5 Cg_endo . . . . . 0 N--CA 1.463 -0.273 0 CA-C-O 120.808 0.253 . . . . 0.43 112.264 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 170' ' ' PRO . 1.5 pp -141.78 147.07 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.892 0.377 . . . . 0.79 111.295 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 220' ' ' GLU . 99.4 t -116.99 123.32 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.037 -0.727 . . . . 1.05 109.037 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 168' ' ' VAL . 42.6 mtp180 -98.81 114.31 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.464 -0.789 . . . . 2.87 110.868 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 222' ' ' LEU . 2.7 t -104.7 125.9 59.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.373 -0.376 . . . . 0.42 111.537 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.413 ' CZ ' ' HD3' ' A' ' 166' ' ' ARG . 20.2 m-85 -76.23 101.96 5.63 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.611 -0.515 . . . . 0.58 109.611 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.2 OUTLIER -67.09 158.03 82.79 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 1.46 111.136 176.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.558 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 50.2 Cg_exo -56.31 144.62 81.68 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 123.387 2.724 . . . . 0.5 112.514 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 92.6 m-20 74.03 30.02 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.618 0.574 . . . . 2.08 111.054 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.603 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 66.37 32.37 7.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.252 -0.885 . . . . 2.74 112.774 173.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.642 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -90.47 167.07 12.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.462 -1.681 . . . . 1.33 106.462 171.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 38.7 ttp180 -148.86 136.44 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.672 -0.811 . . . . 2.49 110.343 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.805 HG21 ' HB1' ' A' ' 184' ' ' ALA . 10.1 t -123.94 172.59 8.82 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.241 -0.891 . . . . 0.52 109.852 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.549 HG22 ' HG2' ' A' ' 158' ' ' ARG . 2.6 t -142.12 128.07 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 109.249 -0.649 . . . . 0.88 109.249 172.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.477 HG23 HD11 ' A' ' 214' ' ' ILE . 3.2 m -118.63 135.26 23.59 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.157 -0.929 . . . . 1.31 108.884 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.485 ' HA ' HG22 ' A' ' 156' ' ' ILE . 61.5 Cg_exo -51.26 146.06 25.08 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 121.872 1.714 . . . . 0.59 110.532 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.23 81.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.373 -0.602 . . . . 0.35 109.373 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 35.6 mmt180 -65.11 111.24 2.83 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.695 -1.139 . . . . 2.81 109.974 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 26.9 p -78.43 130.41 36.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.877 0.37 . . . . 1.44 110.782 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.2 22.61 44.04 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.628 -0.796 . . . . 0.43 112.539 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 1.4 p -137.58 153.44 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 0.97 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 40.3 p -91.05 164.64 13.88 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.834 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.736 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 5.2 m -55.4 -32.93 30.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.268 0.556 . . . . 1.39 109.608 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.649 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.6 tpt180 -53.29 -48.23 68.53 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 115.202 -0.908 . . . . 3.53 112.171 -175.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.0 t70 -75.96 -49.93 16.34 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.377 0.608 . . . . 1.19 110.564 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.1 p -59.61 -55.77 30.33 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.951 -1.022 . . . . 1.34 110.689 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 177' ' ' VAL . 0.1 OUTLIER -92.28 -5.33 52.55 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.069 -1.052 . . . . 1.08 112.659 -176.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 17.6 ptpt -61.2 -40.03 92.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 116.85 -1.94 . . . . 1.15 107.716 167.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 182' ' ' LYS . 6.4 ttpm? -66.24 -38.27 87.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.976 -0.556 . . . . 1.8 109.92 174.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.805 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -49.96 -54.19 21.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.226 0.536 . . . . 0.3 110.467 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.545 HD21 HG11 ' A' ' 224' ' ' VAL . 6.0 mt -62.64 -51.05 68.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.519 -0.764 . . . . 1.46 111.251 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 67.5 mtp -67.58 -21.82 65.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.509 -0.314 . . . . 1.45 111.846 -173.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.4 mtt -77.84 -25.92 49.08 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.535 -0.542 . . . . 0.85 109.535 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.476 ' HB2' HD23 ' A' ' 161' ' ' LEU . 11.1 tpt180 -87.6 -11.28 49.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.511 -0.768 . . . . 2.12 109.356 174.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.26 4.43 44.09 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.731 -0.668 . . . . 0.53 113.251 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 186' ' ' MET . 5.3 mp -97.43 176.87 5.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 1.28 111.599 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.39 146.88 63.88 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.52 110.293 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -4.61 15.59 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.354 2.703 . . . . 0.52 113.303 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.169 0.509 . . . . 1.74 110.029 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.7 t -107.49 28.41 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.615 -0.72 . . . . 1.69 110.388 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.48 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.2 m -151.25 155.44 38.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.231 -0.441 . . . . 0.52 110.189 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HA ' ' CZ2' ' A' ' 210' ' ' TRP . . . -131.33 173.34 11.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.148 -1.056 . . . . 0.39 108.148 169.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.571 HG21 HD21 ' A' ' 181' ' ' LEU . 13.1 t -114.44 136.73 50.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.276 0.56 . . . . 1.06 111.343 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--N 1.318 -0.776 0 CA-C-N 115.218 -0.901 . . . . 2.49 110.139 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 6.9 mm . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.595 -0.52 . . . . 0.9 109.595 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.78 140.31 14.94 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.847 -0.901 . . . . 0.37 110.847 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.736 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 90.2 m95 -68.02 -14.37 62.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.277 0.539 . . . . 0.31 110.619 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -99.32 0.39 42.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.3 110.388 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.7 m -75.07 140.78 43.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.754 -0.657 . . . . 0.31 110.106 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.27 121.19 20.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.451 . . . . 1.73 110.193 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 169' ' ' VAL . 4.1 tt -67.97 -28.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.29 111.733 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -72.87 -8.39 55.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.228 0.537 . . . . 1.07 110.342 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -83.62 -17.08 42.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.67 0.748 . . . . 3.87 109.568 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -101.82 9.84 40.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.344 -0.843 . . . . 1.21 110.007 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' HB2' ' A' ' 155' ' ' PRO . 63.0 m -39.92 130.7 2.01 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.747 1.018 . . . . 0.39 113.747 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.42 -1.18 61.88 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.508 -0.769 . . . . 0.53 112.347 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 157' ' ' VAL . 38.7 mt-10 -105.61 138.26 42.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.8 0.333 . . . . 2.16 110.205 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -84.46 128.9 34.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.294 0.569 . . . . 2.03 110.598 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 159' ' ' VAL . 48.9 mt -103.61 169.43 8.53 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.265 -0.88 . . . . 1.19 109.957 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -147.16 136.55 22.69 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.104 -0.702 . . . . 2.63 109.104 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.545 HG11 HD21 ' A' ' 185' ' ' LEU . 72.3 t -99.32 144.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.935 0.398 . . . . 0.97 110.944 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -109.64 145.8 35.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.865 -0.791 . . . . 1.94 108.865 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.312 -1.022 0 CA-C-O 121.381 0.61 . . . . 1.12 110.399 177.035 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 83.4 Cg_endo . . . . . 0 N--CA 1.459 -0.521 0 N-CA-C 111.737 -0.14 . . . . 0.43 111.737 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 17.4 pt -134.62 144.74 34.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 0.79 110.965 176.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -124.41 117.05 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.806 0.812 . . . . 1.05 108.977 173.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 18.1 mtm-85 -83.59 130.57 34.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.557 -1.201 . . . . 2.87 110.506 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 167' ' ' THR . 7.5 t -120.64 117.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.201 -0.909 . . . . 0.42 111.215 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.48 ' HB2' ' HA ' ' A' ' 223' ' ' HIS . 10.2 m-85 -71.77 102.83 2.93 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.991 0.424 . . . . 0.58 110.392 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 27.8 mt -55.46 151.04 21.49 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 124.294 1.038 . . . . 1.46 111.5 173.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.562 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 60.5 Cg_exo -54.06 161.69 4.76 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.022 2.481 . . . . 0.5 111.869 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 67.76 14.78 9.55 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.206 -1.035 . . . . 2.08 108.206 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 63.01 40.22 9.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 113.645 -1.616 . . . . 2.74 112.235 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.711 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 3.0 mm-40 -96.7 -176.55 3.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.378 -1.342 . . . . 1.33 107.378 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 30.1 ttp180 -145.81 127.11 14.86 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.232 -0.987 . . . . 2.49 111.66 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.675 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.1 t -109.55 176.66 4.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.611 -1.177 . . . . 0.52 108.544 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.458 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.1 t -141.32 126.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.676 -0.861 . . . . 0.88 108.676 168.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.475 HG23 HD11 ' A' ' 214' ' ' ILE . 9.2 m -107.53 127.54 27.61 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.764 -0.653 . . . . 1.31 109.956 167.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 71.9 Cg_exo -50.51 142.51 30.42 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.163 1.909 . . . . 0.59 110.461 169.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.432 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -64.7 88.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.35 110.228 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.448 ' O ' HG12 ' A' ' 175' ' ' VAL . 29.0 mmt180 -70.87 110.98 5.94 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.085 -0.961 . . . . 2.81 109.181 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.2 p -82.38 126.54 32.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.246 -0.434 . . . . 1.44 110.904 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.14 22.51 29.8 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.539 -0.839 . . . . 0.43 111.944 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 172' ' ' ARG . 1.3 p -138.1 154.59 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.061 0.457 . . . . 0.97 110.151 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.4 p -86.23 158.87 19.62 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.94 -0.573 . . . . 0.47 110.72 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.777 ' O ' HD12 ' A' ' 181' ' ' LEU . 42.0 t -45.84 -49.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.224 -0.658 . . . . 1.39 109.224 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 11.8 tpt180 -41.57 -56.18 2.65 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 124.743 1.277 . . . . 3.53 113.239 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.747 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.5 t70 -67.5 -47.66 69.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.255 0.55 . . . . 1.19 110.622 -176.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.8 t -64.28 -47.74 78.36 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.047 -0.661 . . . . 1.34 110.183 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -93.03 -2.58 55.54 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.271 -0.971 . . . . 1.08 112.464 -175.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 14.5 ptmm? -69.95 -31.4 69.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.27 -1.382 . . . . 1.15 107.27 167.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.56 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.0 OUTLIER -65.94 -41.73 90.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.08 -0.964 . . . . 1.8 109.418 168.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.675 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.61 -55.95 13.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.55 -0.295 . . . . 0.3 110.983 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -53.96 -51.9 62.37 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.494 -0.321 . . . . 1.46 110.911 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -25.29 67.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 1.45 112.363 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 24.2 mmt -78.48 -31.52 47.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.812 0.339 . . . . 0.85 110.222 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.706 ' HD3' HD13 ' A' ' 161' ' ' LEU . 15.4 tpt180 -77.52 -14.86 59.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.458 0.647 . . . . 2.12 109.975 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.03 55.86 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.53 111.543 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.414 ' HB2' HD12 ' A' ' 185' ' ' LEU . 13.7 mt -108.68 176.89 4.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.079 -0.341 . . . . 1.28 110.079 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 193' ' ' GLU . 46.1 pt -122.63 140.96 34.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.52 111.489 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.52 -10.55 26.99 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.55 2.833 . . . . 0.52 112.739 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.421 ' HB2' HD12 ' A' ' 191' ' ' ILE . 38.0 mt-10 -62.38 -44.19 97.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.336 0.589 . . . . 1.74 110.505 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.4 m -97.04 20.17 11.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.403 -0.817 . . . . 1.69 110.989 -176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.545 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 72.8 m -128.39 156.66 42.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.542 -0.299 . . . . 0.52 110.713 -175.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -130.03 152.93 48.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.39 109.995 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.522 HG13 ' CE2' ' A' ' 210' ' ' TRP . 3.5 m -110.68 126.96 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.791 0.805 . . . . 1.06 111.108 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.539 ' CZ ' ' HG3' ' A' ' 225' ' ' GLU . 51.7 p90 . . . . . 0 C--N 1.311 -1.1 0 CA-C-N 115.51 -0.768 . . . . 2.49 109.456 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' A' ' 198' ' ' TYR . 1.2 mm . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.216 -1.031 . . . . 0.9 108.216 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.62 151.26 18.58 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.467 -1.349 . . . . 0.37 113.004 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.522 ' CE2' HG13 ' A' ' 197' ' ' VAL . 69.1 m95 -70.52 -18.43 62.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.872 0.368 . . . . 0.31 110.598 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -97.82 -1.96 42.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 2.3 110.564 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.3 m -70.34 142.02 52.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.829 -0.623 . . . . 0.31 109.788 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.99 119.16 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.265 -0.642 . . . . 1.73 109.265 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 177' ' ' VAL . 4.4 tt -71.24 -27.01 27.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.29 111.377 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.0 t -70.84 -7.78 47.88 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.479 0.656 . . . . 1.07 109.717 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -88.37 -6.99 57.37 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.498 0.666 . . . . 3.87 109.487 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.423 HD13 HD21 ' A' ' 222' ' ' LEU . 22.8 mt -112.61 7.48 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.431 -0.804 . . . . 1.21 110.038 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 61.0 m -42.29 134.5 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.916 -1.038 . . . . 0.39 113.7 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.4 57.64 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.53 112.335 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 157' ' ' VAL . 41.6 mt-10 -113.36 148.92 34.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.864 0.364 . . . . 2.16 110.391 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.6 mp0 -92.26 126.61 37.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.217 0.532 . . . . 2.03 111.448 -176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.446 ' HB2' HG13 ' A' ' 159' ' ' VAL . 80.8 mt -99.56 155.13 17.74 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.22 -0.9 . . . . 1.19 110.144 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -119.34 124.72 47.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.743 0.306 . . . . 2.63 110.219 173.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.575 HG21 HD23 ' A' ' 181' ' ' LEU . 72.6 t -105.7 116.93 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.569 0.7 . . . . 0.97 109.408 172.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.539 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 54.0 mm-40 -119.55 133.02 55.86 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.921 -1.036 . . . . 1.94 109.19 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.562 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 41.3 t . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 1.12 111.187 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.463 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 55.1 Cg_endo . . . . . 0 N--CA 1.456 -0.695 0 N-CA-C 111.64 -0.177 . . . . 0.43 111.64 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.587 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 39.5 pt -140.63 139.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.745 0.307 . . . . 0.79 111.081 -178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 217' ' ' LEU . 88.4 t -112.53 118.76 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.149 -0.685 . . . . 1.05 109.149 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.627 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 66.1 mtm180 -97.02 115.74 27.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.632 -0.713 . . . . 2.87 110.538 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.67 ' CG1' HG23 ' A' ' 224' ' ' VAL . 13.5 t -105.85 127.02 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.233 -0.44 . . . . 0.42 111.653 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 27.3 m-85 -74.22 103.09 4.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.302 -0.408 . . . . 0.58 110.161 173.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.2 mm? -55.04 163.27 1.58 Allowed Pre-proline 0 N--CA 1.474 0.737 0 CA-C-O 121.331 0.586 . . . . 1.46 112.013 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.417 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 77.2 Cg_exo -51.24 160.48 2.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.964 2.443 . . . . 0.5 111.047 163.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 67.89 6.99 5.46 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.069 0.462 . . . . 2.08 110.213 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 164' ' ' LYS . 8.1 mmpt? 70.2 39.39 1.31 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.134 -0.939 . . . . 2.74 111.88 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 4.1 mm-40 -91.02 -178.89 5.32 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.549 -0.908 . . . . 1.33 108.549 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 33.0 ttp180 -147.38 132.89 18.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.006 -0.677 . . . . 2.49 111.541 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.784 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.6 t -120.64 -177.74 3.54 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.459 -1.246 . . . . 0.52 108.743 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.627 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.39 129.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.321 0.581 . . . . 0.88 111.127 170.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.535 HG23 HD11 ' A' ' 214' ' ' ILE . 5.1 m -112.26 131.86 22.37 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.964 -1.016 . . . . 1.31 109.551 172.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 74.0 Cg_exo -48.35 141.86 18.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.504 2.136 . . . . 0.59 111.859 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.81 83.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.35 110.44 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.565 ' O ' HG12 ' A' ' 175' ' ' VAL . 31.1 mmt180 -72.55 113.65 9.81 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 2.81 110.041 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 41.9 t -82.81 124.75 30.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 1.44 110.757 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.06 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.72 -0.752 . . . . 0.43 111.915 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 172' ' ' ARG . 8.5 p -135.27 150.92 29.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.746 -0.464 . . . . 0.97 109.746 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 57.4 p -81.38 155.49 25.9 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.165 -0.471 . . . . 0.47 110.777 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.744 ' O ' HD12 ' A' ' 181' ' ' LEU . 53.0 t -46.46 -46.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.18 -0.674 . . . . 1.39 109.18 173.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 9.5 tpt180 -41.51 -54.98 2.99 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 124.319 1.012 . . . . 3.53 113.125 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.8 t70 -68.6 -48.95 62.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.502 0.668 . . . . 1.19 110.772 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.469 ' O ' HG11 ' A' ' 169' ' ' VAL . 3.3 m -64.59 -46.79 81.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.325 -0.852 . . . . 1.34 111.02 -173.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -93.25 -4.49 51.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.928 -1.109 . . . . 1.08 112.529 -177.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.3 ptpt -67.23 -34.41 77.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 118.123 -1.431 . . . . 1.15 107.697 168.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.7 OUTLIER -67.56 -36.57 81.2 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.571 -0.741 . . . . 1.8 109.48 171.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.784 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.94 -52.1 52.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.662 -0.245 . . . . 0.3 110.825 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.507 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.2 mm? -58.62 -50.97 71.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.435 -0.348 . . . . 1.46 111.067 176.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.48 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 49.2 mtt -68.47 -20.99 64.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.515 0.561 . . . . 1.45 112.515 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 18.4 mmt -80.97 -20.32 42.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 0.85 109.722 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.496 ' HB3' ' CD1' ' A' ' 190' ' ' LEU . 10.2 tpt180 -91.09 -17.03 26.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.695 0.76 . . . . 2.12 109.144 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.56 6.32 41.24 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 114.785 -1.098 . . . . 0.53 112.835 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.496 ' CD1' ' HB3' ' A' ' 188' ' ' ARG . 5.2 mp -104.96 174.64 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.112 0.482 . . . . 1.28 111.718 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.1 pt -119.74 144.17 36.53 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.52 110.53 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.76 -4.44 15.36 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.53 2.82 . . . . 0.52 113.593 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -69.38 -42.13 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 1.74 111.095 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 25.5 p -97.17 15.47 22.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 1.69 110.609 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.619 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.6 m -123.1 149.6 44.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.07 -0.514 . . . . 0.52 110.661 -175.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -118.49 152.23 36.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.813 -0.44 . . . . 0.39 109.813 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.692 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 13.6 t -118.88 124.54 73.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.097 0.475 . . . . 1.06 110.867 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.53 ' HA ' HG12 ' A' ' 208' ' ' ILE . 51.9 p90 . . . . . 0 C--N 1.313 -1.021 0 CA-C-N 115.483 -0.78 . . . . 2.49 109.764 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 198' ' ' TYR . 14.7 mm . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 109.61 -0.515 . . . . 0.9 109.61 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 212' ' ' THR . . . -85.31 131.06 10.21 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.675 -1.37 . . . . 0.37 109.675 171.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.692 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 57.6 m95 -65.38 -21.08 66.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.037 0.446 . . . . 0.31 110.194 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.02 1.7 52.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.533 0.683 . . . . 2.3 110.086 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.5 m -72.37 145.75 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.906 -0.588 . . . . 0.31 110.282 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.61 115.02 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.497 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.535 HD11 HG23 ' A' ' 169' ' ' VAL . 2.4 tt -62.58 -29.4 46.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.29 111.505 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.479 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -73.24 -8.25 55.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.857 -0.61 . . . . 1.07 110.563 -173.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -82.27 -21.69 36.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.52 0.676 . . . . 3.87 109.815 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 157' ' ' VAL . 13.0 mt -97.64 11.79 35.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.476 -0.783 . . . . 1.21 110.031 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.459 HG23 ' HB2' ' A' ' 155' ' ' PRO . 94.9 m -37.68 129.66 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.497 0.925 . . . . 0.39 113.497 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.16 -14.03 29.64 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.816 -0.629 . . . . 0.53 112.302 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.31 158.31 26.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.954 0.407 . . . . 2.16 110.306 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.5 mt-10 -109.48 115.48 30.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.596 0.712 . . . . 2.03 109.933 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.443 ' HB2' HG22 ' A' ' 159' ' ' VAL . 36.4 mt -95.6 164.67 12.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.644 -1.162 . . . . 1.19 110.989 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 2.1 m-70 -126.64 123.62 38.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 2.63 110.614 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.67 HG23 ' CG1' ' A' ' 159' ' ' VAL . 98.4 t -101.61 112.37 34.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.666 0.746 . . . . 0.97 109.631 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.501 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 57.9 mm-40 -116.09 124.92 51.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.833 -1.076 . . . . 1.94 109.082 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.417 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 47.9 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 1.12 111.871 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.494 ' HB2' HG23 ' A' ' 218' ' ' THR . 65.1 Cg_endo . . . . . 0 N--CA 1.461 -0.422 0 CA-C-O 120.574 0.156 . . . . 0.43 112.19 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.573 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 2.0 pp -146.42 147.43 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.888 0.375 . . . . 0.79 111.682 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 217' ' ' LEU . 98.4 t -119.72 125.69 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.818 -0.808 . . . . 1.05 108.818 174.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.597 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 62.5 mtm180 -99.05 116.84 32.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.756 -0.656 . . . . 2.87 110.678 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.415 HG12 HG23 ' A' ' 224' ' ' VAL . 2.0 t -106.11 120.56 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.282 -0.417 . . . . 0.42 111.411 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 33.7 m-85 -72.6 103.27 3.51 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.039 -0.356 . . . . 0.58 110.039 174.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.705 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -66.07 156.44 84.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 120.892 0.377 . . . . 1.46 110.749 176.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.578 ' HB3' HG23 ' A' ' 226' ' ' VAL . 93.0 Cg_exo -43.75 150.54 0.53 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.785 2.99 . . . . 0.5 112.97 171.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 74.69 10.86 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.554 -0.748 . . . . 2.08 110.037 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 76.03 32.36 0.63 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.144 -0.935 . . . . 2.74 112.558 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.1 mm100 -86.11 173.39 9.88 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.32 -0.993 . . . . 1.33 108.32 171.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 19.3 ttp180 -147.48 130.76 16.53 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.738 -0.785 . . . . 2.49 111.487 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.748 HG21 ' HB1' ' A' ' 184' ' ' ALA . 6.2 t -113.79 179.07 4.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.608 -1.178 . . . . 0.52 108.837 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.597 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.25 128.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.53 0.681 . . . . 0.88 110.756 165.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.485 HG23 HD11 ' A' ' 214' ' ' ILE . 2.7 m -108.95 145.26 31.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.58 -1.191 . . . . 1.31 109.61 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.42 145.05 29.57 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.05 1.833 . . . . 0.59 111.313 171.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -68.43 79.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.333 0.587 . . . . 0.35 109.996 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.464 ' O ' HG12 ' A' ' 175' ' ' VAL . 15.1 mmm180 -64.27 111.79 2.77 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.081 -0.963 . . . . 2.81 110.72 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.559 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 76.3 m -77.72 126.54 31.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.572 -0.74 . . . . 1.44 110.935 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.18 21.93 39.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.777 -0.725 . . . . 0.43 112.174 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 172' ' ' ARG . 1.7 p -131.69 150.93 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.082 0.468 . . . . 0.97 110.368 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 51.4 p -87.18 158.95 19.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.786 -0.643 . . . . 0.47 111.121 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.756 ' O ' HD12 ' A' ' 181' ' ' LEU . 59.6 t -48.4 -44.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 1.39 109.704 173.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 12.0 tpt180 -43.77 -51.28 7.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.217 -0.902 . . . . 3.53 113.224 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.626 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 12.2 t70 -72.77 -50.93 21.32 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.743 0.782 . . . . 1.19 110.609 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.4 p -59.69 -51.89 67.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.606 -1.179 . . . . 1.34 110.568 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -90.86 -3.67 57.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 118.812 -1.155 . . . . 1.08 112.994 -177.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.0 ptpt -66.35 -33.69 76.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 118.195 -1.402 . . . . 1.15 107.755 170.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.2 OUTLIER -70.6 -39.57 73.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.393 -0.822 . . . . 1.8 109.49 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.748 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.58 -52.61 37.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.975 0.417 . . . . 0.3 111.116 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.511 HD21 HG11 ' A' ' 224' ' ' VAL . 5.5 mt -61.58 -51.05 70.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 1.46 111.261 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -26.67 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.531 . . . . 1.45 112.432 -174.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.5 mmt -75.6 -18.73 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.058 0.456 . . . . 0.85 110.954 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.48 ' HG3' ' HG ' ' A' ' 161' ' ' LEU . 4.2 mmp_? -96.04 -12.11 25.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.487 0.66 . . . . 2.12 110.05 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.05 19.13 40.63 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.179 -0.918 . . . . 0.53 111.675 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 188' ' ' ARG . 14.8 mt -102.62 168.55 9.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.168 -0.308 . . . . 1.28 110.168 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.7 pt -127.39 143.43 47.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 121.317 0.58 . . . . 0.52 111.777 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 -4.37 15.31 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.521 2.814 . . . . 0.52 112.854 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -75.46 -34.71 60.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 1.74 110.657 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 60.4 m -107.3 7.56 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 1.69 111.74 -175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.506 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 83.9 m -127.49 145.48 50.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.919 -0.313 . . . . 0.52 111.248 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -111.52 160.79 16.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.39 109.835 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 224' ' ' VAL . 12.7 t -117.21 125.05 73.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.001 0.429 . . . . 1.06 110.124 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.586 ' CZ ' ' HG3' ' A' ' 225' ' ' GLU . 52.4 p90 . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 115.777 -0.647 . . . . 2.49 110.4 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 198' ' ' TYR . 7.6 mm . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 109.253 -0.647 . . . . 0.9 109.253 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.74 140.76 15.22 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.386 -1.086 . . . . 0.37 110.386 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.598 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 56.7 m95 -68.75 -13.16 62.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.074 0.464 . . . . 0.31 110.451 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.75 5.54 43.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 2.3 110.333 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 177' ' ' VAL . 49.3 m -72.0 137.89 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.072 -0.513 . . . . 0.31 110.051 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.502 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 13.0 t70 -74.05 112.88 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.73 109.995 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.485 HD11 HG23 ' A' ' 169' ' ' VAL . 4.2 tt -62.04 -26.02 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.181 -0.463 . . . . 0.29 112.141 -175.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 173' ' ' CYS . 2.0 t -70.11 -8.65 51.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.708 0.289 . . . . 1.07 111.157 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.501 ' HB3' HD12 ' A' ' 217' ' ' LEU . 1.7 t90 -87.11 -20.85 26.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.737 0.78 . . . . 3.87 109.29 175.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.597 HD23 HD21 ' A' ' 222' ' ' LEU . 6.9 mp -100.07 12.83 35.97 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 1.21 110.674 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 155' ' ' PRO . 90.8 m -39.21 129.73 1.69 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.764 -1.562 . . . . 0.39 113.059 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.61 -7.86 51.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.698 -0.683 . . . . 0.53 112.356 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -96.64 164.11 12.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.86 0.362 . . . . 2.16 110.92 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 38.2 mt-10 -113.87 122.8 48.13 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.328 0.585 . . . . 2.03 110.87 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.597 HD21 HD23 ' A' ' 217' ' ' LEU . 26.1 mt -99.29 161.49 13.59 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 1.19 111.081 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 26.3 m-70 -124.64 127.2 46.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.425 . . . . 2.63 110.138 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 197' ' ' VAL . 75.5 t -104.98 130.31 56.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.221 0.534 . . . . 0.97 109.66 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 6.7 mm-40 -128.65 130.06 46.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.162 -0.926 . . . . 1.94 110.466 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.578 HG23 ' HB3' ' A' ' 162' ' ' PRO . 99.6 t . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 109.622 -0.51 . . . . 1.12 109.622 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.53 ' HB2' HG21 ' A' ' 218' ' ' THR . 40.8 Cg_endo . . . . . 0 N--CA 1.464 -0.213 0 N-CA-C 111.665 -0.167 . . . . 0.43 111.665 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.464 HD12 HG11 ' A' ' 168' ' ' VAL . 22.0 pt -141.37 158.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.453 0.644 . . . . 0.79 111.861 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 130.27 48.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.903 -1.044 . . . . 1.05 108.934 169.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 9.0 mtm180 -99.6 130.23 45.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.089 -0.959 . . . . 2.87 110.337 -169.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' A' ' 222' ' ' LEU . 6.0 t -115.54 125.73 72.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.453 -0.339 . . . . 0.42 111.581 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -77.15 103.38 7.05 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.223 -0.298 . . . . 0.58 110.236 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.743 HD22 ' H ' ' A' ' 161' ' ' LEU . 2.0 mm? -51.97 162.84 0.74 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 121.12 0.486 . . . . 1.46 111.429 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.468 ' HB3' HG23 ' A' ' 226' ' ' VAL . 78.5 Cg_exo -52.71 154.56 12.13 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.807 2.338 . . . . 0.5 111.889 166.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 64.91 15.48 9.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.688 0.756 . . . . 2.08 110.091 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 70.05 37.34 1.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.776 -1.102 . . . . 2.74 113.396 171.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.7 mm-40 -86.23 176.44 7.95 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.621 -1.251 . . . . 1.33 107.621 168.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -144.91 126.23 14.83 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.463 -0.895 . . . . 2.49 111.54 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.707 HG21 ' HB1' ' A' ' 184' ' ' ALA . 8.1 t -107.72 172.68 6.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.068 -1.424 . . . . 0.52 108.441 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 156' ' ' ILE . 2.4 t -142.97 129.04 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 121.014 0.435 . . . . 0.88 110.081 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.12 131.38 24.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.329 -0.851 . . . . 1.31 109.751 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 73.0 Cg_exo -51.75 140.13 47.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.102 1.868 . . . . 0.59 110.548 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.557 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -61.2 101.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 0.35 110.221 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 215' ' ' SER . 35.9 mmt180 -81.03 111.13 17.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.011 -0.995 . . . . 2.81 110.386 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 p -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.436 -0.347 . . . . 1.44 110.911 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.54 19.82 57.64 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.718 -0.953 . . . . 0.43 110.718 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 179' ' ' ASP . 46.8 t -129.53 132.12 66.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.952 -0.624 . . . . 0.97 110.137 -175.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.5 p -78.02 162.15 26.94 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.907 -0.405 . . . . 0.47 109.907 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.785 ' O ' HD12 ' A' ' 181' ' ' LEU . 5.9 m -52.09 -36.5 20.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.616 -0.883 . . . . 1.39 108.616 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 54.2 ttt180 -43.75 -58.84 2.5 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.807 -1.088 . . . . 3.53 112.729 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.556 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -71.61 -46.1 60.17 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 1.19 110.598 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.5 p -62.46 -57.25 11.89 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.946 -1.025 . . . . 1.34 110.887 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -90.16 0.0 57.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 118.889 -1.124 . . . . 1.08 112.486 -176.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 17.9 ptpt -67.95 -33.96 75.68 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 117.559 -1.656 . . . . 1.15 107.427 165.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 187' ' ' MET . 12.8 tptt -60.79 -43.67 97.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.161 -0.927 . . . . 1.8 108.921 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.707 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -48.05 -58.95 3.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.388 0.43 . . . . 0.3 111.432 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 181' ' ' LEU . 2.9 mm? -52.95 -51.3 61.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.338 -0.392 . . . . 1.46 110.463 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 16.4 mtt -67.99 -21.29 65.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.29 0.478 . . . . 1.45 112.29 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.3 mmt -77.54 -27.3 51.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.207 0.527 . . . . 0.85 109.622 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 188' ' ' ARG . 25.8 tpt180 -85.88 -19.73 30.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.522 -0.763 . . . . 2.12 109.929 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.06 14.88 29.86 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.744 -0.662 . . . . 0.53 111.756 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.45 ' HB2' HD12 ' A' ' 185' ' ' LEU . 12.9 mt -108.07 177.13 4.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.07 -0.344 . . . . 1.28 110.07 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 193' ' ' GLU . 43.8 pt -124.64 146.51 52.89 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 121.179 0.514 . . . . 0.52 111.022 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.467 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 96.6 Cg_endo -77.86 -12.37 16.37 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.275 2.65 . . . . 0.52 112.597 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.449 ' HB2' HD12 ' A' ' 191' ' ' ILE . 24.0 mt-10 -65.74 -26.62 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 1.74 110.819 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 20.0 t -114.43 19.34 16.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.317 -0.401 . . . . 1.69 110.779 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.456 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.4 m -125.99 157.62 37.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.719 -0.219 . . . . 0.52 110.887 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.13 154.42 45.76 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.39 109.966 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.534 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 19.2 t -117.71 126.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.533 0.682 . . . . 1.06 111.536 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.494 ' OH ' ' HG3' ' A' ' 225' ' ' GLU . 54.9 p90 . . . . . 0 C--N 1.313 -1.008 0 CA-C-N 115.087 -0.961 . . . . 2.49 109.073 173.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.496 ' CD1' HD22 ' A' ' 222' ' ' LEU . 6.3 mt . . . . . 0 N--CA 1.444 -0.763 0 CA-C-O 120.757 0.313 . . . . 0.9 110.36 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.11 146.82 18.9 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.492 -0.861 . . . . 0.37 111.58 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.712 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 69.0 m95 -70.15 -13.71 62.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.31 110.704 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -94.79 1.02 55.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.3 110.206 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.8 m -74.03 129.24 37.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.925 -0.579 . . . . 0.31 110.684 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.89 117.22 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.564 -0.532 . . . . 1.73 109.564 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 tt -66.75 -21.14 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.593 0.59 . . . . 0.29 112.593 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 172' ' ' ARG . 67.8 p -71.04 -6.85 42.2 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.28 -0.262 . . . . 1.07 111.646 -175.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -90.01 -10.6 44.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.461 0.648 . . . . 3.87 109.977 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 217' ' ' LEU . 6.3 mp -106.41 14.13 27.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.065 0.936 . . . . 1.21 110.291 -174.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.557 HG23 ' HB2' ' A' ' 171' ' ' ALA . 3.3 m -53.83 142.69 23.2 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.673 -1.603 . . . . 0.39 111.869 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 74.68 -3.21 44.27 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.026 -0.534 . . . . 0.53 112.387 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -104.96 171.2 7.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.602 -0.518 . . . . 2.16 109.602 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.1 mt-10 -121.18 125.88 48.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.744 0.783 . . . . 2.03 110.845 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.535 ' HB2' HG13 ' A' ' 159' ' ' VAL . 27.6 mt -101.14 166.07 10.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.44 -1.255 . . . . 1.19 109.325 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.81 119.8 10.68 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.802 0.811 . . . . 2.63 110.914 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 197' ' ' VAL . 88.8 t -101.46 134.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.97 110.923 -175.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.494 ' HG3' ' OH ' ' A' ' 198' ' ' TYR . 27.3 mm-40 -129.32 132.9 47.22 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 1.94 109.669 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 162' ' ' PRO . 92.4 t . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.12 110.718 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.487 ' HB2' ' CG2' ' A' ' 218' ' ' THR . 39.0 Cg_endo . . . . . 0 N--CA 1.462 -0.359 0 CA-C-O 120.655 0.19 . . . . 0.43 112.056 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.525 ' HB ' HG12 ' A' ' 168' ' ' VAL . 1.9 pp -139.44 150.85 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.237 0.541 . . . . 0.79 111.697 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.3 OUTLIER -131.42 132.92 62.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.405 -0.816 . . . . 1.05 108.928 175.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.613 ' HG2' HG13 ' A' ' 168' ' ' VAL . 36.0 mtm-85 -102.77 129.75 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.753 -0.658 . . . . 2.87 111.155 -168.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 167' ' ' THR . 25.9 t -112.13 122.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.267 -0.424 . . . . 0.42 111.828 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 223' ' ' HIS . 30.8 m-85 -74.71 103.53 5.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.023 -0.362 . . . . 0.58 110.023 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.523 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -63.7 160.78 41.79 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.89 0.376 . . . . 1.46 110.379 173.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.797 ' HD3' HG22 ' A' ' 224' ' ' VAL . 82.1 Cg_exo -45.06 152.17 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.364 2.709 . . . . 0.5 112.316 167.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.1 m120 68.63 25.44 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 2.08 111.176 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 68.75 28.13 5.62 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.398 0.888 . . . . 2.74 113.398 171.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 1.7 mm-40 -89.7 169.48 11.26 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.392 -0.966 . . . . 1.33 108.392 173.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 33.4 ttp180 -146.68 135.07 21.88 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 120.264 -0.574 . . . . 2.49 110.155 175.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.62 HG21 ' CB ' ' A' ' 184' ' ' ALA . 2.1 t -109.73 174.4 5.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.866 -1.061 . . . . 0.52 108.845 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' A' ' 158' ' ' ARG . 2.9 t -138.97 127.19 27.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.823 -0.806 . . . . 0.88 108.823 168.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.444 HG23 HD11 ' A' ' 214' ' ' ILE . 11.0 m -119.8 137.08 25.27 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 115.661 -0.699 . . . . 1.31 109.598 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.64 142.77 59.89 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.912 1.742 . . . . 0.59 110.527 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -68.78 80.36 0.29 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.515 0.674 . . . . 0.35 109.196 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 175' ' ' VAL . 21.4 mmm180 -69.37 110.76 4.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.544 -1.207 . . . . 2.81 109.886 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.1 p -85.48 116.68 23.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.011 -0.54 . . . . 1.44 110.36 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.06 23.89 7.16 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.491 -0.861 . . . . 0.43 111.497 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 172' ' ' ARG . 3.4 p -143.35 156.45 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.217 0.532 . . . . 0.97 110.838 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.5 p -93.31 161.49 14.38 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.517 -0.765 . . . . 0.47 110.933 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.664 ' O ' HD12 ' A' ' 181' ' ' LEU . 16.0 t -48.86 -49.51 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.185 -0.461 . . . . 1.39 109.966 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 3.6 ptm180 -48.7 -44.75 38.37 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 113.276 0.843 . . . . 3.53 113.276 -172.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.564 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 15.7 t70 -71.5 -50.55 30.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.602 0.715 . . . . 1.19 110.208 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.414 ' O ' HG11 ' A' ' 169' ' ' VAL . 2.9 m -62.1 -46.29 89.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.083 -0.962 . . . . 1.34 110.925 -175.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -95.43 -3.97 45.99 Favored 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 119.429 -0.908 . . . . 1.08 112.826 -175.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.9 ptpt -67.51 -35.34 78.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 118.098 -1.441 . . . . 1.15 107.294 167.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.102 -0.953 . . . . 1.8 109.563 170.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -49.9 -56.19 11.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.699 0.285 . . . . 0.3 111.026 172.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.428 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.3 mm? -56.3 -50.09 72.41 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.033 -0.531 . . . . 1.46 110.678 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 50.6 mtt -70.1 -20.91 63.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.326 0.491 . . . . 1.45 112.326 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 19.1 mmt -75.32 -20.33 59.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.479 . . . . 0.85 109.878 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.416 ' HG2' ' HG3' ' A' ' 165' ' ' GLN . 11.5 tpt180 -97.9 -11.56 23.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.653 -0.703 . . . . 2.12 109.623 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.39 46.45 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.277 -0.874 . . . . 0.53 112.061 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.1 mt -104.74 175.78 5.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.79 0.328 . . . . 1.28 110.21 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -125.86 145.18 50.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.058 0.456 . . . . 0.52 110.694 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 86.4 Cg_endo -76.27 -4.96 15.73 Favored 'Trans proline' 0 C--O 1.23 0.084 0 C-N-CA 123.239 2.626 . . . . 0.52 112.752 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.39 -45.35 76.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.572 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.72 29.75 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 1.69 110.091 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 74.1 m -135.25 150.54 50.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.52 110.229 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.55 ' O ' ' HB ' ' A' ' 224' ' ' VAL . . . -133.24 147.93 51.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.352 -0.981 . . . . 0.39 108.352 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.59 ' HA ' ' HB ' ' A' ' 224' ' ' VAL . 84.9 t -99.74 135.6 34.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.742 -0.783 . . . . 1.06 111.797 -170.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 223' ' ' HIS . 35.7 m-85 . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 114.575 -1.193 . . . . 2.49 110.959 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 5.1 mm . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.088 0.47 . . . . 0.9 110.239 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.72 131.9 11.0 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.521 -0.763 . . . . 0.37 111.4 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.516 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 51.9 m95 -67.5 -17.95 64.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 0.31 111.245 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -99.44 6.37 46.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.615 0.721 . . . . 2.3 110.045 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 177' ' ' VAL . 86.7 m -74.34 143.6 44.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.31 109.855 174.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.55 ' HB2' ' CE3' ' A' ' 216' ' ' TRP . 1.1 m-20 -70.5 115.11 9.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.904 0.383 . . . . 1.73 110.329 177.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.444 HD11 HG23 ' A' ' 169' ' ' VAL . 2.6 tt -64.6 -30.49 50.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.29 111.819 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 172' ' ' ARG . 30.3 t -66.18 -6.49 13.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.141 -0.481 . . . . 1.07 111.702 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 213' ' ' ASP . 31.6 m0 -90.95 -12.22 36.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.012 -0.43 . . . . 3.87 110.703 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.0 mt -102.01 9.6 40.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 1.21 110.387 -175.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.568 HG23 ' HB2' ' A' ' 171' ' ' ALA . 4.0 m -46.41 139.04 5.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.39 113.519 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.34 7.71 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.769 -0.65 . . . . 0.53 112.362 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 157' ' ' VAL . 47.7 mt-10 -93.44 168.69 10.89 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.607 -0.516 . . . . 2.16 109.607 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -117.63 124.05 47.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.081 0.944 . . . . 2.03 111.591 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.466 ' HB2' HG22 ' A' ' 159' ' ' VAL . 78.9 mt -96.14 160.83 14.24 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.038 -1.437 . . . . 1.19 108.975 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 160' ' ' PHE . 1.5 t60 -151.32 115.18 4.94 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.947 -0.76 . . . . 2.63 108.947 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.797 HG22 ' HD3' ' A' ' 162' ' ' PRO . 0.9 OUTLIER -102.19 153.68 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.686 0.755 . . . . 0.97 111.882 -177.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -113.43 172.78 6.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.199 -1.364 . . . . 1.94 108.654 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.314 -0.948 0 CA-C-O 120.911 0.386 . . . . 1.12 111.142 -179.483 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.431 -0.211 . . . . 5.63 110.431 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.93 72.6 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.172 2.582 . . . . 3.38 112.847 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 77.4 mt-30 -84.45 154.36 22.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.983 -0.553 . . . . 3.3 110.294 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -101.92 93.69 3.9 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.638 0.256 . . . . 2.33 110.344 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.535 ' HB2' ' CG2' ' A' ' 218' ' ' THR . 23.2 Cg_endo -85.38 157.75 10.95 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.797 2.331 . . . . 0.43 111.504 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.453 HG21 ' C13' ' A' ' 301' ' ' 6FS . 2.1 pp -141.28 153.05 19.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.423 0.63 . . . . 0.79 112.321 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -130.34 126.98 62.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.079 -0.964 . . . . 1.05 109.248 173.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.584 ' HG2' HG22 ' A' ' 168' ' ' VAL . 52.8 mtm-85 -94.68 126.29 39.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.516 -0.766 . . . . 2.87 110.739 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 222' ' ' LEU . 3.5 t -108.86 124.27 65.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.842 -0.617 . . . . 0.42 111.15 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 25.3 m-85 -76.62 102.9 6.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 110.147 -0.316 . . . . 0.58 110.147 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.573 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -63.02 161.36 31.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 121.071 0.463 . . . . 1.46 111.515 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.522 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 77.0 Cg_exo -47.71 153.19 2.43 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.291 2.661 . . . . 0.5 111.783 168.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 4.6 m-20 70.76 18.15 6.31 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.78 0.432 . . . . 2.08 110.804 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 67.48 36.46 3.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.941 -0.572 . . . . 2.74 111.996 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.546 ' HA ' HE21 ' A' ' 165' ' ' GLN . 0.0 OUTLIER -95.18 174.47 7.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.458 -0.942 . . . . 1.33 108.458 174.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.7 ttp180 -147.39 129.47 15.49 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.811 -0.755 . . . . 2.49 111.953 175.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.592 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.5 t -107.99 175.9 5.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.48 -1.237 . . . . 0.52 109.41 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.584 HG22 ' HG2' ' A' ' 158' ' ' ARG . 5.7 t -141.27 128.97 22.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.022 -0.733 . . . . 0.88 109.022 172.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.94 137.45 29.64 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.892 -0.594 . . . . 1.31 109.619 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 50.0 Cg_exo -53.99 142.96 63.38 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.902 1.734 . . . . 0.59 110.175 171.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.542 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -67.26 83.09 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.615 0.721 . . . . 0.35 109.771 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 172' ' ' ARG . 18.5 mmm180 -66.73 111.03 3.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.358 -1.292 . . . . 2.81 111.134 -174.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 14.3 p -77.67 132.86 38.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 1.44 110.43 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.42 17.75 79.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.608 -0.806 . . . . 0.43 111.129 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 179' ' ' ASP . 34.2 t -121.89 133.19 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.247 0.546 . . . . 0.97 110.708 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.7 p -83.73 155.93 22.84 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.543 -0.753 . . . . 0.47 110.593 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.783 ' O ' HD12 ' A' ' 181' ' ' LEU . 67.2 t -45.09 -47.37 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 123.33 0.394 . . . . 1.39 110.709 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 0.7 OUTLIER -49.6 -43.55 46.54 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 113.165 0.802 . . . . 3.53 113.165 -174.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.6 t70 -72.34 -50.76 24.4 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.803 0.811 . . . . 1.19 109.824 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.4 p -61.56 -50.53 72.25 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.301 -1.318 . . . . 1.34 110.474 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.783 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.15 -5.75 54.55 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.28 -0.968 . . . . 1.08 113.174 -175.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.503 ' N ' HD13 ' A' ' 181' ' ' LEU . 18.0 ptpt -69.18 -31.31 69.84 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 117.845 -1.542 . . . . 1.15 107.864 169.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -44.49 96.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.466 -0.788 . . . . 1.8 109.008 168.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.05 -50.32 48.18 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.639 -0.709 . . . . 0.3 111.892 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.497 ' CD2' HD22 ' A' ' 181' ' ' LEU . 2.1 mm? -58.88 -52.06 67.37 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 1.46 110.524 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.7 mmt -60.69 -25.8 66.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.935 -0.575 . . . . 1.45 112.371 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 20.0 mmt -75.15 -18.01 60.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.126 0.489 . . . . 0.85 110.862 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.434 ' HD3' ' CB ' ' A' ' 165' ' ' GLN . 10.9 mmm180 -95.25 -21.11 18.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.579 0.704 . . . . 2.12 109.679 171.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.95 10.86 36.04 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.897 -1.047 . . . . 0.53 111.143 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.98 177.21 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 1.28 110.685 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 16.5 pt -129.08 145.26 55.92 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.028 -0.533 . . . . 0.52 111.079 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.84 ' HA ' ' SG ' ' A' ' 195' ' ' CYS . 61.4 Cg_endo -72.54 -4.19 14.83 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.381 2.721 . . . . 0.52 113.759 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.31 -49.76 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.939 0.4 . . . . 1.74 111.725 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 77.2 m -96.34 16.42 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.734 0.642 . . . . 1.69 112.734 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.84 ' SG ' ' HA ' ' A' ' 192' ' ' PRO . 1.3 p -115.88 160.52 20.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 0.52 111.981 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.492 ' HA ' ' HE1' ' A' ' 210' ' ' TRP . . . -125.38 155.16 40.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.398 -0.819 . . . . 0.39 109.292 169.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.524 HG23 ' CE2' ' A' ' 210' ' ' TRP . 17.6 t -117.39 122.07 69.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.372 0.606 . . . . 1.06 111.097 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.756 ' CE1' ' HE3' ' A' ' 205' ' ' LYS . 50.6 p90 -155.55 147.69 23.58 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.222 -0.899 . . . . 2.49 109.405 175.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.432 ' HG2' HD11 ' A' ' 208' ' ' ILE . 14.7 ptm180 -114.12 137.21 52.03 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.168 -0.332 . . . . 1.57 111.084 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.463 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 20.2 mm -82.35 122.78 37.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.705 0.764 . . . . 0.88 110.905 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.562 ' NE2' ' HE2' ' A' ' 206' ' ' LYS . 0.8 OUTLIER -99.44 -149.28 0.36 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.452 -1.249 . . . . 2.41 108.295 175.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -52.88 81.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.432 0.693 . . . . 1.91 112.427 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.79 11.6 24.39 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.494 -0.384 . . . . 1.12 112.791 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 200' ' ' ILE . 13.3 pt-20 -130.85 -177.75 4.5 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 120.872 0.367 . . . . 1.54 110.679 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.756 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 11.2 mtpt -121.25 129.35 53.12 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.135 -0.484 . . . . 1.69 110.585 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.562 ' HE2' ' NE2' ' A' ' 201' ' ' GLN . 61.7 mmtt -109.98 97.36 29.17 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.455 -0.943 . . . . 1.66 108.455 173.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.711 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 15.2 Cg_exo -68.22 118.22 5.48 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.934 1.756 . . . . 0.58 112.685 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.432 HD11 ' HG2' ' A' ' 199' ' ' ARG . 5.4 mt -89.16 163.75 2.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.182 -0.917 . . . . 0.9 110.291 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.42 145.81 17.91 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.694 -0.765 . . . . 0.37 111.229 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.595 ' CZ3' HD11 ' A' ' 181' ' ' LEU . 48.7 m95 -66.76 -16.05 63.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.166 0.508 . . . . 0.31 110.29 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 2.3 110.769 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 177' ' ' VAL . 24.1 m -70.18 137.29 50.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.398 -0.364 . . . . 0.31 110.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.03 116.16 10.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.432 -0.581 . . . . 1.73 109.432 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 175' ' ' VAL . 7.7 tt -69.68 -20.86 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.292 0.479 . . . . 0.29 112.292 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.503 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 81.6 p -71.0 -6.57 39.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 1.07 111.261 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -91.73 -16.42 26.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.262 0.553 . . . . 3.87 110.975 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.5 mp -99.41 11.93 37.75 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.077 0.941 . . . . 1.21 111.035 -175.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.542 HG23 ' HB2' ' A' ' 171' ' ' ALA . 4.3 m -50.0 138.67 15.15 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.516 -1.674 . . . . 0.39 113.293 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.41 -2.63 28.48 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.53 112.798 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 157' ' ' VAL . 48.2 mt-10 -115.1 131.77 56.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.885 -0.413 . . . . 2.16 109.885 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.7 mt-10 -83.4 136.08 34.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.717 0.77 . . . . 2.03 111.032 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.542 ' HB2' HG13 ' A' ' 159' ' ' VAL . 54.1 mt -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.552 -1.204 . . . . 1.19 110.58 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -127.33 134.52 49.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.241 0.544 . . . . 2.63 110.815 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.706 HG21 HD23 ' A' ' 181' ' ' LEU . 86.5 t -114.76 116.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.555 -0.748 . . . . 0.97 109.145 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 66.0 mm-40 -120.16 133.66 55.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.542 -0.754 . . . . 1.94 109.925 -172.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.8 t -64.05 130.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.135 -0.484 . . . . 1.12 111.092 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 196' ' ' ALA . 52.1 mt -81.6 83.78 6.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.842 -0.617 . . . . 1.69 110.495 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.57 114.88 29.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.798 -0.637 . . . . 2.12 110.452 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.9 41.41 32.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.674 -0.694 . . . . 4.42 111.124 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 55.2 t 50.49 86.93 0.14 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.127 -1.397 . . . . 5.77 112.519 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.91 135.5 12.58 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.282 1.988 . . . . 7.15 111.713 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.397 -0.811 . . . . 9.01 110.072 178.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.513 ' C11' ' O3 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 110.27 -0.27 . . . . 5.63 110.27 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -67.85 -25.7 38.96 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.434 2.09 . . . . 3.38 111.339 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.426 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 24.7 tp60 -121.06 121.1 37.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.235 -0.893 . . . . 3.3 108.89 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.4 ' CE ' ' HA ' ' A' ' 154' ' ' LYS . 2.2 tpmt? -69.72 110.54 6.69 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 123.276 0.36 . . . . 2.33 110.152 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.528 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 42.3 Cg_endo -85.29 146.92 9.98 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.495 2.13 . . . . 0.43 111.736 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.426 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 16.6 pt -143.13 143.94 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.175 0.512 . . . . 0.79 111.545 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 220' ' ' GLU . 89.3 t -117.59 117.73 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.627 -0.879 . . . . 1.05 108.627 170.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.618 ' HG2' HG22 ' A' ' 168' ' ' VAL . 87.4 mtm180 -97.28 113.62 25.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.039 -0.528 . . . . 2.87 110.867 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.493 ' CG1' HG23 ' A' ' 224' ' ' VAL . 24.3 t -99.04 126.54 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.214 -0.448 . . . . 0.42 111.456 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 25.1 m-85 -78.25 101.05 6.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.647 -0.501 . . . . 0.58 109.647 171.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.669 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.4 OUTLIER -58.72 168.36 1.45 Allowed Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 122.553 0.341 . . . . 1.46 111.789 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 81.7 Cg_exo -47.12 149.44 3.63 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.915 2.41 . . . . 0.5 111.449 167.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.83 8.22 6.65 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.709 0.766 . . . . 2.08 109.22 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.83 48.44 16.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.153 -1.385 . . . . 2.74 112.022 178.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 11.9 mm-40 -80.39 -176.91 5.91 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.628 -1.619 . . . . 1.33 106.628 166.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.409 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 30.5 ttp180 -147.56 131.09 16.75 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.56 -1.256 . . . . 2.49 112.052 175.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.669 ' HB ' HD21 ' A' ' 161' ' ' LEU . 5.5 t -112.18 173.0 6.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.125 -1.398 . . . . 0.52 108.988 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.618 HG22 ' HG2' ' A' ' 158' ' ' ARG . 3.3 t -139.37 129.08 30.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.818 -0.438 . . . . 0.88 109.818 172.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 180' ' ' SER . 73.1 t -127.27 120.95 22.42 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.461 -0.79 . . . . 1.31 109.615 175.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 52.1 Cg_exo -50.22 135.28 38.35 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.008 2.472 . . . . 0.59 111.454 174.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.88 105.96 0.52 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.35 110.243 -177.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.656 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 3.6 mmp_? -100.7 111.04 23.21 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 2.81 111.31 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.83 123.82 26.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.76 -0.654 . . . . 1.44 109.886 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 -7.69 59.29 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.683 -0.967 . . . . 0.43 110.683 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 179' ' ' ASP . 53.7 t -103.7 128.54 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.215 0.531 . . . . 0.97 110.047 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 178' ' ' ARG . 25.5 p -78.08 156.63 29.89 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.528 -0.76 . . . . 0.47 110.062 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.765 ' O ' HD12 ' A' ' 181' ' ' LEU . 23.3 t -48.39 -43.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.851 -0.425 . . . . 1.39 109.851 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 1.3 ptm180 -53.56 -47.01 70.45 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 112.726 0.639 . . . . 3.53 112.726 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.495 ' HB3' HG13 ' A' ' 175' ' ' VAL . 21.0 t70 -68.12 -50.25 55.91 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.698 0.761 . . . . 1.19 109.875 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 169' ' ' VAL . 2.1 p -59.62 -55.53 33.3 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.091 -1.413 . . . . 1.34 110.732 -175.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.93 -2.5 56.75 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 118.78 -1.168 . . . . 1.08 113.334 -174.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.447 ' HB2' ' HG3' ' A' ' 192' ' ' PRO . 18.5 ptpt -70.95 -32.76 69.74 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 117.989 -1.485 . . . . 1.15 107.909 169.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -37.55 87.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.169 -0.678 . . . . 1.8 109.169 169.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -52.04 -52.52 50.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.694 -0.23 . . . . 0.3 111.283 173.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.457 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -56.74 -52.23 65.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.798 0.333 . . . . 1.46 110.59 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 17.6 mmt -62.79 -22.37 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.667 0.617 . . . . 1.45 112.667 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 18.1 mmt -71.65 -38.22 70.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.823 0.345 . . . . 0.85 110.207 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.508 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 11.8 mmm180 -73.85 -23.6 59.64 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.519 0.676 . . . . 2.12 109.685 172.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.77 9.52 37.43 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.022 -0.99 . . . . 0.53 111.468 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.4 mt -96.99 177.0 5.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.937 0.398 . . . . 1.28 110.666 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.1 pt -124.8 141.77 39.05 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.52 110.776 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 60.9 Cg_endo -72.26 -10.01 25.13 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 123.242 2.628 . . . . 0.52 112.472 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -54.57 -48.01 72.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.825 -0.625 . . . . 1.74 111.301 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 83.7 m -102.3 25.78 8.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.49 -0.777 . . . . 1.69 111.173 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.549 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 78.0 m -131.79 151.41 51.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.555 -0.293 . . . . 0.52 110.764 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.446 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -123.35 158.67 30.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.402 -0.592 . . . . 0.39 109.402 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.504 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 41.4 t -112.22 134.67 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.895 0.855 . . . . 1.06 112.474 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -134.72 174.74 10.24 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.17 -1.377 . . . . 2.49 109.913 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.454 ' NE ' ' HG2' ' A' ' 220' ' ' GLU . 9.0 ptm180 -150.03 136.23 18.81 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.364 -0.976 . . . . 1.57 108.364 169.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.561 HG12 ' CD2' ' A' ' 223' ' ' HIS . 27.6 mm -86.62 122.61 38.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.817 0.818 . . . . 0.88 110.814 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 203' ' ' GLY . 2.1 tp-100 -102.32 -145.31 0.36 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 113.985 -1.461 . . . . 2.41 108.733 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.85 81.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.745 0.418 . . . . 1.91 111.876 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.59 8.85 10.53 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.537 -0.363 . . . . 1.12 112.697 -177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.72 -179.71 5.22 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.319 0.581 . . . . 1.54 111.397 -172.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.49 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 36.7 mtpt -116.98 134.68 54.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.405 -0.816 . . . . 1.69 110.957 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.419 ' HB2' ' HG3' ' A' ' 199' ' ' ARG . 72.5 mmtt -117.57 112.44 39.04 Favored Pre-proline 0 C--N 1.315 -0.926 0 N-CA-C 109.227 -0.657 . . . . 1.66 109.227 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.77 118.48 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.2 1.933 . . . . 0.58 111.458 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.431 HD11 ' CG ' ' A' ' 199' ' ' ARG . 16.3 mt -93.49 160.05 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.125 0.488 . . . . 0.9 111.304 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -97.51 145.53 17.86 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.884 -0.887 . . . . 0.37 110.884 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.578 ' O ' ' HD2' ' A' ' 178' ' ' ARG . 62.0 m95 -70.73 -18.39 62.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.951 0.405 . . . . 0.31 110.791 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -89.58 -5.78 56.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 2.3 110.387 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 177' ' ' VAL . 98.0 m -69.34 146.6 52.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.646 -0.706 . . . . 0.31 110.071 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.459 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 12.1 t70 -79.1 129.8 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.851 -0.426 . . . . 1.73 109.851 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.87 -21.68 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.832 0.348 . . . . 0.29 111.759 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.439 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 44.6 t -75.85 -7.75 55.24 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.098 -0.376 . . . . 1.07 110.399 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 13.0 m0 -82.36 -11.12 58.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.385 0.612 . . . . 3.87 109.586 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 220' ' ' GLU . 18.8 mt -114.54 6.87 15.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.468 -0.787 . . . . 1.21 110.385 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 155' ' ' PRO . 21.1 m -42.94 134.71 3.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.091 0.774 . . . . 0.39 113.091 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 71.36 12.68 73.14 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.87 -0.605 . . . . 0.53 112.266 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.454 ' HG2' ' NE ' ' A' ' 199' ' ' ARG . 7.5 tp10 -115.33 141.21 48.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.956 -0.387 . . . . 2.16 109.956 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.9 123.07 33.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 2.03 110.123 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 159' ' ' VAL . 8.7 mp -99.29 170.5 8.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.625 -0.716 . . . . 1.19 110.121 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.561 ' CD2' HG12 ' A' ' 200' ' ' ILE . 12.1 p80 -149.0 130.25 14.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.509 -0.552 . . . . 2.63 109.509 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.549 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 47.3 t -98.57 135.37 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.105 -0.498 . . . . 0.97 110.794 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -118.95 126.22 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.091 -0.958 . . . . 1.94 110.231 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.69 129.83 26.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.421 . . . . 1.12 111.384 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 196' ' ' ALA . 79.1 mt -89.18 101.73 14.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.752 -0.658 . . . . 1.69 110.391 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.84 97.57 3.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.998 -0.546 . . . . 2.12 110.448 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -91.74 60.64 4.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.313 0.577 . . . . 4.42 110.476 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.0 m -71.76 125.9 91.57 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.783 -0.644 . . . . 5.77 110.592 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.66 39.06 0.81 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.892 2.395 . . . . 7.15 112.44 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.2 tp . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.605 -0.712 . . . . 9.01 109.787 -177.228 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.534 ' C1 ' ' HA ' ' A' ' 167' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 120.836 0.351 . . . . 5.63 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.08 141.47 47.6 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.34 2.693 . . . . 3.38 112.543 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -79.9 112.95 17.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.201 -0.454 . . . . 3.3 110.336 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -108.87 98.18 28.26 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.23 -0.441 . . . . 2.33 109.811 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.29 145.13 38.11 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.443 2.095 . . . . 0.43 112.977 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.469 HD12 HG11 ' A' ' 168' ' ' VAL . 14.8 pt -140.13 154.75 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.696 -0.684 . . . . 0.79 110.701 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 218' ' ' THR . 98.4 t -121.2 126.86 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 108.814 -0.81 . . . . 1.05 108.814 172.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 11.1 mtp180 -102.9 107.03 17.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.401 -0.818 . . . . 2.87 110.879 -174.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 222' ' ' LEU . 3.5 t -97.44 125.56 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.471 -0.331 . . . . 0.42 111.441 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -72.63 103.23 3.51 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.189 0.518 . . . . 0.58 110.232 173.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.735 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 28.3 mt -56.86 155.02 16.24 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 1.46 110.963 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 62.8 Cg_exo -53.17 153.8 15.5 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.8 2.333 . . . . 0.5 111.421 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 5.2 m-20 71.79 18.48 5.14 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.428 0.632 . . . . 2.08 110.474 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.26 35.4 5.96 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.985 -1.007 . . . . 2.74 112.558 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.735 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.5 mm100 -94.49 -179.62 4.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.602 -1.258 . . . . 1.33 107.602 171.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -147.24 138.33 23.79 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.871 -0.732 . . . . 2.49 110.704 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.621 HG21 ' HB1' ' A' ' 184' ' ' ALA . 13.5 t -119.17 171.96 7.92 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.854 -1.066 . . . . 0.52 109.042 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.469 HG11 HD12 ' A' ' 156' ' ' ILE . 3.1 t -141.17 129.82 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.748 -0.464 . . . . 0.88 109.748 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.409 HG13 HD11 ' A' ' 214' ' ' ILE . 3.3 p -131.75 130.39 22.29 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.274 -0.875 . . . . 1.31 109.251 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.446 ' HA ' HG22 ' A' ' 156' ' ' ILE . 10.2 Cg_exo -49.24 144.01 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.359 2.706 . . . . 0.59 112.014 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.73 82.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.29 0.567 . . . . 0.35 109.76 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -70.76 110.65 5.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.282 -0.872 . . . . 2.81 110.82 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 32.3 m -80.45 118.35 21.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.651 -0.704 . . . . 1.44 109.564 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.53 17.65 32.97 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.788 -0.925 . . . . 0.43 110.788 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 179' ' ' ASP . 18.3 t -128.38 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.179 -0.51 . . . . 0.97 110.351 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.474 ' OG1' ' HG3' ' A' ' 178' ' ' ARG . 32.7 p -70.62 148.8 47.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.903 -0.59 . . . . 0.47 109.872 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.823 ' O ' HD12 ' A' ' 181' ' ' LEU . 14.5 p -49.51 -37.71 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.888 -0.412 . . . . 1.39 109.888 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -57.94 -34.8 70.27 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.489 -0.778 . . . . 3.53 112.174 -173.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.651 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -77.02 -49.91 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.9 0.857 . . . . 1.19 109.714 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -53.25 59.44 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.714 -1.13 . . . . 1.34 110.716 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -88.96 0.69 56.42 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.0 -1.08 . . . . 1.08 112.887 -177.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.651 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 17.3 ptpt -69.05 -35.56 76.71 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.257 -1.377 . . . . 1.15 107.736 167.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -65.15 -38.23 89.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.666 -0.814 . . . . 1.8 109.26 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.621 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -48.92 -54.69 14.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.946 -0.301 . . . . 0.3 110.631 172.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.478 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -58.76 -53.75 54.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.466 -0.334 . . . . 1.46 111.045 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.89 -24.63 64.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.086 -0.506 . . . . 1.45 112.291 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 12.4 mmt -78.19 -41.22 35.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.515 -0.55 . . . . 0.85 109.515 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.533 ' NE ' ' HG3' ' A' ' 165' ' ' GLN . 15.2 tpt180 -71.0 -18.12 62.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.695 -0.684 . . . . 2.12 109.802 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.28 4.08 44.18 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.687 -0.688 . . . . 0.53 112.824 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 190' ' ' LEU . 5.4 mp -102.18 175.29 5.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.94 0.4 . . . . 1.28 111.543 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.5 pt -119.31 139.89 28.26 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.944 -0.571 . . . . 0.52 110.381 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 55.6 Cg_endo -69.15 -14.3 37.77 Favored 'Trans proline' 0 N--CA 1.47 0.113 0 C-N-CA 123.348 2.699 . . . . 0.52 112.469 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -63.09 -37.04 85.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 1.74 110.846 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 75.7 m -101.42 17.3 23.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.954 -0.566 . . . . 1.69 110.764 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.415 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 85.2 m -128.99 156.91 43.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.163 -0.471 . . . . 0.52 110.784 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -124.96 158.33 33.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.389 -0.597 . . . . 0.39 109.389 173.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.637 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 96.1 t -106.88 139.09 29.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.782 0.801 . . . . 1.06 111.792 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -136.86 173.48 11.65 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.229 -1.35 . . . . 2.49 109.899 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.457 ' CG ' HD11 ' A' ' 208' ' ' ILE . 11.2 ptm180 -152.36 141.16 21.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.132 -1.062 . . . . 1.57 108.132 168.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.636 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 18.5 mm -89.4 121.28 39.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.764 0.792 . . . . 0.88 110.492 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.771 ' OE1' ' HE3' ' A' ' 206' ' ' LYS . 8.7 tt0 -105.88 -142.66 0.37 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.315 -1.311 . . . . 2.41 107.554 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.55 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.663 0.616 . . . . 1.91 112.663 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.58 5.17 6.27 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 116.121 -0.491 . . . . 1.12 113.643 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.17 176.98 8.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.73 0.765 . . . . 1.54 111.842 -171.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.636 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 46.3 mtpt -109.59 131.62 54.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.249 -0.887 . . . . 1.69 111.443 -171.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.771 ' HE3' ' OE1' ' A' ' 201' ' ' GLN . 5.4 mptp? -118.51 118.47 33.68 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.62 -0.718 . . . . 1.66 110.35 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 3.7 Cg_exo -79.1 117.36 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.05 1.834 . . . . 0.58 111.511 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.457 HD11 ' CG ' ' A' ' 199' ' ' ARG . 6.4 mt -91.31 162.05 2.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.129 -0.487 . . . . 0.9 110.883 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 141.47 17.7 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.719 -0.753 . . . . 0.37 111.244 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.637 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 61.2 m95 -70.5 -12.91 61.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.731 0.301 . . . . 0.31 111.148 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.98 -12.91 40.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.492 . . . . 2.3 110.116 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.6 m -60.8 127.97 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.31 111.09 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 215' ' ' SER . 13.6 t70 -68.05 127.98 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 1.73 110.038 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.409 HD11 HG13 ' A' ' 169' ' ' VAL . 7.8 tt -68.53 -20.53 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.132 -0.486 . . . . 0.29 112.153 -172.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.476 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 34.8 t -69.29 -11.73 61.06 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.112 -0.367 . . . . 1.07 111.244 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -89.76 -17.97 27.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 3.87 110.083 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 220' ' ' GLU . 33.4 mt -94.84 3.99 54.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 1.21 109.999 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.44 ' HA ' HG22 ' A' ' 157' ' ' VAL . 58.4 m -43.07 139.78 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.39 113.331 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.42 -8.67 46.03 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.368 -0.833 . . . . 0.53 112.088 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 34.5 mm-40 -102.6 154.96 18.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.279 0.562 . . . . 2.16 111.168 -175.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 35.5 mt-10 -101.39 124.09 46.51 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.342 -0.845 . . . . 2.03 109.379 174.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 217' ' ' LEU . 7.0 mp -96.01 173.38 7.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.948 -0.569 . . . . 1.19 110.218 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -137.99 135.21 35.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.15 -0.685 . . . . 2.63 109.15 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.439 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 86.8 t -103.52 124.9 58.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.101 -0.64 . . . . 0.97 110.264 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -109.62 119.11 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.39 -0.823 . . . . 1.94 108.801 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.08 126.75 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.718 -0.475 . . . . 1.12 109.718 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 196' ' ' ALA . 63.2 mt -79.45 88.68 5.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.728 -0.669 . . . . 1.69 109.699 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -94.17 97.66 10.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.178 -0.919 . . . . 2.12 111.058 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -82.08 67.7 8.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.556 -0.747 . . . . 4.42 109.061 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.5 m 44.29 71.67 1.43 Allowed Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.448 1.092 . . . . 5.77 112.599 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.11 152.0 56.11 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.134 2.556 . . . . 7.15 112.338 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 232' ' ' LEU . 1.3 pt? . . . . . 0 C--O 1.248 1.013 0 CA-C-N 116.191 -0.458 . . . . 9.01 110.273 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.543 ' C11' ' O3 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.839 -0.43 . . . . 5.63 109.839 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.19 -38.82 33.75 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.913 2.409 . . . . 3.38 112.649 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -132.15 120.39 22.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.847 0.356 . . . . 3.3 110.888 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -120.87 96.28 48.72 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.694 -0.484 . . . . 2.33 109.694 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 71.6 Cg_endo -70.8 148.29 58.02 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.507 2.138 . . . . 0.43 111.843 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.545 HD12 HG11 ' A' ' 168' ' ' VAL . 20.7 pt -138.19 152.93 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.098 0.475 . . . . 0.79 111.628 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.403 ' HB ' HD11 ' A' ' 214' ' ' ILE . 90.3 t -124.69 129.82 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.734 -0.839 . . . . 1.05 108.734 172.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 168' ' ' VAL . 38.6 mtm-85 -101.51 123.01 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.855 -0.611 . . . . 2.87 110.477 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 222' ' ' LEU . 40.8 t -108.23 127.77 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.415 -0.357 . . . . 0.42 111.722 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -80.51 99.45 8.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.205 -0.665 . . . . 0.58 109.205 170.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.7 OUTLIER -61.78 167.85 4.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.655 0.983 . . . . 1.46 113.655 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 73.7 Cg_exo -49.96 152.82 6.93 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.787 2.991 . . . . 0.5 111.842 167.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.69 13.8 7.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.296 1.046 . . . . 2.08 109.047 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.648 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 57.82 44.83 19.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.89 -1.505 . . . . 2.74 112.108 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -82.44 178.16 8.37 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.819 -1.549 . . . . 1.33 106.819 166.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 166' ' ' ARG . 12.2 ttp180 -148.6 129.75 14.55 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.542 -0.863 . . . . 2.49 111.06 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.79 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.6 t -118.67 177.92 4.66 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.129 -0.942 . . . . 0.52 109.494 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.545 HG11 HD12 ' A' ' 156' ' ' ILE . 2.4 t -142.81 129.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.702 -0.481 . . . . 0.88 109.702 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 214' ' ' ILE . 5.2 m -124.06 131.63 24.24 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.391 -0.822 . . . . 1.31 109.72 173.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 78.1 Cg_exo -49.4 146.36 14.23 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.634 2.223 . . . . 0.59 112.143 175.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.559 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -66.81 80.21 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.601 . . . . 0.35 110.222 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -64.64 112.22 3.09 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.055 -0.975 . . . . 2.81 111.131 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.6 136.59 36.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.933 -0.576 . . . . 1.44 110.333 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.84 14.69 82.32 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.016 -0.834 . . . . 0.43 111.016 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 179' ' ' ASP . 55.3 t -126.78 135.11 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.038 0.447 . . . . 0.97 110.763 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.7 p -83.13 167.09 18.12 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.817 -0.629 . . . . 0.47 110.326 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.837 ' O ' HD12 ' A' ' 181' ' ' LEU . 2.4 m -53.4 -37.73 30.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 108.487 -0.931 . . . . 1.39 108.487 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.8 tmm_? -44.56 -62.72 1.09 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.174 -0.921 . . . . 3.53 112.619 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.696 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 30.1 t70 -68.05 -44.37 76.55 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.394 0.616 . . . . 1.19 111.034 -174.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.8 p -62.13 -54.65 38.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.462 -0.79 . . . . 1.34 110.656 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -91.52 -2.66 57.11 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.396 -0.922 . . . . 1.08 112.848 -175.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 13.6 ptmm? -68.34 -36.04 78.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.68 -1.23 . . . . 1.15 107.68 168.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.89 -36.38 83.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.24 -0.891 . . . . 1.8 109.345 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.79 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.63 -55.78 22.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.525 -0.307 . . . . 0.3 111.097 173.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.564 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.5 mm? -53.83 -50.48 66.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.376 -0.375 . . . . 1.46 110.774 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 37.2 mtt -70.31 -21.69 62.9 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.342 0.497 . . . . 1.45 112.342 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 16.4 mmt -76.3 -18.98 58.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 0.85 110.119 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.47 ' HB2' HD23 ' A' ' 161' ' ' LEU . 7.3 tpm_? -97.33 -11.83 23.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.439 -0.8 . . . . 2.12 109.768 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 94.85 19.71 30.72 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.53 111.955 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.502 ' HB2' HD12 ' A' ' 185' ' ' LEU . 7.7 mt -116.83 172.24 7.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.642 0.258 . . . . 1.28 110.437 -176.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.7 pt -121.57 142.76 36.39 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.497 . . . . 0.52 110.683 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 73.9 Cg_endo -75.15 -13.1 21.21 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 123.258 2.639 . . . . 0.52 112.968 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.37 -41.41 93.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 1.74 110.952 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 37.9 t -94.36 8.0 43.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.945 -0.571 . . . . 1.69 110.785 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.427 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 73.1 m -116.29 158.18 23.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.65 0.262 . . . . 0.52 110.878 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -128.11 157.55 40.45 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.39 110.053 174.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 224' ' ' VAL . 13.9 t -118.89 124.1 72.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.136 0.493 . . . . 1.06 110.717 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.73 ' CB ' ' HA ' ' A' ' 207' ' ' PRO . 55.1 p90 -154.66 154.65 33.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.672 -0.694 . . . . 2.49 110.597 175.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.664 ' HG3' HD11 ' A' ' 208' ' ' ILE . 81.4 mtp180 -106.44 130.3 54.27 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.021 -0.424 . . . . 1.57 111.272 -175.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.432 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 20.0 mm -82.57 123.03 38.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.972 0.892 . . . . 0.88 110.516 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.452 ' NE2' ' HA ' ' A' ' 201' ' ' GLN . 1.5 tp60 -105.06 -143.2 0.37 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.957 -1.474 . . . . 2.41 108.707 177.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.84 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.076 0.399 . . . . 1.91 112.076 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.61 9.83 20.68 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.381 -0.438 . . . . 1.12 112.467 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -130.01 -177.78 4.44 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 120.841 0.353 . . . . 1.54 110.807 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.645 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 7.9 mtpt -122.54 122.3 38.56 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.011 -0.54 . . . . 1.69 110.942 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.08 97.08 10.63 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.153 -1.054 . . . . 1.66 108.153 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.73 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 23.2 Cg_exo -65.85 129.82 23.05 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.509 2.139 . . . . 0.58 113.035 -175.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.664 HD11 ' HG3' ' A' ' 199' ' ' ARG . 2.6 mm -90.81 164.06 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.845 -0.798 . . . . 0.9 108.845 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.2 138.2 13.74 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.563 -0.827 . . . . 0.37 111.205 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.677 ' HA ' HG22 ' A' ' 177' ' ' VAL . 62.3 m95 -68.06 -18.62 64.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.137 0.494 . . . . 0.31 110.244 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -95.08 6.67 48.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.553 -0.748 . . . . 2.3 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 99.9 m -86.33 144.3 27.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.31 110.354 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.96 128.02 34.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.03 -0.532 . . . . 1.73 111.184 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.447 HD11 HG23 ' A' ' 169' ' ' VAL . 6.5 tt -72.7 -26.95 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.683 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.559 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 44.3 t -68.06 -14.96 63.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 1.07 110.596 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -86.16 -13.06 48.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.446 0.641 . . . . 3.87 109.615 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.483 HD13 HD21 ' A' ' 222' ' ' LEU . 10.3 mt -105.71 8.28 32.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.495 -0.775 . . . . 1.21 109.868 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.7 m -40.56 134.57 1.74 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.772 1.027 . . . . 0.39 113.772 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.5 4.5 61.04 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.522 -0.763 . . . . 0.53 112.281 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.63 162.58 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.714 -0.476 . . . . 2.16 109.714 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 41.2 mt-10 -111.9 129.45 56.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.589 0.709 . . . . 2.03 111.456 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 217' ' ' LEU . 66.3 mt -97.77 155.41 17.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.455 -1.248 . . . . 1.19 109.81 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.83 116.0 16.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.702 0.763 . . . . 2.63 109.904 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 197' ' ' VAL . 79.4 t -100.83 137.77 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 0.97 110.997 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.504 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 17.8 mm-40 -131.74 135.5 46.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.855 -1.066 . . . . 1.94 109.694 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 19.5 t -68.11 126.36 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 110.054 -0.35 . . . . 1.12 110.054 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 196' ' ' ALA . 44.5 mt -75.98 82.6 2.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.347 0.594 . . . . 1.69 110.712 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.4 ' HG3' HG12 ' A' ' 226' ' ' VAL . 42.3 mt-10 -110.04 97.63 7.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.652 -0.704 . . . . 2.12 110.434 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.22 59.59 5.66 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.972 -0.558 . . . . 4.42 110.144 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 75.5 t 55.62 80.74 0.28 Allowed Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 114.506 -1.225 . . . . 5.77 111.071 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.74 -11.29 8.01 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.063 2.509 . . . . 7.15 112.071 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.6 tp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.673 -0.679 . . . . 9.01 110.032 -177.853 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.505 ' C1 ' ' HA ' ' A' ' 167' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.593 0.235 . . . . 5.63 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -54.1 -37.03 86.89 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.067 2.511 . . . . 3.38 112.134 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -89.29 107.96 19.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.064 -0.516 . . . . 3.3 109.697 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -74.93 115.48 44.87 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.752 -0.462 . . . . 2.33 109.752 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.434 ' HB2' HG23 ' A' ' 218' ' ' THR . 88.5 Cg_endo -76.09 144.02 26.36 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.342 2.028 . . . . 0.43 112.264 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 170' ' ' PRO . 1.5 pp -141.78 147.07 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.892 0.377 . . . . 0.79 111.295 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 220' ' ' GLU . 99.4 t -116.99 123.32 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.037 -0.727 . . . . 1.05 109.037 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 168' ' ' VAL . 42.6 mtp180 -98.81 114.31 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.464 -0.789 . . . . 2.87 110.868 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 222' ' ' LEU . 2.7 t -104.7 125.9 59.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.373 -0.376 . . . . 0.42 111.537 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.413 ' CZ ' ' HD3' ' A' ' 166' ' ' ARG . 20.2 m-85 -76.23 101.96 5.63 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.611 -0.515 . . . . 0.58 109.611 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.2 OUTLIER -67.09 158.03 82.79 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 1.46 111.136 176.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.558 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 50.2 Cg_exo -56.31 144.62 81.68 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 123.387 2.724 . . . . 0.5 112.514 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 92.6 m-20 74.03 30.02 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.618 0.574 . . . . 2.08 111.054 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.603 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 66.37 32.37 7.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.252 -0.885 . . . . 2.74 112.774 173.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.642 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -90.47 167.07 12.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.462 -1.681 . . . . 1.33 106.462 171.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 38.7 ttp180 -148.86 136.44 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.672 -0.811 . . . . 2.49 110.343 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.805 HG21 ' HB1' ' A' ' 184' ' ' ALA . 10.1 t -123.94 172.59 8.82 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.241 -0.891 . . . . 0.52 109.852 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.549 HG22 ' HG2' ' A' ' 158' ' ' ARG . 2.6 t -142.12 128.07 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 109.249 -0.649 . . . . 0.88 109.249 172.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.477 HG23 HD11 ' A' ' 214' ' ' ILE . 3.2 m -118.63 135.26 23.59 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.157 -0.929 . . . . 1.31 108.884 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.485 ' HA ' HG22 ' A' ' 156' ' ' ILE . 61.5 Cg_exo -51.26 146.06 25.08 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 121.872 1.714 . . . . 0.59 110.532 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.23 81.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.373 -0.602 . . . . 0.35 109.373 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 35.6 mmt180 -65.11 111.24 2.83 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.695 -1.139 . . . . 2.81 109.974 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 26.9 p -78.43 130.41 36.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.877 0.37 . . . . 1.44 110.782 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.2 22.61 44.04 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.628 -0.796 . . . . 0.43 112.539 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 1.4 p -137.58 153.44 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 0.97 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 40.3 p -91.05 164.64 13.88 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.834 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.736 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 5.2 m -55.4 -32.93 30.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.268 0.556 . . . . 1.39 109.608 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.649 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.6 tpt180 -53.29 -48.23 68.53 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 115.202 -0.908 . . . . 3.53 112.171 -175.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.0 t70 -75.96 -49.93 16.34 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.377 0.608 . . . . 1.19 110.564 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.1 p -59.61 -55.77 30.33 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.951 -1.022 . . . . 1.34 110.689 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 177' ' ' VAL . 0.1 OUTLIER -92.28 -5.33 52.55 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.069 -1.052 . . . . 1.08 112.659 -176.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 17.6 ptpt -61.2 -40.03 92.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 116.85 -1.94 . . . . 1.15 107.716 167.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 182' ' ' LYS . 6.4 ttpm? -66.24 -38.27 87.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.976 -0.556 . . . . 1.8 109.92 174.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.805 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -49.96 -54.19 21.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.226 0.536 . . . . 0.3 110.467 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.545 HD21 HG11 ' A' ' 224' ' ' VAL . 6.0 mt -62.64 -51.05 68.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.519 -0.764 . . . . 1.46 111.251 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 67.5 mtp -67.58 -21.82 65.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.509 -0.314 . . . . 1.45 111.846 -173.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.4 mtt -77.84 -25.92 49.08 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.535 -0.542 . . . . 0.85 109.535 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.476 ' HB2' HD23 ' A' ' 161' ' ' LEU . 11.1 tpt180 -87.6 -11.28 49.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.511 -0.768 . . . . 2.12 109.356 174.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.26 4.43 44.09 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.731 -0.668 . . . . 0.53 113.251 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 186' ' ' MET . 5.3 mp -97.43 176.87 5.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 1.28 111.599 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.39 146.88 63.88 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.644 . . . . 0.52 110.293 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -4.61 15.59 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.354 2.703 . . . . 0.52 113.303 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.169 0.509 . . . . 1.74 110.029 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 227' ' ' LEU . 48.7 t -107.49 28.41 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.615 -0.72 . . . . 1.69 110.388 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.48 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.2 m -151.25 155.44 38.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.231 -0.441 . . . . 0.52 110.189 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.571 ' HB2' ' HG ' ' A' ' 227' ' ' LEU . . . -131.33 173.34 11.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.148 -1.056 . . . . 0.39 108.148 169.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.571 HG21 HD21 ' A' ' 181' ' ' LEU . 13.1 t -114.44 136.73 50.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.276 0.56 . . . . 1.06 111.343 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -135.36 168.53 19.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.218 -0.901 . . . . 2.49 110.139 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -138.6 136.26 35.79 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.447 -0.945 . . . . 1.57 108.447 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.64 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 21.7 mm -87.82 119.56 35.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.971 0.891 . . . . 0.88 110.963 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.58 ' HA ' ' NE2' ' A' ' 201' ' ' GLN . 0.4 OUTLIER -98.14 -146.86 0.32 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.952 -1.476 . . . . 2.41 108.809 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.15 80.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.079 0.399 . . . . 1.91 112.079 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.3 13.03 27.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.324 -0.465 . . . . 1.12 112.125 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -132.14 -178.35 4.86 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.084 0.469 . . . . 1.54 110.96 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.64 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 42.6 mtpt -120.78 136.1 54.98 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.859 -0.61 . . . . 1.69 111.195 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -122.35 112.99 31.06 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.079 -0.712 . . . . 1.66 109.079 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.18 125.97 11.92 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.003 1.802 . . . . 0.58 112.944 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 6.9 mm -84.09 162.2 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.421 -0.809 . . . . 0.9 109.595 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.78 140.31 14.94 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.847 -0.901 . . . . 0.37 110.847 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.736 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 90.2 m95 -68.02 -14.37 62.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.277 0.539 . . . . 0.31 110.619 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -99.32 0.39 42.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.3 110.388 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.7 m -75.07 140.78 43.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.754 -0.657 . . . . 0.31 110.106 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.27 121.19 20.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.451 . . . . 1.73 110.193 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 169' ' ' VAL . 4.1 tt -67.97 -28.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.29 111.733 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -72.87 -8.39 55.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.228 0.537 . . . . 1.07 110.342 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -83.62 -17.08 42.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.67 0.748 . . . . 3.87 109.568 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -101.82 9.84 40.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.344 -0.843 . . . . 1.21 110.007 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.434 HG23 ' HB2' ' A' ' 155' ' ' PRO . 63.0 m -39.92 130.7 2.01 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.747 1.018 . . . . 0.39 113.747 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.42 -1.18 61.88 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.508 -0.769 . . . . 0.53 112.347 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 157' ' ' VAL . 38.7 mt-10 -105.61 138.26 42.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.8 0.333 . . . . 2.16 110.205 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -84.46 128.9 34.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.294 0.569 . . . . 2.03 110.598 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 159' ' ' VAL . 48.9 mt -103.61 169.43 8.53 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.265 -0.88 . . . . 1.19 109.957 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -147.16 136.55 22.69 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.104 -0.702 . . . . 2.63 109.104 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.545 HG11 HD21 ' A' ' 185' ' ' LEU . 72.3 t -99.32 144.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.935 0.398 . . . . 0.97 110.944 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -109.64 145.8 35.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.865 -0.791 . . . . 1.94 108.865 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 8.3 t -83.52 114.77 24.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.381 0.61 . . . . 1.12 110.399 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' A' ' 196' ' ' ALA . 4.2 mm? -104.85 90.81 3.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.162 -0.926 . . . . 1.69 110.401 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -94.14 133.03 38.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.22 -0.9 . . . . 2.12 111.207 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 20.8 m120 58.84 56.21 4.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.629 0.728 . . . . 4.42 111.527 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 232' ' ' LEU . 9.1 t -65.67 117.33 40.29 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.733 -1.121 . . . . 5.77 110.998 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.09 20.46 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.935 2.423 . . . . 7.15 112.817 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.544 ' H ' HG12 ' A' ' 230' ' ' VAL . 93.0 mt . . . . . 0 C--O 1.246 0.916 0 CA-C-N 115.666 -0.697 . . . . 9.01 110.861 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.71 ' C19' ' N1 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.639 0.256 . . . . 5.63 110.725 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.23 108.74 0.53 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.868 2.378 . . . . 3.38 111.905 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -75.2 120.74 21.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.357 -0.383 . . . . 3.3 110.25 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -116.12 91.16 31.04 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 2.33 110.361 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 83.4 Cg_endo -77.52 144.59 22.74 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.387 2.058 . . . . 0.43 111.737 175.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 17.4 pt -134.62 144.74 34.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 0.79 110.965 176.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.2 OUTLIER -124.41 117.05 49.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.806 0.812 . . . . 1.05 108.977 173.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 18.1 mtm-85 -83.59 130.57 34.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.557 -1.201 . . . . 2.87 110.506 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 167' ' ' THR . 7.5 t -120.64 117.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.201 -0.909 . . . . 0.42 111.215 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.48 ' HB2' ' HA ' ' A' ' 223' ' ' HIS . 10.2 m-85 -71.77 102.83 2.93 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.991 0.424 . . . . 0.58 110.392 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 27.8 mt -55.46 151.04 21.49 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 124.294 1.038 . . . . 1.46 111.5 173.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.562 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 60.5 Cg_exo -54.06 161.69 4.76 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.022 2.481 . . . . 0.5 111.869 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 67.76 14.78 9.55 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.206 -1.035 . . . . 2.08 108.206 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 63.01 40.22 9.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 113.645 -1.616 . . . . 2.74 112.235 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.711 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 3.0 mm-40 -96.7 -176.55 3.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.378 -1.342 . . . . 1.33 107.378 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 30.1 ttp180 -145.81 127.11 14.86 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.232 -0.987 . . . . 2.49 111.66 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.675 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.1 t -109.55 176.66 4.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.611 -1.177 . . . . 0.52 108.544 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.458 HG13 ' CG ' ' A' ' 158' ' ' ARG . 2.1 t -141.32 126.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.676 -0.861 . . . . 0.88 108.676 168.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.475 HG23 HD11 ' A' ' 214' ' ' ILE . 9.2 m -107.53 127.54 27.61 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.764 -0.653 . . . . 1.31 109.956 167.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 71.9 Cg_exo -50.51 142.51 30.42 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.163 1.909 . . . . 0.59 110.461 169.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.432 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -64.7 88.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.35 110.228 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.448 ' O ' HG12 ' A' ' 175' ' ' VAL . 29.0 mmt180 -70.87 110.98 5.94 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.085 -0.961 . . . . 2.81 109.181 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.2 p -82.38 126.54 32.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.246 -0.434 . . . . 1.44 110.904 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.14 22.51 29.8 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.539 -0.839 . . . . 0.43 111.944 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 172' ' ' ARG . 1.3 p -138.1 154.59 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.061 0.457 . . . . 0.97 110.151 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.4 p -86.23 158.87 19.62 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.94 -0.573 . . . . 0.47 110.72 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.777 ' O ' HD12 ' A' ' 181' ' ' LEU . 42.0 t -45.84 -49.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.224 -0.658 . . . . 1.39 109.224 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 11.8 tpt180 -41.57 -56.18 2.65 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 124.743 1.277 . . . . 3.53 113.239 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.747 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.5 t70 -67.5 -47.66 69.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.255 0.55 . . . . 1.19 110.622 -176.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.8 t -64.28 -47.74 78.36 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.047 -0.661 . . . . 1.34 110.183 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -93.03 -2.58 55.54 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.271 -0.971 . . . . 1.08 112.464 -175.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 14.5 ptmm? -69.95 -31.4 69.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.27 -1.382 . . . . 1.15 107.27 167.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.56 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.0 OUTLIER -65.94 -41.73 90.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.08 -0.964 . . . . 1.8 109.418 168.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.675 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.61 -55.95 13.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.55 -0.295 . . . . 0.3 110.983 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.4 mm? -53.96 -51.9 62.37 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.494 -0.321 . . . . 1.46 110.911 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -25.29 67.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 1.45 112.363 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 24.2 mmt -78.48 -31.52 47.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.812 0.339 . . . . 0.85 110.222 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.706 ' HD3' HD13 ' A' ' 161' ' ' LEU . 15.4 tpt180 -77.52 -14.86 59.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.458 0.647 . . . . 2.12 109.975 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.03 55.86 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.53 111.543 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.414 ' HB2' HD12 ' A' ' 185' ' ' LEU . 13.7 mt -108.68 176.89 4.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.079 -0.341 . . . . 1.28 110.079 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 193' ' ' GLU . 46.1 pt -122.63 140.96 34.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.52 111.489 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.52 -10.55 26.99 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.55 2.833 . . . . 0.52 112.739 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.421 ' HB2' HD12 ' A' ' 191' ' ' ILE . 38.0 mt-10 -62.38 -44.19 97.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.336 0.589 . . . . 1.74 110.505 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.4 m -97.04 20.17 11.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.403 -0.817 . . . . 1.69 110.989 -176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.545 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 72.8 m -128.39 156.66 42.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.542 -0.299 . . . . 0.52 110.713 -175.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -130.03 152.93 48.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.39 109.995 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.522 HG13 ' CE2' ' A' ' 210' ' ' TRP . 3.5 m -110.68 126.96 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.791 0.805 . . . . 1.06 111.108 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.678 ' CE1' ' HE3' ' A' ' 205' ' ' LYS . 51.7 p90 -158.23 156.04 30.04 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.51 -0.768 . . . . 2.49 109.456 173.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.619 ' HG3' HD11 ' A' ' 208' ' ' ILE . 81.7 mtp180 -103.61 159.06 15.93 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.931 -0.308 . . . . 1.57 111.133 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 20.5 mm -108.06 124.35 64.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.908 0.861 . . . . 0.88 111.202 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.482 ' CD ' ' HE3' ' A' ' 206' ' ' LYS . 5.6 tt0 -99.52 -148.72 0.35 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.968 -1.469 . . . . 2.41 107.473 174.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -54.27 82.08 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.164 0.586 . . . . 1.91 112.433 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 60.81 7.81 8.98 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 121.612 -0.328 . . . . 1.12 112.621 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -126.12 179.88 5.04 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 120.707 0.289 . . . . 1.54 110.458 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.678 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 14.8 mtpt -120.65 137.75 54.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.243 0.544 . . . . 1.69 111.616 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.482 ' HE3' ' CD ' ' A' ' 201' ' ' GLN . 70.9 mmtt -121.12 96.53 48.31 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 107.983 -1.118 . . . . 1.66 107.983 173.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.651 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 26.8 Cg_exo -64.78 124.1 12.67 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.676 2.25 . . . . 0.58 113.531 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.619 HD11 ' HG3' ' A' ' 199' ' ' ARG . 1.2 mm -97.13 161.55 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 108.216 -1.031 . . . . 0.9 108.216 175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.62 151.26 18.58 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.467 -1.349 . . . . 0.37 113.004 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.522 ' CE2' HG13 ' A' ' 197' ' ' VAL . 69.1 m95 -70.52 -18.43 62.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.872 0.368 . . . . 0.31 110.598 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -97.82 -1.96 42.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 2.3 110.564 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.3 m -70.34 142.02 52.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.829 -0.623 . . . . 0.31 109.788 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.99 119.16 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.265 -0.642 . . . . 1.73 109.265 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 177' ' ' VAL . 4.4 tt -71.24 -27.01 27.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.29 111.377 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.0 t -70.84 -7.78 47.88 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.479 0.656 . . . . 1.07 109.717 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -88.37 -6.99 57.37 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.498 0.666 . . . . 3.87 109.487 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.423 HD13 HD21 ' A' ' 222' ' ' LEU . 22.8 mt -112.61 7.48 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.431 -0.804 . . . . 1.21 110.038 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 61.0 m -42.29 134.5 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.916 -1.038 . . . . 0.39 113.7 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.4 57.64 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.53 112.335 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 157' ' ' VAL . 41.6 mt-10 -113.36 148.92 34.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.864 0.364 . . . . 2.16 110.391 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.6 mp0 -92.26 126.61 37.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.217 0.532 . . . . 2.03 111.448 -176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.446 ' HB2' HG13 ' A' ' 159' ' ' VAL . 80.8 mt -99.56 155.13 17.74 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.22 -0.9 . . . . 1.19 110.144 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -119.34 124.72 47.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.743 0.306 . . . . 2.63 110.219 173.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.575 HG21 HD23 ' A' ' 181' ' ' LEU . 72.6 t -105.7 116.93 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.569 0.7 . . . . 0.97 109.408 172.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.539 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 54.0 mm-40 -119.55 133.02 55.86 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.921 -1.036 . . . . 1.94 109.19 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.562 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 41.3 t -67.29 128.54 30.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 1.12 111.187 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 196' ' ' ALA . 79.2 mt -86.1 88.08 7.53 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.708 -0.678 . . . . 1.69 110.774 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.35 139.4 31.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.167 -0.47 . . . . 2.12 109.865 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.48 59.52 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.621 0.576 . . . . 4.42 110.466 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.02 142.68 83.04 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.624 -0.716 . . . . 5.77 111.165 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.29 133.38 55.65 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.079 2.52 . . . . 7.15 112.176 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 232' ' ' LEU . 2.0 pt? . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.395 -0.812 . . . . 9.01 110.355 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.57 ' C1 ' ' HA ' ' A' ' 167' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 19.1 m . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.233 -0.284 . . . . 5.63 110.233 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 32.3 Cg_exo -61.02 89.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.186 2.591 . . . . 3.38 112.399 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -121.46 146.54 46.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.878 -0.601 . . . . 3.3 109.535 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.559 ' HE2' ' N1 ' ' A' ' 301' ' ' 6FS . 0.7 OUTLIER -105.73 91.07 4.76 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.322 -0.621 . . . . 2.33 109.322 175.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.463 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 55.1 Cg_endo -81.42 138.97 11.25 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.527 2.152 . . . . 0.43 111.64 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.587 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 39.5 pt -140.63 139.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.745 0.307 . . . . 0.79 111.081 -178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 217' ' ' LEU . 88.4 t -112.53 118.76 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.149 -0.685 . . . . 1.05 109.149 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.627 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 66.1 mtm180 -97.02 115.74 27.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.632 -0.713 . . . . 2.87 110.538 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.67 ' CG1' HG23 ' A' ' 224' ' ' VAL . 13.5 t -105.85 127.02 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.233 -0.44 . . . . 0.42 111.653 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 27.3 m-85 -74.22 103.09 4.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.302 -0.408 . . . . 0.58 110.161 173.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.2 mm? -55.04 163.27 1.58 Allowed Pre-proline 0 N--CA 1.474 0.737 0 CA-C-O 121.331 0.586 . . . . 1.46 112.013 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.417 ' HB3' ' CG2' ' A' ' 226' ' ' VAL . 77.2 Cg_exo -51.24 160.48 2.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.964 2.443 . . . . 0.5 111.047 163.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 67.89 6.99 5.46 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.069 0.462 . . . . 2.08 110.213 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 164' ' ' LYS . 8.1 mmpt? 70.2 39.39 1.31 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.134 -0.939 . . . . 2.74 111.88 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 4.1 mm-40 -91.02 -178.89 5.32 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.549 -0.908 . . . . 1.33 108.549 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 33.0 ttp180 -147.38 132.89 18.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.006 -0.677 . . . . 2.49 111.541 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.784 HG21 ' HB1' ' A' ' 184' ' ' ALA . 12.6 t -120.64 -177.74 3.54 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.459 -1.246 . . . . 0.52 108.743 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.627 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.39 129.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.321 0.581 . . . . 0.88 111.127 170.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.535 HG23 HD11 ' A' ' 214' ' ' ILE . 5.1 m -112.26 131.86 22.37 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.964 -1.016 . . . . 1.31 109.551 172.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 74.0 Cg_exo -48.35 141.86 18.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.504 2.136 . . . . 0.59 111.859 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.81 83.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.35 110.44 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.565 ' O ' HG12 ' A' ' 175' ' ' VAL . 31.1 mmt180 -72.55 113.65 9.81 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 2.81 110.041 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 41.9 t -82.81 124.75 30.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 1.44 110.757 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.06 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.72 -0.752 . . . . 0.43 111.915 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 172' ' ' ARG . 8.5 p -135.27 150.92 29.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.746 -0.464 . . . . 0.97 109.746 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 57.4 p -81.38 155.49 25.9 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.165 -0.471 . . . . 0.47 110.777 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.744 ' O ' HD12 ' A' ' 181' ' ' LEU . 53.0 t -46.46 -46.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 109.18 -0.674 . . . . 1.39 109.18 173.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 9.5 tpt180 -41.51 -54.98 2.99 Favored 'General case' 0 C--O 1.219 -0.515 0 O-C-N 124.319 1.012 . . . . 3.53 113.125 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 13.8 t70 -68.6 -48.95 62.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.502 0.668 . . . . 1.19 110.772 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.469 ' O ' HG11 ' A' ' 169' ' ' VAL . 3.3 m -64.59 -46.79 81.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.325 -0.852 . . . . 1.34 111.02 -173.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -93.25 -4.49 51.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.928 -1.109 . . . . 1.08 112.529 -177.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.3 ptpt -67.23 -34.41 77.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 118.123 -1.431 . . . . 1.15 107.697 168.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.7 OUTLIER -67.56 -36.57 81.2 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.571 -0.741 . . . . 1.8 109.48 171.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.784 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.94 -52.1 52.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.662 -0.245 . . . . 0.3 110.825 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.507 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.2 mm? -58.62 -50.97 71.87 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.435 -0.348 . . . . 1.46 111.067 176.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.48 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 49.2 mtt -68.47 -20.99 64.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.515 0.561 . . . . 1.45 112.515 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 18.4 mmt -80.97 -20.32 42.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 0.85 109.722 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.496 ' HB3' ' CD1' ' A' ' 190' ' ' LEU . 10.2 tpt180 -91.09 -17.03 26.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.695 0.76 . . . . 2.12 109.144 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.56 6.32 41.24 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 114.785 -1.098 . . . . 0.53 112.835 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.496 ' CD1' ' HB3' ' A' ' 188' ' ' ARG . 5.2 mp -104.96 174.64 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.112 0.482 . . . . 1.28 111.718 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.1 pt -119.74 144.17 36.53 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.52 110.53 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.76 -4.44 15.36 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.53 2.82 . . . . 0.52 113.593 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -69.38 -42.13 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.868 0.366 . . . . 1.74 111.095 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 25.5 p -97.17 15.47 22.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 1.69 110.609 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.619 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.6 m -123.1 149.6 44.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.07 -0.514 . . . . 0.52 110.661 -175.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -118.49 152.23 36.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.813 -0.44 . . . . 0.39 109.813 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.692 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 13.6 t -118.88 124.54 73.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.097 0.475 . . . . 1.06 110.867 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.729 ' CB ' ' HA ' ' A' ' 207' ' ' PRO . 51.9 p90 -155.23 149.61 26.09 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.483 -0.78 . . . . 2.49 109.764 174.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 6.8 ptm180 -106.41 152.11 24.04 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.062 -0.347 . . . . 1.57 110.062 -172.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.46 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 22.2 mm -98.37 122.42 50.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.84 0.829 . . . . 0.88 110.532 174.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 203' ' ' GLY . 4.6 tt0 -99.78 -146.6 0.34 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.19 -1.368 . . . . 2.41 107.885 175.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -55.78 80.54 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.292 0.637 . . . . 1.91 112.386 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.02 9.04 12.29 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.508 -0.377 . . . . 1.12 112.524 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -127.87 -178.98 4.72 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 120.797 0.332 . . . . 1.54 110.354 -172.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.644 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 9.3 mtpt -124.19 129.76 51.36 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.952 0.406 . . . . 1.69 110.925 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 24.5 mmtp -113.71 98.96 48.87 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.298 -1.001 . . . . 1.66 108.298 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.729 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 31.4 Cg_exo -62.27 121.79 9.96 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.184 1.923 . . . . 0.58 112.295 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 198' ' ' TYR . 14.7 mm -77.24 148.02 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.9 109.61 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 212' ' ' THR . . . -85.31 131.06 10.21 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.675 -1.37 . . . . 0.37 109.675 171.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.692 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 57.6 m95 -65.38 -21.08 66.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.037 0.446 . . . . 0.31 110.194 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -96.02 1.7 52.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.533 0.683 . . . . 2.3 110.086 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.5 m -72.37 145.75 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.906 -0.588 . . . . 0.31 110.282 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.61 115.02 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.497 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.535 HD11 HG23 ' A' ' 169' ' ' VAL . 2.4 tt -62.58 -29.4 46.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.29 111.505 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.479 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -73.24 -8.25 55.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.857 -0.61 . . . . 1.07 110.563 -173.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -82.27 -21.69 36.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.52 0.676 . . . . 3.87 109.815 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 157' ' ' VAL . 13.0 mt -97.64 11.79 35.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.476 -0.783 . . . . 1.21 110.031 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.459 HG23 ' HB2' ' A' ' 155' ' ' PRO . 94.9 m -37.68 129.66 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.497 0.925 . . . . 0.39 113.497 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.16 -14.03 29.64 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.816 -0.629 . . . . 0.53 112.302 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.31 158.31 26.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.954 0.407 . . . . 2.16 110.306 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.5 mt-10 -109.48 115.48 30.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.596 0.712 . . . . 2.03 109.933 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.443 ' HB2' HG22 ' A' ' 159' ' ' VAL . 36.4 mt -95.6 164.67 12.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.644 -1.162 . . . . 1.19 110.989 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 2.1 m-70 -126.64 123.62 38.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.404 -0.362 . . . . 2.63 110.614 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.67 HG23 ' CG1' ' A' ' 159' ' ' VAL . 98.4 t -101.61 112.37 34.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.666 0.746 . . . . 0.97 109.631 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.501 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 57.9 mm-40 -116.09 124.92 51.58 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.833 -1.076 . . . . 1.94 109.082 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.417 ' CG2' ' HB3' ' A' ' 162' ' ' PRO . 47.9 t -55.75 134.05 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 1.12 111.871 -173.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 196' ' ' ALA . 38.7 mt -78.9 89.02 4.7 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.686 -0.688 . . . . 1.69 110.336 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -109.48 97.59 7.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.479 -0.782 . . . . 2.12 109.874 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -155.02 53.61 0.64 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.749 -0.659 . . . . 4.42 109.235 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 43.6 t 57.27 90.1 0.09 OUTLIER Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 114.517 -1.22 . . . . 5.77 111.258 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.36 -60.7 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.617 2.211 . . . . 7.15 111.609 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.4 mt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.287 -0.863 . . . . 9.01 110.022 179.526 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.559 ' N1 ' ' HE2' ' A' ' 154' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.3 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.663 0.268 . . . . 5.63 110.402 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.19 -21.44 23.58 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.1 2.533 . . . . 3.38 112.797 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -123.98 152.09 42.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.337 -0.392 . . . . 3.3 110.33 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -113.87 96.41 41.19 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.434 -0.348 . . . . 2.33 110.143 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.494 ' HB2' HG23 ' A' ' 218' ' ' THR . 65.1 Cg_endo -79.95 149.6 20.34 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.621 2.214 . . . . 0.43 112.19 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.573 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 2.0 pp -146.42 147.43 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.888 0.375 . . . . 0.79 111.682 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 217' ' ' LEU . 98.4 t -119.72 125.69 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.818 -0.808 . . . . 1.05 108.818 174.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.597 ' CG ' ' HB ' ' A' ' 168' ' ' VAL . 62.5 mtm180 -99.05 116.84 32.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.756 -0.656 . . . . 2.87 110.678 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.415 HG12 HG23 ' A' ' 224' ' ' VAL . 2.0 t -106.11 120.56 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.282 -0.417 . . . . 0.42 111.411 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 33.7 m-85 -72.6 103.27 3.51 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.039 -0.356 . . . . 0.58 110.039 174.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.705 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -66.07 156.44 84.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 120.892 0.377 . . . . 1.46 110.749 176.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.578 ' HB3' HG23 ' A' ' 226' ' ' VAL . 93.0 Cg_exo -43.75 150.54 0.53 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.785 2.99 . . . . 0.5 112.97 171.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 74.69 10.86 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.554 -0.748 . . . . 2.08 110.037 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt 76.03 32.36 0.63 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.144 -0.935 . . . . 2.74 112.558 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 2.1 mm100 -86.11 173.39 9.88 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.32 -0.993 . . . . 1.33 108.32 171.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 19.3 ttp180 -147.48 130.76 16.53 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.738 -0.785 . . . . 2.49 111.487 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.748 HG21 ' HB1' ' A' ' 184' ' ' ALA . 6.2 t -113.79 179.07 4.06 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.608 -1.178 . . . . 0.52 108.837 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.597 ' HB ' ' CG ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -157.25 128.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.53 0.681 . . . . 0.88 110.756 165.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.485 HG23 HD11 ' A' ' 214' ' ' ILE . 2.7 m -108.95 145.26 31.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.58 -1.191 . . . . 1.31 109.61 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.42 145.05 29.57 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.05 1.833 . . . . 0.59 111.313 171.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -68.43 79.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.333 0.587 . . . . 0.35 109.996 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.464 ' O ' HG12 ' A' ' 175' ' ' VAL . 15.1 mmm180 -64.27 111.79 2.77 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.081 -0.963 . . . . 2.81 110.72 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.559 ' HA ' ' CB ' ' A' ' 215' ' ' SER . 76.3 m -77.72 126.54 31.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.572 -0.74 . . . . 1.44 110.935 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.18 21.93 39.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.777 -0.725 . . . . 0.43 112.174 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 172' ' ' ARG . 1.7 p -131.69 150.93 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.082 0.468 . . . . 0.97 110.368 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 51.4 p -87.18 158.95 19.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.786 -0.643 . . . . 0.47 111.121 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.756 ' O ' HD12 ' A' ' 181' ' ' LEU . 59.6 t -48.4 -44.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 1.39 109.704 173.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 12.0 tpt180 -43.77 -51.28 7.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.217 -0.902 . . . . 3.53 113.224 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.626 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 12.2 t70 -72.77 -50.93 21.32 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.743 0.782 . . . . 1.19 110.609 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.4 p -59.69 -51.89 67.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.606 -1.179 . . . . 1.34 110.568 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -90.86 -3.67 57.18 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 118.812 -1.155 . . . . 1.08 112.994 -177.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.0 ptpt -66.35 -33.69 76.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 118.195 -1.402 . . . . 1.15 107.755 170.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 187' ' ' MET . 0.2 OUTLIER -70.6 -39.57 73.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.393 -0.822 . . . . 1.8 109.49 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.748 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.58 -52.61 37.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.975 0.417 . . . . 0.3 111.116 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.511 HD21 HG11 ' A' ' 224' ' ' VAL . 5.5 mt -61.58 -51.05 70.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 1.46 111.261 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -26.67 67.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.531 . . . . 1.45 112.432 -174.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.5 mmt -75.6 -18.73 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.058 0.456 . . . . 0.85 110.954 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.48 ' HG3' ' HG ' ' A' ' 161' ' ' LEU . 4.2 mmp_? -96.04 -12.11 25.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.487 0.66 . . . . 2.12 110.05 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.05 19.13 40.63 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.179 -0.918 . . . . 0.53 111.675 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 188' ' ' ARG . 14.8 mt -102.62 168.55 9.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.168 -0.308 . . . . 1.28 110.168 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.7 pt -127.39 143.43 47.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 121.317 0.58 . . . . 0.52 111.777 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 -4.37 15.31 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.521 2.814 . . . . 0.52 112.854 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -75.46 -34.71 60.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 1.74 110.657 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 60.4 m -107.3 7.56 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 1.69 111.74 -175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.506 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 83.9 m -127.49 145.48 50.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.919 -0.313 . . . . 0.52 111.248 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.561 ' N ' HD21 ' A' ' 227' ' ' LEU . . . -111.52 160.79 16.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.906 -0.588 . . . . 0.39 109.835 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 224' ' ' VAL . 12.7 t -117.21 125.05 73.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.001 0.429 . . . . 1.06 110.124 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.791 ' CE1' ' HE3' ' A' ' 205' ' ' LYS . 52.4 p90 -152.86 150.31 29.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.777 -0.647 . . . . 2.49 110.4 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 15.1 ptm180 -105.97 145.19 31.65 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.057 -0.349 . . . . 1.57 110.057 -171.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 24.3 mm -91.44 123.75 43.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.98 0.895 . . . . 0.88 110.918 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.481 ' HA ' ' NE2' ' A' ' 201' ' ' GLN . 1.9 tp60 -103.27 -142.84 0.36 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.944 -1.48 . . . . 2.41 109.012 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.38 77.59 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.841 0.456 . . . . 1.91 112.046 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.77 9.85 15.69 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.559 -0.353 . . . . 1.12 112.282 -175.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -127.38 -176.14 3.65 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.791 0.329 . . . . 1.54 110.646 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.791 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 10.3 mtpt -121.14 129.15 53.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.055 0.455 . . . . 1.69 111.21 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 34.3 mmtp -114.29 98.23 48.07 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.145 -1.057 . . . . 1.66 108.145 173.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.701 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 28.4 Cg_exo -63.2 124.73 14.39 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.372 2.048 . . . . 0.58 113.222 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 198' ' ' TYR . 7.6 mm -82.84 161.78 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.253 -0.647 . . . . 0.9 109.253 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.74 140.76 15.22 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.386 -1.086 . . . . 0.37 110.386 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.598 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 56.7 m95 -68.75 -13.16 62.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.074 0.464 . . . . 0.31 110.451 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.75 5.54 43.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 2.3 110.333 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 177' ' ' VAL . 49.3 m -72.0 137.89 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.072 -0.513 . . . . 0.31 110.051 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.502 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 13.0 t70 -74.05 112.88 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.73 109.995 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.485 HD11 HG23 ' A' ' 169' ' ' VAL . 4.2 tt -62.04 -26.02 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.181 -0.463 . . . . 0.29 112.141 -175.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 173' ' ' CYS . 2.0 t -70.11 -8.65 51.29 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.708 0.289 . . . . 1.07 111.157 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.501 ' HB3' HD12 ' A' ' 217' ' ' LEU . 1.7 t90 -87.11 -20.85 26.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.737 0.78 . . . . 3.87 109.29 175.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.597 HD23 HD21 ' A' ' 222' ' ' LEU . 6.9 mp -100.07 12.83 35.97 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 1.21 110.674 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 155' ' ' PRO . 90.8 m -39.21 129.73 1.69 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.764 -1.562 . . . . 0.39 113.059 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.61 -7.86 51.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.698 -0.683 . . . . 0.53 112.356 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -96.64 164.11 12.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.86 0.362 . . . . 2.16 110.92 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 38.2 mt-10 -113.87 122.8 48.13 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.328 0.585 . . . . 2.03 110.87 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.597 HD21 HD23 ' A' ' 217' ' ' LEU . 26.1 mt -99.29 161.49 13.59 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 1.19 111.081 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 198' ' ' TYR . 26.3 m-70 -124.64 127.2 46.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.425 . . . . 2.63 110.138 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.644 HG22 HG22 ' A' ' 197' ' ' VAL . 75.5 t -104.98 130.31 56.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.221 0.534 . . . . 0.97 109.66 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 198' ' ' TYR . 6.7 mm-40 -128.65 130.06 46.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.162 -0.926 . . . . 1.94 110.466 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.578 HG23 ' HB3' ' A' ' 162' ' ' PRO . 99.6 t -68.01 126.43 27.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.622 -0.51 . . . . 1.12 109.622 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.561 HD21 ' N ' ' A' ' 196' ' ' ALA . 1.0 OUTLIER -85.43 82.81 8.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.494 -0.558 . . . . 1.69 109.494 -178.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -84.6 95.87 9.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.56 -0.746 . . . . 2.12 109.896 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -133.3 59.41 1.74 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.604 0.716 . . . . 4.42 109.39 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.17 114.96 35.97 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.723 -1.126 . . . . 5.77 110.785 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -90.19 26.97 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.07 2.513 . . . . 7.15 112.879 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 41.4 tp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.324 -0.846 . . . . 9.01 110.382 179.052 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.513 ' C1 ' ' HA ' ' A' ' 167' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.123 -0.325 . . . . 5.63 110.123 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.74 -26.49 79.83 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.204 2.603 . . . . 3.38 112.818 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -85.36 139.14 31.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.633 -0.506 . . . . 3.3 109.633 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.87 114.7 55.74 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.328 -0.396 . . . . 2.33 110.129 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.53 ' HB2' HG21 ' A' ' 218' ' ' THR . 40.8 Cg_endo -80.64 158.16 21.83 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.52 2.147 . . . . 0.43 111.665 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.476 HG21 ' C13' ' A' ' 301' ' ' 6FS . 22.0 pt -141.37 158.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.453 0.644 . . . . 0.79 111.861 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 130.27 48.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.903 -1.044 . . . . 1.05 108.934 169.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 9.0 mtm180 -99.6 130.23 45.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.089 -0.959 . . . . 2.87 110.337 -169.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' A' ' 222' ' ' LEU . 6.0 t -115.54 125.73 72.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.453 -0.339 . . . . 0.42 111.581 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -77.15 103.38 7.05 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.223 -0.298 . . . . 0.58 110.236 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.743 HD22 ' H ' ' A' ' 161' ' ' LEU . 2.0 mm? -51.97 162.84 0.74 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 121.12 0.486 . . . . 1.46 111.429 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.468 ' HB3' HG23 ' A' ' 226' ' ' VAL . 78.5 Cg_exo -52.71 154.56 12.13 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.807 2.338 . . . . 0.5 111.889 166.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 64.91 15.48 9.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.688 0.756 . . . . 2.08 110.091 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 70.05 37.34 1.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.776 -1.102 . . . . 2.74 113.396 171.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.7 mm-40 -86.23 176.44 7.95 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.621 -1.251 . . . . 1.33 107.621 168.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -144.91 126.23 14.83 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.463 -0.895 . . . . 2.49 111.54 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.707 HG21 ' HB1' ' A' ' 184' ' ' ALA . 8.1 t -107.72 172.68 6.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.068 -1.424 . . . . 0.52 108.441 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 156' ' ' ILE . 2.4 t -142.97 129.04 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 121.014 0.435 . . . . 0.88 110.081 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.12 131.38 24.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.329 -0.851 . . . . 1.31 109.751 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 73.0 Cg_exo -51.75 140.13 47.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.102 1.868 . . . . 0.59 110.548 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.557 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -61.2 101.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 0.35 110.221 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 215' ' ' SER . 35.9 mmt180 -81.03 111.13 17.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.011 -0.995 . . . . 2.81 110.386 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 p -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.436 -0.347 . . . . 1.44 110.911 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.54 19.82 57.64 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.718 -0.953 . . . . 0.43 110.718 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 179' ' ' ASP . 46.8 t -129.53 132.12 66.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.952 -0.624 . . . . 0.97 110.137 -175.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.5 p -78.02 162.15 26.94 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.907 -0.405 . . . . 0.47 109.907 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.785 ' O ' HD12 ' A' ' 181' ' ' LEU . 5.9 m -52.09 -36.5 20.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.616 -0.883 . . . . 1.39 108.616 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 54.2 ttt180 -43.75 -58.84 2.5 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.807 -1.088 . . . . 3.53 112.729 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.556 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 14.1 t70 -71.61 -46.1 60.17 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 1.19 110.598 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.5 p -62.46 -57.25 11.89 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.946 -1.025 . . . . 1.34 110.887 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -90.16 0.0 57.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 118.889 -1.124 . . . . 1.08 112.486 -176.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 17.9 ptpt -67.95 -33.96 75.68 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 117.559 -1.656 . . . . 1.15 107.427 165.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 187' ' ' MET . 12.8 tptt -60.79 -43.67 97.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.161 -0.927 . . . . 1.8 108.921 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.707 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -48.05 -58.95 3.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.388 0.43 . . . . 0.3 111.432 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 181' ' ' LEU . 2.9 mm? -52.95 -51.3 61.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.338 -0.392 . . . . 1.46 110.463 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 16.4 mtt -67.99 -21.29 65.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.29 0.478 . . . . 1.45 112.29 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 19.3 mmt -77.54 -27.3 51.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.207 0.527 . . . . 0.85 109.622 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 188' ' ' ARG . 25.8 tpt180 -85.88 -19.73 30.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.522 -0.763 . . . . 2.12 109.929 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.06 14.88 29.86 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.744 -0.662 . . . . 0.53 111.756 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.45 ' HB2' HD12 ' A' ' 185' ' ' LEU . 12.9 mt -108.07 177.13 4.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.07 -0.344 . . . . 1.28 110.07 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 193' ' ' GLU . 43.8 pt -124.64 146.51 52.89 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 121.179 0.514 . . . . 0.52 111.022 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.467 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 96.6 Cg_endo -77.86 -12.37 16.37 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.275 2.65 . . . . 0.52 112.597 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.449 ' HB2' HD12 ' A' ' 191' ' ' ILE . 24.0 mt-10 -65.74 -26.62 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 1.74 110.819 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 20.0 t -114.43 19.34 16.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.317 -0.401 . . . . 1.69 110.779 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.456 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 96.4 m -125.99 157.62 37.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.719 -0.219 . . . . 0.52 110.887 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -128.13 154.42 45.76 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.39 109.966 174.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.534 HG23 ' CZ2' ' A' ' 210' ' ' TRP . 19.2 t -117.71 126.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.533 0.682 . . . . 1.06 111.536 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.734 ' CB ' ' HA ' ' A' ' 207' ' ' PRO . 54.9 p90 -154.71 150.86 28.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.087 -0.961 . . . . 2.49 109.073 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.435 ' CG ' HD11 ' A' ' 208' ' ' ILE . 13.3 ptm180 -115.09 131.36 56.95 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.531 -0.731 . . . . 1.57 111.507 -170.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.549 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 14.2 mm -84.88 122.79 38.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.728 0.775 . . . . 0.88 111.638 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.587 ' CD ' ' HE3' ' A' ' 206' ' ' LYS . 8.3 mt-30 -95.62 -153.05 0.38 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.154 -1.385 . . . . 2.41 108.517 173.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.411 ' H ' ' HB3' ' A' ' 201' ' ' GLN . 20.6 t70 -54.66 85.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.668 0.27 . . . . 1.91 111.623 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 62.16 7.87 15.24 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 116.247 -0.433 . . . . 1.12 113.18 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 200' ' ' ILE . 15.3 pt-20 -123.97 176.24 6.46 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 117.616 0.708 . . . . 1.54 111.039 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.616 ' HE3' ' CE1' ' A' ' 198' ' ' TYR . 12.8 mtpt -123.48 127.14 47.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.047 0.451 . . . . 1.69 110.792 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.587 ' HE3' ' CD ' ' A' ' 201' ' ' GLN . 70.6 mmtt -110.72 98.29 36.9 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 108.643 -0.873 . . . . 1.66 108.643 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.734 ' HA ' ' CB ' ' A' ' 198' ' ' TYR . 6.6 Cg_exo -72.25 117.73 5.28 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.844 1.696 . . . . 0.58 112.89 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.496 ' CD1' HD22 ' A' ' 222' ' ' LEU . 6.3 mt -91.02 152.04 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.241 -0.891 . . . . 0.9 110.36 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.11 146.82 18.9 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.492 -0.861 . . . . 0.37 111.58 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.712 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 69.0 m95 -70.15 -13.71 62.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.31 110.704 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -94.79 1.02 55.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.3 110.206 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 51.8 m -74.03 129.24 37.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.925 -0.579 . . . . 0.31 110.684 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.89 117.22 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.564 -0.532 . . . . 1.73 109.564 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.1 tt -66.75 -21.14 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.593 0.59 . . . . 0.29 112.593 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 172' ' ' ARG . 67.8 p -71.04 -6.85 42.2 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.28 -0.262 . . . . 1.07 111.646 -175.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -90.01 -10.6 44.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.461 0.648 . . . . 3.87 109.977 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 217' ' ' LEU . 6.3 mp -106.41 14.13 27.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.065 0.936 . . . . 1.21 110.291 -174.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.557 HG23 ' HB2' ' A' ' 171' ' ' ALA . 3.3 m -53.83 142.69 23.2 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.673 -1.603 . . . . 0.39 111.869 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 74.68 -3.21 44.27 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.026 -0.534 . . . . 0.53 112.387 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -104.96 171.2 7.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.602 -0.518 . . . . 2.16 109.602 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 43.1 mt-10 -121.18 125.88 48.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.744 0.783 . . . . 2.03 110.845 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.535 ' HB2' HG13 ' A' ' 159' ' ' VAL . 27.6 mt -101.14 166.07 10.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.44 -1.255 . . . . 1.19 109.325 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.81 119.8 10.68 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.802 0.811 . . . . 2.63 110.914 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 197' ' ' VAL . 88.8 t -101.46 134.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.97 110.923 -175.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.494 ' HG3' ' OH ' ' A' ' 198' ' ' TYR . 27.3 mm-40 -129.32 132.9 47.22 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 1.94 109.669 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 162' ' ' PRO . 92.4 t -67.0 130.38 32.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.12 110.718 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 196' ' ' ALA . 61.1 mt -83.96 81.85 8.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.377 0.608 . . . . 1.69 109.676 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -88.43 98.18 11.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.033 -0.985 . . . . 2.12 111.138 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -126.7 54.24 1.62 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.974 0.892 . . . . 4.42 109.156 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 7.9 t -78.49 120.9 82.75 Favored Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 114.393 -1.276 . . . . 5.77 110.366 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.06 83.58 0.26 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.674 2.249 . . . . 7.15 111.971 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.382 -0.818 . . . . 9.01 109.942 178.594 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.506 ' C1 ' ' HA ' ' A' ' 167' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.314 -0.254 . . . . 5.63 110.314 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.81 78.42 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.652 2.235 . . . . 3.38 111.531 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -78.57 136.58 37.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.5 . . . . 3.3 111.024 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -119.47 85.44 31.81 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 109.369 -0.604 . . . . 2.33 109.369 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.487 ' HB2' ' CG2' ' A' ' 218' ' ' THR . 39.0 Cg_endo -82.04 147.81 14.99 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.43 2.086 . . . . 0.43 112.056 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.525 ' HB ' HG12 ' A' ' 168' ' ' VAL . 1.9 pp -139.44 150.85 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.237 0.541 . . . . 0.79 111.697 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 220' ' ' GLU . 0.3 OUTLIER -131.42 132.92 62.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.405 -0.816 . . . . 1.05 108.928 175.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.613 ' HG2' HG13 ' A' ' 168' ' ' VAL . 36.0 mtm-85 -102.77 129.75 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.753 -0.658 . . . . 2.87 111.155 -168.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 167' ' ' THR . 25.9 t -112.13 122.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.267 -0.424 . . . . 0.42 111.828 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 223' ' ' HIS . 30.8 m-85 -74.71 103.53 5.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.023 -0.362 . . . . 0.58 110.023 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.523 HD21 ' HB ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -63.7 160.78 41.79 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.89 0.376 . . . . 1.46 110.379 173.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.797 ' HD3' HG22 ' A' ' 224' ' ' VAL . 82.1 Cg_exo -45.06 152.17 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.364 2.709 . . . . 0.5 112.316 167.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.1 m120 68.63 25.44 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 2.08 111.176 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 68.75 28.13 5.62 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.398 0.888 . . . . 2.74 113.398 171.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 1.7 mm-40 -89.7 169.48 11.26 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.392 -0.966 . . . . 1.33 108.392 173.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 33.4 ttp180 -146.68 135.07 21.88 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 120.264 -0.574 . . . . 2.49 110.155 175.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.62 HG21 ' CB ' ' A' ' 184' ' ' ALA . 2.1 t -109.73 174.4 5.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.866 -1.061 . . . . 0.52 108.845 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' A' ' 158' ' ' ARG . 2.9 t -138.97 127.19 27.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.823 -0.806 . . . . 0.88 108.823 168.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.444 HG23 HD11 ' A' ' 214' ' ' ILE . 11.0 m -119.8 137.08 25.27 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 115.661 -0.699 . . . . 1.31 109.598 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.64 142.77 59.89 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.912 1.742 . . . . 0.59 110.527 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 218' ' ' THR . . . -68.78 80.36 0.29 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.515 0.674 . . . . 0.35 109.196 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 175' ' ' VAL . 21.4 mmm180 -69.37 110.76 4.84 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.544 -1.207 . . . . 2.81 109.886 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.1 p -85.48 116.68 23.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.011 -0.54 . . . . 1.44 110.36 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.06 23.89 7.16 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.491 -0.861 . . . . 0.43 111.497 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 172' ' ' ARG . 3.4 p -143.35 156.45 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.217 0.532 . . . . 0.97 110.838 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.5 p -93.31 161.49 14.38 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.517 -0.765 . . . . 0.47 110.933 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.664 ' O ' HD12 ' A' ' 181' ' ' LEU . 16.0 t -48.86 -49.51 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 116.185 -0.461 . . . . 1.39 109.966 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 210' ' ' TRP . 3.6 ptm180 -48.7 -44.75 38.37 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 113.276 0.843 . . . . 3.53 113.276 -172.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.564 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 15.7 t70 -71.5 -50.55 30.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.602 0.715 . . . . 1.19 110.208 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.414 ' O ' HG11 ' A' ' 169' ' ' VAL . 2.9 m -62.1 -46.29 89.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.083 -0.962 . . . . 1.34 110.925 -175.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -95.43 -3.97 45.99 Favored 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 119.429 -0.908 . . . . 1.08 112.826 -175.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 18.9 ptpt -67.51 -35.34 78.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 118.098 -1.441 . . . . 1.15 107.294 167.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.102 -0.953 . . . . 1.8 109.563 170.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -49.9 -56.19 11.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.699 0.285 . . . . 0.3 111.026 172.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.428 ' CD2' HD22 ' A' ' 181' ' ' LEU . 3.3 mm? -56.3 -50.09 72.41 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.033 -0.531 . . . . 1.46 110.678 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 182' ' ' LYS . 50.6 mtt -70.1 -20.91 63.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.326 0.491 . . . . 1.45 112.326 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 19.1 mmt -75.32 -20.33 59.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.479 . . . . 0.85 109.878 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.416 ' HG2' ' HG3' ' A' ' 165' ' ' GLN . 11.5 tpt180 -97.9 -11.56 23.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.653 -0.703 . . . . 2.12 109.623 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.39 46.45 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.277 -0.874 . . . . 0.53 112.061 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.1 mt -104.74 175.78 5.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.79 0.328 . . . . 1.28 110.21 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -125.86 145.18 50.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.058 0.456 . . . . 0.52 110.694 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 182' ' ' LYS . 86.4 Cg_endo -76.27 -4.96 15.73 Favored 'Trans proline' 0 C--O 1.23 0.084 0 C-N-CA 123.239 2.626 . . . . 0.52 112.752 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.39 -45.35 76.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.572 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.72 29.75 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 1.69 110.091 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 74.1 m -135.25 150.54 50.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.52 110.229 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.55 ' O ' ' HB ' ' A' ' 224' ' ' VAL . . . -133.24 147.93 51.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 108.352 -0.981 . . . . 0.39 108.352 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.59 ' HA ' ' HB ' ' A' ' 224' ' ' VAL . 84.9 t -99.74 135.6 34.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.742 -0.783 . . . . 1.06 111.797 -170.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 223' ' ' HIS . 35.7 m-85 -135.05 166.74 22.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.575 -1.193 . . . . 2.49 110.959 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.642 ' HG3' HD11 ' A' ' 208' ' ' ILE . 48.3 mtp180 -130.3 124.05 31.46 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.993 -1.003 . . . . 1.57 109.055 164.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.607 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 21.0 mm -81.81 115.71 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 C-N-CA 119.405 -0.918 . . . . 0.88 110.123 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.517 ' HA ' ' NE2' ' A' ' 201' ' ' GLN . 0.6 OUTLIER -98.72 -145.69 0.32 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.176 -1.375 . . . . 2.41 108.739 179.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.54 79.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.7 0.625 . . . . 1.91 112.439 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.58 13.23 30.1 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.463 -0.399 . . . . 1.12 112.53 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.55 177.86 7.28 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.172 0.511 . . . . 1.54 111.055 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 45.8 mtpt -115.09 136.13 53.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.595 -0.729 . . . . 1.69 111.087 -175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -119.32 108.45 39.97 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.508 -0.769 . . . . 1.66 108.981 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.91 118.92 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.732 1.622 . . . . 0.58 111.994 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.642 HD11 ' HG3' ' A' ' 199' ' ' ARG . 5.1 mm -87.16 162.57 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.9 110.239 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.72 131.9 11.0 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.521 -0.763 . . . . 0.37 111.4 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.516 ' CZ2' HG23 ' A' ' 197' ' ' VAL . 51.9 m95 -67.5 -17.95 64.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 0.31 111.245 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -99.44 6.37 46.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.615 0.721 . . . . 2.3 110.045 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 177' ' ' VAL . 86.7 m -74.34 143.6 44.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.31 109.855 174.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.55 ' HB2' ' CE3' ' A' ' 216' ' ' TRP . 1.1 m-20 -70.5 115.11 9.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.904 0.383 . . . . 1.73 110.329 177.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.444 HD11 HG23 ' A' ' 169' ' ' VAL . 2.6 tt -64.6 -30.49 50.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.29 111.819 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 172' ' ' ARG . 30.3 t -66.18 -6.49 13.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.141 -0.481 . . . . 1.07 111.702 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 213' ' ' ASP . 31.6 m0 -90.95 -12.22 36.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.012 -0.43 . . . . 3.87 110.703 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.0 mt -102.01 9.6 40.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 1.21 110.387 -175.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.568 HG23 ' HB2' ' A' ' 171' ' ' ALA . 4.0 m -46.41 139.04 5.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.39 113.519 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.34 7.71 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.769 -0.65 . . . . 0.53 112.362 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 157' ' ' VAL . 47.7 mt-10 -93.44 168.69 10.89 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.607 -0.516 . . . . 2.16 109.607 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -117.63 124.05 47.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.081 0.944 . . . . 2.03 111.591 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.466 ' HB2' HG22 ' A' ' 159' ' ' VAL . 78.9 mt -96.14 160.83 14.24 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.038 -1.437 . . . . 1.19 108.975 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 160' ' ' PHE . 1.5 t60 -151.32 115.18 4.94 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.947 -0.76 . . . . 2.63 108.947 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.797 HG22 ' HD3' ' A' ' 162' ' ' PRO . 0.9 OUTLIER -102.19 153.68 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.686 0.755 . . . . 0.97 111.882 -177.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -113.43 172.78 6.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.199 -1.364 . . . . 1.94 108.654 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.9 123.4 50.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 120.911 0.386 . . . . 1.12 111.142 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 196' ' ' ALA . 82.9 mt -81.5 83.27 7.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.742 -0.663 . . . . 1.69 109.578 175.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.26 120.59 20.03 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.462 -0.79 . . . . 2.12 109.743 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -79.42 54.61 1.76 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.564 0.697 . . . . 4.42 110.991 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.513 ' HB ' ' HD3' ' A' ' 231' ' ' PRO . 7.0 t -67.12 -48.93 47.68 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.902 -1.045 . . . . 5.77 110.825 172.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.513 ' HD3' ' HB ' ' A' ' 230' ' ' VAL . 8.8 Cg_exo -71.53 106.73 2.01 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.715 1.61 . . . . 7.15 111.057 173.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.483 -0.77 . . . . 9.01 109.77 178.693 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.545 ' C11' ' O3 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_